Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CRBN | Q96SW2 | 5/20 | 0.38 |
| ▸ | DDB1 | Q16531 | 3/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL27623239 | 1.00 | MAPT (0.46) | MAPTALDH1A1HSD17B10CRBNDDB1 | |
| Alanine SCHEMBL6904183 | 0.85 | ALDH1A1 (0.36) | MAPTALDH1A1HSD17B10HTTTDP1 | |
| SCHEMBL1421444 | 0.81 | CRBN (0.41) | MAPTALDH1A1CRBNDDB1POLB | |
| SCHEMBL9864475 | 0.81 | MAPT (0.38) | MAPTALDH1A1HSD17B10CRBNDDB1 | |
| SCHEMBL9701179 | 0.80 | TDP2 (0.35) | MAPTALDH1A1HSD17B10KDM4ETDP1 | |
| SCHEMBL8899344 | 0.78 | KMT2A (0.41) | MAPTALDH1A1HSD17B10POLBMEN1 | |
| SCHEMBL22498758 | 0.73 | CRBN (0.35) | MAPTALDH1A1CRBNDDB1EPHX2 | |
| SCHEMBL9751662 | 0.73 | CRBN (0.35) | MAPTALDH1A1HSD17B10CRBNDDB1 | |
| SCHEMBL9751620 | 0.72 | CRBN (0.43) | MAPTALDH1A1HSD17B10CRBNDDB1 | |
| SCHEMBL8379436 | 0.70 | MEN1 (0.42) | MAPTALDH1A1HSD17B10CRBNDDB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2308 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4573372-A2 | DETERMINATION OF PROTEIN INFORMATION BY RECODING AMINO ACID POLYMERS INTO DNA POLYMERS | Abrus Bio, Inc. (US) | 2025-06-25 | — | — | EP | claimed |
| EP-4555134-A2 | DETERMINATION OF PROTEIN INFORMATION BY RECODING AMINO ACID POLYMERS INTO DNA POLYMERS | Abrus Bio, Inc. (US) | 2025-05-21 | — | — | EP | claimed |
| WO-2025064836-A2 | AMINO ACID BINDING AGENTS AND THEIR USES | GLYPHIC BIOTECHNOLOGIES, INC. (US) | 2025-03-27 | — | — | WO | claimed |
| US-12188940-B2 | Determination of protein information by recoding amino acid polymers into DNA polymers | ABRUS BIO, INC. (US) | 2025-01-07 | — | — | US | claimed |
| US-20240210410-A1 | DETERMINATION OF PROTEIN INFORMATION BY RECODING AMINO ACID POLYMERS INTO DNA POLYMERS | ABRUS BIO, INC. | 2024-06-27 | — | — | US | claimed |
| WO-2024040236-A2 | DETERMINATION OF PROTEIN INFORMATION BY RECODING AMINO ACID POLYMERS INTO DNA POLYMERS | ABRUS BIO, INC. (US) | 2024-02-22 | — | — | WO | claimed |
| WO-2024015875-A2 | DETERMINATION OF PROTEIN INFORMATION BY RECODING AMINO ACID POLYMERS INTO DNA POLYMERS | ABRUS BIO, INC. (US) | 2024-01-18 | — | — | WO | claimed |
| US-20120157658-A1 | METHODS, COMPOSITIONS, AND APPARATUSES FOR FORMING MACROCYCLIC COMPOUNDS | JOHNSON THOMAS E (US) | 2012-06-21 | — | — | US | claimed |
| US-20100216970-A1 | METHODS, COMPOSITIONS, AND APPARATUSES FOR FORMING MACROCYCLIC COMPOUNDS | JOHNSON THOMAS E | 2010-08-26 | — | — | US | claimed |
| EP-0549752-B1 | PROTEIN SEQUENCING | BECKMAN COULTER INC (US) | 1999-03-17 | — | — | EP | claimed |
| EP-0651883-B1 | PEPTIDES USEFUL AS INTERNAL STANDARDS FOR MICROSEQUENCING AND METHODS FOR THEIR USE | US HEALTH (US) | 1998-05-13 | — | — | EP | claimed |
| US-5270213-A | Protein sequencing | PORTON INSTRUMENTS, INC. (US) | 1993-12-14 | — | — | US | claimed |
| EP-0549752-A1 | PROTEIN SEQUENCING | BECKMAN INSTRUMENTS, INC. (US) | 1993-07-07 | — | — | EP | claimed |
| EP-0368920-B1 | LECTINES FIXING BETA-D-GALACTOSIDE | INCYTE PHARMACEUTICALS, INC. (US) | 1993-06-09 | — | — | EP | claimed |
| WO-1993000355-A1 | PROTEIN SEQUENCING | PORTON INSTRUMENTS, INC. (US) | 1993-01-07 | — | — | WO | claimed |
| US-5143851-A | METHOD FOR SEPARATING DIPHENYLUREA (DPU) AND PHENYLTHIOHYDANTOIN-TRYPTOPHAN (PTH-TRP) ALLOWING UNAMBIGUOUS IDENTIFICATION OF TRP IN AUTOMATIC SEQUENCE ANALYSIS | AMERICAN CYANAMID COMPANY (US) | 1992-09-01 | — | — | US | claimed |
| WO-1992000526-A1 | PEPTIDE SEQUENCING METHOD AND REAGENTS THEREFOR | GARIEPY KATHLEEN COX (US) | 1992-01-09 | — | — | WO | claimed |
| EP-0447746-A1 | A method for separating Diphenylurea(DPU) and phenylthiohydantoin-tryptophan (PTH-TRP) allowing unambiguous indentification of TRP in automatic sequence analysis | AMERICAN CYANAMID COMPANY (US) | 1991-09-25 | — | — | EP | claimed |
| US-5019348-A | Automated chemical conversion unit in a peptide/protein sequenator | BECKMAN INSTRUMENTS, INC. (US) | 1991-05-28 | — | — | US | claimed |
| JP-55036740-A | — | — | None | — | — | JP | disclosed |
| JP-6331620-A | — | — | None | — | — | JP | disclosed |
| JP-56125669-A | — | — | None | — | — | JP | disclosed |
| US-20260147001-A1 | PROTEIN SEQUENCING VIA COUPLING OF POLYMERIZABLE MOLECULES | GLYPHIC BIOTECHNOLOGIES, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| US-20260128128-A1 | SYSTEMS FOR ASSESSING AND IMPROVING THE QUALITY OF MULTIPLEX MOLECULAR ASSAYS | NAUTILUS SUBSIDIARY INC (US) | 2026-05-07 | — | — | US | disclosed |
| WO-2026090002-A1 | MIXTURE OF INTERFERON ALPHA 2B WITH MODIFIED SEQUENCES THEREOF | PHARMAESSENTIA CORPORATION (TW) | 2026-04-30 | — | — | WO | disclosed |
| WO-2026089995-A1 | MIXTURE OF INTERFERON ALPHA 2B WITH OTHER MODIFIED SEQUENCES THEREOF | PHARMAESSENTIA CORPORATION (TW) | 2026-04-30 | — | — | WO | disclosed |
| US-20260118364-A1 | PROTEIN SEQUENCING VIA COUPLING OF POLYMERIZABLE MOLECULES | GLYPHIC BIOTECHNOLOGIES INC (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4732011-A1 | COMPOSITIONS AND METHODS FOR IMPROVING AFFINITY REAGENT AVIDITY | Nautilus Subsidiary, Inc. (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-4281775-B1 | SYSTEMS AND METHODS FOR BIOMOLECULE PREPARATION | NAUTILUS SUBSIDIARY INC (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12613247-B2 | Labelling method to distinguish isobaric amino acids and amino acid combinations | RAPID NOVOR INC. (CA) | 2026-04-28 | — | — | US | disclosed |
| US-20260109749-A1 | Mixture Of Interferon Alpha 2B With Other Modified Sequences Thereof | PHARMAESSENTIA CORPORATION (TW) | 2026-04-23 | — | — | US | disclosed |
| US-20260109974-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE RETENTION | NAUTILUS SUBSIDIARY INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260109750-A1 | Mixture Of Interferon Alpha 2B With Modified Sequences Thereof | PHARMAESSENTIA CORPORATION (TW) | 2026-04-23 | — | — | US | disclosed |
| EP-4720641-A1 | SYSTEMS AND METHODS FOR MACHINE VISION | Nautilus Subsidiary, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| EP-4471790-B1 | SYSTEM AND METHOD FOR DETERMINING MICROBIOME FROM HOST METABOLOME USING A MACHINE LEARNING MODEL | MICROBIOTX HEALTH PRIVATE LTD (IN) | 2026-04-01 | — | — | EP | disclosed |
| EP-4711764-A2 | SYSTEMS AND METHODS FOR BIOMOLECULE QUANTITATION | Nautilus Subsidiary, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| US-12565671-B2 | Methods of combining the detection of biomolecules into a single assay using fluorescent in situ sequencing | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-03-03 | — | — | US | disclosed |
| US-20260049991-A1 | SINGLE-MOLECULE PEPTIDE SEQUENCING USING GUANIDINYLATING AGENTS | GLYPHIC BIOTECHNOLOGIES INC (US) | 2026-02-19 | — | — | US | disclosed |
| EP-4689173-A1 | IMPROVED TRANSFER OF NANOPARTICLES TO ARRAY SURFACES | Nautilus Subsidiary, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| US-12529049-B2 | Characterization and localization of protein modifications | NAUTILUS SUBSIDIARY, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| US-20260016480-A1 | SINGLE-MOLECULE PROTEIN AND PEPTIDE SEQUENCING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2026-01-15 | — | — | US | disclosed |
| US-20260009025-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE RETENTION | NAUTILUS SUBSIDIARY INC (US) | 2026-01-08 | — | — | US | disclosed |
| US-20250388895-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE RETENTION | NAUTILUS SUBSIDIARY INC (US) | 2025-12-25 | — | — | US | disclosed |
| US-12503694-B2 | Systems and methods for biomolecule retention | NAUTILUS SUBSIDIARY, INC. (US) | 2025-12-23 | — | — | US | disclosed |
| US-20250376716-A1 | METHOD FOR DETECTING ANALYTES AT SITES OF OPTICALLY NON-RESOLVABLE DISTANCES | NAUTILUS SUBSIDIARY INC (US) | 2025-12-11 | — | — | US | disclosed |
| US-12493042-B2 | Molecules and methods for iterative polypeptide analysis and processing | WASHINGTON UNIVERSITY (US) | 2025-12-09 | — | — | US | disclosed |
| EP-4655289-A1 | SINGLE-MOLECULE PEPTIDE SEQUENCING USING GUANIDINYLATING AGENTS | Glyphic Biotechnologies, Inc. (US) | 2025-12-03 | — | — | EP | disclosed |
| EP-4281774-B1 | BIOMOLECULE QUANTITATION | NAUTILUS SUBSIDIARY INC (US) | 2025-11-26 | — | — | EP | disclosed |
| US-20250349136-A1 | METHODS AND SYSTEMS FOR COMPUTATIONAL DECODING OF BIOLOGICAL, CHEMICAL, AND PHYSICAL ENTITIES | NAUTILUS SUBSIDIARY INC (US) | 2025-11-13 | — | — | US | disclosed |
| US-12467049-B2 | Methods and kits using nucleic acid encoding and/or label | DF PEPTIDE ACQUISITION LLC | 2025-11-11 | — | — | US | disclosed |
| US-20250327811-A1 | SINGLE-MOLECULE PEPTIDE SEQUENCING USING DITHIOESTER AND THIOCARBAMOYL AMINO ACID REACTIVE GROUPS | GLYPHIC BIOTECHNOLOGIES, INC. | 2025-10-23 | — | — | US | disclosed |
| EP-4634285-A1 | INHIBITION OF PHOTON PHENOMENA ON SINGLE MOLECULE ARRAYS | Nautilus Subsidiary, Inc. (US) | 2025-10-22 | — | — | EP | disclosed |
| EP-4630816-A1 | A METHOD COMPRISING PERFORMING ON A SINGLE-ANALYTE ARRAY AT LEAST 50 CYCLES OF A PROCESS | Nautilus Subsidiary, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| US-20250305034-A1 | NANOSTRUCTURES FOR MODULATION OF ANALYTE CONFORMATION | NAUTILUS SUBSIDIARY INC (US) | 2025-10-02 | — | — | US | disclosed |
| US-20250306018-A1 | METHODS FOR CHARACTERIZING INTERACTIONS BETWEEN ANALYTES | NAUTILUS SUBSIDIARY INC (US) | 2025-10-02 | — | — | US | disclosed |
| US-20250298016-A1 | PLASMONIC PARTICLE SYSTEMS FOR SINGLE-ANALYTE ASSAYS | NAUTILUS SUBSIDIARY, INC. | 2025-09-25 | — | — | US | disclosed |
| EP-4619761-A1 | SINGLE-MOLECULE PEPTIDE SEQUENCING USING DITHIOESTER AND THIOCARBAMOYL AMINO ACID REACTIVE GROUPS | Glyphic Biotechnologies, Inc. (US) | 2025-09-24 | — | — | EP | disclosed |
| US-12422438-B2 | Means and methods for single molecule peptide sequencing | VIB VZW (BE) | 2025-09-23 | — | — | US | disclosed |
| US-20250290064-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE RETENTION | NAUTILUS SUBSIDIARY, INC. | 2025-09-18 | — | — | US | disclosed |
| US-20250281565-A1 | PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH | MICROSINTESIS INC (CA) | 2025-09-11 | — | — | US | disclosed |
| US-20250269045-A1 | UNIQUE PEGYLATED GRANULOCYTE COLONY STIMULATING FACTOR, METHODS OF USE AND PREPARATION THEREOF | PHARMAESSENTIA CORPORATION (TW) | 2025-08-28 | — | — | US | disclosed |
| EP-4606389-A1 | UNIQUE PEGYLATED GRANULOCYTE COLONY STIMULATING FACTOR, METHODS OF USE AND PREPARATION THEREOF | PharmaEssentia Corporation (TW) | 2025-08-27 | — | — | EP | disclosed |
| US-12399181-B2 | Protein sequencing via coupling of polymerizable molecules | GLYPHIC BIOTECHNOLOGIES, INC. | 2025-08-26 | — | — | US | disclosed |
| US-12399180-B2 | Protein sequencing via coupling of polymerizable molecules | GLYPHIC BIOTECHNOLOGIES, INC. (US) | 2025-08-26 | — | — | US | disclosed |
| US-12394223-B2 | Methods and systems for computational decoding of biological, chemical, and physical entities | NAUTILUS SUBSIDIARY, INC. (US) | 2025-08-19 | — | — | US | disclosed |
| US-12379380-B2 | Single-molecule protein and peptide sequencing | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-08-05 | — | — | US | disclosed |
| US-20250222450-A1 | PREPARATION OF ARRAY SURFACES FOR SINGLE-ANALYTE PROCESSES | NAUTILUS SUBSIDIARY, INC. | 2025-07-10 | — | — | US | disclosed |
| WO-2025137166-A1 | FLUIDIC DEVICES FOR SINGLE-ANALYTE ASSAYS | NAUTILUS SUBSIDIARY, INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| US-20250205706-A1 | FLUIDIC DEVICES FOR SINGLE-ANALYTE ASSAYS | NAUTILUS SUBSIDIARY, INC. | 2025-06-26 | — | — | US | disclosed |
| WO-2025128588-A1 | METHODS AND COMPOSITIONS OF PARTICLE-BASED ARRAYS | NAUTILUS SUBSIDIARY, INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| US-20250189519-A1 | METHODS AND COMPOSITIONS OF PARTICLE-BASED ARRAYS | NAUTILUS SUBSIDIARY, INC. | 2025-06-12 | — | — | US | disclosed |
| US-20250188538-A1 | SINGLE-MOLECULE PEPTIDE SEQUENCING USING XANTHATE AMINO ACID REACTIVE GROUPS | GLYPHIC BIOTECHNOLOGIES, INC. | 2025-06-12 | — | — | US | disclosed |
| EP-4565882-A1 | PROTEIN SEQUENCING VIA COUPLING OF POLYMERIZABLE MOLECULES | Glyphic Biotechnologies, Inc. (US) | 2025-06-11 | — | — | EP | disclosed |
| US-20250180578-A1 | METHODS FOR IDENTIFYING MODIFICATIONS OF A POLYPEPTIDE | NAUTILUS SUBSIDIARY INC (US) | 2025-06-05 | — | — | US | disclosed |
| US-20250180577-A1 | PROTEIN SEQUENCING VIA COUPLING OF POLYMERIZABLE MOLECULES | GLYPHIC BIOTECHNOLOGIES, INC. | 2025-06-05 | — | — | US | disclosed |
| US-20250180576-A1 | PROTEIN SEQUENCING VIA COUPLING OF POLYMERIZABLE MOLECULES | GLYPHIC BIOTECHNOLOGIES, INC. | 2025-06-05 | — | — | US | disclosed |
| CN-120092180-A | Protein sequencing by polymerizable molecular coupling | 格里菲克生物技术公司 | 2025-06-03 | — | — | CN | disclosed |
| EP-3704249-B1 | KITS FOR ANALYSIS USING NUCLEIC ACID ENCODING AND/OR LABEL | ENCODIA INC (US) | 2025-05-21 | — | — | EP | disclosed |
| US-12305167-B2 | Systems and methods for biomolecule retention | NAUTILUS SUBSIDIARY, INC. (US) | 2025-05-20 | — | — | US | disclosed |
| US-20250155447-A1 | METHODS AND SYSTEMS FOR PROCESSING POLYMERIC ANALYTES | GLYPHIC BIOTECHNOLOGIES, INC. | 2025-05-15 | — | — | US | disclosed |
| US-12292446-B2 | Kits for analysis using nucleic acid encoding and/or label | Encodia, Inc. (US) | 2025-05-06 | — | — | US | disclosed |
| WO-2025043159-A9 | COMPOSITIONS AND METHODS FOR DETECTING BINDING INTERACTIONS UNDER EQUILIBRIUM OR NON-EQUILIBRIUM CONDITIONS | NAUTILUS SUBSIDIARY, INC. (US) | 2025-05-01 | — | — | WO | disclosed |
| EP-4544077-A1 | METHOD FOR DETECTING ANALYTES AT SITES OF OPTICALLY NON-RESOLVABLE DISTANCES | Nautilus Subsidiary, Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| US-20250102513-A1 | KITS FOR ANALYSIS USING NUCLEIC ACID ENCODING AND/OR LABEL | Encodia, Inc. (US) | 2025-03-27 | — | — | US | disclosed |
| WO-2025064836-A2 | AMINO ACID BINDING AGENTS AND THEIR USES | GLYPHIC BIOTECHNOLOGIES, INC. (US) | 2025-03-27 | — | — | WO | disclosed |
| US-12259393-B2 | Protein sequencing via coupling of polymerizable molecules | GLYPHIC BIOTECHNOLOGIES, INC. (US) | 2025-03-25 | — | — | US | disclosed |
| US-12259394-B2 | Protein sequencing via coupling of polymerizable molecules | GLYPHIC BIOTECHNOLOGIES, INC. (US) | 2025-03-25 | — | — | US | disclosed |
| WO-2025050045-A1 | IGM PROTEASES | CODEXIS, INC. (US) | 2025-03-06 | — | — | WO | disclosed |
| US-20250076303-A1 | MEANS AND METHODS FOR SINGLE MOLECULE PEPTIDE SEQUENCING | UNIVERSITEIT GENT (BE) | 2025-03-06 | — | — | US | disclosed |
| EP-4515026-A1 | SYSTEMS AND METHODS FOR ASSESSING AND IMPROVING THE QUALITY OF MULTIPLEX MOLECULAR ASSAYS | Nautilus Subsidiary, Inc. (US) | 2025-03-05 | — | — | EP | disclosed |
| WO-2025043159-A1 | COMPOSITIONS AND METHODS FOR DETECTING BINDING INTERACTIONS UNDER EQUILIBRIUM OR NON-EQUILIBRIUM CONDITIONS | NAUTILUS SUBSIDIARY, INC. (US) | 2025-02-27 | — | — | WO | disclosed |
| US-20250066841-A1 | COMPOSITIONS AND METHODS FOR DETECTING BINDING INTERACTIONS UNDER EQUILIBRIUM OR NON-EQUILIBRIUM CONDITIONS | NAUTILUS SUBSIDIARY, INC. | 2025-02-27 | — | — | US | disclosed |
| US-20250060371-A1 | KITS FOR ANALYSIS USING NUCLEIC ACID ENCODING AND/OR LABEL | Encodia, Inc. (US) | 2025-02-20 | — | — | US | disclosed |
| CN-119487208-A | Method and system for processing polymer analytes | 格里菲克生物技术公司 | 2025-02-18 | — | — | CN | disclosed |
| US-20250051756-A1 | METHODS AND KITS USING NUCLEIC ACID ENCODING AND/OR LABEL | DF PEPTIDE ACQUISITION LLC | 2025-02-13 | — | — | US | disclosed |
| EP-4504965-A1 | METHODS AND SYSTEMS FOR PROCESSING POLYMERIC ANALYTES | Glyphic Biotechnologies, Inc. (US) | 2025-02-12 | — | — | EP | disclosed |
| EP-4500157-A1 | INTEGRATED ARRAYS FOR SINGLE-ANALYTE PROCESSES | Nautilus Subsidiary, Inc. (US) | 2025-02-05 | — | — | EP | disclosed |
| US-20250035640-A1 | METHODS AND COMPOSITIONS FOR EDMAN-LIKE REACTIONS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2025-01-30 | — | — | US | disclosed |
| WO-2024263696-A1 | COMPOSITIONS AND METHODS FOR IMPROVING AFFINITY REAGENT AVIDITY | NAUTILUS SUBSIDIARY, INC. (US) | 2024-12-26 | — | — | WO | disclosed |
| US-20240426839-A1 | COMPOSITIONS AND METHODS FOR IMPROVING AFFINITY REAGENT AVIDITY | NAUTILUS SUBSIDIARY, INC. | 2024-12-26 | — | — | US | disclosed |
| US-20240409995-A1 | SINGLE-MOLECULE PEPTIDE SEQUENCING THROUGH MOLECULAR BARCODING AND EX-SITU ANALYSIS | GLYPHIC BIOTECHNOLOGIES, INC. | 2024-12-12 | — | — | US | disclosed |
| US-20240402186-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE QUANTITATION | NAUTILUS SUBSIDIARY INC (US) | 2024-12-05 | — | — | US | disclosed |
| US-20240404637-A1 | SYSTEM AND METHOD FOR DETERMINING MICROBIOME FROM HOST METABOLOME USING A MACHINE LEARNING MODEL | MICROBIOTX HEALTH PRIVATE LIMITED (IN) | 2024-12-05 | — | — | US | disclosed |
| EP-4471790-A1 | SYSTEM AND METHOD FOR DETERMINING MICROBIOME FROM HOST METABOLOME USING A MACHINE LEARNING MODEL | MicrobioTx Health Private Limited (IN) | 2024-12-04 | — | — | EP | disclosed |
| US-20240394902-A1 | SYSTEMS AND METHODS FOR MACHINE VISION | NAUTILUS SUBSIDIARY, INC. | 2024-11-28 | — | — | US | disclosed |
| WO-2024243237-A1 | SYSTEMS AND METHODS FOR MACHINE VISION | NAUTILUS SUBSIDIARY, INC. (US) | 2024-11-28 | — | — | WO | disclosed |
| US-20240377409-A1 | KITS FOR ANALYSIS USING NUCLEIC ACID ENCODING AND/OR LABEL | DF PEPTIDE ACQUISITION LLC | 2024-11-14 | — | — | US | disclosed |
| US-20240368585-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE RETENTION | NAUTILUS SUBSIDIARY, INC. | 2024-11-07 | — | — | US | disclosed |
| US-20240369486-A1 | INTEGRATED ARRAYS FOR SINGLE-ANALYTE PROCESSES | NAUTILUS SUBSIDIARY, INC. | 2024-11-07 | — | — | US | disclosed |
| US-12130291-B2 | Kits for analysis using nucleic acid encoding and/or label | Encodia, Inc. (US) | 2024-10-29 | — | — | US | disclosed |
| US-12129463-B2 | Methods and kits using nucleic acid encoding and/or label | Encodia, Inc. (US) | 2024-10-29 | — | — | US | disclosed |
| EP-4449128-A2 | SINGLE-MOLECULE PEPTIDE SEQUENCING THROUGH MOLECULAR BARCODING AND EX-SITU ANALYSIS | Glyphic Biotechnologies, Inc. (US) | 2024-10-23 | — | — | EP | disclosed |
| US-20240342069-A1 | Composition Comprising Fatty Acid Amidoalkyl Betaine and Carboxymethylated Derivative of a Dimethylaminoalkylamine | KENSING, LLC | 2024-10-17 | — | — | US | disclosed |
| US-20240344116-A1 | TRANSFER OF NANOPARTICLES TO ARRAY SURFACES | NAUTILUS SUBSIDIARY, INC. | 2024-10-17 | — | — | US | disclosed |
| US-20240337660-A1 | PROTEIN SEQUENCING VIA COUPLING OF POLYMERIZABLE MOLECULES | GLYPHIC BIOTECHNOLOGIES, INC. | 2024-10-10 | — | — | US | disclosed |
| US-20240337661-A1 | PROTEIN SEQUENCING VIA COUPLING OF POLYMERIZABLE MOLECULES | GLYPHIC BIOTECHNOLOGIES, INC. | 2024-10-10 | — | — | US | disclosed |
| WO-2024206122-A1 | IMPROVED TRANSFER OF NANOPARTICLES TO ARRAY SURFACES | NAUTILUS SUBSIDIARY, INC. (US) | 2024-10-03 | — | — | WO | disclosed |
| CN-118679389-A | Single molecule peptide sequencing by molecular barcoding and ex situ analysis | 格里菲克生物技术公司 | 2024-09-20 | — | — | CN | disclosed |
| US-12092642-B2 | Systems and methods for biomolecule quantitation | NAUTILUS SUBSIDIARY, INC. (US) | 2024-09-17 | — | — | US | disclosed |
| US-12092578-B2 | Integrated arrays for single-analyte processes | NAUTILUS SUBSIDIARY, INC. (US) | 2024-09-17 | — | — | US | disclosed |
| EP-4428536-A2 | METHODS OF COMBINING THE DETECTION OF BIOMOLECULES INTO A SINGLE ASSAY USING FLUORESCENT IN SITU SEQUENCING | President and Fellows of Harvard College (US) | 2024-09-11 | — | — | EP | disclosed |
| US-12071618-B2 | Systems and methods for biomolecule retention | NAUTILUS SUBSIDIARY, INC. (US) | 2024-08-27 | — | — | US | disclosed |
| US-20240280581-A1 | SINGLE-MOLECULE PROTEIN AND PEPTIDE SEQUENCING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2024-08-22 | — | — | US | disclosed |
| US-20240262902-A1 | COMPOUNDS AND METHODS FOR TREATING PAIN | MEDIMMUNE LIMITED (GB) | 2024-08-08 | — | — | US | disclosed |
| WO-2024159162-A1 | SINGLE-MOLECULE PEPTIDE SEQUENCING USING GUANIDINYLATING AGENTS | GLYPHIC BIOTECHNOLOGIES, INC. (US) | 2024-08-02 | — | — | WO | disclosed |
| CN-117925765-B | Biological processing method of food sea cucumber | 威海海洋职业学院 | 2024-08-02 | — | — | CN | disclosed |
| EP-4405683-A1 | METHODS AND SYSTEMS FOR DETERMINING POLYPEPTIDE INTERACTIONS | Nautilus Subsidiary, Inc. (US) | 2024-07-31 | — | — | EP | disclosed |
| US-20240249539-A1 | METHODS AND SYSTEMS FOR COMPUTATIONAL DECODING OF BIOLOGICAL, CHEMICAL, AND PHYSICAL ENTITIES | NAUTILUS SUBSIDIARY, INC. | 2024-07-25 | — | — | US | disclosed |
| EP-4399528-A1 | CHARACTERIZATION AND LOCALIZATION OF PROTEIN MODIFICATIONS | Nautilus Subsidiary, Inc. (US) | 2024-07-17 | — | — | EP | disclosed |
| US-20240229019-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE RETENTION | NAUTILUS SUBSIDIARY, INC. | 2024-07-11 | — | — | US | disclosed |
| EP-4395736-A1 | COMPOSITION COMPRISING FATTY ACID AMIDOALKYL BETAINE AND CARBOXYMETHYLATED DERIVATIVE OF A DIMETHYLAMINOALKYLAMINE | Evonik Operations GmbH (DE) | 2024-07-10 | — | — | EP | disclosed |
| CN-118259020-A | Methods, binders and ClickP compounds for treating and identifying terminal amino acids of peptides | 麻省理工学院 | 2024-06-28 | — | — | CN | disclosed |
| EP-4387979-A1 | SINGLE-MOLECULE PROTEIN AND PEPTIDE SEQUENCING | Massachusetts Institute of Technology (US) | 2024-06-26 | — | — | EP | disclosed |
| US-12019076-B2 | Means and methods for single molecule peptide sequencing | VIB VZW (BE) | 2024-06-25 | — | — | US | disclosed |
| US-20240197744-A1 | TREATING SEX STEROID DEPENDENT CANCER WITH BMX INHIBITORS | CLEVELAND CLINIC FOUNDATION | 2024-06-20 | — | — | US | disclosed |
| US-20240200058-A1 | METHODS AND APPRATUS FOR PROTEIN AND PEPTIDE SEQUENCING | LI SHIFENG (US) | 2024-06-20 | — | — | US | disclosed |
| WO-2024130000-A1 | INHIBITION OF PHOTON PHENOMENA ON SINGLE MOLECULE ARRAYS | NAUTILUS SUBSIDIARY, INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| US-20240201199-A1 | MOLECULES AND METHODS FOR ITERATIVE POLYPEPTIDE ANALYSIS AND PROCESSING | WASHINGTON UNIVERSITY (US) | 2024-06-20 | — | — | US | disclosed |
| US-20240201182-A1 | INHIBITION OF PHOTON PHENOMENA ON SINGLE MOLECULE ARRAYS | NAUTILUS SUBSIDIARY, INC. | 2024-06-20 | — | — | US | disclosed |
| US-20240192202-A1 | FLUIDIC MEDIA FOR SINGLE-ANALTYE ARRAYS | NAUTILUS SUBSIDIARY INC (US) | 2024-06-13 | — | — | US | disclosed |
| WO-2024123807-A1 | METHODS AND APPARATUS FOR PROTEIN AND PEPTIDE SEQUENCING | LI SHIFENG (US) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024124073-A1 | A METHOD COMPRISING PERFORMING ON A SINGLE-ANALYTE ARRAY AT LEAST 50 CYCLES OF A PROCESS | NAUTILUS SUBSIDIARY, INC. (US) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024107755-A1 | SINGLE-MOLECULE PEPTIDE SEQUENCING USING DITHIOESTER AND THIOCARBAMOYL AMINO ACID REACTIVE GROUPS | GLYPHIC BIOTECHNOLOGIES, INC. (US) | 2024-05-23 | — | — | WO | disclosed |
| CN-113474651-B | Single molecule protein and peptide sequencing | 麻省理工学院 | 2024-05-17 | — | — | CN | disclosed |
| US-20240158786-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE RETENTION | NAUTILUS SUBSIDIARY, INC. | 2024-05-16 | — | — | US | disclosed |
| CN-117980319-A | Single molecule protein and peptide sequencing | 麻省理工学院 | 2024-05-03 | — | — | CN | disclosed |
| EP-4360097-A1 | METHODS AND SYSTEMS FOR ASSAY REFINEMENT | Nautilus Subsidiary, Inc. (US) | 2024-05-01 | — | — | EP | disclosed |
| US-11971417-B2 | Single-molecule protein and peptide sequencing | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-04-30 | — | — | US | disclosed |
| CN-117919447-A | PH and thermal response type iron nano-glue and preparation method and application thereof | 中国药科大学 | 2024-04-26 | — | — | CN | disclosed |
| CN-117925765-A | Biological processing method of food sea cucumber | 山东助邦生物科技有限公司 | 2024-04-26 | — | — | CN | disclosed |
| WO-2023196642-A9 | METHODS AND SYSTEMS FOR PROCESSING POLYMERIC ANALYTES | GLYPHIC BIOTECHNOLOGIES, INC. (US) | 2024-04-25 | — | — | WO | disclosed |
| CN-117881388-A | Composition comprising carboxymethylated derivatives of fatty acid amidoalkyl betaines and dimethylaminoalkylamines | 赢创运营有限公司 | 2024-04-12 | — | — | CN | disclosed |
| CN-115947864-B | Fusion protein, growth hormone and preparation method thereof | 君合盟生物制药(杭州)有限公司 | 2024-04-09 | — | — | CN | disclosed |
| WO-2024073599-A1 | PREPARATION OF ARRAY SURFACES FOR SINGLE-ANALYTE PROCESSES | NAUTILUS SUBSIDIARY, INC. (US) | 2024-04-04 | — | — | WO | disclosed |
| US-11935311-B2 | Methods and systems for computational decoding of biological, chemical, and physical entities | NAUTILUS SUBSIDIARY, INC. (US) | 2024-03-19 | — | — | US | disclosed |
| US-11912990-B2 | Systems and methods for biomolecule retention | NAUTILUS SUBSIDIARY, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| EP-3899532-B1 | A LABELLING METHOD TO DISTINGUISH ISOBARIC AMINO ACIDS AND AMINO ACID COMBINATIONS | RAPID NOVOR INC (CA) | 2024-02-14 | — | — | EP | disclosed |
| US-11897949-B2 | Compounds and methods for treating pain | MEDIMMUNE LIMITED (GB) | 2024-02-13 | — | — | US | disclosed |
| WO-2024030919-A1 | PROTEIN SEQUENCING VIA COUPLING OF POLYMERIZABLE MOLECULES | GLYPHIC BIOTECHNOLOGIES, INC. (US) | 2024-02-08 | — | — | WO | disclosed |
| US-20240026036-A1 | COMPOUNDS AND METHODS FOR TREATING PAIN | MEDIMMUNE LTD (GB) | 2024-01-25 | — | — | US | disclosed |
| EP-4305419-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE RETENTION | Nautilus Subsidiary, Inc. (US) | 2024-01-17 | — | — | EP | disclosed |
| US-20240009172-A1 | COMPOSTIONS AND METHODS FOR TREATING PROSTATE CANCER | OREGON HEALTH & SCIENCE UNIVERSITY | 2024-01-11 | — | — | US | disclosed |
| US-11857581-B2 | Antiviral methods and compositions comprising probiotic bacterial molecules | MICROSINTESIS INC. (CA) | 2024-01-02 | — | — | US | disclosed |
| WO-2023250364-A1 | METHOD FOR DETECTING ANALYTES AT SITES OF OPTICALLY NON-RESOLVABLE DISTANCES | NAUTILUS SUBSIDIARY, INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| US-20230407294-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE RETENTION | NAUTILUS SUBSIDIARY, INC. | 2023-12-21 | — | — | US | disclosed |
| WO-2023232799-A1 | DEVICE FOR NEAR-FIELD MOLECULE DETECTION | OXFORD NANOIMAGING LTD. (GB) | 2023-12-07 | — | — | WO | disclosed |
| EP-4281775-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE PREPARATION | Nautilus Subsidiary, Inc. (US) | 2023-11-29 | — | — | EP | disclosed |
| EP-4281774-A2 | METHODS FOR BIOMOLECULE QUANTITATION | Nautilus Subsidiary, Inc. (US) | 2023-11-29 | — | — | EP | disclosed |
| US-20230360732-A1 | SYSTEMS AND METHODS FOR ASSESSING AND IMPROVING THE QUALITY OF MULTIPLEX MOLECULAR ASSAYS | NAUTILUS SUBSIDIARY, INC. | 2023-11-09 | — | — | US | disclosed |
| WO-2023212490-A1 | SYSTEMS AND METHODS FOR ASSESSING AND IMPROVING THE QUALITY OF MULTIPLEX MOLECULAR ASSAYS | NAUTILUS SUBSIDIARY, INC. (US) | 2023-11-02 | — | — | WO | disclosed |
| US-20230340458-A1 | METHODS AND KITS USING NUCLEIC ACID ENCODING AND/OR LABEL | Encodia, Inc. (US) | 2023-10-26 | — | — | US | disclosed |
| US-11787877-B2 | Antibody with non-natural amino acid introduced therein | RIKEN (JP) | 2023-10-17 | — | — | US | disclosed |
| WO-2023196642-A1 | METHODS AND SYSTEMS FOR PROCESSING POLYMERIC ANALYTES | GLYPHIC BIOTECHNOLOGIES, INC. (US) | 2023-10-12 | — | — | WO | disclosed |
| US-11782062-B2 | Kits for analysis using nucleic acid encoding and/or label | Encodia, Inc. (US) | 2023-10-10 | — | — | US | disclosed |
| US-20230314324-A1 | INTEGRATED ARRAYS FOR SINGLE-ANALYTE PROCESSES | NAUTILUS SUBSIDIARY, INC. | 2023-10-05 | — | — | US | disclosed |
| WO-2023192917-A1 | INTEGRATED ARRAYS FOR SINGLE-ANALYTE PROCESSES | NAUTILUS SUBSIDIARY, INC. (US) | 2023-10-05 | — | — | WO | disclosed |
| US-20230305017-A1 | SINGLE-MOLECULE PROTEIN AND PEPTIDE SEQUENCING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2023-09-28 | — | — | US | disclosed |
| US-11760997-B2 | Systems and methods for biomolecule retention | NAUTILUS SUBSIDIARY, INC. (US) | 2023-09-19 | — | — | US | disclosed |
| US-20230287480-A1 | ANALYTE DETECTION SYSTEMS AND METHODS OF USE | NAUTILUS BIOTECHNOLOGY, INC. | 2023-09-14 | — | — | US | disclosed |
| US-11746364-B2 | Enzymatic synthesis of kavalactones and flavokavains | WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) | 2023-09-05 | — | — | US | disclosed |
| US-11739354-B2 | Enzymatic synthesis of kavalactones and flavokavains | WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) | 2023-08-29 | — | — | US | disclosed |
| EP-4231174-A2 | METHODS AND SYSTEMS FOR COMPUTATIONAL DECODING OF BIOLOGICAL, CHEMICAL, AND PHYSICAL ENTITIES | Nautilus Subsidiary, Inc. (US) | 2023-08-23 | — | — | EP | disclosed |
| EP-4217388-A1 | COMPOUNDS AND METHODS FOR TREATING PAIN | MedImmune Limited (GB) | 2023-08-02 | — | — | EP | disclosed |
| US-20230236198-A1 | KITS FOR ANALYSIS USING NUCLEIC ACID ENCODING AND/OR LABEL | Encodia, Inc. (US) | 2023-07-27 | — | — | US | disclosed |
| US-20230226139-A1 | PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH | MICROSINTESIS INC. (CA) | 2023-07-20 | — | — | US | disclosed |
| WO-2023135485-A1 | PROSTATE CANCER MARKERS AND USES THEREOF | OSLO UNIVERSITETSSYKEHUS HF (NO) | 2023-07-20 | — | — | WO | disclosed |
| US-20230221329-A1 | MEANS AND METHODS FOR SINGLE MOLECULE PEPTIDE SEQUENCING | VIB VZW (BE) | 2023-07-13 | — | — | US | disclosed |
| US-20230212322-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE PREPARATION | NAUTILUS SUBSIDIARY, INC. | 2023-07-06 | — | — | US | disclosed |
| WO-2023114732-A2 | SINGLE-MOLECULE PEPTIDE SEQUENCING THROUGH MOLECULAR BARCODING AND EX-SITU ANALYSIS | GLYPHIC BIOTECHNOLOGIES, INC. (US) | 2023-06-22 | — | — | WO | disclosed |
| US-20230168254-A1 | KITS FOR ANALYSIS USING NUCLEIC ACID ENCODING AND/OR LABEL | Encodia, Inc. (US) | 2023-06-01 | — | — | US | disclosed |
| WO-2023085342-A1 | MODIFIED FORM OF SAPB PROTEIN, METHOD FOR PREPARING SAPB PROTEIN AND MODIFIED FORM THEREOF, AND AQUEOUS SOLUTION IN WHICH SAPB PROTEIN OR MODIFIED FORM THEREOF IS DISSOLVED | 長瀬産業株式会社 | 2023-05-19 | — | — | WO | disclosed |
| US-20230149883-A1 | SYSTEMS AND METHODS FOR SURFACE STRUCTURING | NAUTILUS SUBSIDIARY, INC. | 2023-05-18 | — | — | US | disclosed |
| WO-2023081728-A1 | SYSTEMS AND METHODS FOR SURFACE STRUCTURING | NAUTILUS BIOTECHNOLOGY, INC. (US) | 2023-05-11 | — | — | WO | disclosed |
| US-20230146821-A1 | Methods of Combining the Detection of Biomolecules Into a Single Assay Using Fluorescent In Situ Sequencing | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2023-05-11 | — | — | US | disclosed |
| CN-108473542-B | Genetically modified yeast cells and improved methods for producing clot-specific streptokinase | 科学与工业研究委员会 | 2023-05-09 | — | — | CN | disclosed |
| EP-4165549-A1 | METHODS AND SYSTEMS FOR COMPUTATIONAL DECODING OF BIOLOGICAL, CHEMICAL, AND PHYSICAL ENTITIES | Nautilus Biotechnology, Inc. (US) | 2023-04-19 | — | — | EP | disclosed |
| US-20230112919-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE RETENTION | NAUTILUS SUBSIDIARY, INC. | 2023-04-13 | — | — | US | disclosed |
| CN-115947864-A | Fusion protein, growth hormone and preparation method thereof | 君合盟生物制药(杭州)有限公司 | 2023-04-11 | — | — | CN | disclosed |
| US-20230104998-A1 | SINGLE-MOLECULE PROTEIN AND PEPTIDE SEQUENCING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-04-06 | — | — | US | disclosed |
| US-20230107647-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-04-06 | — | — | US | disclosed |
| WO-2023049073-A1 | METHODS AND SYSTEMS FOR DETERMINING POLYPEPTIDE INTERACTIONS | NAUTILUS BIOTECHNOLOGY, INC. (US) | 2023-03-30 | — | — | WO | disclosed |
| WO-2023049177-A1 | SINGLE-MOLECULE PROTEIN AND PEPTIDE SEQUENCING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-03-30 | — | — | WO | disclosed |
| EP-4154943-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INTELLECTUAL DISABILITIES | Mitz, Howard (US) | 2023-03-29 | — | — | EP | disclosed |
| US-20230090454-A1 | METHODS AND SYSTEMS FOR DETERMINING POLYPEPTIDE INTERACTIONS | NAUTILUS SUBSIDIARY, INC. | 2023-03-23 | — | — | US | disclosed |
| WO-2023038859-A1 | CHARACTERIZATION AND LOCALIZATION OF PROTEIN MODIFICATIONS | NAUTILUS BIOTECHNOLOGY, INC. (US) | 2023-03-16 | — | — | WO | disclosed |
| US-20230070896-A1 | CHARACTERIZATION AND LOCALIZATION OF PROTEIN MODIFICATIONS | NAUTILUS BIOTECHNOLOGY, INC. | 2023-03-09 | — | — | US | disclosed |
| WO-2023030699-A1 | COMPOSITION COMPRISING FATTY ACID AMIDOALKYL BETAINE AND CARBOXYMETHYLATED DERIVATIVE OF A DIMETHYLAMINOALKYLAMINE | EVONIK OPERATIONS GMBH (DE) | 2023-03-09 | — | — | WO | disclosed |
| WO-2023021330-A1 | COMPOSITIONS AND METHODS FOR DETERMINING A TREATMENT COURSE OF ACTION | UNIVERSITY OF OSLO (NO) | 2023-02-23 | — | — | WO | disclosed |
| US-20230048421-A1 | AUTOMATED SCREENING OF ENZYME VARIANTS | CODEXIS, INC. (US) | 2023-02-16 | — | — | US | disclosed |
| WO-2023019163-A1 | METHODS AND COMPOSITIONS FOR EDMAN-LIKE REACTIONS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-02-16 | — | — | WO | disclosed |
| US-11573238-B2 | Means and methods for single molecule peptide sequencing | VIB VZW (BE) | 2023-02-07 | — | — | US | disclosed |
| WO-2022271983-A1 | METHODS AND SYSTEMS FOR ASSAY REFINEMENT | NAUTILUS BIOTECHNOLOGY, INC. (US) | 2022-12-29 | — | — | WO | disclosed |
| US-20220412998-A1 | METHODS AND SYSTEMS FOR ASSAY REFINEMENT | NAUTILUS SUBSIDIARY, INC. | 2022-12-29 | — | — | US | disclosed |
| US-11535845-B2 | Automated screening of enzyme variants | CODEXIS, INC. (US) | 2022-12-27 | — | — | US | disclosed |
| US-11513126-B2 | Kits for analysis using nucleic acid encoding and/or label | Encodia, Inc. (US) | 2022-11-29 | — | — | US | disclosed |
| US-11505796-B2 | Systems and methods for biomolecule retention | NAUTILUS BIOTECHNOLOGY, INC. (US) | 2022-11-22 | — | — | US | disclosed |
| US-11499979-B2 | Single-molecule protein and peptide sequencing | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2022-11-15 | — | — | US | disclosed |
| EP-3359256-B1 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INTELLECTUAL DISABILITIES | MITZ HOWARD (US) | 2022-10-05 | — | — | EP | disclosed |
| US-11447807-B2 | Methods of combining the detection of biomolecules into a single assay using fluorescent in situ sequencing | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-09-20 | — | — | US | disclosed |
| US-20220290218-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE RETENTION | NAUTILUS SUBSIDIARY, INC. | 2022-09-15 | — | — | US | disclosed |
| US-20220290130-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE RETENTION | NAUTILUS SUBSIDIARY, INC. | 2022-09-15 | — | — | US | disclosed |
| WO-2022192591-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE RETENTION | NAUTILUS BIOTECHNOLOGY, INC. (US) | 2022-09-15 | — | — | WO | disclosed |
| WO-2022159520-A2 | SYSTEMS AND METHODS FOR BIOMOLECULE QUANTITATION | NAUTILUS BIOTECHNOLOGY, INC. (US) | 2022-07-28 | — | — | WO | disclosed |
| US-20220236282-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE QUANTITATION | NAUTILUS SUBSIDIARY, INC. | 2022-07-28 | — | — | US | disclosed |
| WO-2022159663-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE PREPARATION | NAUTILUS BIOTECHNOLOGY, INC. (US) | 2022-07-28 | — | — | WO | disclosed |
| CN-114793437-A | Methods and reagents for cleaving an N-terminal amino acid from a polypeptide | ENCODIA 公司 | 2022-07-26 | — | — | CN | disclosed |
| US-20220227890-A1 | SYSTEMS AND METHODS FOR BIOMOLECULE PREPARATION | NAUTILUS SUBSIDIARY, INC. | 2022-07-21 | — | — | US | disclosed |
| US-20220227889-A1 | METHODS AND REAGENTS FOR CLEAVAGE OF THE N-TERMINAL AMINO ACID FROM A POLYPEPTIDE | Encodia, Inc. (US) | 2022-07-21 | — | — | US | disclosed |
| US-20220221467-A1 | SYSTEMS AND METHODS FOR MS1-BASED MASS IDENTIFICATION INCLUDING SUPER-RESOLUTION TECHNIQUES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-07-14 | — | — | US | disclosed |
| US-20220214354-A1 | MEANS AND METHODS FOR SINGLE MOLECULE PEPTIDE SEQUENCING | VIB VZW (BE) | 2022-07-07 | — | — | US | disclosed |
| EP-4019529-A1 | PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH | MicroSintesis Inc. (CA) | 2022-06-29 | — | — | EP | disclosed |
| US-20220163536-A1 | IDENTIFYING PEPTIDES AT THE SINGLE MOLECULE LEVEL | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2022-05-26 | — | — | US | disclosed |
| US-11342046-B2 | Methods and systems for engineering biomolecules | CODEXIS, INC. (US) | 2022-05-24 | — | — | US | disclosed |
| US-20220127754-A1 | METHODS AND COMPOSITIONS OF ACCELERATING REACTIONS FOR POLYPEPTIDE ANALYSIS AND RELATED USES | Encodia, Inc. (US) | 2022-04-28 | — | — | US | disclosed |
| WO-2022064043-A1 | COMPOUNDS AND METHODS FOR TREATING PAIN | MEDIMMUNE LIMITED (GB) | 2022-03-31 | — | — | WO | disclosed |
| EP-3948297-A1 | MEANS AND METHODS FOR SINGLE MOLECULE PEPTIDE SEQUENCING | VIB VZW (BE) | 2022-02-09 | — | — | EP | disclosed |
| US-20220026438-A1 | A LABELLING METHOD TO DISTINGUISH ISOBARIC AMINO ACIDS AND AMINO ACID COMBINATIONS | RAPID NOVOR INC. (CA) | 2022-01-27 | — | — | US | disclosed |
| US-20220002769-A1 | ENZYMATIC SYNTHESIS OF KAVALACTONES AND FLAVOKAVAINS | WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) | 2022-01-06 | — | — | US | disclosed |
| US-20220002768-A1 | ENZYMATIC SYNTHESIS OF KAVALACTONES AND FLAVOKAVAINS | WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) | 2022-01-06 | — | — | US | disclosed |
| US-20210390705-A1 | METHODS AND SYSTEMS FOR COMPUTATIONAL DECODING OF BIOLOGICAL, CHEMICAL, AND PHYSICAL ENTITIES | NAUTILUS SUBSIDIARY, INC. | 2021-12-16 | — | — | US | disclosed |
| WO-2021252800-A1 | METHODS AND SYSTEMS FOR COMPUTATIONAL DECODING OF BIOLOGICAL, CHEMICAL, AND PHYSICAL ENTITIES | NAUTILUS BIOTECHNOLOGY, INC. (US) | 2021-12-16 | — | — | WO | disclosed |
| EP-2307444-B1 | ANALYSIS OF LACTOBACILLUS ACIDOPHILUS LA-5 SIGNAL INTERFERENCE MOLECULES | UNIV GUELPH (CA) | 2021-12-08 | — | — | EP | disclosed |
| EP-3914706-A1 | METHODS AND COMPOSITIONS OF ACCELERATING REACTIONS FOR POLYPEPTIDE ANALYSIS AND RELATED USES | Encodia, Inc. (US) | 2021-12-01 | — | — | EP | disclosed |
| US-20210355483-A1 | METHODS AND KITS USING NUCLEIC ACID ENCODING AND/OR LABEL | Encodia, Inc. (US) | 2021-11-18 | — | — | US | disclosed |
| EP-3908835-A1 | SINGLE-MOLECULE PROTEIN AND PEPTIDE SEQUENCING | Massachusetts Institute of Technology (US) | 2021-11-17 | — | — | EP | disclosed |
| US-20210347871-A1 | COMPOUNDS AND METHODS FOR TREATING PAIN | MEDIMMUNE LIMITED (GB) | 2021-11-11 | — | — | US | disclosed |
| US-11162952-B2 | Single molecule peptide sequencing | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-11-02 | — | — | US | disclosed |
| EP-3899532-A1 | A LABELLING METHOD TO DISTINGUISH ISOBARIC AMINO ACIDS AND AMINO ACID COMBINATIONS | Rapid Novor Inc. (CA) | 2021-10-27 | — | — | EP | disclosed |
| CN-113557299-A | Methods and compositions for accelerating polypeptide analysis reactions and related uses | ENCODIA 公司 | 2021-10-26 | — | — | CN | disclosed |
| CN-113508298-A | Labeling method for distinguishing isobaric amino acid and amino acid combination | 快速诺凡公司 | 2021-10-15 | — | — | CN | disclosed |
| CN-113474651-A | Single molecule protein and peptide sequencing | 麻省理工学院 | 2021-10-01 | — | — | CN | disclosed |
| US-11053307-B2 | Compounds and methods for treating pain | MEDIMMUNE LIMITED (GB) | 2021-07-06 | — | — | US | disclosed |
| US-11015224-B2 | RAF gene fusions | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2021-05-25 | — | — | US | disclosed |
| US-11008370-B2 | Genetically modified yeast cell and improved process for production of clot-specific streptokinase | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2021-05-18 | — | — | US | disclosed |
| US-20210128650-A1 | ANTIVIRAL METHODS AND COMPOSITIONS COMPRISING PROBIOTIC BACTERIAL MOLECULES | MICROSINTESIS INC. (CA) | 2021-05-06 | — | — | US | disclosed |
| US-20210107997-A1 | ANTIBODY WITH NON-NATURAL AMINO ACID INTRODUCED THEREIN | RIKEN (JP) | 2021-04-15 | — | — | US | disclosed |
| US-20210072251-A9 | SINGLE MOLECULE PEPTIDE SEQUENCING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2021-03-11 | — | — | US | disclosed |
| US-20210072252-A1 | MOLECULES AND METHODS FOR ITERATIVE POLYPEPTIDE ANALYSIS AND PROCESSING | WASHINGTON UNIVERSITY (US) | 2021-03-11 | — | — | US | disclosed |
| US-10941429-B2 | Enzymatic synthesis of kavalactones and flavokavains | WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) | 2021-03-09 | — | — | US | disclosed |
| EP-3774924-A1 | ANTI-TELOMERASE REVERSE TRANSCRIPTASE ANTIBODIES AND USE THEREOF | Mor Research Applications Ltd. (IL) | 2021-02-17 | — | — | EP | disclosed |
| US-10906990-B2 | Antibody with non-natural amino acid introduced therein | RIKEN (JP) | 2021-02-02 | — | — | US | disclosed |
| CN-112272703-A | Kits for assays employing nucleic acid encoding and/or labeling | ENCODIA有限公司 | 2021-01-26 | — | — | CN | disclosed |
| US-20210018511-A9 | IDENTIFYING PEPTIDES AT THE SINGLE MOLECULE LEVEL | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-01-21 | — | — | US | disclosed |
| US-20210009671-A1 | COMPOUNDS AND METHODS FOR TREATING PAIN | MEDIMMUNE LIMITED (GB) | 2021-01-14 | — | — | US | disclosed |
| EP-3221345-B1 | METALLOPROTEIN COMPOSITIONS | COMMW SCIENT IND RES ORG (AU) | 2020-12-23 | — | — | EP | disclosed |
| US-10870875-B2 | Metalloprotein compositions | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2020-12-22 | — | — | US | disclosed |
| EP-3418929-B1 | AUTOMATED SCREENING OF ENZYME VARIANTS | CODEXIS INC (US) | 2020-12-09 | — | — | EP | disclosed |
| WO-2020243643-A1 | SYSTEMS AND METHODS FOR MS1-BASED MASS IDENTIFICATION INCLUDING SUPER-RESOLUTION TECHNIQUES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2020-12-03 | — | — | WO | disclosed |
| US-10852305-B2 | Molecules and methods for iterative polypeptide analysis and processing | WASHINGTON UNIVERSITY (US) | 2020-12-01 | — | — | US | disclosed |
| US-20200348307-A1 | METHODS AND COMPOSITIONS FOR POLYPEPTIDE ANALYSIS | Encodia, Inc. (US) | 2020-11-05 | — | — | US | disclosed |
| US-20200348308-A1 | KITS FOR ANALYSIS USING NUCLEIC ACID ENCODING AND/OR LABEL | Encodia, Inc. (US) | 2020-11-05 | — | — | US | disclosed |
| WO-2020223133-A1 | METHODS AND REAGENTS FOR CLEAVAGE OF THE N-TERMINAL AMINO ACID FROM A POLYPEPTIDE | Encodia, Inc. (US) | 2020-11-05 | — | — | WO | disclosed |
| US-20200319200-A1 | MOLECULES AND METHODS FOR ITERATIVE POLYPEPTIDE ANALYSIS AND PROCESSING | WASHINGTON UNIVERSITY (US) | 2020-10-08 | — | — | US | disclosed |
| WO-2020201350-A1 | MEANS AND METHODS FOR SINGLE MOLECULE PEPTIDE SEQUENCING | VIB VZW (BE) | 2020-10-08 | — | — | WO | disclosed |
| EP-3704249-A1 | KITS FOR ANALYSIS USING NUCLEIC ACID ENCODING AND/OR LABEL | Encodia, Inc. (US) | 2020-09-09 | — | — | EP | disclosed |
| EP-3704246-A1 | METHODS AND KITS USING NUCLEIC ACID ENCODING AND/OR LABEL | Encodia, Inc. (US) | 2020-09-09 | — | — | EP | disclosed |
| US-20200277597-A1 | AUTOMATED SCREENING OF ENZYME VARIANTS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2020-09-03 | — | — | US | disclosed |
| CN-111579702-A | Method for detecting coverage of protein amino acid sequence | 上海美吉生物医药科技有限公司 | 2020-08-25 | — | — | CN | disclosed |
| EP-3696193-A1 | CHIMERIC PROTEIN COMPOSED OF NGF ANTAGONIST DOMAIN AND A TNFA ANTAGONIST DOMAIN | MedImmune Limited (GB) | 2020-08-19 | — | — | EP | disclosed |
| EP-3688152-A1 | MEANS AND METHODS FOR SINGLE MOLECULE PEPTIDE SEQUENCING | VIB VZW (BE) | 2020-08-05 | — | — | EP | disclosed |
| WO-2020154208-A1 | METHODS AND COMPOSITIONS OF ACCELERATING REACTIONS FOR POLYPEPTIDE ANALYSIS AND RELATED USES | Encodia, Inc. (US) | 2020-07-30 | — | — | WO | disclosed |
| US-20200231956-A1 | MEANS AND METHODS FOR SINGLE MOLECULE PEPTIDE SEQUENCING | UNIVERSITEIT GENT (BE) | 2020-07-23 | — | — | US | disclosed |
| US-10716817-B2 | Antiviral methods and compositions comprising probiotic bacterial molecules | UNIVERSITY OF GUELPH (CA) | 2020-07-21 | — | — | US | disclosed |
| WO-2020146325-A1 | SINGLE-MOLECULE PROTEIN AND PEPTIDE SEQUENCING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-07-16 | — | — | WO | disclosed |
| US-20200217853-A1 | Single-Molecule Protein and Peptide Sequencing | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-07-09 | — | — | US | disclosed |
| US-10696964-B2 | Automated screening of enzyme variants | CODEXIS, INC. (US) | 2020-06-30 | — | — | US | disclosed |
| WO-2020124252-A1 | A LABELLING METHOD TO DISTINGUISH ISOBARIC AMINO ACIDS AND AMINO ACID COMBINATIONS | RAPID NOVOR INC. (CA) | 2020-06-25 | — | — | WO | disclosed |
| US-10687543-B2 | Probiotic bacterial molecules and their use in methods to treat/prevent infection by harmful bacteria and to provide nutritional health | UNIVERSITY OF GUELPH (CA) | 2020-06-23 | — | — | US | disclosed |
| US-20200178567-A1 | PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH | UNIVERSITY OF GUELPH (CA) | 2020-06-11 | — | — | US | disclosed |
| US-10677801-B2 | Diagnosis and treatment of breast cancer | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2020-06-09 | — | — | US | disclosed |
| CN-111148831-A | Means and methods for sequencing single molecule peptides | 非营利性组织佛兰芒综合大学生物技术研究所 | 2020-05-12 | — | — | CN | disclosed |
| EP-1615946-B1 | PROTEOLYTIC AND COVALENT ANTIBODIES | PAUL SUDHIR (US) | 2020-05-06 | — | — | EP | disclosed |
| US-20200123241-A1 | COMPOUNDS AND METHODS FOR TREATING PAIN | MEDIMMUNE LIMITED (GB) | 2020-04-23 | — | — | US | disclosed |
| US-20200124613-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | UNIV TEXAS (US) | 2020-04-23 | — | — | US | disclosed |
| US-10598667-B2 | Functional illumination in living cells | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-03-24 | — | — | US | disclosed |
| US-10590488-B2 | Recurrent gene fusions in cutaneous CD30-positive lymphoproliferative disorders | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2020-03-17 | — | — | US | disclosed |
| US-10583167-B2 | Mammalian glucosidase inhibitors, methods for their use and pharmaceutical compositions thereof | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2020-03-10 | — | — | US | disclosed |
| US-10545153-B2 | Single molecule peptide sequencing | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2020-01-28 | — | — | US | disclosed |
| CN-105765592-B | Methods, devices and systems for automated screening of enzyme variants | 科德克希思公司 | 2019-12-17 | — | — | CN | disclosed |
| US-20190346448-A1 | COMPOSITIONS AND METHODS FOR IDENTIFYING CANCER CELLS | ZOMEDICA INC. | 2019-11-14 | — | — | US | disclosed |
| US-10457728-B2 | Compounds and methods for treating pain | MEDIMMUNE LIMITED (GB) | 2019-10-29 | — | — | US | disclosed |
| WO-2019202536-A1 | GENOTYPING ASSAYS TO IDENTIFY MUTATIONS IN XAF1 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2019-10-24 | — | — | WO | disclosed |
| WO-2019197974-A1 | ANTI-TELOMERASE REVERSE TRANSCRIPTASE ANTIBODIES AND USE THEREOF | MOR RESEARCH APPLICATIONS LTD. (IL) | 2019-10-17 | — | — | WO | disclosed |
| EP-3543703-A1 | IMPROVED SINGLE MOLECULE PEPTIDE SEQUENCING | Board of Regents, The University of Texas System (US) | 2019-09-25 | — | — | EP | disclosed |
| US-20190271015-A1 | ENZYMATIC SYNTHESIS OF KAVALACTONES AND FLAVOKAVAINS | WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH | 2019-09-05 | — | — | US | disclosed |
| US-10392610-B2 | Pregnancy-associated plasma protein-A2 (PAPP-A2) polypeptides | COMO BIOTECH APS (DK) | 2019-08-27 | — | — | US | disclosed |
| EP-3507385-A1 | METHODS OF COMBINING THE DETECTION OF BIOMOLECULES INTO A SINGLE ASSAY USING FLUORESCENT IN SITU SEQUENCING | President and Fellows of Harvard College (US) | 2019-07-10 | — | — | EP | disclosed |
| US-10344060-B2 | Potent and selective inhibitors of Nav1.7 | AMGEN INC. (US) | 2019-07-09 | — | — | US | disclosed |
| EP-2802673-B1 | METHODS AND BIOMARKERS FOR ANALYSIS OF COLORECTAL CANCER | UNIV OSLO HF (NO) | 2019-07-03 | — | — | EP | disclosed |
| US-20190194709-A1 | Methods of Combining the Detection of Biomolecules Into a Single Assay Using Fluorescent In Situ Sequencing | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2019-06-27 | — | — | US | disclosed |
| CN-109872771-A | Methods, devices and systems based on directed evolution | 科德克希思公司 | 2019-06-11 | — | — | CN | disclosed |
| US-10308980-B2 | Methods and biomarkers for analysis of colorectal cancer | OSLO UNIVERSITETSSYKEHUS HF (NO) | 2019-06-04 | — | — | US | disclosed |
| US-20190127488-A1 | ANTIBODY WITH NON-NATURAL AMINO ACID INTRODUCED THEREIN | RIKEN (JP) | 2019-05-02 | — | — | US | disclosed |
| WO-2019063827-A1 | MEANS AND METHODS FOR SINGLE MOLECULE PEPTIDE SEQUENCING | VIB VZW (BE) | 2019-04-04 | — | — | WO | disclosed |
| CN-105814573-B | Method, device and system based on directed evolution | 科德克希思公司 | 2019-03-29 | — | — | CN | disclosed |
| US-10233246-B2 | Antibody and antibody fragment introduced new modification sites | KYOWA HAKKO KIRIN CO., LTD (JP) | 2019-03-19 | — | — | US | disclosed |
| US-10190173-B2 | Recurrent gene fusions in prostate cancer | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2019-01-29 | — | — | US | disclosed |
| EP-3418929-A1 | AUTOMATED SCREENING OF ENZYME VARIANTS | Codexis, Inc. (US) | 2018-12-26 | — | — | EP | disclosed |
| US-20180362596-A1 | A GENETICALLY MODIFIED YEAST CELL AND IMPROVED PROCESS FOR PRODUCTION OF CLOT-SPECIFIC STREPTOKINASE | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2018-12-20 | — | — | US | disclosed |
| EP-2970434-B1 | DUAL REACTIVITY POTENT KUNITZ INHIBITOR OF FIBRINOLYSIS | UNIV CALIFORNIA (US) | 2018-12-05 | — | — | EP | disclosed |
| US-20180280471-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INTELLECTUAL DISABILITIES | MITZ HOWARD (US) | 2018-10-04 | — | — | US | disclosed |
| EP-2554669-B1 | NOVEL ANTIBODY HAVING MODIFICATION SITE INTRODUCED THEREIN, AND ANTIBODY FRAGMENT | KYOWA HAKKO KIRIN CO LTD (JP) | 2018-09-19 | — | — | EP | disclosed |
| EP-3018216-B1 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | UNIV MICHIGAN REGENTS (US) | 2018-09-12 | — | — | EP | disclosed |
| EP-3368549-A1 | A GENETICALLY MODIFIED YEAST CELL AND IMPROVED PROCESS FOR PRODUCTION OF CLOT-SPECIFIC STREPTOKINASE | Council of Scientific and Industrial Research (IN) | 2018-09-05 | — | — | EP | disclosed |
| US-20180222971-A1 | COMPOUNDS AND METHODS FOR TREATING PAIN | MEDIMMUNE LIMITED (GB) | 2018-08-09 | — | — | US | disclosed |
| EP-3049973-B1 | AUTOMATED SCREENING OF ENZYME VARIANTS | CODEXIS INC (US) | 2018-08-08 | — | — | EP | disclosed |
| US-10041123-B2 | Recurrent gene fusions in prostate cancer | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2018-08-07 | — | — | US | disclosed |
| WO-2018127786-A1 | COMPOSITIONS AND METHODS FOR DETERMINING A TREATMENT COURSE OF ACTION | OSLO UNIVERSITETSSYKEHUS HF (NO) | 2018-07-12 | — | — | WO | disclosed |
| US-20180193413-A1 | MAMMALIAN GLUCOSIDASE INHIBITORS, METHODS FOR THEIR USE AND PHARMACEUTICAL COMPOSITIONS THEREOF | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2018-07-12 | — | — | US | disclosed |
| US-20180177834-A1 | Antiviral Methods and Compositions Comprising Probiotic Bacterial Molecules | UNIVERSITY OF GUELPH (CA) | 2018-06-28 | — | — | US | disclosed |
| EP-2704733-B1 | POLYBACTERIAL PREPARATION and method for obtaining thereof | LB BULGARICUM PLC (BG) | 2018-06-20 | — | — | EP | disclosed |
| US-20180119194-A1 | METALLOPROTEIN COMPOSITIONS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2018-05-03 | — | — | US | disclosed |
| US-9957569-B2 | Recurrent gene fusions in prostate cancer | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2018-05-01 | — | — | US | disclosed |
| EP-3306321-A1 | DIAGNOSIS AND TREATMENT OF BREAST CANCER | The Regents of The University of Michigan (US) | 2018-04-11 | — | — | EP | disclosed |
| US-9938582-B2 | Recurrent gene fusions in prostate cancer | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2018-04-10 | — | — | US | disclosed |
| US-9926602-B2 | Recurrent gene fusions in prostate cancer | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2018-03-27 | — | — | US | disclosed |
| US-20180071369-A1 | GLUTAMATE OXALOACETATE TRANSAMINASE 1 (GOT1), PREPARATIONS AND METHODS OF GENERATING SAME AND USES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2018-03-15 | — | — | US | disclosed |
| WO-2018045186-A1 | METHODS OF COMBINING THE DETECTION OF BIOMOLECULES INTO A SINGLE ASSAY USING FLUORESCENT IN SITU SEQUENCING | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2018-03-08 | — | — | WO | disclosed |
| EP-3277308-A1 | GLUTAMATE OXALOACETATE TRANSAMINASE 1 (GOT1), PREPARATIONS AND METHODS OF GENERATING SAME AND USES THEREOF | Yeda Research and Development Co., Ltd. (IL) | 2018-02-07 | — | — | EP | disclosed |
| US-9884911-B2 | Compounds and methods for treating pain | MEDIMMUNE LIMITED (GB) | 2018-02-06 | — | — | US | disclosed |
| US-9879076-B2 | Methods and compositions with immune therapy for treatment of dementia | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2018-01-30 | — | — | US | disclosed |
| US-20180010196-A1 | RECURRENT GENE FUSIONS IN CUTANEOUS CD30-POSITIVE LYMPHOPROLIFERATIVE DISORDERS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2018-01-11 | — | — | US | disclosed |
| EP-2970408-B1 | POTENT AND SELECTIVE INHIBITORS OF NAV1.7 | AMGEN INC (US) | 2018-01-10 | — | — | EP | disclosed |
| US-9861666-B2 | Antiviral methods and compositions comprising probiotic bacterial molecules | GRIFFITHS MANSEL (CA) | 2018-01-09 | — | — | US | disclosed |
| US-20180000126-A1 | Probiotic Bacterial Molecules and their Use in Methods to Treat/Prevent Infection by Harmful Bacteria and to Provide Nutritional Health | UNIV GUELPH (US) | 2018-01-04 | — | — | US | disclosed |
| US-9822417-B2 | Methods and biomarkers for analysis of colorectal cancer | OSLO UNIVERSITETSSYKEHUS HF (NO) | 2017-11-21 | — | — | US | disclosed |
| US-9796766-B2 | Potent and selective inhibitors of NAV1.3 and NAV1.7 | AMGEN INC. (US) | 2017-10-24 | — | — | US | disclosed |
| US-9783853-B2 | Recurrent gene fusions in cancer | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2017-10-10 | — | — | US | disclosed |
| US-20170276686-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2017-09-28 | — | — | US | disclosed |
| EP-3221345-A1 | METALLOPROTEIN COMPOSITIONS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2017-09-27 | — | — | EP | disclosed |
| EP-2591363-B1 | DIAGNOSIS AND TREATMENT OF BREAST CANCER | UNIV MICHIGAN REGENTS (US) | 2017-09-20 | — | — | EP | disclosed |
| US-9745635-B2 | Recurrent gene fusions in prostate cancer | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2017-08-29 | — | — | US | disclosed |
| US-9745625-B2 | Methods and products for analyzing polymers | Life Technologies Corporation (US) | 2017-08-29 | — | — | US | disclosed |
| US-20170242024-A1 | IDENTIFYING PEPTIDES AT THE SINGLE MOLECULE LEVEL | UNIV TEXAS (US) | 2017-08-24 | — | — | US | disclosed |
| US-20170242011-A1 | DIAGNOSIS AND TREATMENT OF BREAST CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2017-08-24 | — | — | US | disclosed |
| EP-3194980-A1 | IMPROVED SINGLE MOLECULE PEPTIDE SEQUENCING | Board of Regents, The University of Texas System (US) | 2017-07-26 | — | — | EP | disclosed |
| US-20170183374-A1 | Methods of Constructing and Screening Libraries of Peptide Structures | PHYLOGICA LIMITED (AU) | 2017-06-29 | — | — | US | disclosed |
| US-9657350-B2 | RNA chimeras in human leukemia and lymphoma | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2017-05-23 | — | — | US | disclosed |
| WO-2017072791-A1 | A GENETICALLY MODIFIED YEAST CELL AND IMPROVED PROCESS FOR PRODUCTION OF CLOT-SPECIFIC STREPTOKINASE | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-05-04 | — | — | WO | disclosed |
| US-9636418-B2 | Potent and selective inhibitors of NAV1.7 | AMGEN INC. (US) | 2017-05-02 | — | — | US | disclosed |
| US-9625469-B2 | Identifying peptides at the single molecule level | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2017-04-18 | — | — | US | disclosed |
| WO-2017062238-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INTELLECTUAL DISABILITIES | MITZ HOWARD (US) | 2017-04-13 | — | — | WO | disclosed |
| WO-2017050820-A1 | FVIII FUSION PROTEINS | NOVO NORDISK A/S (DK) | 2017-03-30 | — | — | WO | disclosed |
| US-20170081731-A1 | RAF GENE FUSIONS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2017-03-23 | — | — | US | disclosed |
| EP-2339020-B1 | Diagnostic methods based on Pregnancy-associated plasma protein-A (PAAP-A) | COMO BIOTECH APS (DK) | 2017-03-08 | — | — | EP | disclosed |
| US-20170052194-A1 | MOLECULES AND METHODS FOR ITERATIVE POLYPEPTIDE ANALYSIS AND PROCESSING | WASHINGTON UNIVERSITY (US) | 2017-02-23 | — | — | US | disclosed |
| CN-106459190-A | Compounds and methods for treating pain | 麦迪穆有限责任公司 | 2017-02-22 | — | — | CN | disclosed |
| US-9567644-B2 | RAF gene fusions | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2017-02-14 | — | — | US | disclosed |
| US-9567373-B2 | Methods of constructing and screening libraries of peptide structures | PHYLOGICA LIMITED (AU) | 2017-02-14 | — | — | US | disclosed |
| US-9568476-B2 | Diagnosis and treatment of breast cancer | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2017-02-14 | — | — | US | disclosed |
| EP-1576138-B1 | 2'-METHYL NUCLEOSIDES IN COMBINATION WITH INTERFERON AND FLAVIVIRIDAE MUTATION | IDENIX PHARMACEUTICALS LLC (US) | 2017-02-01 | — | — | EP | disclosed |
| WO-2017000060-A1 | MAMMALIAN GLUCOSIDASE INHIBITORS, METHODS FOR THEIR USE AND PHARMACEUTICAL COMPOSITIONS THEREOF | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2017-01-05 | — | — | WO | disclosed |
| US-20160362480-A1 | NOVEL OPRF/I FUSION PROTEINS, THEIR PREPARATION AND USE | VALNEVA AUSTRIA GMBH (AT) | 2016-12-15 | — | — | US | disclosed |
| WO-2016196478-A1 | METHODS AND COMPOSITIONS FOR PROGNOSTICATIONS AND/OR CLINICAL MANAGEMENT OF GRAFT-VERSUS-HOST DISEASE AND TRANSPLANT REJECTION | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2016-12-08 | — | — | WO | disclosed |
| EP-3099713-A1 | CHIMERIC PROTEIN COMPOSED OF NGF ANTAGONIST DOMAIN AND A TNFA ANTAGONIST DOMAIN | Medimmune Limited (GB) | 2016-12-07 | — | — | EP | disclosed |
| EP-1280928-B1 | RESISTANCE TO ACETOHYDROXYACID SYNTHASE-INHIBITING HERBICIDES | UNIV LOUISIANA STATE (US) | 2016-11-30 | — | — | EP | disclosed |
| US-9506117-B2 | Methods and biomarkers for detection and prognosis of cervical cancer | OSLO UNIVERSITETSSYKEHUS HF (NO) | 2016-11-29 | — | — | US | disclosed |
| US-20160319369-A1 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2016-11-03 | — | — | US | disclosed |
| US-20160313341-A1 | FUNCTIONAL ILLUMINATION IN LIVING CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-10-27 | — | — | US | disclosed |
| US-9476096-B2 | Recurrent gene fusions in hemangiopericytoma | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2016-10-25 | — | — | US | disclosed |
| US-20160304570-A1 | POTENT AND SELECTIVE INHIBITORS OF NAV1.3 AND NAV1.7 | AMGEN INC. (US) | 2016-10-20 | — | — | US | disclosed |
| WO-2016157190-A1 | GLUTAMATE OXALOACETATE TRANSAMINASE 1 (GOT1), PREPARATIONS AND METHODS OF GENERATING SAME AND USES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2016-10-06 | — | — | WO | disclosed |
| US-9447154-B2 | Nucleic acids encoding a house dust mite allergen, Der p III, and uses thereof | MERCK PATENT GMBH (DE) | 2016-09-20 | — | — | US | disclosed |
| US-9435810-B2 | Molecules and methods for iterative polypeptide analysis and processing | WASHINGTON UNIVERSITY (US) | 2016-09-06 | — | — | US | disclosed |
| WO-2016123517-A2 | RECURRENT GENE FUSIONS IN CUTANEOUS CD30-POSITIVE LYMPHOPROLIFERATIVE DISORDERS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2016-08-04 | — | — | WO | disclosed |
| EP-3049979-A1 | STRUCTURE BASED PREDICTIVE MODELING | Codexis, Inc. (US) | 2016-08-03 | — | — | EP | disclosed |
| EP-3049973-A1 | AUTOMATED SCREENING OF ENZYME VARIANTS | Codexis, Inc. (US) | 2016-08-03 | — | — | EP | disclosed |
| CN-105814573-A | Structure-Based Predictive Modeling | 科德克希思公司 | 2016-07-27 | — | — | CN | disclosed |
| US-9399675-B2 | Methods and compositions for diagnosing Alzheimer's disease and age-related macular degeneration | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2016-07-26 | — | — | US | disclosed |
| CN-105765592-A | AUTOMATED SCREENING OF ENZYME VARIANTS | 科德克希思公司 | 2016-07-13 | — | — | CN | disclosed |
| EP-3033351-A1 | ANTIVIRAL METHODS AND COMPOSITIONS COMPRISING PROBIOTIC BACTERIAL MOLECULES | Griffiths, Mansel (CA) | 2016-06-22 | — | — | EP | disclosed |
| US-20160166597-A1 | 2'-BRANCHED NUCLEOSIDES AND FLAVIVIRIDAE MUTATION | IDENIX PHARMACEUTICALS LLC | 2016-06-16 | — | — | US | disclosed |
| US-9359412-B2 | OprF/I fusion proteins, their preparation and use | VALNEVA AUSTRIA GMBH (AT) | 2016-06-07 | — | — | US | disclosed |
| WO-2016077877-A1 | METALLOPROTEIN COMPOSITIONS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-05-26 | — | — | WO | disclosed |
| EP-3019628-A1 | RECURRENT GENE FUSIONS IN CANCER | The Regents Of The University Of Michigan (US) | 2016-05-18 | — | — | EP | disclosed |
| US-9340590-B2 | Potent and selective inhibitors of NaV1.3 and NaV1.7 | AMGEN INC. (US) | 2016-05-17 | — | — | US | disclosed |
| US-9340577-B2 | HLA binding motifs and peptides and their uses | EPIMMUNE INC. (US) | 2016-05-17 | — | — | US | disclosed |
| EP-3018216-A1 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | The Regents Of The University Of Michigan (US) | 2016-05-11 | — | — | EP | disclosed |
| WO-2016069124-A1 | IMPROVED SINGLE MOLECULE PEPTIDE SEQUENCING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2016-05-06 | — | — | WO | disclosed |
| US-9310379-B2 | Methods of crystallizing antibodies | AJINOMOTO ALTHEA, INC. (US) | 2016-04-12 | — | — | US | disclosed |
| US-20160097104-A1 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2016-04-07 | — | — | US | disclosed |
| US-9284609-B2 | Recurrent gene fusions in prostate cancer | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2016-03-15 | — | — | US | disclosed |
| CN-105377888-A | Dual reactivity potent kunitz inhibitor of fibrinolysis | UNIV CALIFORNIA | 2016-03-02 | — | — | CN | disclosed |
| US-20160039937-A1 | NOVEL ANTIBODY AND ANTIBODY FRAGMENT INTRODUCED NEW MODIFICATION SITES | KYOWA HAKKO KIRIN CO., LTD (JP) | 2016-02-11 | — | — | US | disclosed |
| US-20160024159-A1 | POTENT AND SELECTIVE INHIBITORS OF NAV1.7 | AMGEN INC. (US) | 2016-01-28 | — | — | US | disclosed |
| US-20160017025-A1 | METHODS AND COMPOSITIONS WITH IMMUNE THERAPY FOR TREATMENT OF DEMENTIA | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2016-01-21 | — | — | US | disclosed |
| EP-2970408-A2 | POTENT AND SELECTIVE INHIBITORS OF Nav1.7 | Amgen Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-2970434-A1 | DUAL REACTIVITY POTENT KUNITZ INHIBITOR OF FIBRINOLYSIS | The Regents of The University of California (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-2259787-B1 | IKKI INHIBITOR THERAPIES AND SCREENING METHODS, AND RELATED IKKI DIAGNOSTICS | UNIV MICHIGAN (US) | 2015-12-23 | — | — | EP | disclosed |
| US-20150344902-A1 | Resistance to Acetohydroxyacid Synthase-Inhibiting Herbicides | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2015-12-03 | — | — | US | disclosed |
| US-20150337390-A1 | KITS FOR ANTIANDROGEN THERAPY MONITORING | BANK OF AMERICA, N.A., AS COLLATERAL AGENT | 2015-11-26 | — | — | US | disclosed |
| US-9188584-B2 | Capture agents and related compositions, methods and systems | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2015-11-17 | — | — | US | disclosed |
| EP-2604701-B1 | Recurrent gene fusions in prostate cancer | UNIV MICHIGAN (US) | 2015-11-04 | — | — | EP | disclosed |
| US-9150639-B2 | Antibody and antibody fragment introduced new modification sites | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2015-10-06 | — | — | US | disclosed |
| US-20150274818-A1 | COMPOUNDS AND METHODS FOR TREATING PAIN | MEDIMMUNE LIMITED (GB) | 2015-10-01 | — | — | US | disclosed |
| EP-2478120-B1 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | UNIV MICHIGAN (US) | 2015-09-02 | — | — | EP | disclosed |
| WO-2015114150-A1 | CHIMERIC PROTEIN COMPOSED OF NGF ANTAGONIST DOMAIN AND A TNFA ANTAGONIST DOMAIN | MEDIMMUNE LIMITED (GB) | 2015-08-06 | — | — | WO | disclosed |
| US-9090904-B2 | Resistance to acetohydroxyacid synthase-inhibiting herbicides | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2015-07-28 | — | — | US | disclosed |
| US-20150191795-A1 | RAF GENE FUSIONS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-07-09 | — | — | US | disclosed |
| EP-2628005-B1 | BIOMARKER AND METHOD FOR DETECTING A CHRONIC INFLAMMATORY-ASSOCIATED DISEASE | UNIV OKLAHOMA (US) | 2015-07-01 | — | — | EP | disclosed |
| US-20150134315-A1 | STRUCTURE BASED PREDICTIVE MODELING | CODEXIS, INC. | 2015-05-14 | — | — | US | disclosed |
| US-20150132770-A1 | PREGNANCY-ASSOCIATED PLASMA PROTEIN-A2 (PAPP-A2) POLYNUCLEOTIDES | COMO BIOTECH APS (DK) | 2015-05-14 | — | — | US | disclosed |
| US-20150133307-A1 | AUTOMATED SCREENING OF ENZYME VARIANTS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2015-05-14 | — | — | US | disclosed |
| US-20150111758-A1 | GENE SIGNATURES ASSOCIATED WITH EFFICACY OF POSTMASTECTOMY RADIOTHERAPY IN BREAST CANCER | AARHUS UNIVERSITY (DK) | 2015-04-23 | — | — | US | disclosed |
| US-9005949-B2 | Pregnancy-associated plasma protein-A2 (PAPP-A2) polynucleotides | COMO BIOTECH APS (DK) | 2015-04-14 | — | — | US | disclosed |
| US-20150087526-A1 | PEPTIDE IDENTIFICATION AND SEQUENCING BY SINGLE-MOLECULE DETECTION OF PEPTIDES UNDERGOING DEGRADATION | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2015-03-26 | — | — | US | disclosed |
| EP-1987178-B1 | METHOD OF CONSTRUCTING AND SCREENING LIBRARIES OF PEPTIDE STRUCTURES | PHYLOGICA LTD (AU) | 2015-03-25 | — | — | EP | disclosed |
| CN-103109187-B | Diagnosis and treatment of breast cancer | UNIV MICHIGAN | 2015-03-25 | — | — | CN | disclosed |
| WO-2015038710-A1 | METHODS FOR DIAGNOSING AND TREATING INTRAHEPATIC CHOLANGIOCARCINOMA | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2015-03-19 | — | — | WO | disclosed |
| US-8980646-B2 | Proteolytic and covalent antibodies | PAUL, SUDHIR (US) | 2015-03-17 | — | — | US | disclosed |
| CN-102159949-B | Multi-ligand capture agents and related compositions, methods and systems | CALIFORNIA INST OF TECHN | 2015-03-04 | — | — | CN | disclosed |
| US-8969527-B2 | Recurrent gene fusions in prostate cancer | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2015-03-03 | — | — | US | disclosed |
| WO-2015021530-A1 | ANTIVIRAL METHODS AND COMPOSITIONS COMPRISING PROBIOTIC BACTERIAL MOLECULES | GRIFFITHS MANSEL (CA) | 2015-02-19 | — | — | WO | disclosed |
| US-20150044188-A1 | ANTIVIRAL METHODS AND COMPOSITIONS COMPRISING PROBIOTIC BACTERIAL MOLECULES | GRIFFITHS MANSEL (CA) | 2015-02-12 | — | — | US | disclosed |
| US-8945556-B2 | RAF gene fusions | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2015-02-03 | — | — | US | disclosed |
| EP-2310855-B1 | MULTI-LIGAND CAPTURE AGENTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | CALIFORNIA INST OF TECHN (US) | 2015-01-28 | — | — | EP | disclosed |
| US-20150023988-A1 | POTENT AND SELECTIVE INHIBITORS OF NAV1.7 | AMGEN INC. (US) | 2015-01-22 | — | — | US | disclosed |
| WO-2015006723-A1 | RECURRENT GENE FUSIONS IN CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2015-01-15 | — | — | WO | disclosed |
| EP-2823059-A2 | GENE SIGNATURES ASSOCIATED WITH EFFICACY OF POSTMASTECTOMY RADIOTHERAPY IN BREAST CANCER | Oslo Universitetssykehus HF (NO) | 2015-01-14 | — | — | EP | disclosed |
| EP-1246597-B1 | POLYPEPTIDES AND POLYNUCLEOTIDES FOR ENHANCING IMMUNE REACTIVITY TO HER-2 PROTEIN | UNIV OHIO STATE (US) | 2015-01-14 | — | — | EP | disclosed |
| EP-2079851-B1 | METHOD USING SPINK1 AS A PROSTATE CANCER MARKER | UNIV MICHIGAN (US) | 2015-01-07 | — | — | EP | disclosed |
| EP-2817627-A2 | METHODS AND BIOMARKERS FOR DETECTION AND PROGNOSIS OF CERVICAL CANCER | Oslo Universitetssykehus HF (NO) | 2014-12-31 | — | — | EP | disclosed |
| EP-2397469-B1 | Diarylhydantoin compounds | UNIV CALIFORNIA (US) | 2014-12-31 | — | — | EP | disclosed |
| EP-1346061-B1 | PREGNANCY-ASSOCIATED PLASMA PROTEIN-A2 (PAPP-A2) | COMO BIOTECH APS (DK) | 2014-12-17 | — | — | EP | disclosed |
| US-20140364481-A1 | RNA CHIMERAS IN HUMAN LEUKEMIA AND LYMPHOMA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2014-12-11 | — | — | US | disclosed |
| US-20140364331-A1 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2014-12-11 | — | — | US | disclosed |
| US-8906830-B2 | Capture agents and related compositions, methods and systems | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2014-12-09 | — | — | US | disclosed |
| US-8900819-B2 | ADRB2 cancer markers | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2014-12-02 | — | — | US | disclosed |
| US-20140349860-A1 | IDENTIFYING PEPTIDES AT THE SINGLE MOLECULE LEVEL | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-11-27 | — | — | US | disclosed |
| US-20140342361-A1 | METHODS AND BIOMARKERS FOR ANALYSIS OF COLORECTAL CANCER | OSLO UNIVERSITETSSYKEHUS HF (NO) | 2014-11-20 | — | — | US | disclosed |
| EP-2802673-A1 | METHODS AND BIOMARKERS FOR ANALYSIS OF COLORECTAL CANCER | Oslo Universitetssykehus HF (NO) | 2014-11-19 | — | — | EP | disclosed |
| US-8865642-B2 | Natural plant products for control of cancer metastasis | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2014-10-21 | — | — | US | disclosed |
| US-20140302100-A1 | METHODS AND BIOMARKERS FOR ANALYSIS OF COLORECTAL CANCER | OSLO UNIVERSITETSSYKEHUS HF (NO) | 2014-10-09 | — | — | US | disclosed |
| WO-2014165277-A2 | POTENT AND SELECTIVE INHIBITORS OF Nav1.7 | AMGEN INC. (US) | 2014-10-09 | — | — | WO | disclosed |
| US-20140295444-A1 | DIAGNOSIS AND TREATMENT OF BREAST CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2014-10-02 | — | — | US | disclosed |
| WO-2014160752-A2 | FUNCTIONAL ILLUMINATION IN LIVING CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-10-02 | — | — | WO | disclosed |
| WO-2014151747-A1 | METHODS AND COMPOSITIONS WITH IMMUNE THERAPY FOR TREATMENT OF DEMENTIA | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2014-09-25 | — | — | WO | disclosed |
| US-20140286900-A1 | 2'-BRANCHED NUCLEOSIDES AND FLAVIVIRIDAE MUTATION | IDENIX PHARMACEUTICALS, INC. (US) | 2014-09-25 | — | — | US | disclosed |
| US-20140273004-A1 | MOLECULES AND METHODS FOR ITERATIVE POLYPEPTIDE ANALYSIS AND PROCESSING | WASHINGTON UNIVERSITY (US) | 2014-09-18 | — | — | US | disclosed |
| WO-2014144658-A1 | DUAL REACTIVITY POTENT KUNITZ INHIBITOR OF FIBRINOLYSIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-09-18 | — | — | WO | disclosed |
| EP-2773772-A1 | METHODS AND BIOMARKERS FOR ANALYSIS OF COLORECTAL CANCER | Oslo Universitetssykehus HF (NO) | 2014-09-10 | — | — | EP | disclosed |
| EP-2761300-A2 | RECURRENT GENE FUSIONS IN BREAST CANCER | The Regents Of The University Of Michigan (US) | 2014-08-06 | — | — | EP | disclosed |
| US-8790878-B2 | Diagnosis and treatment of breast cancer | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2014-07-29 | — | — | US | disclosed |
| US-20140199209-A1 | METHODS AND PRODUCTS FOR ANALYZING POLYMERS | Life Technologies Corporation (US) | 2014-07-17 | — | — | US | disclosed |
| CN-103930437-A | Potent and selective inhibitors of Nav1.3 and Nav1.7 | AMGEN INC | 2014-07-16 | — | — | CN | disclosed |
| US-20140178871-A1 | RECURRENT GENE FUSIONS IN HEMANGIOPERICYTOMA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2014-06-26 | — | — | US | disclosed |
| US-8759072-B2 | Protein exhibiting activity of pyrethrin biosynthetic enzyme, gene encoding the protein, and vector bearing the gene | AN EDUCATIONAL FOUNDATION KINKI UNIVERSITY (JP) | 2014-06-24 | — | — | US | disclosed |
| US-20140171625-A1 | CARDIOTROPHIN RELATED MOLECULES FOR ENHANCED THERAPEUTICS | FATE THERAPEUTICS, INC. (US) | 2014-06-19 | — | — | US | disclosed |
| US-8748155-B2 | Protein exhibiting activity of pyrethrin biosynthetic enzyme, gene encoding the protein, and vector bearing the gene | AN EDUCATIONAL FOUNDATION KINKI UNIVERSITY (JP) | 2014-06-10 | — | — | US | disclosed |
| US-20140128268-A1 | Methods of Constructing and Screening Libraries of Peptide Structures | PHYLOGICA LIMITED (AU) | 2014-05-08 | — | — | US | disclosed |
| US-8674085-B2 | 2′-branched nucleosides and Flaviviridae mutation | IDENIX PHARMACEUTICALS, INC. (US) | 2014-03-18 | — | — | US | disclosed |
| US-20140072544-A1 | POLYBACTERIAL PREPARATION WITH HEALTH BENEFITS: ANTIOXIDANT EFFECT, REDUCTION OF CHOLESTEROL CONCENTRATION, ANTI-INFLAMMATORY IMMUNOMODULATING EFFECT AND RELEASE OF BIOACTIVE PEPTIDES INHIBITING ANGIOTENSIN-CONVERTING ENZYME | LB BULGARICUM PLC (BG) | 2014-03-13 | — | — | US | disclosed |
| US-20140073577-A1 | POTENT AND SELECTIVE INHIBITORS OF NAV1.3 AND NAV1.7 | AMGEN INC. (US) | 2014-03-13 | — | — | US | disclosed |
| EP-2704733-A2 | POLYBACTERIAL PREPARATION WITH HEALTH BENEFITS: ANTIOXIDANT EFFECT, REDUCTION OF CHOLESTEROL CONCENTRATION, ANTI-INFLAMMATORY IMMUNOMODULATING EFFECT AND RELEASE OF BIOACTIVE PEPTIDES INHIBITING ANGIOTENSIN-CONVERTING ENZYME | LB Bulgaricum PLC (BG) | 2014-03-12 | — | — | EP | disclosed |
| US-8669231-B2 | Activation of peptide prodrugs by hK2 | GENSPERA, INC. (US) | 2014-03-11 | — | — | US | disclosed |
| US-20140050756-A1 | NOVEL OPRF/I FUSION PROTEINS, THEIR PREPARATION AND USE | VALNEVA AUSTRIA GMBH (AT) | 2014-02-20 | — | — | US | disclosed |
| WO-2014026010-A1 | RECURRENT GENE FUSIONS IN HEMANGIOPERICYTOMA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2014-02-13 | — | — | WO | disclosed |
| EP-2686339-A1 | NOVEL OPRF/I FUSION PROTEINS, THEIR PREPARATION AND USE | Valneva Austria GmbH (AT) | 2014-01-22 | — | — | EP | disclosed |
| EP-2686340-A2 | POTENT AND SELECTIVE INHIBITORS OF NAV1.3 AND NAV1.7 | Amgen Inc. (US) | 2014-01-22 | — | — | EP | disclosed |
| US-20130337456-A1 | COMPARATIVE SEQUENCE ANALYSIS PROCESSES AND SYSTEMS | SEQUENOM, INC. (US) | 2013-12-19 | — | — | US | disclosed |
| EP-2157175-B1 | Protein exhibiting activity of pyrethrin biosynthetic enzyme, gene endcoding the protein, and vector bearing the gene | EDUCATIONAL FOUNDATION KINKI UNIVERSITY (JP) | 2013-12-18 | — | — | EP | disclosed |
| EP-2670424-A2 | CARDIOTROPHIN RELATED MOLECULES FOR ENHANCED THERAPEUTICS | Fate Therapeutics, Inc. (US) | 2013-12-11 | — | — | EP | disclosed |
| EP-2145180-B1 | COMPARATIVE SEQUENCE ANALYSIS PROCESSES AND SYSTEMS | SEQUENOM INC (US) | 2013-12-04 | — | — | EP | disclosed |
| US-8580509-B2 | Recurrent gene fusions in prostate cancer | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2013-11-12 | — | — | US | disclosed |
| US-8575070-B2 | Methods of constructing and screening libraries of peptide structures | PHYLOGICA LIMITED (AU) | 2013-11-05 | — | — | US | disclosed |
| EP-2655402-A1 | OPRF/I AGENTS AND THEIR USE IN HOSPITALIZED AND OTHER PATIENTS | Intercell Austria AG (AT) | 2013-10-30 | — | — | EP | disclosed |
| US-20130266575-A1 | OprF/I AGENTS AND USE THEREOF IN HOSPITALIZED AND OTHER PATIENTS | VALNEVA AUSTRIA GMBH (AT) | 2013-10-10 | — | — | US | disclosed |
| EP-1716153-B1 | METHODS, COMPOSITIONS, AND APPARATUSES FOR FORMING MACROCYCLIC COMPOUNDS | JOHNSON THOMAS E (US) | 2013-10-09 | — | — | EP | disclosed |
| WO-2013132354-A2 | GENE SIGNATURES ASSOCIATED WITH EFFICACY OF POSTMASTECTOMY RADIOTHERAPY IN BREAST CANCER | OSLO UNIVERSITETSSYKEHUS HF (NO) | 2013-09-12 | — | — | WO | disclosed |
| WO-2013124738-A2 | METHODS AND BIOMARKERS FOR DETECTION AND PROGNOSIS OF CERVICAL CANCER | OSLO UNIVERSITETSSYKEHUS HF (NO) | 2013-08-29 | — | — | WO | disclosed |
| EP-2628005-A1 | BIOMARKER AND METHOD FOR DETECTING A CHRONIC INFLAMMATORY-ASSCOCIATED DISEASE | The Board of Regents of the University of Oklahoma (US) | 2013-08-21 | — | — | EP | disclosed |
| CN-1774511-B | Fragmentation-based methods and systems for sequence variation detection and discovery | SEQUENOM INC | 2013-08-21 | — | — | CN | disclosed |
| US-20130203615-A1 | ANTIANDROGEN THERAPY MONITORING METHODS AND COMPOSITIONS | GEN-PROBE INCORPORATED (US) | 2013-08-08 | — | — | US | disclosed |
| CN-103233063-A | SPINK1 as a prostate cancer marker and uses thereof | UNIV MICHIGAN | 2013-08-07 | — | — | CN | disclosed |
| US-20130195761-A1 | COMPOSITIONS COMPRISING ANTI-CAP37 ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2013-08-01 | — | — | US | disclosed |
| WO-2013112745-A1 | PEPTIDE IDENTIFICATION AND SEQUENCING BY SINGLE-MOLECULE DETECTION OF PEPTIDES UNDERGOING DEGRADATION | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2013-08-01 | — | — | WO | disclosed |
| WO-2013104990-A1 | METHODS AND BIOMARKERS FOR ANALYSIS OF COLORECTAL CANCER | OSLO UNIVERSITETSSYKEHUS HF (NO) | 2013-07-18 | — | — | WO | disclosed |
| EP-2612870-A1 | Recurrent gene fusions in prostate cancer | The Regents of the University of Michigan (US) | 2013-07-10 | — | — | EP | disclosed |
| EP-2094866-B1 | DIAGNOSIS AND TREATMENT OF BREAST CANCER | UNIV MICHIGAN (US) | 2013-07-03 | — | — | EP | disclosed |
| WO-2013089882-A2 | RECURRENT GENE FUSIONS IN BREAST CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2013-06-20 | — | — | WO | disclosed |
| EP-2604701-A2 | Recurrent gene fusions in prostate cancer | The Regents Of The University Of Michigan (US) | 2013-06-19 | — | — | EP | disclosed |
| US-8450071-B2 | Biomarker and method for detecting a chronic inflammatory-associated disease | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2013-05-28 | — | — | US | disclosed |
| EP-2591363-A2 | DIAGNOSIS AND TREATMENT OF BREAST CANCER | The Regents Of The University Of Michigan (US) | 2013-05-15 | — | — | EP | disclosed |
| EP-1613723-B1 | FRAGMENTATION-BASED METHODS FOR SEQUENCE VARIATION DETECTION AND DISCOVERY | SEQUENOM INC (US) | 2013-05-15 | — | — | EP | disclosed |
| CN-103109187-A | Diagnosis and treatment of breast cancer | UNIV MICHIGAN | 2013-05-15 | — | — | CN | disclosed |
| WO-2013064908-A1 | METHODS AND BIOMARKERS FOR ANALYSIS OF COLORECTAL CANCER | OSLO UNIVERSITETSSYKEHUS HF (NO) | 2013-05-10 | — | — | WO | disclosed |
| US-20130109076-A1 | PROTEIN EXHIBITING ACTIVITY OF PYRETHRIN BIOSYNTHETIC ENZYME, GENE ENCODING THE PROTEIN, AND VECTOR BEARING THE GENE | DAINIHON JOCHUGIKU CO., LTD. (JP) | 2013-05-02 | — | — | US | disclosed |
| US-20130096021-A1 | RECURRENT GENE FUSIONS IN BREAST CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2013-04-18 | — | — | US | disclosed |
| US-20130095482-A1 | METHODS OF DETECTING PREGNANCY-ASSOCIATED PLASMA PROTEIN-A2 (PAPP-A2) | COMO BIOTECH APS (DK) | 2013-04-18 | — | — | US | disclosed |
| US-20130095569-A1 | PREGNANCY-ASSOCIATED PLASMA PROTEIN-A2 (PAPP-A2) POLYNUCLEOTIDES | COMO BIOTECH APS (DK) | 2013-04-18 | — | — | US | disclosed |
| EP-1934363-B1 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | UNIV MICHIGAN (US) | 2013-03-20 | — | — | EP | disclosed |
| CN-101652484-B | Prostate cancer marker SPINK1 and application thereof | UNIV MICHIGAN | 2013-03-20 | — | — | CN | disclosed |
| US-20130040858-A1 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2013-02-14 | — | — | US | disclosed |
| WO-2013022821-A1 | ANTIANDROGEN THERAPY MONITORING METHODS AND COMPOSITIONS | GEN-PROBE INCORPORATED (US) | 2013-02-14 | — | — | WO | disclosed |
| EP-2554669-A1 | NOVEL ANTIBODY HAVING MODIFICATION SITE INTRODUCED THEREIN, AND ANTIBODY FRAGMENT | Kyowa Hakko Kirin Co., Ltd. (JP) | 2013-02-06 | — | — | EP | disclosed |
| CN-101341256-B | Recurrent gene fusions in prostate cancer | UNIV MICHIGAN | 2013-01-23 | — | — | CN | disclosed |
| US-20130017225-A1 | NATURAL PLANT PRODUCTS FOR CONTROL OF CANCER METASTASIS | University of Maryland ,Baltimore (US) | 2013-01-17 | — | — | US | disclosed |
| WO-2012178023-A1 | IDENTIFYING PEPTIDES AT THE SINGLE MOLECULE LEVEL | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-12-27 | — | — | WO | disclosed |
| CN-102812130-A | Recurrent Gene Fusions In Prostate Cancer | UNIV MICHIGAN | 2012-12-05 | — | — | CN | disclosed |
| US-20120295809-A1 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2012-11-22 | — | — | US | disclosed |
| US-20120296070-A1 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2012-11-22 | — | — | US | disclosed |
| WO-2012149615-A2 | POLYBACTERIAL PREPARATION WITH HEALTH BENEFITS: ANTIOXIDANT EFFECT, REDUCTION OF CHOLESTEROL CONCENTRATION, ANTI-INFLAMMATORY IMMUNOMODULATING EFFECT AND RELEASE OF BIOACTIVE PEPTIDES INHIBITING ANGIOTENSIN-CONVERTING ENZYME | LB BULGARICUM PLC (BG) | 2012-11-08 | — | — | WO | disclosed |
| EP-2167689-B1 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | UNIV MICHIGAN (US) | 2012-10-31 | — | — | EP | disclosed |
| US-8287875-B2 | Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor | MERCK PATENT GMBH (DE) | 2012-10-16 | — | — | US | disclosed |
| WO-2012126879-A1 | NOVEL OPRF/I FUSION PROTEINS, THEIR PREPARATION AND USE | INTERCELL AG (AT) | 2012-09-27 | — | — | WO | disclosed |
| EP-2115162-B1 | ADRB2 CANCER MARKERS | UNIV MICHIGAN (US) | 2012-09-26 | — | — | EP | disclosed |
| US-20120238491-A1 | IMMUNOLOGICALLY ACTIVE LIPOPEPTIDES AND METHODS FOR USE THEREOF | THERIMUNEX PHARMACEUTICALS, INC. (US) | 2012-09-20 | — | — | US | disclosed |
| WO-2012125973-A2 | POTENT AND SELECTIVE INHIBITORS OF NAV1.3 AND NAV1.7 | AMGEN INC. (US) | 2012-09-20 | — | — | WO | disclosed |
| US-20120217161-A1 | Methods and Products for Analyzing Polymers | Life Technologies Corporation (US) | 2012-08-30 | — | — | US | disclosed |
| EP-1621554-B2 | Immunoglobulins devoid of light chains | UNIV BRUXELLES (BE) | 2012-08-29 | — | — | EP | disclosed |
| CN-102639709-A | Recurrent gene fusions in cancer | UNIV MICHIGAN | 2012-08-15 | — | — | CN | disclosed |
| WO-2012106463-A2 | CARDIOTROPHIN RELATED MOLECULES FOR ENHANCED THERAPEUTICS | FATE THERAPEUTICS, INC. (US) | 2012-08-09 | — | — | WO | disclosed |
| US-20120201841-A1 | POLYPEPTIDES AND POLYNUCLEOTIDES FOR ENHANCING IMMUNE REACTIVITY TO HER-2 PROTEIN | THE OHIO STATE UNIVERSITY (US) | 2012-08-09 | — | — | US | disclosed |
| EP-2478120-A2 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | The Regents Of The University Of Michigan (US) | 2012-07-25 | — | — | EP | disclosed |
| CN-102603883-A | Antibacterial peptide, as well as preparation method and application thereof | INST ZOOLOGY CAS | 2012-07-25 | — | — | CN | disclosed |
| US-8211645-B2 | Recurrent gene fusions in prostate cancer | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2012-07-03 | — | — | US | disclosed |
| WO-2012084272-A1 | OPRF/I AGENTS AND THEIR USE IN HOSPITALIZED AND OTHER PATIENTS | INTERCELL AG (AT) | 2012-06-28 | — | — | WO | disclosed |
| US-20120164177-A1 | RHINOVIRUS VACCINES | DONALD DANFORTH PLANT SCIENCE CENTER (US) | 2012-06-28 | — | — | US | disclosed |
| US-20120157658-A1 | METHODS, COMPOSITIONS, AND APPARATUSES FOR FORMING MACROCYCLIC COMPOUNDS | JOHNSON THOMAS E (US) | 2012-06-21 | — | — | US | disclosed |
| US-20120142549-A1 | RAF GENE FUSIONS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2012-06-07 | — | — | US | disclosed |
| US-8168440-B2 | Polymeric sulfated surfactants for capillary electrophoresis (CE) and CE-mass spectrometry (CE-MS) | GEORGIA STATE UNIVERSITY (US) | 2012-05-01 | — | — | US | disclosed |
| US-8168380-B2 | Methods and products for analyzing polymers | Life Technologies Corporation (US) | 2012-05-01 | — | — | US | disclosed |
| WO-2012051516-A1 | BIOMARKER AND METHOD FOR DETECTING A CHRONIC INFLAMMATORY-ASSCOCIATED DISEASE | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2012-04-19 | — | — | WO | disclosed |
| US-8153760-B2 | Rhinovirus vaccines | DONALD DANFORTH PLANT SCIENCE CENTER (US) | 2012-04-10 | — | — | US | disclosed |
| US-8129180-B2 | Protein exhibiting activity of pyrethrin biosynthetic enzyme, gene encoding the protein, and vector bearing the gene | AN EDUCATIONAL FOUNDATION KINKI UNIVERSITY (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20120046196-A1 | ADRB2 Cancer Markers | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2012-02-23 | — | — | US | disclosed |
| US-20120040434-A1 | Protein exhibiting activity of pyrethrin biosynthetic enzyme, gene encoding the protein, and vector bearing the gene | DAINIHON JOCHUGIKU CO., LTD. (JP) | 2012-02-16 | — | — | US | disclosed |
| US-20120035244-A1 | PARP1 TARGETED THERAPY | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2012-02-09 | — | — | US | disclosed |
| US-8110657-B2 | Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein | THE OHIO STATE UNIVERSITY (US) | 2012-02-07 | — | — | US | disclosed |
| US-8110187-B2 | Preparing cytotoxic lymphocyte maturation factor (CLMF) from genetically engineered lymphoblastoid cells; for treating and preventing tumors and inflammation | HOFFMAN-LA ROCHE INC. (US) | 2012-02-07 | — | — | US | disclosed |
| WO-2012015937-A2 | PARP1 TARGETED THERAPY | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2012-02-02 | — | — | WO | disclosed |
| US-20120015839-A1 | RECURRENT GENE FUSIONS IN CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2012-01-19 | — | — | US | disclosed |
| US-20120009582-A1 | DIAGNOSIS AND TREATMENT OF BREAST CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2012-01-12 | — | — | US | disclosed |
| WO-2012006421-A2 | DIAGNOSIS AND TREATMENT OF BREAST CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2012-01-12 | — | — | WO | disclosed |
| US-20120009621-A1 | NOVEL ANTIBODY AND ANTIBODY FRAGMENT INTRODUCED NEW MODIFICATION SITES | KYOWA HAKKO KIRIN CO., LTD (JP) | 2012-01-12 | — | — | US | disclosed |
| US-20110280910-A1 | NOVEL SURFACE EXPOSED IMMUNOGLOBULIN D-BINDING PROTEIN FROM MORAXELLA CATARRHALIS | ARNE FORSGREN ET AL. (SE) | 2011-11-17 | — | — | US | disclosed |
| US-8058003-B2 | ADRB2 cancer markers | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2011-11-15 | — | — | US | disclosed |
| US-20110275102-A1 | ACTIVATION OF MUTATED RAC-PK | NOVARTIS AG (CH) | 2011-11-10 | — | — | US | disclosed |
| US-8053571-B2 | Methods, compositions, and apparatuses for forming macrocyclic compounds | JOHNSON THOMAS E | 2011-11-08 | — | — | US | disclosed |
| EP-2382328-A2 | RECURRENT GENE FUSIONS IN CANCER | The Regents of the University of Michigan (US) | 2011-11-02 | — | — | EP | disclosed |
| US-20110262400-A1 | PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH | UNIVERSITY OF GUELPH (CA) | 2011-10-27 | — | — | US | disclosed |
| US-20110263515-A1 | CAPTURE AGENTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-10-27 | — | — | US | disclosed |
| US-8043851-B2 | DNA encoding a neoculin acidic subunit of curculin | MITSUKAN GROUP CORPORATION (JP) | 2011-10-25 | — | — | US | disclosed |
| US-20110257372-A1 | IMMUNOGLOBULINS DEVOID OF LIGHT CHAINS | VRIJE UNIVERSITEIT BRUSSEL (BE) | 2011-10-20 | — | — | US | disclosed |
| US-20110250623-A1 | BIOMARKER AND METHOD FOR DETECTING A CHRONIC INFLAMMATORY-ASSOCIATED DISEASE | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA | 2011-10-13 | — | — | US | disclosed |
| US-20110245147-A1 | Activation of Peptide Prodrugs by HK2 | INSPYR THERAPEUTICS, INC. | 2011-10-06 | — | — | US | disclosed |
| US-8026213-B2 | Methods for treating muscle diseases and disorders | ACORDA THERAPEUTICS, INC. (US) | 2011-09-27 | — | — | US | disclosed |
| WO-2011115651-A2 | NATURAL PLANT PRODUCTS FOR CONTROL OF CANCER METASTASIS | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2011-09-22 | — | — | WO | disclosed |
| US-20110210272-A1 | Methods and Products for Analyzing Polymers | Life Technologies Corporation (US) | 2011-09-01 | — | — | US | disclosed |
| EP-1270642-B1 | BRANCHED POLYALKYLENE GLYCOLS | KYOWA HAKKO KIRIN CO LTD (JP) | 2011-08-31 | — | — | EP | disclosed |
| EP-2358899-A2 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | The Regents of the University of Michigan (US) | 2011-08-24 | — | — | EP | disclosed |
| CN-102159949-A | Multi-ligand capture agents and related compositions, methods and systems | CALIFORNIA INST OF TECHN | 2011-08-17 | — | — | CN | disclosed |
| US-7994136-B1 | Metalloproteinase inhibitor | AMGEN INC. (US) | 2011-08-09 | — | — | US | disclosed |
| US-7981434-B2 | Surface exposed immunoglobulin D-binding protein from Moraxella catarrhalis | ARNE FORSGREN ET AL. (SE) | 2011-07-19 | — | — | US | disclosed |
| EP-1654283-B1 | IMPROVED METHOD OF PURIFYING TFPI AND TFPI ANALOGS | NOVARTIS VACCINES & DIAGNOSTIC (US) | 2011-07-13 | — | — | EP | disclosed |
| EP-2339020-A1 | Diagnostic methods based on Pregnancy-associated plasma protein-A (PAAP-A) | Como Biotech APS (DK) | 2011-06-29 | — | — | EP | disclosed |
| US-7968678-B2 | Glial mitogenic factors, their preparation and use | ACORDA THERAPEUTICS, INC. (US) | 2011-06-28 | — | — | US | disclosed |
| US-20110151493-A1 | POLYPEPTIDE DISULFIDE BOND ANALYSIS | AMGEN INC. (US) | 2011-06-23 | — | — | US | disclosed |
| US-20110144015-A1 | METHODS FOR TREATING MUSCLE DISEASES AND DISORDERS | SKLAR ROBERT | 2011-06-16 | — | — | US | disclosed |
| EP-2331703-A2 | ASSESSING EXPRESSION OF ENDOGENOUS AND EXOGENOUS GENES | Promega Corporation (US) | 2011-06-15 | — | — | EP | disclosed |
| US-20110129813-A1 | 2'-BRANCHED NUCLEOSIDES AND FLAVIVIRIDAE MUTATION | IDENIX PHARMACEUTICALS LLC | 2011-06-02 | — | — | US | disclosed |
| EP-2325205-A2 | Crystals of whole antibodies and fragments thereof and methods for making and using them | Altus Pharmaceuticals Inc. (US) | 2011-05-25 | — | — | EP | disclosed |
| US-20110117116-A1 | NUCLEIC ACIDS ENCODING A HOUSE DUST MITE ALLERGEN, DER P III, AND USES THEREFOR | MERCK PATENT GMBH (DE) | 2011-05-19 | — | — | US | disclosed |
| US-7943137-B2 | FPRL1 ligands and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-05-17 | — | — | US | disclosed |
| US-20110104680-A1 | RECURRENT GENE FUSIONS IN LUNG CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2011-05-05 | — | — | US | disclosed |
| US-20110091920-A1 | METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX | COMO BIOTECH APS (DK) | 2011-04-21 | — | — | US | disclosed |
| EP-2310855-A1 | MULTI-LIGAND CAPTURE AGENTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | California Institute of Technology (US) | 2011-04-20 | — | — | EP | disclosed |
| EP-2307444-A1 | ANALYSIS OF LACTOBACILLUS ACIDOPHILUS LA-5 SIGNAL INTERFERENCE MOLECULES | University Of Guelph (CA) | 2011-04-13 | — | — | EP | disclosed |
| EP-2301957-A2 | Altered fibronectin-binding protein of staphylococcus aureus | Wyeth LLC (US) | 2011-03-30 | — | — | EP | disclosed |
| WO-2011034906-A2 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2011-03-24 | — | — | WO | disclosed |
| US-20110065113-A1 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2011-03-17 | — | — | US | disclosed |
| US-7906477-B2 | Activation of peptide prodrugs by hK2 | GENSPERA, INC. (US) | 2011-03-15 | — | — | US | disclosed |
| US-20110059522-A1 | NUCLEIC ACIDS ENCODING A HOUSE DUST MITE ALLERGEN, DER P III, AND USES THEREOF | MERCK PATENT GMBH (DE) | 2011-03-10 | — | — | US | disclosed |
| US-7897371-B2 | Using protein kinase inhibitors to treat and prevent glycogen metabolism defects and cell proliferative disorders | NOVARTIS AG (CH) | 2011-03-01 | — | — | US | disclosed |
| US-20110047634-A1 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA | ST. JUDE CHILDREN'S RESEARCH HOSPITAL | 2011-02-24 | — | — | US | disclosed |
| US-20110034677-A1 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2011-02-10 | — | — | US | disclosed |
| US-20110028399-A1 | CITRULLINATED CYTOKINES | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2011-02-03 | — | — | US | disclosed |
| US-20110020926-A1 | NOVEL TASTE-MODIFYING POLYPEPTIDE NAS, DNA THEREOF AND USE THEREOF | MIZKAN HOLDINGS CO., LTD. (JP) | 2011-01-27 | — | — | US | disclosed |
| EP-2276503-A2 | CITRULLINATED CYTOKINES | Katholieke Universiteit Leuven (BE) | 2011-01-26 | — | — | EP | disclosed |
| EP-0948625-B1 | USPA1 AND USPA2 ANTIGENS OF MORAXELLA CATARRHALIS | UNIV TEXAS (US) | 2011-01-26 | — | — | EP | disclosed |
| EP-2259787-A2 | IKKI INHIBITOR THERAPIES AND SCREENING METHODS, AND RELATED IKKI DIAGNOSTICS | The Regents of the University of Michigan (US) | 2010-12-15 | — | — | EP | disclosed |
| US-7851433-B2 | Method of purifying TFPI and TFPI analogs | NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) | 2010-12-14 | — | — | US | disclosed |
| US-7842788-B2 | Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods | AMGEN INC. (US) | 2010-11-30 | — | — | US | disclosed |
| CN-1412310-B | Enzyme with protease activity | NOVOZYMES AS | 2010-11-24 | — | — | CN | disclosed |
| US-7833525-B2 | Crystals of whole antibodies and fragments thereof and methods for making and using them | AJINOMOTO ALTHEA INC. | 2010-11-16 | — | — | US | disclosed |
| US-20100279301-A1 | METHODS AND COMPOSITIONS FOR DIAGNOSING BLADDER CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2010-11-04 | — | — | US | disclosed |
| US-7824851-B2 | With purine or pyrimidine base; for use in combination with drugs that induce mutation in Flaviviridae at location other than mutation of nucleotide that results in change from serine to a different amino acid in highly conserved consensus sequence XRXSGXXXT of domain B of the RNA polymerase region | IDENIX PHARMACEUTICALS, INC. (US) | 2010-11-02 | — | — | US | disclosed |
| US-7820378-B2 | Fragmentation-based methods and systems for sequence variation detection and discovery | SEQUENOM, INC. (US) | 2010-10-26 | — | — | US | disclosed |
| WO-2010118259-A1 | IMMUNOLOGICALLY ACTIVE LIPOPEPTIDES AND METHODS FOR USE THEREOF | THERIMUNEX PHARMACEUTICALS, INC. (US) | 2010-10-14 | — | — | WO | disclosed |
| US-20100257617-A1 | Transgenic animals comprising gene fusions | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2010-10-07 | — | — | US | disclosed |
| US-7799533-B2 | Polypeptides, their production and use | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-09-21 | — | — | US | disclosed |
| EP-1492810-B1 | NOVEL FLUORESCENT PROTEINS | UNIV HONG KONG CHINESE (HK) | 2010-09-08 | — | — | EP | disclosed |
| US-7790367-B2 | Method for screening a library of VHH polypeptides | VRIJE UNIVERSITEIT BRUSSEL (BE) | 2010-09-07 | — | — | US | disclosed |
| US-7786047-B2 | Immunoglobulins devoid of light chains | VRIJE UNIVERSITEIT BRUSSEL (BE) | 2010-08-31 | — | — | US | disclosed |
| US-20100216970-A1 | METHODS, COMPOSITIONS, AND APPARATUSES FOR FORMING MACROCYCLIC COMPOUNDS | JOHNSON THOMAS E | 2010-08-26 | — | — | US | disclosed |
| US-7776526-B2 | Method for the dissociation of the extracellular haemoglobin molecule of Arenicola marina and the characterization of the protein chains forming the molecule and the nucleotide sequences coding for said protein chains | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-08-17 | — | — | US | disclosed |
| US-7771731-B2 | Altered fibronectin-binding protein of Staphylococcus aureus | WYETH LLC (US) | 2010-08-10 | — | — | US | disclosed |
| US-20100184224-A1 | PLANT CELL WALL LOOSENING ACTIVITY OF GROUP 2/3 ALLERGENS OF GRASS POLLEN | THE PENN STATE RESEARCH FOUNDATION (US) | 2010-07-22 | — | — | US | disclosed |
| WO-2010081001-A2 | RECURRENT GENE FUSIONS IN CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2010-07-15 | — | — | WO | disclosed |
| US-7750114-B2 | Peptides having a high cysteine content | KEREK FRANZ | 2010-07-06 | — | — | US | disclosed |
| US-20100167291-A1 | ASSESSING EXPRESSION OF ENDOGENOUS AND EXOGENOUS GENES | PROMEGA CORPORATION (US) | 2010-07-01 | — | — | US | disclosed |
| EP-1400550-B1 | BRANCHED POLYALKYLENE GLYCOLS | KYOWA HAKKO KIRIN CO LTD (JP) | 2010-06-23 | — | — | EP | disclosed |
| WO-2010065322-A1 | CONCURRENT IDENTIFICATION OF MULTITUDES OF POLYPEPTIDES | RESEARCH TRIANGLE INSTITUTE (US) | 2010-06-10 | — | — | WO | disclosed |
| US-20100136574-A1 | METHOD FOR DETECTING A CHRONIC INFLAMMATORY-ASSOCIATED DISEASE | PEREIRA H ANNE | 2010-06-03 | — | — | US | disclosed |
| EP-2192131-A1 | Immunoglobulins devoid of light chains | Vrije Universiteit Brussel (BE) | 2010-06-02 | — | — | EP | disclosed |
| US-20100129804-A1 | SPINK1 AS A PROSTATE CANCER MARKER AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2010-05-27 | — | — | US | disclosed |
| WO-2010059702-A2 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2010-05-27 | — | — | WO | disclosed |
| US-7722871-B2 | Immunoglobulins devoid of light chains | VRIJE UNIVERSITEIT BRUSSEL (BE) | 2010-05-25 | — | — | US | disclosed |
| US-7718606-B2 | Methods for treating muscle diseases and disorders | ACORDA THERAPEUTICS, INC. (US) | 2010-05-18 | — | — | US | disclosed |
| US-7718369-B2 | diagnostic markers and clinical targets for prostate cancer; androgen regulated genes and ETS family member genes | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2010-05-18 | — | — | US | disclosed |
| US-7718437-B2 | Method for analyzing N-terminal protein adducts | ADDUCT ANALYS AB (SE) | 2010-05-18 | — | — | US | disclosed |
| US-20100112071-A1 | POLYPEPTIDES AND POLYNUCLEOTIDES FOR ENHANCING IMMUNE REACTIVITY TO HER-2 PROTEIN | THE OHIO STATE UNIVERSITY (US) | 2010-05-06 | — | — | US | disclosed |
| EP-0703783-B1 | METHODS OF MAKING IMMUNOGENIC HLA-A2.1 BINDING PEPTIDES | EPIMMUNE INC (US) | 2010-05-05 | — | — | EP | disclosed |
| EP-1041083-B1 | Modified timp | ORIENTAL YEAST CO LTD (JP) | 2010-05-05 | — | — | EP | disclosed |
| US-7709632-B2 | such as porphyrins, chlorins, texaphyrins via cyclization, oligomerization | JOHNSON THOMAS E | 2010-05-04 | — | — | US | disclosed |
| US-7704924-B2 | Library of compounds comprising pyrrolobenzodiazepine moieties | SPIROGEN LIMITED (GB) | 2010-04-27 | — | — | US | disclosed |
| US-20100098729-A1 | NOVEL SURFACE EXPOSED IMMUNOGLOBULIN D-BINDING PROTEIN FROM FORAXELLA CATARRHALIS | ARNE FORSGREN ET AL. (SE) | 2010-04-22 | — | — | US | disclosed |
| US-7691367-B2 | Branched polyalkylene glycols | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2010-04-06 | — | — | US | disclosed |
| EP-2167689-A2 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | The Regents of the University of Michigan (US) | 2010-03-31 | — | — | EP | disclosed |
| EP-0656946-B2 | IMMUNOGLOBULINS DEVOID OF LIGHT CHAINS | UNIV BRUXELLES (BE) | 2010-03-31 | — | — | EP | disclosed |
| US-20100069252-A1 | EFFICIENT METHOD FOR PARTIAL SEQUENCING OF PEPTIDE/PROTEIN USING ACID OR BASE LABILE XANTHATES | CHIBBER BAKSHY AKSHAYKIRIT | 2010-03-18 | — | — | US | disclosed |
| WO-2010030461-A2 | ASSESSING EXPRESSION OF ENDOGENOUS AND EXOGENOUS GENES | PROMEGA CORPORATION (US) | 2010-03-18 | — | — | WO | disclosed |
| US-20100062510-A1 | Protein exhibiting activity of pyrethrin biosynthetic enzyme, gene encoding the protein, and vector bearing the gene | AN EDUCATIONAL FOUNDATION KINKI UNIVERSITY (JP) | 2010-03-11 | — | — | US | disclosed |
| EP-2157175-A1 | Protein exhibiting activity of pyrethrin biosynthetic enzyme, gene endcoding the protein, and vector bearing the gene | Educational Foundation Kinki University (JP) | 2010-02-24 | — | — | EP | disclosed |
| US-7666429-B2 | Nucleic acids encoding a house dust mite allergen Der P III, and uses therefor | MERCK PATENT GMBH (DE) | 2010-02-23 | — | — | US | disclosed |
| US-7666430-B2 | Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein | THE OHIO STATE UNIVERSITY (US) | 2010-02-23 | — | — | US | disclosed |
| CN-101652484-A | Prostate cancer marker SPINKI and application thereof | UNIV MICHIGAN US | 2010-02-17 | — | — | CN | disclosed |
| US-20100029013-A1 | Methods for Detecting Asymmetric Dimethylarginine in a Biological Sample | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-02-04 | — | — | US | disclosed |
| US-7655480-B2 | Method for predicting sepsis or an acute infectious inflammatory response | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2010-02-02 | — | — | US | disclosed |
| EP-2145180-A1 | COMPARATIVE SEQUENCE ANALYSIS PROCESSES AND SYSTEMS | SEQUENOM, INC. (US) | 2010-01-20 | — | — | EP | disclosed |
| US-20100009896-A1 | CAPTURE AGENTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-01-14 | — | — | US | disclosed |
| US-20100010201-A1 | Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods | AMGEN INC. (US) | 2010-01-14 | — | — | US | disclosed |
| WO-2009155711-A1 | ANALYSIS OF LACTOBACILLUS ACIDOPHILUS LA-5 SIGNAL INTERFERENCE MOLECULES | UNIVERSITY OF GUELPH (CA) | 2009-12-30 | — | — | WO | disclosed |
| WO-2009155420-A1 | MULTI-LIGAND CAPTURE AGENTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2009-12-23 | — | — | WO | disclosed |
| EP-1589107-B1 | Immunoglobulins devoid of light chains | UNIV BRUXELLES (BE) | 2009-12-23 | — | — | EP | disclosed |
| EP-1498427-B1 | Immunoglobulins devoid of light chains | UNIV BRUXELLES (BE) | 2009-12-16 | — | — | EP | disclosed |
| US-20090304714-A1 | IKKi Inhibitor Therapies and Screening Methods, and Related IKKi Diagnostics | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2009-12-10 | — | — | US | disclosed |
| EP-2115162-A2 | ADRB2 CANCER MARKERS | The Regents of the University of Michigan (US) | 2009-11-11 | — | — | EP | disclosed |
| WO-2009132401-A2 | CITRULLINATED CYTOKINES | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2009-11-05 | — | — | WO | disclosed |
| EP-1559721-B1 | FPRL1 LIGANDS AND USE THEREOF | TAKEDA PHARMACEUTICAL (JP) | 2009-11-04 | — | — | EP | disclosed |
| US-7611834-B2 | Methods and devices for protein assays | SANDIA CORPORATION (US) | 2009-11-03 | — | — | US | disclosed |
| US-7611844-B2 | Methods for detecting asymmetric dimethylarginine in a biological sample | BOARD OF TRUSTEES OF THE LELAND STANFORD JR. UNIVERSITY (US) | 2009-11-03 | — | — | US | disclosed |
| US-7604975-B2 | Comprises endopeptidase for use as tool in identifying modulators which prevent bacterial infection; enzyme inhibitors | THE ROCKEFELLER UNIVERSITY (US) | 2009-10-20 | — | — | US | disclosed |
| US-7604804-B2 | Two gp120 binding molecules that target the CD4 binding pocket on a trimeric HIV gp120 complex and gp120 binding molecules are separated by a spacer/linker of sufficient length to provide for binding of the gp120 binding molecules to the CD-4 binding sites on trimeric gp120 sites on virion surface | UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) | 2009-10-20 | — | — | US | disclosed |
| US-20090246867-A1 | Glial mitogenic factors, their preparation and use | ACORDA THERAPEUTICS, INC. | 2009-10-01 | — | — | US | disclosed |
| WO-2009120801-A2 | IKKI INHIBITOR THERAPIES AND SCREENING METHODS, AND RELATED IKKI DIAGNOSTICS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2009-10-01 | — | — | WO | disclosed |
| US-20090239221-A1 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2009-09-24 | — | — | US | disclosed |
| EP-2094866-A2 | DIAGNOSIS AND TREATMENT OF BREAST CANCER | The Regents of the University of Michigan (US) | 2009-09-02 | — | — | EP | disclosed |
| WO-2009105335-A1 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA | ST.JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2009-08-27 | — | — | WO | disclosed |
| EP-1120425-B1 | PROCESS FOR ELIMINATING N-TERMINAL METHIONINE | TAKEDA PHARMACEUTICAL (JP) | 2009-08-26 | — | — | EP | disclosed |
| US-20090208937-A1 | Recurrent gene fusions in prostate cancer | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2009-08-20 | — | — | US | disclosed |
| US-7576194-B2 | UspA2 nucleic acid of moraxella catarrhalis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2009-08-18 | — | — | US | disclosed |
| US-20090202583-A1 | Rhinovirus Vaccines | SMITH THOMAS J | 2009-08-13 | — | — | US | disclosed |
| EP-0754232-B2 | PLANT LYSOPHOSPHATIDIC ACID ACYLTRANSFERASES | CALGENE LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| US-7569683-B2 | UspA2 nucleic acid of Moraxella catarrhalis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2009-08-04 | — | — | US | disclosed |
| US-7569706-B2 | Glycerol derivative | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2009-08-04 | — | — | US | disclosed |
| EP-2079851-A2 | SPINK1 AS A PROSTATE CANCER MARKER AND USES THEREOF | The Regents of the University of Michigan (US) | 2009-07-22 | — | — | EP | disclosed |
| US-20090181858-A1 | Adding photoregulated amino acids to the genetic code | THE SCRIPPS RESEARCH INSTITUTE (US) | 2009-07-16 | — | — | US | disclosed |
| US-7560286-B2 | Mass spectrometric method for structural analysis of chain nitrogen-containing compounds using sqauric acid | SUNTORY HOLDINGS LIMITED (JP) | 2009-07-14 | — | — | US | disclosed |
| US-7553630-B2 | Methods for detecting metalloproteinase inhibitors | AMGEN INC. (US) | 2009-06-30 | — | — | US | disclosed |
| US-7547765-B2 | Branched polyalkylene glycols | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2009-06-16 | — | — | US | disclosed |
| EP-1007570-B1 | MONOSPECIFIC ANTIBODY REACTIVE WITH FIBRINOGEN AND FIBRINOPEPTIDE B | NEW YORK BLOOD CT INC (US) | 2009-06-10 | — | — | EP | disclosed |
| US-7541449-B2 | Human kunitz-type inhibitors and methods relating thereto | STC.UNM (US) | 2009-06-02 | — | — | US | disclosed |
| US-7541338-B2 | Glial mitogenic factors, their preparation and use | ACORDA THERAPEUTICS, INC. (US) | 2009-06-02 | — | — | US | disclosed |
| US-20090137788-A1 | USPA1 AND USPA2 ANTIGENS OF MORAXELLA CATARRHALIS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-05-28 | — | — | US | disclosed |
| US-20090118486-A1 | USPA1 AND USPA2 ANTIGENS OF MORAXELLA CATARRHALIS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-05-07 | — | — | US | disclosed |
| US-20090093617-A1 | Crystals of whole antibodies and fragments thereof and methods for making and using them | ALTUS PHARMACEUTICALS INC. (US) | 2009-04-09 | — | — | US | disclosed |
| EP-1621554-B1 | Immunoglobulins devoid of light chains | UNIV BRUXELLES (BE) | 2009-04-08 | — | — | EP | disclosed |
| US-20090075334-A1 | POLYPEPTIDES, THEIR PRODUCTION AND USE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-03-19 | — | — | US | disclosed |
| US-20090075833-A1 | ADRB2 CANCER MARKERS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2009-03-19 | — | — | US | disclosed |
| EP-1738177-B1 | METHOD FOR ANALYZING N-TERMINAL PROTEIN ADDUCTS | ADDUCT ANALYS AB (SE) | 2009-02-11 | — | — | EP | disclosed |
| US-7485616-B2 | Methods of investigating, diagnosing, and treating amyloidosis | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2009-02-03 | — | — | US | disclosed |
| US-7482008-B1 | Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor | MERCK PATENT GMBH (DE) | 2009-01-27 | — | — | US | disclosed |
| US-20090025108-A1 | Resistance to Acetohydroxyacid Synthase-Inhibiting Herbicides in Rice | CROUGHAN TIMOTHY P | 2009-01-22 | — | — | US | disclosed |
| US-20090018073-A1 | Methods for treating muscle diseases and disorders | ACORDA THERAPEUTICS, INC. (US) | 2009-01-15 | — | — | US | disclosed |
| WO-2009009432-A2 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2009-01-15 | — | — | WO | disclosed |
| EP-0956354-B1 | RECOMBINANT N-PROTEINASE, AND THE PRODUCTION, METHODS AND USES THEREOF | UNIV LIEGE (BE) | 2009-01-14 | — | — | EP | disclosed |
| EP-2011875-A1 | Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods | Amgen Inc. (US) | 2009-01-07 | — | — | EP | disclosed |
| EP-1409684-B1 | NOVEL SURFACE EXPOSED IMMUNOGLOBULIN D-BINDING PROTEIN FROM MORAXELLA CATARRHALIS | FORSGREN ARNE (SE) | 2009-01-07 | — | — | EP | disclosed |
| EP-1087013-B1 | Immunoglobulins devoid of light chains | UNIV BRUXELLES (BE) | 2009-01-07 | — | — | EP | disclosed |
| CN-101341256-A | Recurrent gene fusions in prostate cancer | UNIV MICHIGAN (US) | 2009-01-07 | — | — | CN | disclosed |
| US-20090006002-A1 | COMPARATIVE SEQUENCE ANALYSIS PROCESSES AND SYSTEMS | SEQUENOM, INC. (US) | 2009-01-01 | — | — | US | disclosed |
| EP-2008092-A2 | POLYMERIC SULFATED SURFACTANTS FOR CAPILLARY ELECTROPHORESIS (CE) AND CE-MASS SPECTROMETRY (CE-MS) | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2008-12-31 | — | — | EP | disclosed |
| US-7470432-B2 | Surface explosed immunoglobulin D-binding protein from Moraxella catarrhalis | ARNE FORSGREN ET AL (SE) | 2008-12-30 | — | — | US | disclosed |
| EP-1716153-A4 | METHODS, COMPOSITIONS, AND APPARATUSES FOR FORMING MACROCYCLIC COMPOUNDS | JOHNSON THOMAS E (US) | 2008-12-17 | — | — | EP | disclosed |
| US-20080305522-A1 | Novel Taste-Modifying Polypeptide Nas, Dna Thereof and Use Thereof | MITSUKAN GROUP CORPORATION (JP) | 2008-12-11 | — | — | US | disclosed |
| WO-2008138129-A1 | THURICIN 17 FOR PROMOTING PLANT GROWTH AND DISEASE RESISTANCE AND TRANSGENIC PLANTS | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2008-11-20 | — | — | WO | disclosed |
| EP-1987178-A2 | METHOD OF CONSTRUCTING AND SCREENING LIBRARIES OF PEPTIDE STRUCTURES | Phylogica Limited (AU) | 2008-11-05 | — | — | EP | disclosed |
| EP-1319669-B1 | Chemically modified tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods | AMGEN INC (US) | 2008-10-29 | — | — | EP | disclosed |
| US-20080260762-A1 | HLA binding motifs and peptides and their uses | Biotech Synergy, Inc. | 2008-10-23 | — | — | US | disclosed |
| WO-2008128111-A1 | COMPARATIVE SEQUENCE ANALYSIS PROCESSES AND SYSTEMS | SEQUENOM, INC. (US) | 2008-10-23 | — | — | WO | disclosed |
| US-7435719-B2 | Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods | AMGEN INC. (US) | 2008-10-14 | — | — | US | disclosed |
| US-20080248585-A1 | Protein/Peptide Sequencing By Chemical Degradation in the Gas Phase | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2008-10-09 | — | — | US | disclosed |
| US-20080248953-A1 | Use of Bacteriocins For Promoting Plant Growth and Disease Resistance | MCGILL UNIVERSITY | 2008-10-09 | — | — | US | disclosed |
| US-20080234190-A1 | Glial mitogenic factors, their preparation and use | ACORDA THERAPEUTICS, INC. | 2008-09-25 | — | — | US | disclosed |
| US-20080213240-A1 | RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK | NOVARTIS AG (CH) | 2008-09-04 | — | — | US | disclosed |
| EP-1576138-A4 | 2-BRANCHED NUCLEOSIDES AND FLAVIVIRIDAE MUTATION | IDENIX CAYMAN LTD (KY) | 2008-09-03 | — | — | EP | disclosed |
| US-7419956-B2 | A G protein-coupled receptor protein for the treatment of digestive diseases | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-09-02 | — | — | US | disclosed |
| US-20080207714-A1 | Diagnosis And Treatment Of Breast Cancer | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2008-08-28 | — | — | US | disclosed |
| EP-1961424-A1 | Activation of peptide prodrugs by HK2 | The John Hopkins University (US) | 2008-08-27 | — | — | EP | disclosed |
| EP-1298214-B1 | Plant thioesterases | CALGENE LLC (US) | 2008-08-13 | — | — | EP | disclosed |
| US-7410796-B2 | Proteinase inhibitor, precursor thereof and genetic sequences encoding same | HEXIMA LIMITED (AU) | 2008-08-12 | — | — | US | disclosed |
| US-7410776-B2 | Polypeptides, their production and use | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-08-12 | — | — | US | disclosed |
| EP-1948799-A1 | USE OF BACTERIOCINS FOR PROMOTING PLANT GROWTH AND DISEASE RESISTANCE | McGill University (CA) | 2008-07-30 | — | — | EP | disclosed |
| WO-2008089397-A2 | ADRB2 CANCER MARKERS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2008-07-24 | — | — | WO | disclosed |
| US-7402407-B1 | Chemically targeted positional identification of post-translationally phosphorylated peptides | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2008-07-22 | — | — | US | disclosed |
| US-7399905-B2 | Resistance to acetohydroxyacid synthase-inhibiting herbicides in rice | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2008-07-15 | — | — | US | disclosed |
| EP-1797177-A4 | ADDING PHOTOREGULATED AMINO ACIDS TO THE GENETIC CODE | SCRIPPS RESEARCH INST (US) | 2008-07-09 | — | — | EP | disclosed |
| EP-1934363-A2 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2008-06-25 | — | — | EP | disclosed |
| WO-2008073599-A2 | EFFICIENT METHOD FOR PARTIAL SEQUENCING OF PEPTIDE/PROTEIN USING ACID OR BASE LABILE XANTHATES | OZONE RESEARCH FRONTIER LTD. (US) | 2008-06-19 | — | — | WO | disclosed |
| US-7384756-B1 | Methods for treating muscle diseases and disorders | ACORDA THERAPEUTICS, INC. (US) | 2008-06-10 | — | — | US | disclosed |
| US-20080134367-A1 | Nucleic acids encoding monomers of a type II serine proteinase inhibitor | HEXIMA LIMITED (AU) | 2008-06-05 | — | — | US | disclosed |
| US-20080125350-A1 | BRANCHED POLYALKYLENE GLYCOLS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2008-05-29 | — | — | US | disclosed |
| WO-2008060945-A2 | DIAGNOSIS AND TREATMENT OF BREAST CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2008-05-22 | — | — | WO | disclosed |
| US-7374910-B2 | DNA encoding galanin receptor activating peptide | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-05-20 | — | — | US | disclosed |
| WO-2008058239-A2 | SPINK1 AS A PROSTATE CANCER MARKER AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2008-05-15 | — | — | WO | disclosed |
| US-20080081768-A1 | Methods of constructing and screening libraries of peptide structures | PHYLOGICA LIMITED (AU) | 2008-04-03 | — | — | US | disclosed |
| US-20080076680-A1 | System and apparatus for automated protein analysis priority | OZONE RESEARCH FRONTIER LTD. (US) | 2008-03-27 | — | — | US | disclosed |
| US-7344724-B2 | UspA1 and UspA2 antigens of Moraxella catarrhalis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2008-03-18 | — | — | US | disclosed |
| US-7335488-B2 | Spontaneously fluorescent protein comprising a p-hydroxybenzylidene-imidazolidinone chromophore; reporter genes | THE CHINESE UNIVERSITY OF HONG KONG (HK) | 2008-02-26 | — | — | US | disclosed |
| US-7320868-B2 | Leptin binding domain compositions and methods thereto | BECKMAN COULTER, INC. | 2008-01-22 | — | — | US | disclosed |
| US-20080015117-A1 | REACTOR FOR AUTOMATED PROTEIN ANALYSIS | OZONE RESEARCH FRONTIER LTD. (US) | 2008-01-17 | — | — | US | disclosed |
| EP-1107969-B1 | COLLECTIONS OF COMPOUNDS | SPIROGEN LTD (GB) | 2008-01-16 | — | — | EP | disclosed |
| US-7319019-B1 | Glial mitogenic factors lacking an N-terminal signal sequence | ACORDA THERAPEUTICS, INC. (US) | 2008-01-15 | — | — | US | disclosed |
| EP-1040189-B1 | POLYPEPTIDES, THEIR PRODUCTION AND USE | TAKEDA PHARMACEUTICAL (JP) | 2008-01-09 | — | — | EP | disclosed |
| US-7314724-B2 | Therapeutic applications of laminin and laminin-derived protein fragments | UNIVERSITY OF WASHINGTON (US) | 2008-01-01 | — | — | US | disclosed |
| US-7309596-B2 | Isolated monomers of a type II serine proteinase inhibitor | HEXIMA LIMITED (AU) | 2007-12-18 | — | — | US | disclosed |
| EP-1642136-A4 | METHOD OF ISOLATING A PROTEIN | PROTEOME SYSTEMS INTELLECTUAL (AU) | 2007-12-12 | — | — | EP | disclosed |
| EP-0959682-B1 | THERAPEUTIC APPLICATIONS OF LAMININ AND LAMININ-DERIVED PROTEIN FRAGMENTS | UNIV WASHINGTON (US) | 2007-11-28 | — | — | EP | disclosed |
| EP-0529031-B9 | IMPROVED INHIBITORS OF THROMBIN | BIOGEN INC (US) | 2007-11-21 | — | — | EP | disclosed |
| US-7291713-B2 | Branched polyalkylene glycols | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-11-06 | — | — | US | disclosed |
| US-7288646-B2 | USPA2 nucleic acid of Moraxella catarrhalis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-10-30 | — | — | US | disclosed |
| WO-2007120805-A2 | SYSTEM AND APPARATUS FOR AUTOMATED PROTEIN ANALYSIS | OZONE RESEARCH FRONTIER LTD. (US) | 2007-10-25 | — | — | WO | disclosed |
| US-7285531-B1 | Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor | ACORDA THERAPEUTICS, INC. (US) | 2007-10-23 | — | — | US | disclosed |
| US-20070243622-A1 | POLYMERIC SULFATED SURFACTANTS FOR CAPILLARY ELECTROPHORESIS (CE) AND CE-MASS SPECTROMETRY (CE-MS) | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2007-10-18 | — | — | US | disclosed |
| US-7282483-B2 | Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF | AMGEN INC. (US) | 2007-10-16 | — | — | US | disclosed |
| US-20070238133-A1 | Immunoglobulins devoid of light chains | VRIJE UNIVERSITEIT BRUSSEL (BE) | 2007-10-11 | — | — | US | disclosed |
| WO-2007112444-A2 | POLYMERIC SULFATED SURFACTANTS FOR CAPILLARY ELECTROPHORESIS (CE) AND CE-MASS SPECTROMETRY (CE-MS) | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2007-10-04 | — | — | WO | disclosed |
| US-20070231925-A1 | Methods and devices for protein assays | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC | 2007-10-04 | — | — | US | disclosed |
| EP-1840220-A2 | Anthrax lethal factor is a MAPK kinase protease | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the Secretary of the Department of Health and Human Services (US) | 2007-10-03 | — | — | EP | disclosed |
| US-7276378-B2 | Increasing ionization efficiency in mass spectrometry | AGILENT TECHNOLOGIES, INC. (US) | 2007-10-02 | — | — | US | disclosed |
| US-20070218075-A1 | Altered Fibronectin-Binding Protein of Staphylococcus Aureus | WYETH | 2007-09-20 | — | — | US | disclosed |
| US-20070217965-A1 | Methods, compositions, and apparatuses for forming macrocyclic compounds | JOHNSON THOMAS E | 2007-09-20 | — | — | US | disclosed |
| US-20070212702-A1 | Recurrent gene fusions in prostate cancer | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2007-09-13 | — | — | US | disclosed |
| US-7264944-B1 | TNF receptors, TNF binding proteins and DNAs coding for them | AMGEN INC. (US) | 2007-09-04 | — | — | US | disclosed |
| WO-2007097923-A2 | METHOD OF CONSTRUCTING AND SCREENING LIBRARIES OF PEPTIDE STRUCTURES | PHYLOGICA LIMITED (AU) | 2007-08-30 | — | — | WO | disclosed |
| CN-101023100-A | HER2 antibody composition | GENENTECH INC | 2007-08-22 | — | — | CN | disclosed |
| US-20070190659-A1 | Method for analyzing n-terminal protein adducts | ADDUCT ANALYS AB (SE) | 2007-08-16 | — | — | US | disclosed |
| EP-0790255-B1 | Monoclonal antibodies directed to the cytotoxic lymphocyte maturation factor | HOFFMANN LA ROCHE (CH) | 2007-08-08 | — | — | EP | disclosed |
| US-20070178541-A1 | Method of isolating a protein | PROTEOME SYSTEMS INTELLECTUAL PROPERTY PTY LTD (AU) | 2007-08-02 | — | — | US | disclosed |
| EP-0790309-B1 | Cytotoxic lymphocyte maturation factor 40kD subunit and monoclonal antibodies directed thereto | HOFFMANN LA ROCHE (CH) | 2007-07-25 | — | — | EP | disclosed |
| US-20070166768-A1 | Method for predicting sepsis or an acute infectious inflammatory response | BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA, THE | 2007-07-19 | — | — | US | disclosed |
| EP-1310510-B1 | Topologically segregated, encoded solid phase libraries | AVENTIS PHARMA INC (US) | 2007-07-11 | — | — | EP | disclosed |
| EP-0790308-B1 | Cytotoxic lymphocyte maturation factor 35kD subunit and monoclonal antibodies directed thereto | HOFFMANN LA ROCHE (CH) | 2007-07-04 | — | — | EP | disclosed |
| US-7238776-B2 | Polypeptide for use in the treatment and prevention of tumors, inflammation, eating, hypertriglyceridaemia, cachexia and microorganismal infections | AMGEN INC. (US) | 2007-07-03 | — | — | US | disclosed |
| US-7238489-B2 | Identification of sortase gene | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-07-03 | — | — | US | disclosed |
| EP-1801123-A2 | Crystals of whole antibodies and fragments thereof and methods for making and using them | Altus Pharmaceuticals Inc. (US) | 2007-06-27 | — | — | EP | disclosed |
| US-20070141669-A1 | Pregnancy-associated plasma protein-A2 (PAPP-A2) | OXVIG CLAUS | 2007-06-21 | — | — | US | disclosed |
| EP-1797177-A2 | ADDING PHOTOREGULATED AMINO ACIDS TO THE GENETIC CODE | The Scripps Research Institute (US) | 2007-06-20 | — | — | EP | disclosed |
| EP-0742438-B1 | Screening of combinatorial peptide libraries for selection of peptide ligand useful in affinity purification of target proteins | BAYER CORP (US) | 2007-06-20 | — | — | EP | disclosed |
| EP-1302542-B1 | NOVEL PHYSIOLOGICALLY ACTIVE PEPTIDE AND USE THEREOF | TAKEDA PHARMACEUTICAL (JP) | 2007-06-13 | — | — | EP | disclosed |
| WO-2007056848-A1 | USE OF BACTERIOCINS FOR PROMOTING PLANT GROWTH AND DISEASE RESISTANCE | MCGILL UNIVERSITY (CA) | 2007-05-24 | — | — | WO | disclosed |
| US-20070105092-A1 | Proteolytic and covalent antibodies | COVALENT BIOSCIENCE INCORPORATED | 2007-05-10 | — | — | US | disclosed |
| US-7211424-B1 | Mammalian Subtilisin/kexin isozyme SKI-1: a proprotein convertase with a unique cleavage specificity | INSTITUT DE RECHERCHES CLINIQUES DE MONTREAL (CA) | 2007-05-01 | — | — | US | disclosed |
| US-20070092948-A1 | NOVEL HUMAN KUNITZ-TYPE INHIBITORS AND METHODS RELATING THERETO | ZYMOGENETICS, INC. | 2007-04-26 | — | — | US | disclosed |
| US-20070077240-A1 | Immunoglobulins devoid of light chains | VRIJE UNIVERSITEIT BRUSSEL | 2007-04-05 | — | — | US | disclosed |
| US-20070071827-A1 | Polypeptides and Polynucleotides for Enhancing Immune Reactivity to HER-2 Protein | THE OHIO STATE UNIVERSITY (US) | 2007-03-29 | — | — | US | disclosed |
| US-20070066515-A1 | Novel glycoprotein and pharmaceutical composition containing the same | KUREHA CORPORATION (JP) | 2007-03-22 | — | — | US | disclosed |
| WO-2007033187-A2 | RECURRENT GENE FUSIONS IN PROSTATE CANCER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2007-03-22 | — | — | WO | disclosed |
| US-20070065819-A1 | Novel fprl1 ligands and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-03-22 | — | — | US | disclosed |
| EP-0907724-B1 | VON WILLEBRAND FACTOR MULTIMERASE | BAXTER AG (AT) | 2007-03-21 | — | — | EP | disclosed |
| US-7192915-B1 | Methods for treating multiple sclerosis with GGF-related polypeptides | ACORDA THERAPEUTICS, INC. (US) | 2007-03-20 | — | — | US | disclosed |
| US-20070055049-A1 | HLA binding motifs and peptides and their uses | EPIMMUNE INC. | 2007-03-08 | — | — | US | disclosed |
| US-20070054365-A1 | Proteinase inhibitor, precursor thereof and genetic sequences encoding same | ANDERSON MARILYN A | 2007-03-08 | — | — | US | disclosed |
| US-7183071-B2 | Anthrax lethal factor is a MAPK kinase protease | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2007-02-27 | — | — | US | disclosed |
| US-20070037160-A1 | conatacting an extracellular haemoglobin sample from annelids with dissociating agent e.g. a mixture containing dithiothreitol (DTT) or tris(2-carboxyethyl)phosphine (TCEP) hydrochloride or beta-mercaptoethanol and a dissociation buffer for a sufficient length of time in order to separate the chains | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2007-02-15 | — | — | US | disclosed |
| WO-2007015690-A1 | PROTEIN/PEPTIDE SEQUENCING BY CHEMICAL DEGRADATION IN THE GAS PHASE | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2007-02-08 | — | — | WO | disclosed |
| EP-1749024-A2 | ALTERED FIBRONECTIN-BINDING PROTEIN OF STAPHYLOCOCCUS AUREUS | Wyeth a Corporation of the State of Delaware (US) | 2007-02-07 | — | — | EP | disclosed |
| US-20070025985-A1 | Immunoglobulins devoid of light chains | VRIJE UNIVERSITEIT BRUSSEL (BE) | 2007-02-01 | — | — | US | disclosed |
| EP-1738177-A1 | METHOD FOR ANALYZING N-TERMINAL PROTEIN ADDUCTS | Adduct Analys AB (SE) | 2007-01-03 | — | — | EP | disclosed |
| US-20060286085-A1 | Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods | SILBIGER SCOTT M | 2006-12-21 | — | — | US | disclosed |
| EP-1263452-A4 | METHODS AND COMPOSITIONS FOR GENERATING ANGIOSTATIN | UNIV NORTHWESTERN (US) | 2006-12-20 | — | — | EP | disclosed |
| EP-0686695-B1 | Rat protein kinase C and production thereof | TAKEDA PHARMACEUTICAL (JP) | 2006-12-06 | — | — | EP | disclosed |
| EP-1724341-A1 | NOVEL TASTE SENSATION-MODIFYING PEPTIDE NAS, DNA THEREOF AND USE OF THE SAME | Mitsukan Group Corporation (JP) | 2006-11-22 | — | — | EP | disclosed |
| US-7135456-B1 | Glial mitogenic factors, their preparation and use | ACORDA THERAPEUTICS, INC. (US) | 2006-11-14 | — | — | US | disclosed |
| EP-1716153-A2 | METHODS, COMPOSITIONS, AND APPARATUSES FOR FORMING MACROCYCLIC COMPOUNDS | Johnson, Thomas E. (US) | 2006-11-02 | — | — | EP | disclosed |
| US-20060234328-A1 | Anthrax lethal factor is a MAPK kinase protease | THE GOVERNMENT OF THE UNITED STATES OF AMERICA (US) | 2006-10-19 | — | — | US | disclosed |
| EP-0656788-B1 | HLA BINDING PEPTIDES AND THEIR USES | PHARMEXA INC (US) | 2006-10-18 | — | — | EP | disclosed |
| CN-1849142-A | 2'-branched nucleosides and flaviviridae mutation | IDENIX CAYMAN LTD (KY) | 2006-10-18 | — | — | CN | disclosed |
| US-20060223059-A1 | Methods for detecting endocrine cancer | MOUNT SINAI HOSPITAL (CA) | 2006-10-05 | — | — | US | disclosed |
| US-7115554-B1 | Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III | ACORDA THERAPEUTICS, INC. (US) | 2006-10-03 | — | — | US | disclosed |
| US-20060217317-A1 | Activation of peptide prodrugs by hk2 | INSPYR THERAPEUTICS, INC. | 2006-09-28 | — | — | US | disclosed |
| EP-1704868-A1 | HLA binding peptides and their uses | Pharmexa Inc. (US) | 2006-09-27 | — | — | EP | disclosed |
| EP-1705184-A1 | Treatment of neoplastic diseases using a combination of plasminogen activators and sulfhydryl donors | NORTHWESTERN UNIVERSITY (US) | 2006-09-27 | — | — | EP | disclosed |
| US-20060205918-A1 | Preparation of high molecular weight polysuccinimides | AQUERO COMPANY | 2006-09-14 | — | — | US | disclosed |
| EP-0755446-B1 | CARDIOTROPHIN AND USES THEREFOR | GENENTECH INC (US) | 2006-09-13 | — | — | EP | disclosed |
| US-7101692-B2 | Identification of sortase gene | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-09-05 | — | — | US | disclosed |
| EP-1575995-A4 | ACTIVATION OF PEPTIDE PRODRUGS BY HK2 | UNIV JOHNS HOPKINS (US) | 2006-08-30 | — | — | EP | disclosed |
| US-7094749-B1 | Glial mitogenic factors, their preparation and use | ACORDA THERAPEUTICS, INC. (US) | 2006-08-22 | — | — | US | disclosed |
| US-20060183679-A1 | Peptides having a high cysteine content | KEREK FRANZ | 2006-08-17 | — | — | US | disclosed |
| US-7090999-B2 | Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use | SANOFI-AVENTIS (FR) | 2006-08-15 | — | — | US | disclosed |
| EP-1686136-A1 | NOVEL GLYCOPROTEIN AND MEDICINAL COMPOSITION CONTAINING THE SAME | Kureha Corporation (JP) | 2006-08-02 | — | — | EP | disclosed |
| US-7083940-B2 | Polynucleotide encoding a polypeptide which has proteolytic activity for insulin like growth factor binding protein; use in diagnosis of fetal abnormalities | COMO BIOTECH APS (DK) | 2006-08-01 | — | — | US | disclosed |
| WO-2006078648-A2 | RHINOVIRUS VACCINES | DONALD DANFORTH PLANT SCIENCE CENTER (US) | 2006-07-27 | — | — | WO | disclosed |
| US-20060155109-A1 | Novel physiologically active peptide and its use | OHTAKI TETSUYA | 2006-07-13 | — | — | US | disclosed |
| US-7071317-B2 | Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods | AMGEN INC. (US) | 2006-07-04 | — | — | US | disclosed |
| US-20060134107-A1 | Immunoglobulins devoid of light chains | VRIJE UNIVERSITEIT BRUSSEL | 2006-06-22 | — | — | US | disclosed |
| US-20060134746-A1 | Adding photoregulated amino acids to the genetic code | THE SCRIPPS RESEARCH INSTITUTE (US) | 2006-06-22 | — | — | US | disclosed |
| US-7064181-B1 | Physiologically active peptide and its use | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-06-20 | — | — | US | disclosed |
| EP-0964869-B1 | Methods and compositions for the treatment of neoplastic diseases | UNIV NORTHWESTERN (US) | 2006-06-14 | — | — | EP | disclosed |
| US-7060284-B1 | Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein | THE OHIO STATE UNIVERSITY (US) | 2006-06-13 | — | — | US | disclosed |
| US-20060121026-A1 | Immunoglobulins devoid of light chains | VRIJE UNIVERSITEIT BRUSSEL | 2006-06-08 | — | — | US | disclosed |
| US-7056693-B2 | Anthrax lethal factor is a mapk kinase protease | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2006-06-06 | — | — | US | disclosed |
| US-7053170-B2 | Preparation of high molecular weight polysuccinimides | AQUERO COMPANY (US) | 2006-05-30 | — | — | US | disclosed |
| EP-1659132-A1 | Biologically active bactericidal/permeability-increasing protein fragments | NEW YORK UNIVERSITY (US) | 2006-05-24 | — | — | EP | disclosed |
| CN-1774511-A | Fragmentation-based methods and systems for sequence variation detection and discovery | SEQUENOM INC (US) | 2006-05-17 | — | — | CN | disclosed |
| US-7045299-B2 | Physiologically active peptide and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-05-16 | — | — | US | disclosed |
| US-20060099671-A1 | Methods and compositions for generating angiostatin | NORTHWESTERN UNIVERSITY | 2006-05-11 | — | — | US | disclosed |
| EP-1654283-A1 | IMPROVED METHOD OF PURIFYING TFPI AND TFPI ANALOGS | CHIRON CORPORATION (US) | 2006-05-10 | — | — | EP | disclosed |
| US-7037888-B1 | Methods for treating muscle diseases and disorders | ACORDA THERAPEUTICS, INC. (US) | 2006-05-02 | — | — | US | disclosed |
| US-20060088915-A1 | Novel physiologically active peptide and use thereof | OHTAKI TETSUYA | 2006-04-27 | — | — | US | disclosed |
| US-7029899-B1 | Selective toxicity of amino-terminal modified rnase a superfamily polypeptides | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2006-04-18 | — | — | US | disclosed |
| US-20060073530-A1 | Methods and compositions involving sortase B | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-04-06 | — | — | US | disclosed |
| EP-1642136-A1 | METHOD OF ISOLATING A PROTEIN | Proteome Systems Intellectual Property Pty Ltd. (AU) | 2006-04-05 | — | — | EP | disclosed |
| US-20060068480-A1 | Polypeptides and polypeptide analogues | OLIVER WIEDOW (DE) | 2006-03-30 | — | — | US | disclosed |
| WO-2006034410-A2 | ADDING PHOTOREGULATED AMINO ACIDS TO THE GENETIC CODE | THE SCRIPPS RESARCH INSTITUTE (US) | 2006-03-30 | — | — | WO | disclosed |
| EP-0733064-B1 | NUCLEIC ACIDS ENCODING A HOUSE DUST MITE ALLERGEN, (DER P III), AND USES THEREFOR | IMMULOGIC PHARMA CORP (US) | 2006-03-15 | — | — | EP | disclosed |
| US-20060051344-A1 | Antibody and utilization of the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-03-09 | — | — | US | disclosed |
| WO-2006025859-A2 | METHODS, COMPOSITIONS, AND APPARATUSES FOR FORMING MACROCYCLIC COMPOUNDS | JOHNSON THOMAS E (US) | 2006-03-09 | — | — | WO | disclosed |
| EP-0711351-B1 | WAX ESTERS IN TRANSFORMED PLANTS | CALGENE LLC (US) | 2006-03-01 | — | — | EP | disclosed |
| CN-1741810-A | Glycopeptide antibiotic derivatives | LEUVEN K U RES & DEV (BE) | 2006-03-01 | — | — | CN | disclosed |
| EP-0939808-B1 | SPRUCE BUDWORM ANTIFREEZE PROTEINS, GENES AND METHODS OF USING SAME | UNIV KINGSTON (CA) | 2006-02-15 | — | — | EP | disclosed |
| EP-0754232-B1 | PLANT LYSOPHOSPHATIDIC ACID ACYLTRANSFERASES | CALGENE LLC (US) | 2006-02-15 | — | — | EP | disclosed |
| EP-0687296-B1 | VARIANTS OF BILE SALT-STIMULATED LIPASE, DNA MOLECULES ENCODING THEM, AND TRANSGENIC NON-HUMAN MAMMALS | AREXIS AB (SE) | 2006-02-08 | — | — | EP | disclosed |
| US-20060025589-A1 | 2-Thiohydantoine derivative compounds and use thereof for the treatment of diabetes | LABORATOIRES FOURNIER S.A. (FR) | 2006-02-02 | — | — | US | disclosed |
| EP-1621554-A1 | Immunoglobulins devoid of light chains | VRIJE UNIVERSITEIT BRUSSEL (BE) | 2006-02-01 | — | — | EP | disclosed |
| US-20060021095-A1 | Synthetic DNA sequence having enhanced insecticidal activity in maize | SYNGENTA INVESTMENT CORPORATION | 2006-01-26 | — | — | US | disclosed |
| US-20060019352-A1 | Methods of increasing the production of cobalamins using cob gene expression | AVENTIS PHARMA S.A. | 2006-01-26 | — | — | US | disclosed |
| EP-1618216-A2 | FRAGMENTATION-BASED METHODS AND SYSTEMS FOR DE NOVO SEQUENCING | SEQUENOM, INC. (US) | 2006-01-25 | — | — | EP | disclosed |
| US-20060014143-A1 | Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis | YAMAMOTO NOBUTO | 2006-01-19 | — | — | US | disclosed |
| EP-0723019-B1 | 5'-flanking region of an Arabidopsis gene coding for a 2S albumin precursor | BAYER BIOSCIENCE NV (BE) | 2006-01-18 | — | — | EP | disclosed |
| EP-1615946-A2 | PROTEOLYTIC AND COVALENT ANTIBODIES | The University of Texas (US) | 2006-01-18 | — | — | EP | disclosed |
| EP-1613723-A2 | FRAGMENTATION-BASED METHODS AND SYSTEMS FOR SEQUENCE VARIATION DETECTION AND DISCOVERY | SEQUENOM, INC. (US) | 2006-01-11 | — | — | EP | disclosed |
| EP-0652230-B1 | Biologically active bactericidal/permeability-increasing protein fragments | UNIV NEW YORK (US) | 2005-12-14 | — | — | EP | disclosed |
| WO-2005116064-A2 | ALTERED FIBRONECTIN-BINDING PROTEIN OF STAPHYLOCOCCUS AUREUS | WYETH (US) | 2005-12-08 | — | — | WO | disclosed |
| US-6972280-B2 | Glial mitogenic factors, their preparation and use | ACORDA THERAPEUTICS, INC. (US) | 2005-12-06 | — | — | US | disclosed |
| US-20050250149-A1 | Proteinase inhibitor, precursor thereof and genetic sequences encoding same | ANDERSON MARILYN A | 2005-11-10 | — | — | US | disclosed |
| US-20050245731-A1 | DNA encoding tumor necrosis factor inhibitory protein and its use | YEDA RESEARCH AND DEVELOPMENT COMPANY LTD. (IL) | 2005-11-03 | — | — | US | disclosed |
| WO-2005101020-A1 | METHOD FOR ANALYZING N-TERMINAL PROTEIN ADDUCTS | ADDUCT ANALYS AB (SE) | 2005-10-27 | — | — | WO | disclosed |
| EP-1589107-A1 | Immunoglobulins devoid of light chains | VRIJE UNIVERSITEIT BRUSSEL (BE) | 2005-10-26 | — | — | EP | disclosed |
| US-6955916-B2 | Proteinase inhibitor, precursor thereof and genetic sequences encoding same | HEXIMA LIMITED (AU) | 2005-10-18 | — | — | US | disclosed |
| WO-2005094259-A2 | LEPTIN BINDING DOMAIN COMPOSITIONS AND METHODS THERETO | GERTTER ARIEH (IL) | 2005-10-13 | — | — | WO | disclosed |
| US-6949506-B2 | Relaxin-like factor and methods and uses thereof | BAS MEDICAL, INC. (US) | 2005-09-27 | — | — | US | disclosed |
| WO-2005088292-A1 | SEPARATION AND IDENTIFICATION OF ANALYTES BY GEL ELECTROPHORESIS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2005-09-22 | — | — | WO | disclosed |
| US-20050209137-A1 | Leptin binding domain compositions and methods thereto | BECKMAN COULTER, INC. | 2005-09-22 | — | — | US | disclosed |
| US-20050208015-A1 | Glycerol derivative | TECNO NETWORK SHIKOKU CO., LTD (JP) | 2005-09-22 | — | — | US | disclosed |
| EP-1576138-A2 | 2-BRANCHED NUCLEOSIDES AND FLAVIVIRIDAE MUTATION | Idenix (Cayman) Limited (KY) | 2005-09-21 | — | — | EP | disclosed |
| EP-1575995-A2 | ACTIVATION OF PEPTIDE PRODRUGS BY HK2 | The Johns Hopkins University (US) | 2005-09-21 | — | — | EP | disclosed |
| US-6946278-B2 | Proteinase inhibitor, precursor thereof and genetic sequences encoding same | HEXIMA LIMITED (AU) | 2005-09-20 | — | — | US | disclosed |
| US-6946264-B1 | Metalloproteinase inhibitor | AMGEN INC. (US) | 2005-09-20 | — | — | US | disclosed |
| EP-0703785-B8 | METHODS FOR TREATING MUSCLE DISEASES AND DISORDERS | ACORDA THERAPEUTICS INC (US) | 2005-09-14 | — | — | EP | disclosed |
| US-6943280-B2 | Resistance to acetohydroxycid synthase-inhibiting herbicides | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2005-09-13 | — | — | US | disclosed |
| US-20050196390-A1 | Metalloproteinase inhibitor | AMGEN INC. (US) | 2005-09-08 | — | — | US | disclosed |
| US-20050196822-A1 | Anthrax lethal factor is a mapk kinase protease | THE GOV. OF THE USA AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES (US) | 2005-09-08 | — | — | US | disclosed |
| US-20050198705-A1 | Resistance to acetohydroxyacid synthase-inhibiting herbicides | CROUGHAN TIMOTHY P (US) | 2005-09-08 | — | — | US | disclosed |
| US-6933134-B2 | DNA molecules encoding vascular endothelial cell growth factor II subunits | MERCK & CO., INC. (US) | 2005-08-23 | — | — | US | disclosed |
| US-20050176632-A1 | a protein with specific amino acid sequence; drug screening; inhibitors in prevention /remedies for cancer, ovary diseases, inflammatory diseases, diabetic retinopathy | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-08-11 | — | — | US | disclosed |
| US-20050176642-A1 | Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric GP120 | UNIVERSITY OF MARYLAND, BALTIMORE | 2005-08-11 | — | — | US | disclosed |
| US-20050176091-A1 | Process for producing kiss-1 peptide | TAKEDA CHEMICAL INDUSTRIES, LTD (JP) | 2005-08-11 | — | — | US | disclosed |
| EP-1559721-A1 | NOVEL FPRL1 LIGANDS AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2005-08-03 | — | — | EP | disclosed |
| EP-1557430-A1 | ANTIBODY AND UTILIZATION OF THE SAME | Takeda Pharmaceutical Company Limited (JP) | 2005-07-27 | — | — | EP | disclosed |
| US-20050158708-A1 | Methods and compositions related to tagging of membrane surface proteins | PROTEOLOGICS, LTD. (IL) | 2005-07-21 | — | — | US | disclosed |
| EP-0703785-B1 | METHODS FOR TREATING MUSCLE DISEASES AND DISORDERS | CAMBRIDGE NEUROSCIENCE RES (US) | 2005-07-20 | — | — | EP | disclosed |
| WO-2005064346-A2 | USE OF ANTI-PARAFIBROMIN ANTIBODIES TO DIAGNOSE HYPERPARATHYROIDISM-JAW TUMOR SYNDROME (HPT-JT) AND PARATHYROID CANCER | GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2005-07-14 | — | — | WO | disclosed |
| US-6916782-B1 | Gene coding for heliomicine and use thereof | AVENTIS CROPSCIENCE S.A. (FR) | 2005-07-12 | — | — | US | disclosed |
| EP-1550651-A1 | GLYCEROL DERIVATIVE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2005-07-06 | — | — | EP | disclosed |
| EP-0964693-A4 | NOVEL BACTERIOCINS, TRANSPORT AND VECTOR SYSTEM AND METHOD OF USE THEREOF | UNIV ALBERTA (CA) | 2005-06-29 | — | — | EP | disclosed |
| EP-1546728-A2 | METHODS FOR DETECTING ENDOCRINE CANCER | MOUNT SINAI HOSPITAL (CA) | 2005-06-29 | — | — | EP | disclosed |
| US-6911203-B2 | Anthrax lethal factor is a MAPK kinase protease | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2005-06-28 | — | — | US | disclosed |
| US-20050133371-A1 | Apparatus and method for Edman degradation on a microfluidic device utilizing an electroosmotic flow pump | WEST VIRGINIA UNIVERSITY RESEARCH CORPORATION | 2005-06-23 | — | — | US | disclosed |
| US-20050137131-A1 | UspA1 and UspA2 antigens of Moraxella catarrhalis | THE BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM | 2005-06-23 | — | — | US | disclosed |
| EP-1181307-A4 | METHODS FOR CARBON-CENTERED RADICAL MEDIATED HEAVY HYDROGEN LABELING OF COMPOUNDS | ANDERSON VERNON E (US) | 2005-06-22 | — | — | EP | disclosed |
| US-20050131221-A1 | UspA1 and UspA2 antigens of Moraxella catarrhalis | THE BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM | 2005-06-16 | — | — | US | disclosed |
| EP-1416955-A4 | IDENTIFICATION OF SORTASE GENE | UNIV CALIFORNIA (US) | 2005-06-15 | — | — | EP | disclosed |
| US-20050123569-A1 | Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor | MERCK PATENT GMBH (DE) | 2005-06-09 | — | — | US | disclosed |
| US-20050112590-A1 | Fragmentation-based methods and systems for sequence variation detection and discovery | JPMORGAN CHASE BANK, N.A. | 2005-05-26 | — | — | US | disclosed |
| US-20050106666-A1 | Glial mitogenic factors, their preparation and use | CAMBRIDGE NEUROSCIENCE (US) | 2005-05-19 | — | — | US | disclosed |
| US-6893835-B2 | Anthrax lethal factor is a MAPK kinase protease | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2005-05-17 | — | — | US | disclosed |
| US-6893843-B2 | Nucleic acids | Wiedow, Oliver (DE) | 2005-05-17 | — | — | US | disclosed |
| US-20050069984-A1 | Identification of sortase gene | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-03-31 | — | — | US | disclosed |
| US-20050063936-A1 | Branched polyalkylene glycols | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2005-03-24 | — | — | US | disclosed |
| EP-0674712-B1 | A PROTEINASE INHIBITOR, PRECURSOR THEREOF AND GENETIC SEQUENCES ENCODING SAME | HEXIMA LTD (AU) | 2005-03-23 | — | — | EP | disclosed |
| US-20050053916-A1 | Diagnostic for long term response of HBV carrier to 3TC therapy | NIH - DEITR | 2005-03-10 | — | — | US | disclosed |
| US-20050053594-A1 | RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK | ALESSI DARIO (GB) | 2005-03-10 | — | — | US | disclosed |
| WO-2005019265-A1 | IMPROVED METHOD OF PURIFYING TFPI AND TFPI ANALOGS | CHIRON CORPORATION (US) | 2005-03-03 | — | — | WO | disclosed |
| EP-0462065-B1 | New signal sequences | SYNGENTA PARTICIPATIONS AG (CH) | 2005-03-02 | — | — | EP | disclosed |
| EP-1007570-A4 | MONOSPECIFIC ANTIBODY REACTIVE WITH FIBRINOGEN AND FIBRINOPEPTIDE B | NEW YORK BLOOD CT INC (US) | 2005-02-23 | — | — | EP | disclosed |
| US-20050037475-A1 | Method of purifying TFPI and TFPI analogs | CHIRON CORPORATION (US) | 2005-02-17 | — | — | US | disclosed |
| US-20050031588-A1 | With purine or pyrimidine base; for use in combination with drugs that induce mutation in Flaviviridae at location other than mutation of nucleotide that results in change from serine to a different amino acid in highly conserved consensus sequence XRXSGXXXT of domain B of the RNA polymerase region | IDENIX PHARMACEUTICALS LLC | 2005-02-10 | — | — | US | disclosed |
| US-20050027104-A1 | Novel surface explosed immunoglobulin d-binding protein from foraxella catarrhalis | ARNE FORSGREN ET AL. (SE) | 2005-02-03 | — | — | US | disclosed |
| US-6849450-B2 | Antibodies to the metalloproteinase inhibitor | CHILDRENS HOSPITAL OF LOS ANGELES (US) | 2005-02-01 | — | — | US | disclosed |
| EP-1498427-A1 | Immunoglobulins devoid of light chains | VRIJE UNIVERSITEIT BRUSSEL (BE) | 2005-01-19 | — | — | EP | disclosed |
| US-20050009053-A1 | Fragmentation-based methods and systems for de novo sequencing | SEQUENOM, INC. | 2005-01-13 | — | — | US | disclosed |
| WO-2005001480-A1 | METHOD OF ISOLATING A PROTEIN | PROTEOME SYSTEMS INTELLECTUAL PROPERTY PTY LTD (AU) | 2005-01-06 | — | — | WO | disclosed |
| US-20050004021-A1 | Novel human kunitz-type inhibitors and methods relating thereto | ZYMOGENETICS, INC. | 2005-01-06 | — | — | US | disclosed |
| EP-1492810-A2 | NOVEL FLUORESCENT PROTEINS | THE CHINESE UNIVERSITY OF HONG KONG (HK) | 2005-01-05 | — | — | EP | disclosed |
| EP-1423405-A4 | PLASMODIUM FALCIPARUM AMA-1 PROTEIN AND USES THEREOF | US ARMY (US) | 2005-01-05 | — | — | EP | disclosed |
| US-6838259-B2 | Process for producing kiss-1 peptide | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2005-01-04 | — | — | US | disclosed |
| EP-0653940-B1 | GLIAL MITOGENIC FACTORS, THEIR PREPARATION AND USE | LUDWIG INST CANCER RES (US) | 2004-12-29 | — | — | EP | disclosed |
| US-20040253638-A1 | Immunoglobulins devoid of light chains | VRIJE UNIVERSITEIT BRUSSEL | 2004-12-16 | — | — | US | disclosed |
| US-20040253686-A1 | Novel human kunitz-type inhibitors and methods relating thereto | ZYMOGENETICS, INC. | 2004-12-16 | — | — | US | disclosed |
| US-6828475-B1 | Fpr purification of beta-ketoacyl-CoA synthase condensing enzyme free from intact cells; genetic engineering | CALGENE LLC | 2004-12-07 | — | — | US | disclosed |
| US-20040229236-A1 | Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use | AVENTIS PHARMA | 2004-11-18 | — | — | US | disclosed |
| WO-2004097369-A2 | FRAGMENTATION-BASED METHODS AND SYSTEMS FOR DE NOVO SEQUENCING | SEQUENOM, INC. (US) | 2004-11-11 | — | — | WO | disclosed |
| EP-0975742-B1 | AMINOPEPTIDASE DERIVED FROM BACILLUS LICHENIFORMIS AND PROCESS FOR PREPARATION OF NATURAL TYPE PROTEINS | LG CHEMICAL LTD (KR) | 2004-11-10 | — | — | EP | disclosed |
| US-20040214252-A1 | Methods for detecting asymmetric dimethylarginine in a biological sample | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-10-28 | — | — | US | disclosed |
| US-6806074-B2 | NUCLEOTIDE SEQUENCES CODING ENZYME INHIBITORS FOR USE IN BIOLOGICAL PEST CONTROL | HEXIMA LIMITED (AU) | 2004-10-19 | — | — | US | disclosed |
| WO-2004087735-A2 | PROTEOLYTIC AND COVALENT ANTIBODIES | THE UNIVERSITY OF TEXAS (US) | 2004-10-14 | — | — | WO | disclosed |
| US-20040203026-A1 | Biologically active bactericidal/permeability-increasing protein fragments | ELSBACH PETER (US) | 2004-10-14 | — | — | US | disclosed |
| US-6803203-B1 | PROTEIN KINASES; FOR MONITORING IN VITRO ACTIVITY IN EUKARYOTIC CELLS; DRUG SCREENING; KITS | BROOKHAVEN SCIENCE ASSOCIATES | 2004-10-12 | — | — | US | disclosed |
| US-20040191867-A1 | DNA sequences coding for a mammalian glucuronyl C5-epimerase and a process for its production | BIOTIE THERAPIES, LTD. (FI) | 2004-09-30 | — | — | US | disclosed |
| EP-1233780-A4 | IDENTIFICATION OF SORTASE GENE | UNIV CALIFORNIA (US) | 2004-09-22 | — | — | EP | disclosed |
| US-20040181038-A1 | Novel fabh enzyme, compositions capable of binding to said enzyme and methods of use thereof | SMITHKLINE BEECHAM CORPORATION | 2004-09-16 | — | — | US | disclosed |
| US-6790671-B1 | FOR GENERATING MULTIPLE EXPRESSION MAPS TO DETERMINE GENETIC BASIS OF ANY PHENOTYPIC TRAIT OR DISEASE PROCESS | PRINCETON UNIVERSITY | 2004-09-14 | — | — | US | disclosed |
| US-20040175822-A1 | Apparatus and method for edman degradation using a microfluidic system | WEST VIRGINIA UNIVERSITY RESEARCH CORPORATION | 2004-09-09 | — | — | US | disclosed |
| US-20040171071-A1 | Method for separating and/or detecting and/or identifying and/or quantifying prion proteins | APOH TECHNOLOGIES SA (FR) | 2004-09-02 | — | — | US | disclosed |
| EP-0308378-B2 | Tumor necrosis factor (TNF)inhibitory protein and its purification | YEDA RES & DEV (IL) | 2004-09-01 | — | — | EP | disclosed |
| US-20040166586-A1 | Increasing ionization efficiency in mass spectrometry | MYERSON JOEL (US) | 2004-08-26 | — | — | US | disclosed |
| US-6780598-B1 | DETERMINING LOCATION, LENGTH, AND POTENCY OF AMINO ACID RESIDUES BY FITTING HYDROPHILICITY/HYDROPHOBICITY PLOT GENERATED TO MATHEMATICALLY GENERATED CONTINUOUS CURVE, GENERATING POTENTIAL EPITOPES | KOKOLUS WILLIAM J (US) | 2004-08-24 | — | — | US | disclosed |
| US-20040157780-A1 | CTL inducing peptides from c-erb2 (HER-2/neu) | EPIMMUNE INC. | 2004-08-12 | — | — | US | disclosed |
| EP-1009802-B1 | METHODS FOR ANALYZIMG POLYMERS | CHAN EUGENE Y (US) | 2004-08-11 | — | — | EP | disclosed |
| US-6774221-B1 | BY REACTING A DIKETONE WITH OXIDIZED N- TERMINAL METHIONINE RESIDUE WITH 3,4-DIAMINOBENZOIC ACID IN THE PRESENCE OF ACETIC ACID AND SODIUM FORMATE, FORMIC ACID AND SODIUM FORMATE, OR FORMIC ACID AND SODIUM ACETATE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2004-08-10 | — | — | US | disclosed |
| US-6773706-B2 | Identification of sortase gene | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-08-10 | — | — | US | disclosed |
| US-20040146984-A1 | Glycosylated LPXTGases and uses thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-07-29 | — | — | US | disclosed |
| US-20040147467-A1 | Nucleic acids encoding isav polypeptides | MICROTEK INTERNATIONAL (1998) LTD. (CA) | 2004-07-29 | — | — | US | disclosed |
| CN-1159441-C | USPA1 and USPA2 antigens of Moraxella catarrhalis | �¿���˹�ݴ�ѧϵͳ���»� | 2004-07-28 | — | — | CN | disclosed |
| CN-1158303-C | Method for removing N-terminal methionine | ����ҩƷ��ҵ��ʽ���� | 2004-07-21 | — | — | CN | disclosed |
| US-6765087-B1 | FOR THE FORMATION OF A COMPLETE ANTIGEN BINDING SITE OR SEVERAL ANTIGEN BINDING SITES | VRIJE UNIVERSITEIT BRUSSEL (BE) | 2004-07-20 | — | — | US | disclosed |
| US-6764844-B1 | USED FOR MANUFACTURE OF EPIMERASES | BIOTIE THERAPIES, CORP. (FI) | 2004-07-20 | — | — | US | disclosed |
| WO-2004059283-A2 | APPARATUS AND METHOD FOR EDMAN DEGRADATION USING A MICROFLUIDIC SYSTEM | WEST VIRGINIA UNIVERSITY RESEARCH CORPORATION (US) | 2004-07-15 | — | — | WO | disclosed |
| EP-1183265-A4 | NOVEL FABH ENZYME, COMPOSITIONS CAPABLE OF BINDING TO SAID ENZYME AND METHODS OF USE THEREOF | SMITHKLINE BEECHAM CORP (US) | 2004-07-14 | — | — | EP | disclosed |
| EP-1431763-A1 | Method for detecting a metabolic disease | BioVisioN AG (DE) | 2004-06-23 | — | — | EP | disclosed |
| US-6753417-B2 | PEPTIDE FOR USE IN THE DIAGNOSIS AND PREVENTION OF IMMUNOLOGICAL AND INFECTIOUS DISORDERS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2004-06-22 | — | — | US | disclosed |
| US-6752991-B1 | Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor | IMMULOGIC PHARMACEUTICAL CO. | 2004-06-22 | — | — | US | disclosed |
| WO-2004050839-A2 | FRAGMENTATION-BASED METHODS AND SYSTEMS FOR SEQUENCE VARIATION DETECTION AND DISCOVERY | SEQUENOM, INC. (US) | 2004-06-17 | — | — | WO | disclosed |
| US-20040116678-A1 | Cardiac hypertrophy factor and uses therefor | GENENTECH, INC. | 2004-06-17 | — | — | US | disclosed |
| US-20040110665-A1 | Desleucyl glycopeptide antibiotics and methods of making same | KAHNE DANIEL (US) | 2004-06-10 | — | — | US | disclosed |
| US-20040110190-A1 | Plant cell wall loosening activity of group 2/3 allergens of grass pollen | ENERGY, U.S. DEPARTMENT OF | 2004-06-10 | — | — | US | disclosed |
| WO-2004046169-A2 | ACTIVATION OF PEPTIDE PRODRUGS BY HK2 | THE JOHNS HOPKINS UNIVERSITY (US) | 2004-06-03 | — | — | WO | disclosed |
| WO-2004046331-A2 | 2’-BRANCHED NUCLEOSIDES AND FLAVIVIRIDAE MUTATION | IDENIX (CAYMAN) LIMITED (KY) | 2004-06-03 | — | — | WO | disclosed |
| WO-2004046314-A2 | METHODS FOR DETECTING ASYMMETRIC DIMETHYLARGININE IN A BIOLOGICAL SAMPLE | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2004-06-03 | — | — | WO | disclosed |
| EP-1423405-A2 | PLASMODIUM FALCIPARUM AMA-1 PROTEIN AND USES THEREOF | Walter Reed Army Institute of Research (US) | 2004-06-02 | — | — | EP | disclosed |
| EP-0787190-B1 | HEPATITIS E VIRUS ANTIGENS AND USES THEREFOR | GENELABS TECH INC (US) | 2004-05-19 | — | — | EP | disclosed |
| US-20040092736-A1 | Collections of compounds | SPIROGEN LIMITED | 2004-05-13 | — | — | US | disclosed |
| EP-1416955-A2 | IDENTIFICATION OF SORTASE GENE | The Regents of the University of California (US) | 2004-05-12 | — | — | EP | disclosed |
| US-20040087771-A1 | Antimicrobial peptides of the family of defensins, polynucleotides encoding said peptides, transformed vectors and organisms containing them | RHOBIO (FR) | 2004-05-06 | — | — | US | disclosed |
| WO-2002038796-A9 | METHODS FOR DETERMINING PROTEASE CLEAVAGE SITE MOTIFS | BETH ISRAEL HOSPITAL (US) | 2004-04-29 | — | — | WO | disclosed |
| EP-1409684-A1 | NOVEL SURFACE EXPOSED IMMUNOGLOBULIN D-BINDING PROTEIN FROM MORAXELLA CATARRHALIS | Forsgren, Arne (SE) | 2004-04-21 | — | — | EP | disclosed |
| WO-2004031729-A2 | DIAGNOSTIC FOR LONG TERM RESPONSE OF HBV CARRIER TO 3TC THERAPY | GEORGETOWN UNIVERSITY (US) | 2004-04-15 | — | — | WO | disclosed |
| US-20040072984-A1 | Preparation of high molecular weight polysuccinimides | AQUERO COMPANY | 2004-04-15 | — | — | US | disclosed |
| US-6720488-B2 | ENCODE FOR INSECTICIDAL POLYPEPTIDES, PARTICULARLY INSECTICIDAL PROTEINS FROM BACILLUS THURINGIENSIS | SYNGENTA INVESTMENT CORPORATION | 2004-04-13 | — | — | US | disclosed |
| WO-2004029285-A2 | METHODS FOR DETECTING ENDOCRINE CANCER | MOUNT SINAI HOSPITAL (CA) | 2004-04-08 | — | — | WO | disclosed |
| US-20040067525-A1 | Method for structural analysis of organic compound | SUNTORY LIMITED (JP) | 2004-04-08 | — | — | US | disclosed |
| US-6716634-B1 | Increasing ionization efficiency in mass spectrometry | AGILENT TECHNOLOGIES, INC. | 2004-04-06 | — | — | US | disclosed |
| US-6716636-B1 | USING MASS SPECTROMETRY. | TARGET DISCOVERY, INC. | 2004-04-06 | — | — | US | disclosed |
| WO-2003020885-A9 | IDENTIFICATION OF SORTASE GENE | UNIV CALIFORNIA (US) | 2004-04-01 | — | — | WO | disclosed |
| EP-1400550-A1 | BRANCHED POLYALKYLENE GLYCOLS | Kyowa Hakko Kogyo Co., Ltd (JP) | 2004-03-24 | — | — | EP | disclosed |
| EP-0726953-B1 | HUMAN KUNITZ-TYPE PROTEASE INHIBITORS | ZYMOGENETICS INC (US) | 2004-03-24 | — | — | EP | disclosed |
| US-6699704-B1 | USEFUL FOR HYDROLYZING PHYTATE TO INOSITOL AND INORGANIC PHOSPHATES; USED AS FEED ADDITIVES | ROCHE VITAMINS INC. | 2004-03-02 | — | — | US | disclosed |
| US-6696266-B1 | DIAGNOSING AND MONITORING LIVER INJURY OR FAILURE; SENSITIVE, ACCURATE, INEXPENSIVE MEASUREMENT IN BLOOD | ASAHI KASEI PHARMA CORPORATION (JP) | 2004-02-24 | — | — | US | disclosed |
| US-20040029181-A1 | Novel metal complex and method for determining amino acid sequence of protein using the same | SHIMADZU CORPORATION (JP) | 2004-02-12 | — | — | US | disclosed |
| US-6689356-B1 | RECOMBINANT NUCLEAR POLYHEDROSIS VIRUS WHICH, IN INSECT CELLS INFECTED THEREWITH, EXPRESSES A FOREIGN PROTEIN WHICH IS AN INSECTICIDAL TOXIN | THE REGENTS OF THE UNVIERSITY OF CALIFORNIA | 2004-02-10 | — | — | US | disclosed |
| WO-2004011025-A1 | PLANT CELL WALL LOOSENING ACTIVITY OF GROUP 2/3 ALLERGENS OF GRASS POLLEN | THE PENN STATE RESEARCH FOUNDATION (US) | 2004-02-05 | — | — | WO | disclosed |
| US-6683046-B1 | HETERODIMERIC PROTEIN SYNERGISTIC WITH INTERLEUKIN 2 | HOFFMANN-LA ROCHE INC. | 2004-01-27 | — | — | US | disclosed |
| US-6683155-B1 | PURIFIED AND ISOLATED POLYPEPTIDE COMPRISING SPECIFIED AMINO ACID SEQUENCE; REGULATING DEGRADATION OF EXTRACELLULAR MATRIX | AMGEN INC. | 2004-01-27 | — | — | US | disclosed |
| CN-1134539-C | Thrombopoietin | ��Ĭɭ�����ѧ����˾ | 2004-01-14 | — | — | CN | disclosed |
| US-20040006018-A1 | Cardiotrophin and uses therefor | GENENTECH, INC. | 2004-01-08 | — | — | US | disclosed |
| US-6670157-B1 | Preparing pristinamycin IIB involving introducing disabling mutation into a gene target in a microorganism that produces pristinamycin IIA and IIB | AVENTIS PHARMA S.A. (FR) | 2003-12-30 | — | — | US | disclosed |
| EP-0771146-B1 | FIBRIN(OGEN) DEGRADATION AND CLOT LYSIS BY FIBRINOLYTIC MATRIX METALLOPROTEINASE | NEW YORK BLOOD CT INC (US) | 2003-12-10 | — | — | EP | disclosed |
| US-6660836-B1 | Generating hydroxyl radical in a solution of a peptide or protein, an electron scavenger source, a heavy hydrogen source, a heavy hydrogen donor, and an oxygen trapping system | CASE WESTERN RESERVE UNIVERSITY | 2003-12-09 | — | — | US | disclosed |
| US-6660498-B1 | Expressing an immunogenic fragment of Major Merozoite Surface Protein 142 in a baculovirus expression system, comprising silkworms (hemolymph) infected with a nuclear polyhedrosis virus | UNIVERSITY OF HAWAII | 2003-12-09 | — | — | US | disclosed |
| US-6656709-B1 | Introducing a plasmid comprising a DNA sequence into pseudomonas; biosynthesis; coenzyme B12 | RHONE-POULENC BIOCHIMIE, ET AL. (FR) | 2003-12-02 | — | — | US | disclosed |
| US-6656746-B2 | Nuclelotide sequences coding enzyme inhibitor for use in the treatment of blood sisorders | ZYMOGENETICS, INC. | 2003-12-02 | — | — | US | disclosed |
| US-20030219404-A1 | Branched polyalkylene glycols | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2003-11-27 | — | — | US | disclosed |
| US-20030219814-A1 | Novel fluorescent proteins | THE CHINESE UNIVERSITY OF HONG KONG (HK) | 2003-11-27 | — | — | US | disclosed |
| US-6652862-B2 | Hybrid Dna sequence | NEW YORK UNIVERSITY | 2003-11-25 | — | — | US | disclosed |
| US-20030217381-A1 | Resistance to acetohydroxycid synthase-inhibiting herbicides | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE | 2003-11-20 | — | — | US | disclosed |
| US-6649736-B1 | Generating hydroxyl radical in solution comprising a peptide or protein and an electron scavenger source; use in determining which atoms are solvent accessible | CASE WESTERN RESERVE UNIVERSITY | 2003-11-18 | — | — | US | disclosed |
| EP-1360964-A1 | USE OF GALANIN-LIKE PEPTIDE | Takeda Chemical Industries, Ltd. (JP) | 2003-11-12 | — | — | EP | disclosed |
| EP-1361285-A2 | Protein kinase peptide substrate determination using peptide libraries | SMITHKLINE BEECHAM CORPORATION (US) | 2003-11-12 | — | — | EP | disclosed |
| US-20030208038-A1 | Methods for carbon-centered radical mediated heavy hydrogen labeling of compounds | CASE WESTERN UNIVERSITY | 2003-11-06 | — | — | US | disclosed |
| US-20030207799-A1 | GLIAL MITOGENIC FACTORS, THEIR PREPARATION AND USE | ACORDA THERAPEUTICS, INC. | 2003-11-06 | — | — | US | disclosed |
| US-20030208035-A1 | Antifungal and/or antibacterial peptides, preparation methods, compositions containing same and methods of treating mammals and/or plants | ENTOMED (S.A.) (FR) | 2003-11-06 | — | — | US | disclosed |
| US-20030204059-A1 | Purification and characterization of cytotoxic lymphocyte maturation factor and monoclonal antibodies thereto | HOFFMANN-LAROCHE | 2003-10-30 | — | — | US | disclosed |
| WO-2003087150-A2 | NOVEL FLUORESCENT PROTEINS CONTAINING FQYGF IN THE CHROMOPHORE | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2003-10-23 | — | — | WO | disclosed |
| EP-1353944-A2 | METHODS OF INVESTIGATING, DIAGNOSING, AND TREATING AMYLOIDOSIS | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 2003-10-22 | — | — | EP | disclosed |
| US-6632981-B1 | Transgenic plants and tissues with chimeric construction; gene expression control | NOVARTIS FINANCE CORPORATION | 2003-10-14 | — | — | US | disclosed |
| US-20030185822-A1 | HLA-A2.1 binding peptides and their uses | PHARMEXA INC. | 2003-10-02 | — | — | US | disclosed |
| EP-0556395-B1 | NOVEL CYTOKINE | SANKYO CO (JP) | 2003-10-01 | — | — | EP | disclosed |
| EP-1345968-A2 | CRYSTALS OF WHOLE ANTIBODIES AND FRAGMENTS THEREOF AND METHODS FOR MAKING AND USING THEM | Altus Biologics Inc. (US) | 2003-09-24 | — | — | EP | disclosed |
| EP-1346061-A2 | PREGNANCY-ASSOCIATED PLASMA PROTEIN-A2 (PAPP-A2) | Como Biotech APS (DK) | 2003-09-24 | — | — | EP | disclosed |
| US-20030175311-A1 | Recombinant coccidiosis vaccines | ALPHARMA INC. | 2003-09-18 | — | — | US | disclosed |
| WO-2003076459-A1 | AN EARLY DETECTION MARKER FOR CHRONIC INFLAMMATORY ASSOCIATED DISEASES | HELOISE, ANNE, PEREIRA, PH. D. (US) | 2003-09-18 | — | — | WO | disclosed |
| US-20030170745-A1 | Early detection marker for chronic inflammatory associated diseases | PEREIRA HELOISE ANNE (US) | 2003-09-11 | — | — | US | disclosed |
| CN-1441809-A | Antifungal and/or antibacterial peptides, preparation methods and composition containing same | ENTOMED S A (FR) | 2003-09-10 | — | — | CN | disclosed |
| EP-0959682-A4 | THERAPEUTIC AND DIAGNOSTIC APPLICATIONS OF LAMININ AND LAMININ-DERIVED PROTEIN FRAGMENTS | UNIV WASHINGTON (US) | 2003-09-03 | — | — | EP | disclosed |
| US-20030158376-A1 | Relaxin-like factor and methods and uses thereof | CORTHERA, INC. | 2003-08-21 | — | — | US | disclosed |
| EP-0693938-B1 | PEPTIDES FOR USE IN VACCINATION AND INDUCTION OF NEUTRALIZING ANTIBODIES AGAINST HUMAN IMMUNODEFICIENCY VIRUS | TRIPEP AB (SE) | 2003-08-20 | — | — | EP | disclosed |
| US-6608192-B1 | Pyrrolobenzodiazepines | SPIROGEN LIMITED (GB) | 2003-08-19 | — | — | US | disclosed |
| US-20030153020-A1 | Identification of sortase gene | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-08-14 | — | — | US | disclosed |
| US-20030148377-A1 | Binding compounds and methods for identifying binding compounds | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 2003-08-07 | — | — | US | disclosed |
| EP-1333093-A2 | Human muscle nad: arginine adpribosyltransferase | The Government of the United States of America, as represented by the Secretary Department of Health and Human Services (US) | 2003-08-06 | — | — | EP | disclosed |
| US-6602700-B1 | Increasing free ferulic acid content of a plant-derived composition using feruloyl esterase of given amino acid sequence; used in food and feed compositions, nutraceuticals and in pulping | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2003-08-05 | — | — | US | disclosed |
| US-20030143693-A1 | Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods | AMGEN INC. | 2003-07-31 | — | — | US | disclosed |
| EP-0609580-B1 | Recombinant CMV neutralising proteins | AVENTIS PASTEUR (FR) | 2003-07-30 | — | — | EP | disclosed |
| US-20030138831-A1 | Method for sequencing and characterizing polymeric biomolecules using aptamers and a method for producing aptamers | PRAELUX INCORPORATED (US) | 2003-07-24 | — | — | US | disclosed |
| US-20030133933-A1 | Novel integrin alpha subunit | BRENNER MICHAEL B (US) | 2003-07-17 | — | — | US | disclosed |
| US-20030129720-A1 | Proteinase inhibitor, precursor thereof and genetic sequences encoding same | HEXIMA LIMITED (AU) | 2003-07-10 | — | — | US | disclosed |
| US-20030124529-A1 | Polynucleotide encoding a polypeptide which has proteolytic activity for insulin like growth factor binding protein; use in diagnosis of fetal abnormalities | COMO BIOTECH APS (DK) | 2003-07-03 | — | — | US | disclosed |
| EP-0480024-B1 | DNA ENCODING PLANT THIOESTERASES | CALGENE LLC (US) | 2003-06-25 | — | — | EP | disclosed |
| US-6582965-B1 | Determination of sequence of preferential peptides; obtain peptide, fragment, expose to spectrum analysis, compare to control, determine the amino-acid sequence of the peptide | OXFORD GLYCOSCIENCES (UK) LTD (GB) | 2003-06-24 | — | — | US | disclosed |
| US-20030113711-A1 | Protein kinase peptide substrate determination using peptide libraries | SMITHKLINE BEECHAM CORPORATION | 2003-06-19 | — | — | US | disclosed |
| EP-1319669-A2 | Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods | Amgen Inc., (US) | 2003-06-18 | — | — | EP | disclosed |
| EP-0707641-B1 | AN ENZYME WITH PROTEASE ACTIVITY | NOVOZYMES AS (DK) | 2003-06-11 | — | — | EP | disclosed |
| EP-1114060-B1 | PROCESS FOR PRODUCING PEPTIDES FROM BIOLOGICAL FLUIDS AND PEPTIDES OBTAINABLE BY SAID PROCESS | NIZO FOOD RES (NL) | 2003-06-11 | — | — | EP | disclosed |
| US-6576609-B1 | Administering plasminogen activator to treat neoplastic disease | NORTHWESTERN UNIVERSITY | 2003-06-10 | — | — | US | disclosed |
| EP-0964869-A4 | METHODS AND COMPOSITIONS FOR GENERATING ANGIOSTATIN | UNIV NORTHWESTERN (US) | 2003-06-04 | — | — | EP | disclosed |
| US-6573060-B1 | Screening for compounds that inhibit ATPase activity; phosphorylated aminoglycoside antibiotics; use in treatment of cancer and infectious diseases | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2003-06-03 | — | — | US | disclosed |
| EP-0392225-B1 | Disease-resistant transgenic plants | SYNGENTA PARTICIPATIONS AG (CH) | 2003-05-28 | — | — | EP | disclosed |
| US-6569434-B1 | Growth factor comprising a first C subunit amino acid sequence and a second C subunit amino-acid sequence, wherein said first and second subunit comprise the amino acid sequence as set forth in SEQ ID NO:45. | MERCK & CO., INC. | 2003-05-27 | — | — | US | disclosed |
| US-20030096333-A1 | Anthrax lethal factor is a MAPK kinase protease | DUESBERY NICHOLAS (US) | 2003-05-22 | — | — | US | disclosed |
| US-20030096388-A1 | Proteinase inhibitor, precursor thereof and genetic sequences encoding same | HEXIMA LIMITED (AU) | 2003-05-22 | — | — | US | disclosed |
| EP-1310510-A2 | Topologically segregated, encoded solid phase libraries | SELECTIDE CORPORATION (US) | 2003-05-14 | — | — | EP | disclosed |
| US-6562596-B1 | Provides purified and isolated polypeptide products having primary structural conformation and biological properties of naturally occurring mammalian tissue inhibitor of metalloproteinase type three | AMGEN INC. | 2003-05-13 | — | — | US | disclosed |
| EP-0648838-B1 | Tissue inhibitor of metalloproteinase type three (TIMP-3) | AMGEN INC (US) | 2003-05-02 | — | — | EP | disclosed |
| CN-1412310-A | Enzyme with protease activity | NOVOZYMES AS (DK) | 2003-04-23 | — | — | CN | disclosed |
| WO-1994020127-A9 | HLA-A2.1 BINDING PEPTIDES AND THEIR USES | CYTEL CORP (US) | 2003-04-17 | — | — | WO | disclosed |
| WO-2003031983-A2 | METHOD FOR DETECTING AMINO ACIDS | CONSEQUENCE GMBH (DE) | 2003-04-17 | — | — | WO | disclosed |
| CN-1411509-A | Process for producing Kiss-1 peptide | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-04-16 | — | — | CN | disclosed |
| CN-1105184-C | An enzyme with protease activity | NOVOZYMES ALS (DK) | 2003-04-09 | — | — | CN | disclosed |
| EP-0887646-B1 | A method for de novo peptide sequence determination | OXFORD GLYCOSCIENCES UK LTD (GB) | 2003-04-02 | — | — | EP | disclosed |
| EP-1298214-A2 | Plant thioesterases | Calgene LLC (US) | 2003-04-02 | — | — | EP | disclosed |
| US-6537791-B1 | Of given sequence; can use to prevent and treat cancer and infectious diseases by inhibiting nucleic acid metabolism; drug screening | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2003-03-25 | — | — | US | disclosed |
| US-20030054550-A1 | Cardiac hypertrophy factor and uses therefor | GENENTECH, INC. | 2003-03-20 | — | — | US | disclosed |
| US-6534635-B1 | Tissue inhibitors of metalloproteinase (TIMP); electron-accepting group causes it to lose its ability to bind to metalloproteinase; carbamylation; inhibition of metastasis of cancer or vascularization | ORIENTAL YEAST CO., LTD. (JP) | 2003-03-18 | — | — | US | disclosed |
| WO-2003020885-A2 | IDENTIFICATION OF SORTASE GENE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-03-13 | — | — | WO | disclosed |
| EP-1027455-A4 | METHODS AND COMPOSITIONS FOR TARGETING DNA METABOLIC PROCESSES USING AMINOGLYCOSIDE DERIVATIVES | UNIV VIRGINIA (US) | 2003-03-12 | — | — | EP | disclosed |
| US-6531306-B1 | Of given amino acid sequence; use for treatment of cancer and infectious diseases by disruption of nucleic acid metabolism and induction of apoptosis; drug screening | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2003-03-11 | — | — | US | disclosed |
| US-6531277-B2 | Diagnosing urogenital disorders in humans; obtain tissue sample, detect protein in sample tissue, compare to control | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2003-03-11 | — | — | US | disclosed |
| US-20030045471-A1 | DNA molecules encoding vascular endothelial cell growth factor II subunits | MERCK & CO., INC. (US) | 2003-03-06 | — | — | US | disclosed |
| US-20030046726-A1 | Synthetic DNA sequence having enhanced insecticidal activity in maize | SYNGENTA INVESTMENT CORPORATION | 2003-03-06 | — | — | US | disclosed |
| EP-0705279-B1 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORP (US) | 2003-02-19 | — | — | EP | disclosed |
| US-20030032777-A1 | Precursor polypeptide of phytosulfokine derived from Arabidopsis thaliana and a gene encoding said polypeptide | NAGOYA UNIVERSITY (JP) | 2003-02-13 | — | — | US | disclosed |
| US-20030032772-A1 | UspA1 and UspA2 antigens of moraxella catarrhalis | THE BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM | 2003-02-13 | — | — | US | disclosed |
| US-6518243-B1 | Desleucyl glycopeptide antibiotics and methods of making same | TRUSTEES OF PRINCETON UNIVERSITY | 2003-02-11 | — | — | US | disclosed |
| US-6518401-B2 | Polypeptide for use in the treatment and prevention of tumors and infections | NEW YORK UNIVERSITY | 2003-02-11 | — | — | US | disclosed |
| US-20030027303-A1 | Proteinase inhibitor, precursor thereof and genetic sequences encoding same | HEXIMA LIMITED (AU) | 2003-02-06 | — | — | US | disclosed |
| EP-1280928-A2 | RESISTANCE TO ACETOHYDROXYACID SYNTHASE-INHIBITING HERBICIDES | Board of Supervisors of Louisiana State University and Agricultural and Mechanical College (US) | 2003-02-05 | — | — | EP | disclosed |
| US-6515120-B1 | DNA/RNA sequences; structural characterization; aptamers thatrecognize and bind to specific nucleotides | PRAELUX INCORPORATED | 2003-02-04 | — | — | US | disclosed |
| US-20030022178-A1 | Identification of sortase gene | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-01-30 | — | — | US | disclosed |
| EP-1173193-A4 | DESLEUCYL GLYCOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING SAME | UNIV PRINCETON (US) | 2003-01-29 | — | — | EP | disclosed |
| US-6511823-B1 | Heparin binding neurotrophic factor gene sequence | AMERICAN CYANAMID CORPORATION | 2003-01-28 | — | — | US | disclosed |
| EP-0859000-B1 | Isoxazole amide and crotonamid derivatives and drug and diagnostic uses thereof | AVENTIS PHARMA GMBH (DE) | 2003-01-22 | — | — | EP | disclosed |
| WO-2003004651-A1 | NOVEL SURFACE EXPOSED IMMUNOGLOBULIN D-BINDING PROTEIN FROM MORAXELLA CATARRHALIS | FORSGREN ARNE (SE) | 2003-01-16 | — | — | WO | disclosed |
| WO-2002077195-A9 | PLASMODIUM FALCIPARUM AMA-1 PROTEIN AND USES THEREOF | US ARMY (US) | 2003-01-09 | — | — | WO | disclosed |
| EP-1270642-A1 | BRANCHED POLYALKYLENE GLYCOLS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2003-01-02 | — | — | EP | disclosed |
| US-20030004098-A1 | Leukaemia inhibitory factor | GEARING DAVID PAUL (US) | 2003-01-02 | — | — | US | disclosed |
| US-20020193308-A1 | Recombinant protein and its use in therapy and diagnostics | ZETESIS S.P.A. | 2002-12-19 | — | — | US | disclosed |
| US-20020187535-A1 | Polypeptides and polypeptide analogues | CHRISTOPHERS ENNO (DE) | 2002-12-12 | — | — | US | disclosed |
| US-20020187521-A1 | Anthrax lethal factor is a MAPK kinase protease | DUESBERY NICHOLAS (US) | 2002-12-12 | — | — | US | disclosed |
| WO-2002099077-A2 | METHODS AND COMPOSITIONS RELATED TO TAGGING OF MEMBRANE SURFACE PROTEINS | PROTEOLOGICS, INC. (US) | 2002-12-12 | — | — | WO | disclosed |
| EP-1263452-A2 | METHODS AND COMPOSITIONS FOR GENERATING ANGIOSTATIN | NORTHWESTERN UNIVERSITY (US) | 2002-12-11 | — | — | EP | disclosed |
| EP-0831871-B1 | RELAXIN-LIKE FACTOR AND METHODS AND USES THEREOF | CONNECTIVE THERAPEUTICS INC (US) | 2002-12-11 | — | — | EP | disclosed |
| US-6492324-B1 | APJ ligand polypeptides | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-12-10 | — | — | US | disclosed |
| US-20020183485-A1 | TNF receptors, TNF binding proteins and DNAs coding for them | AMGEN BOULDER INC. | 2002-12-05 | — | — | US | disclosed |
| US-6485925-B1 | Anthrax lethal factor is a MAPK kinase protease | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2002-11-26 | — | — | US | disclosed |
| US-6482864-B1 | Sustained-release preparation of physiologically active polypeptide and production thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-11-19 | — | — | US | disclosed |
| US-20020169118-A1 | TNF receptors, TNF binding proteins and DNAs coding for them | AMGEN, INC. | 2002-11-14 | — | — | US | disclosed |
| US-6479632-B1 | Tumor necrosis factor inhibitory protein and its purification | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2002-11-12 | — | — | US | disclosed |
| US-20020165163-A1 | Tumor necrosis factor inhibitory protein and its purification | YEDA RESEARCH DEVELOPMENT COMPANY LTD. (IL) | 2002-11-07 | — | — | US | disclosed |
| US-20020165354-A1 | Tumor necrosis factor inhibitory protein and its purification | YEDA RESEARCH AND DEVELOPMENT COMPANY LTD. (IL) | 2002-11-07 | — | — | US | disclosed |
| EP-0689550-B1 | ANTIMICROBIAL PEPTIDES FROM BOVINE NEUTROPHILS | UNIV CALIFORNIA (US) | 2002-11-06 | — | — | EP | disclosed |
| US-20020155112-A1 | TNF receptors, TNF binding proteins and DNAs coding for them | AMGEN, INC. | 2002-10-24 | — | — | US | disclosed |
| EP-0278355-B2 | Novel expression system | NOVARTIS AG (CH) | 2002-10-23 | — | — | EP | disclosed |
| WO-2002081413-A2 | ONE DIMENSIONAL UNICHEMO PROTECTION (UCP) IN ORGANIC SYNTHESIS | CARLSBERG A/S (DK) | 2002-10-17 | — | — | WO | disclosed |
| EP-0640689-B1 | p40 Homodimer of interleukin-12 | HOFFMANN LA ROCHE (CH) | 2002-10-16 | — | — | EP | disclosed |
| WO-2002079231-A2 | NUCLEIC ACIDS ENCODING ISAV POLYPEPTIDES | MICROTEK INTERNATIONAL (1998) LTD. (CA) | 2002-10-10 | — | — | WO | disclosed |
| US-20020146684-A1 | One dimensional unichemo protection (UCP) in organic synthesis | CARLSBERG A/S (DK) | 2002-10-10 | — | — | US | disclosed |
| EP-1246597-A2 | POLYPEPTIDES AND POLYNUCLEOTIDES FOR ENHANCING IMMUNE REACTIVITY TO HER-2 PROTEIN | THE OHIO STATE UNIVERSITY (US) | 2002-10-09 | — | — | EP | disclosed |
| WO-2002077195-A2 | PLASMODIUM FALCIPARUM AMA-1 PROTEIN AND USES THEREOF | WALTER REED ARMY INSTITUTE OF RESEARCH (US) | 2002-10-03 | — | — | WO | disclosed |
| EP-0986398-A4 | METHOD FOR THE PRODUCTION OF VACCINES AGAINST CELL SURFACE PROTEINS | UNIV VIRGINIA (US) | 2002-10-02 | — | — | EP | disclosed |
| US-20020137189-A1 | Cardiac hypertrophy factor and uses therefor | GENENTECH, INC. | 2002-09-26 | — | — | US | disclosed |
| US-20020137050-A1 | Biologically active bactericidal/permeability-increasing protein fragments | NEW YORK UNIVERSITY | 2002-09-26 | — | — | US | disclosed |
| US-20020136719-A1 | Crystals of whole antibodies and fragments thereof and methods for making and using them | AJINOMOTO ALTHEA INC. | 2002-09-26 | — | — | US | disclosed |
| EP-1243654-A1 | Precursor polypeptides of phytosulfokine derived from Arabidopsis thaliana and cDNAs encoding said polypeptides | NAGOYA UNIVERSITY (JP) | 2002-09-25 | — | — | EP | disclosed |
| US-6455042-B1 | Method of treating ulcerative colitis or crohn's disease by administering an antibody toαEβ7 integrin | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2002-09-24 | — | — | US | disclosed |
| WO-2002072636-A2 | CRYSTALS OF WHOLE ANTIBODIES AND FRAGMENTS THEREOF AND METHODS FOR MAKING AND USING THEM | ALTUS BIOLOGICS INC. (US) | 2002-09-19 | — | — | WO | disclosed |
| US-6451573-B1 | RECOMBINANT TYPE II SERINE PROTEINASE INHIBITOR PRECURSOR, WHEREIN SAID PI PRECURSOR COMPRISES AT LEAST THREE PI MONOMERS COVALENTLY LINKED TO EACH OTHER, AT LEAST ONE OF THE MONOMERS HAS A CHYMOTRYPSIN SPECIFIC SITE AND AT LEAST TRYPSIN SITE | THE UNIVERSITY OF MELBOURNE (AU) | 2002-09-17 | — | — | US | disclosed |
| US-6444642-B1 | ADMINISTERING TO MAMMAL EFFECTIVE AMOUNT OF NEUREGULIN POLYPEPTIDE WITH P185.SUP.ERBB2 PROTEIN BINDING ACTIVITY TO STIMULATE MYOGENESIS OF MUSCLE CELLS | CENES PHARMACEUTICALS, INC. | 2002-09-03 | — | — | US | disclosed |
| US-20020119455-A1 | Detecting preferential compounds in sample; obtain sample, label, detect signal, classify compounds | U. S. GENOMICS, INC. | 2002-08-29 | — | — | US | disclosed |
| EP-1233780-A1 | IDENTIFICATION OF SORTASE GENE | The Regents of the University of California (US) | 2002-08-28 | — | — | EP | disclosed |
| US-6440727-B1 | TRANSGENIC PLANTS WITH ENHANCED PROTECTION AGAINST PATHOGENS AND PREDATORS; GENETIC ENGINEERING | THE UNIVERSITY OF MELBOURNE (AU) | 2002-08-27 | — | — | US | disclosed |
| US-6440693-B1 | GIVEN AMINO ACID SEQUENCE; RECOMBINANT TUMOR NECROSIS FACTOR (TNF)-BINDING PROTEIN USEFUL IN PHARMACEUTICALS FOR INHIBITING TNF | AMGEN BOULDER INC. | 2002-08-27 | — | — | US | disclosed |
| US-20020111309-A1 | Therapeutic applications of laminin and laminin-derived protein fragments | THE UNIVERSITY OF WASHINGTON | 2002-08-15 | — | — | US | disclosed |
| US-6432400-B1 | PEPTIDE COMPRISING A C-TERMINAL FRAGMENT OF PANCREATIC LIPASE WITH RECOGNITION SITE FOR A COLIPASE WITH THREE TOPOLOGICALLY DISTINCT RECOGNITION SITES: INTERFACIAL, LIPASE AND MICELLAR, | LABORATOIRE LAPHAL (LABORATOIRE DE PHARMACOLOGIE APPLIQUEE) (FR) | 2002-08-13 | — | — | US | disclosed |
| US-20020107360-A1 | Hepatitis E virus antigens and uses therefor | GENELABS TECHNOLOGIES, INC. | 2002-08-08 | — | — | US | disclosed |
| EP-0771146-A4 | FIBRIN(OGEN) DEGRADATION AND CLOT LYSIS BY FIBRINOLYTIC MATRIX METALLOPROTEINASE | NEW YORK BLOOD CT INC (US) | 2002-08-07 | — | — | EP | disclosed |
| EP-0618976-B1 | SYNTHETIC DNA SEQUENCE HAVING ENHANCED INSECTICIDAL ACTIVITY IN MAIZE | SYNGENTA PARTICIPATIONS AG (CH) | 2002-08-07 | — | — | EP | disclosed |
| US-6428998-B1 | CULTURING THE HOST CELL TRANSFECTED WITH NUCLETIDE SEQUENCE OF SAID N-PROTEINASE UNDER CONDITIONS SUITABLE FOR THE EXPRESSION OF THE POLYPEPTIDE AND ISOLATING IT | UNIVERSITY OF LIEGE (BE) | 2002-08-06 | — | — | US | disclosed |
| US-6429296-B2 | DISPERSING A COMPLEX OF HUMAN GROWTH HORMONE AND ZINC CONTAINING HUMAN GROWTH HORMONE AND ZINC AT A MOLAR RATIO 1:1.6 TO 1:2.4 IN OIL PHASE CONTAINING BIODEGRADABLE POLYMER TO MAKE SOLID-IN-OIL EMULSION, ADDING WATER, IN-WATER | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-08-06 | — | — | US | disclosed |
| US-6428997-B1 | CULTURING BACILLUS LICHENIFORMIS STRAINS CAPABLE OF PRODUCING SAID AMINOPEPTIDASE, CENTRIFUGING THE CULTURE BROTH, CONCENTRATING THE SUPERNATANT AND PURIFYING THE AMINOPEPTIDASE | LG CHEMICAL LTD. (KR) | 2002-08-06 | — | — | US | disclosed |
| US-20020102562-A1 | Recombinant CMV neutralizing proteins | PASTEUR MERIEUX SERUMS ET VACCINES S.A. | 2002-08-01 | — | — | US | disclosed |
| US-20020098560-A1 | Novel human kunitz-type inhibitors and methods relating thereto | ZYMOGENETICS, INC. | 2002-07-25 | — | — | US | disclosed |
| US-20020090676-A1 | TNF receptors, TNF binding proteins and DNAs coding for them | AMGEN, INC. | 2002-07-11 | — | — | US | disclosed |
| US-20020090698-A1 | RECOMBINANT PROCESS FOR THE PRODUCTION IN PSEUDOMONAS PUTIDA OF THE CYTOCHROME C551 OF PSEUDOMONAS AERUGINOSA | MINISTERO DELL'UNIVERSITA'E DELLA RICERCA SCIENTIFICIA E TECNOLOGICA (IT) | 2002-07-11 | — | — | US | disclosed |
| US-20020090654-A1 | METALLOPROTEINASE INHIBITOR | CHILDRENS HOSPITAL OF LOS ANGELES | 2002-07-11 | — | — | US | disclosed |
| US-6417158-B1 | ADMINISTERING RECOMBINANT POLYPEPTIDES TO ANIMALS TO BIND TO TNF ENCODED BY DNA SEQUENCE | AMGEN, INC. | 2002-07-09 | — | — | US | disclosed |
| US-6410272-B1 | GENERATION OF HURIDIN COMPOUNDS; OBTAIN YEAST CELLS, TRANSFORM WITH VECTORS CODING HURIDIN COMPOUNDS, ISOLATE HURIDIN COMPOUND | CIBA-GEIGY CORPORATION A CORP. OF NEW YORK | 2002-06-25 | — | — | US | disclosed |
| WO-2000049871-A9 | AN ANTI-ANGIOGENIC KRINGLE PROTEIN AND ITS MUTANTS | FORD HENRY HEALTH SYSTEM (US) | 2002-06-20 | — | — | WO | disclosed |
| EP-1060377-A4 | REAGENTS AND METHODS FOR PROTEIN MICROSEQUENCING | BIOTRACES INC (US) | 2002-06-12 | — | — | EP | disclosed |
| EP-1213356-A2 | Synthetic DNA sequence having enhanced insecticidal activity in maize | Syngenta Participations AG (CH) | 2002-06-12 | — | — | EP | disclosed |
| US-20020068327-A1 | Lipolytic agent linked to a targeting agent. | TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE | 2002-06-06 | — | — | US | disclosed |
| US-6399355-B1 | LIPOLYTIC AGENT LINKED TO A TARGETING AGENT. | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2002-06-04 | — | — | US | disclosed |
| US-20020065221-A1 | Control of protein synthesis, and screening method for agents | DUNDEE, UNIVERSITY OF (GB) | 2002-05-30 | — | — | US | disclosed |
| EP-1209237-A2 | Synthetic DNA sequence having enhanced insecticidal activity in maize | Syngenta Participations AG (CH) | 2002-05-29 | — | — | EP | disclosed |
| US-6395306-B1 | FOR RHEUMATOID ARTHRITIS | PAN PACIFIC PHARMACEUTICALS, INC. | 2002-05-28 | — | — | US | disclosed |
| CN-1350547-A | Allergenicity of airborne and contact allergens with thioredoxin | UNIV CALIFORNIA (US) | 2002-05-22 | — | — | CN | disclosed |
| WO-2002038796-A2 | METHODS FOR DETERMINING PROTEASE CLEAVAGE SITE MOTIFS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2002-05-16 | — | — | WO | disclosed |
| WO-2002032953-A2 | PREGNANCY-ASSOCIATED PLASMA PROTEIN-A2 (PAPP-A2) | COMO BIOTECH APS (DK) | 2002-04-25 | — | — | WO | disclosed |
| EP-0500785-B1 | A HUMAN T CELL REACTIVE FELINE PROTEIN (TRFP) ISOLATED FROM HOUSE DUST AND USES THEREFOR | IMMULOGIC PHARMA CORP (US) | 2002-04-17 | — | — | EP | disclosed |
| US-6372141-B1 | CHROMATOGRAPHY PACKING WHEREIN THE HYDROPHILIC/HYDROPHOBIC BALANCE ON STATIONARY PHASE SURFACE CAN BE CHANGED BY TEMPERATURE WHILE FIXING THE MOBILE PHASE TO AN AQUEOUS SYSTEM; TEMPERATURE-RESPONSIVE POLYALKYLACRYLAMIDE | AMERSHAM PHARMACIA BIOTECH K.K. (JP) | 2002-04-16 | — | — | US | disclosed |
| US-6372499-B1 | TRANSFECTION EFFICIENCY | I.D.M. IMMUNO-DESIGNED MOLECULES (FR) | 2002-04-16 | — | — | US | disclosed |
| US-6365390-B1 | RECOMBINANT DNA INCLUDING VECTOR SEQUENCE AND SEQUENCE ENCODING A FERULOYL ESTERASE OF DEFINED AMINO ACID SEQUENCE; FOR CULTURE PRODUCTION OF THE ENZYME | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2002-04-02 | — | — | US | disclosed |
| US-6361966-B1 | SCREENING ESCHERICHIA MUTANT CELLS RESISTANT TO OVER-EXPRESSION TOXICITY BY CULTURING THE TRANSFORMED CELLS WITH AN EXPRESSION VECTOR, INDUCE EXPRESSION FOR A TOXIC EFFECT AND SELECT VIABLE CELLS | MEDICAL RESEARCH COUNCIL (GB) | 2002-03-26 | — | — | US | disclosed |
| US-6358722-B1 | GENETICALLY ENGINEERED POLYPEPTIDE; FOR USE ANIMAL FEEDS | ROCHE VITAMINS, INC. | 2002-03-19 | — | — | US | disclosed |
| WO-2001058921-A9 | METHODS AND COMPOSITIONS FOR GENERATING ANGIOSTATIN | UNIV NORTHWESTERN (US) | 2002-03-14 | — | — | WO | disclosed |
| US-6355420-B1 | MOVING PLURALITY OF INDIVIDUAL UNITS OF POLYMER OF LINKED UNITS THROUGH CHANNEL AND EXPOSING TO AGENT SELECTED FROM ELECTROMAGNETIC RADIATION, QUENCHING SOURCE AND FLUORESCENCE SOURCE, DETECTING SIGNALS RESULTING FROM INTERACTION | US GENOMICS | 2002-03-12 | — | — | US | disclosed |
| EP-1183265-A1 | NOVEL FABH ENZYME, COMPOSITIONS CAPABLE OF BINDING TO SAID ENZYME AND METHODS OF USE THEREOF | SmithKline Beecham Corporation (US) | 2002-03-06 | — | — | EP | disclosed |
| EP-1181307-A1 | METHODS FOR CARBON-CENTERED RADICAL MEDIATED HEAVY HYDROGEN LABELING OF COMPOUNDS | Anderson, Vernon E. (US) | 2002-02-27 | — | — | EP | disclosed |
| US-6348569-B1 | A THERMAL HYSTERESIS, ANTIFREEZE PROTEINS ISOLATED FROM THE EASTERN SPRUCE BUDWORM CHORISTONEURA FUMIFERANA; FOR IMPROVING STORAGE OF FROZEN FOODS AND THE VIABILITY OF BIOLOGICS | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2002-02-19 | — | — | US | disclosed |
| US-6348642-B1 | TRANSFORMED PLANTS AND PLANT CELLS FOR ALTERED FATTY ACID BIOSYNTHESIS | CALGENE, LLC | 2002-02-19 | — | — | US | disclosed |
| US-20020019335-A1 | Methods of investigating, diagnosing, and treating amyloidosis | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-02-14 | — | — | US | disclosed |
| EP-1179178-A1 | IMPROVED METHOD OF IDENTIFYING AND LOCATING IMMUNOBIOLOGICALLY-ACTIVE LINEAR PEPTIDES | Kokolus, William J. (US) | 2002-02-13 | — | — | EP | disclosed |
| EP-1175491-A1 | RECOMBINANT PROTEIN UK114 AND ITS USE IN THERAPY AND DIAGNOSTICS | Zetesis S.P.A. (IT) | 2002-01-30 | — | — | EP | disclosed |
| US-20020009718-A1 | ENDOMETRIOSIS-SPECIFIC SECRETORY PROTEIN | MISSOURI, THE CURATORS OF THE UNIVERSITY OF | 2002-01-24 | — | — | US | disclosed |
| EP-1173193-A1 | DESLEUCYL GLYCOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING SAME | The Trustees of Princeton University (US) | 2002-01-23 | — | — | EP | disclosed |
| US-6340461-B1 | FOR IMMUNOTHERAPY | TERMAN DAVID STEPHEN (US) | 2002-01-22 | — | — | US | disclosed |
| CN-1077438-C | Recombinant coccidiosis vaccines | HEFFMANN LA ROCHE AG F (CH) | 2002-01-09 | — | — | CN | disclosed |
| US-6335176-B1 | REAGENT IS SUCCINIMIDYL MOIETY LINKED TO KINASE SUBSTRATE; CAN BE LINKED TO FREE PRIMARY OR SECONDARY AMINE IN COMPOUND TO BE PHOSPHORYLATED | PHARMACOPEIA, INC. | 2002-01-01 | — | — | US | disclosed |
| CN-1076204-C | Recombinant coccidiosis vaccines | HOFFMANN LA ROCHE (CH) | 2001-12-19 | — | — | CN | disclosed |
| EP-0651809-B1 | A FAMILY OF MAP2 PROTEIN KINASES | REGENERON PHARMA (US) | 2001-12-05 | — | — | EP | disclosed |
| CN-1323355-A | Optical identification of polymers | US GENOMICS INC (US) | 2001-11-21 | — | — | CN | disclosed |
| US-6320100-B1 | NUCLEOTIDE SEQUENCES CODING INSECTICIDAL PROTEINS; FOR USE IN BIOLOGICAL PEST CONTROL | SYNGENTA INVESTMENTS, INC. | 2001-11-20 | — | — | US | disclosed |
| WO-2001085970-A2 | RESISTANCE TO ACETOHYDROXYACID SYNTHASE-INHIBITING HERBICIDES | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2001-11-15 | — | — | WO | disclosed |
| CN-1322211-A | Process for eliminating N-terminal methionine | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2001-11-14 | — | — | CN | disclosed |
| US-6313091-B1 | ADMINISTERING EFFECTIVE AMOUNT OF TUMOR NECROSIS FACTOR-STIMULATED GENE-6 PROTEIN TO TREAT RHEUMATOID ARTHRITIS | NEW YORK UNIVERSITY | 2001-11-06 | — | — | US | disclosed |
| US-6310190-B1 | NUCLEOTIDE SEQUENCES CODING MICRORGANISM PROTEIN; FOR USE IN THE DIAGNOSIS, TREATMENT AND PREVENTION OF INFECTIONS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS | 2001-10-30 | — | — | US | disclosed |
| US-6309843-B1 | MONITORING THE ACTIVATION OR INDUCTION OF OVULATION IN HUMANS; OBTAIN UTERINE FLUID OR ENDOMETRIAL BIOPSY, DETECT DISTRIBUTION OF PREFERENTIAL GLYCOPROTEIN, EVALUATE DISRUPTION OF UTERINE ACTIVITY | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2001-10-30 | — | — | US | disclosed |
| US-6309859-B1 | Method for removing N-terminal methionine | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-10-30 | — | — | US | disclosed |
| WO-2001077167-A2 | METHODS OF INVESTIGATING, DIAGNOSING, AND TREATING AMYLOIDOSIS | UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 2001-10-18 | — | — | WO | disclosed |
| CN-1073159-C | Human kunitz-type protease inhibitors | ZYMOGENETICS INC (US) | 2001-10-17 | — | — | CN | disclosed |
| US-6303358-B1 | ENZYMATIC POLYPEPTIDE FOR USE IN THE TREATMENT OF ALZHEIMER'S NEUROPATHIES, AND DIABETES | REGENERON PHARMACEUTICALS, INC. | 2001-10-16 | — | — | US | disclosed |
| EP-0656788-A4 | HLA BINDING PEPTIDES AND THEIR USES | EPIMMUNE INC (US) | 2001-10-04 | — | — | EP | disclosed |
| EP-1138772-A1 | PROCESS FOR PRODUCING APELIN | Takeda Chemical Industries, Ltd. (JP) | 2001-10-04 | — | — | EP | disclosed |
| US-6297035-B1 | EXTRACELLULAR SIGNAL REGULATED KINASE; FOR THE TREATMENT OF ALZHEIMER'S AND DIABETIES | REGENERON PHARMACEUTICALS, INC. | 2001-10-02 | — | — | US | disclosed |
| US-6294352-B1 | NUCLEOTIDE SEQUENCE WHICH CODE POLYPEPTIDE WHICH BINDS TUMOR NECROSIS FACTOR; FOR THE REDUCTION OF SIDE EFFECTS ASSOCIATED WITH TUMOR NECROSIS FACTOR TREATMENTS | AMGEN INC. | 2001-09-25 | — | — | US | disclosed |
| US-6291221-B1 | LIVESTOCK FEEDS; DNA SEQUENCE HYBRIDIZES WITH COMPLEMENTARY STRAND; GENETIC ENGINEERING | ROCHE VITAMINS INC. | 2001-09-18 | — | — | US | disclosed |
| US-6287811-B1 | CULTURING HOST CELLS TRANSFORMED OR TRANSFECTED WITH SPECIFIC NUCLEOTIDE SEQUENCE, THEN ISOLATING PROTEIN | NEW YORK UNIVERSITY | 2001-09-11 | — | — | US | disclosed |
| EP-1129181-A2 | MAMMALIAN SUBTILISIN/KEXIN ISOZYME SKI-1: A PROPROTEIN CONVERTASE WITH A UNIQUE CLEAVAGE SPECIFICITY | INSTITUT DE RECHERCHES CLINIQUES DE MONTREAL (CA) | 2001-09-05 | — | — | EP | disclosed |
| WO-2000039280-A9 | LEUKOCYTE-DERIVED INTERFERON PREPARATIONS | — | 2001-08-23 | — | — | WO | disclosed |
| US-6277963-B1 | ANTIBODY WHICH BINDS TO PEPTIDE FROM N-TERMIAL PORTION OF DEFINED AMINO ACID SEQUENCE; FOR STUDYING EFFECTS OF SELECTIVE NEUTRALIZATION OF MICROTUBULE-ASSOCIATED PROTEIN 2 KINASE (MAP2 KINASE) FUNCTION | REGENERON PHARMACEUTICALS, INC. | 2001-08-21 | — | — | US | disclosed |
| US-20010014471-A1 | RECOMBINANT PROTEIN AND ITS USE IN THERAPY AND DIAGNOSTICS | ZETESIS SPA (IT) | 2001-08-16 | — | — | US | disclosed |
| EP-0956354-A4 | RECOMBINANT N-PROTEINASE, AND THE PRODUCTION, METHODS AND USES THEREOF | PROCKOP DARWIN J (US) | 2001-08-16 | — | — | EP | disclosed |
| WO-2001058921-A2 | METHODS AND COMPOSITIONS FOR GENERATING ANGIOSTATIN | NORTHWESTERN UNIVERSITY (US) | 2001-08-16 | — | — | WO | disclosed |
| US-6271346-B1 | POLYPEPTIDE ASSOCIATED WITH TUMOR NECROSIS FACTOR; FOR TREATMENT OF INFLAMMATION, PARASITIC INFECTION AND IMMUNE DEFECTS; ANTITUMOR AGENTS; VIRICIDES | AMGEN INC. | 2001-08-07 | — | — | US | disclosed |
| EP-0656946-B1 | IMMUNOGLOBULINS DEVOID OF LIGHT CHAINS | UNIV BRUXELLES (BE) | 2001-08-01 | — | — | EP | disclosed |
| US-6265376-B1 | ISOLATED FROM THE PRIMITIVE HUNTING SPIDER, PLECTREURYS TRISTIS ARE DESCRIBED, AND THEIR AMINO ACID SEQUENCES ARE PRESENTED. | NOVARTIS AG (CH) | 2001-07-24 | — | — | US | disclosed |
| US-20010008764-A1 | FERTILITY-RELATED PROTEINS, AND METHODS OF USE THEREOF | AX ROY (US) | 2001-07-19 | — | — | US | disclosed |
| US-6261821-B1 | AMINO ACID SEQUENCE OF PROTEASE-SENSITIVE PEPTIDE; TRANSGENIC PLANTS WITH DISEASE RESISTANCE; BIOLOGICAL PEST CONTROL | THE UNIVERSITY OF MELBOURNE (AU) | 2001-07-17 | — | — | US | disclosed |
| US-6262342-B1 | CHEMICALLY REGULATABLE DNA SEQUENCES DERIVED FROM 5' REGION OF GENES ENCODING PATHOGENESIS RELATED PROTEINS CAPABLE OF REGULATING TRANSCRIPTION OF AN ASSOCIATED DNA SEQUENCE IN PLANTS/TISSUES, CHIMERIC CONSTRUCTS, AND TRANSGENIC PLANTS | NOVARTIS FINANCE CORPORATION | 2001-07-17 | — | — | US | disclosed |
| US-6261548-B1 | POLYPEPTIDES FOR LEUKEMIA INHIBITOR FACTORS WITH AMINO ACID SEQUENCES | AMRAD CORPORATION LIMITED (AU) | 2001-07-17 | — | — | US | disclosed |
| EP-1114060-A1 | PROCESS FOR PRODUCING PEPTIDES FROM BIOLOGICAL FLUIDS AND PEPTIDES OBTAINABLE BY SAID PROCESS | NIZO food research (NL) | 2001-07-11 | — | — | EP | disclosed |
| US-6258561-B1 | CULTURING CELL TRANSFORMED WITH VECTOR WHICH CODES FOR FUSION PROTEIN OF LIGAND LINKED TO PEPTIDE HAVING CYSTEINE AT N-TERMINUS AND SUBJECTING EXPRESSED PROTEIN TO REACTION WHICH CLEAVES PEPTIDE BOND ON N-TERMINAL SIDE OF CYSTEINE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-07-10 | — | — | US | disclosed |
| EP-1109912-A1 | PHENOLIC ACID ESTERASES, CODING SEQUENCES AND METHODS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2001-06-27 | — | — | EP | disclosed |
| CN-1301172-A | Sustained-release preparation of physiologically active polypeptide and production thereof | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2001-06-27 | — | — | CN | disclosed |
| EP-1107969-A2 | COLLECTIONS OF COMPOUNDS | Spirogen Limited (GB) | 2001-06-20 | — | — | EP | disclosed |
| EP-1108031-A2 | 17 kDa FOAM PROTEIN | Vaag, Pia (DK) | 2001-06-20 | — | — | EP | disclosed |
| EP-1105535-A1 | OPTICALLY CHARACTERIZING POLYMERS | U.S. Genomics (US) | 2001-06-13 | — | — | EP | disclosed |
| US-6245739-B1 | HUMAN LEUKOCYTE ELASTASE INHIBITORS | Wiedow, Oliver (DE) | 2001-06-12 | — | — | US | disclosed |
| CN-1066150-C | Bridged indoles as matrix metalloprotease inhibitors | SYNTEX INC (US) | 2001-05-23 | — | — | CN | disclosed |
| WO-2001034188-A1 | MALARIA VACCINE | UNIVERSITY OF HAWAII (US) | 2001-05-17 | — | — | WO | disclosed |
| US-6232286-B1 | APPLYING POLYPEPTIDE FACTOR ISOLATED FROM RAT I-EJ TRANSFORMED FIBROBLAST CELL LINE; TREATING NERVOUS SYSTEM DISORDERS, MULIPLE SCLEROSIS | CAMBRIDGE NEUROSCIENCE | 2001-05-15 | — | — | US | disclosed |
| US-6221675-B1 | DETECTING TUMOR NECROSIS FACTOR IN A SAMPLE BY ADDING RECOMBINANT POLYPEPTIDE OF DEFINED AMINO ACID SEQUENCE AND DETECTING THE COMPLEX FORMED | AMGEN, INC. | 2001-04-24 | — | — | US | disclosed |
| US-6214970-B1 | POLYPEPTIDE OF DEFINED AMINO ACID SEQUENCE FROM OPEN READING FRAME 2; DIAGNOSIS; VACCINES | GENELABS TECHNOLOGIES, INC. | 2001-04-10 | — | — | US | disclosed |
| US-6210905-B1 | ANTIGEN BINDING REGION OF ANTIBODY WHICH BINDS EPITOPE OF DEFINED AMINO ACID SEQUENCE; FOR DETECTING THE PROTEIN IN BIOLOGICAL SAMPLE | NEW YORK UNIVERSITY | 2001-04-03 | — | — | US | disclosed |
| US-6210928-B1 | PRODUCING BOVINE GROWTH HORMONE HAVING AN N-TERMINUS ALANINE IN BACTERIA BY EXPRESSING A DNA SEQUENCE WITH CODON FOR N-TERMINUS ALANINE IMMEDIATELY DOWNSTREAM OF TRANSLATION START SIGNAL METHIONINE CODON | MONSANTO COMPANY | 2001-04-03 | — | — | US | disclosed |
| US-6211148-B1 | Antimicrobial peptides from bovine neutrophis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-04-03 | — | — | US | disclosed |
| EP-0495096-B1 | PLANT FATTY ACID SYNTHASES | CALGENE LLC (US) | 2001-03-28 | — | — | EP | disclosed |
| EP-1086228-A1 | RECOMBINANT PRODUCTION OF TOXOPLASMA SAG1 ANTIGEN | SMITHKLINE BEECHAM BIOLOGICALS s.a. (BE) | 2001-03-28 | — | — | EP | disclosed |
| EP-1087013-A2 | Immunoglobulins devoid of light chains | VRIJE UNIVERSITEIT BRUSSEL (BE) | 2001-03-28 | — | — | EP | disclosed |
| EP-0663443-B2 | Dextranase enzyme, method for its production and DNA encoding the enzyme | CT INGENIERIA GENETICA BIOTECH (CU) | 2001-03-21 | — | — | EP | disclosed |
| EP-0804564-A4 | NEURAL AXON OUTGROWTH MODULATORS | UNIV CALIFORNIA (US) | 2001-03-21 | — | — | EP | disclosed |
| US-6204241-B1 | POLYPEPTIDES FOUND IN VERTEBRATE SPECIES, WHICH POLYPEPTIDES ARE MITOGENIC GROWTH FACTORS FOR GLIAL CELLS, INCLUDING SCHWANN CELLS. | CAMBRIDGE NEUROSCIENCE, INC. | 2001-03-20 | — | — | US | disclosed |
| EP-1080204-A2 | BETA-GLUCOSIDASE CODING SEQUENCES AND PROTEIN FROM ORPINOMYCES PC-2 | University of Georgia Research Foundation, Inc. (US) | 2001-03-07 | — | — | EP | disclosed |
| CN-1062902-C | Fatty acyl reductases | CALGENE INC (US) | 2001-03-07 | — | — | CN | disclosed |
| US-6194377-B1 | Methods for treating nervous system pathophysiologies using glial growth factors | CAMBRIDGE NEUROSCIENCE, INC. | 2001-02-27 | — | — | US | disclosed |
| US-6191107-B1 | COMPLEXES WITH BIODREGADABLE POLYMERS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-02-20 | — | — | US | disclosed |
| US-6190905-B1 | CLEANING CONTACT LENS; INCUBATING CONTACT LENS WITH PROTEOLYTIC ENZYME, WASH SEVERAL TIMES IN BUFFER, STORE FOR UTILIZATION | NOVOZYMES A/S (DK) | 2001-02-20 | — | — | US | disclosed |
| US-6190860-B1 | USING DNA PROBE WHICH HYBRIDIZES TO NUCLEOTIDE SEQUENCE WHICH CODES FOR GLYCOPROTEIN 55; DIAGNOSIS OF CYTOMEGALO VIRUS | CHIRON CORPORATION | 2001-02-20 | — | — | US | disclosed |
| US-6187571-B1 | TRANSFORMING PLANT CELLS WITH DNA SEQUENCE CODING FOR OXALATE OXIDASE OF DEFINED AMINO ACID SEQUENCE, THEN SELECTING PLANTS WHICH EXPRESS THIS ENZYME; DISEASE RESISTANT, TRANSGENIC PLANTS | BIOGEMMA (FR) | 2001-02-13 | — | — | US | disclosed |
| WO-2001009368-A1 | FOLLISTATIN ANTAGONISTS | THE GENERAL HOSPITAL CORPORATION (US) | 2001-02-08 | — | — | WO | disclosed |
| WO-2001008636-A2 | POLYPEPTIDES AND POLYNUCLEOTIDES FOR ENHANCING IMMUNE REACTIVITY TO HER-2 PROTEIN | THE OHIO STATE UNIVERSITY (US) | 2001-02-08 | — | — | WO | disclosed |
| CN-1283228-A | Polypeptide, their production method and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2001-02-07 | — | — | CN | disclosed |
| US-6180771-B1 | GIVEN NUCLEOTIDE SEQUENCE; USEFUL FOR PHARMACEUTICAL ADMINISTRATION OR METHODS OF DIAGNOSING SENSITIVITY TO HOUSE DUST MITES | IMMULOGIC PHARMACEUTICAL CORP. | 2001-01-30 | — | — | US | disclosed |
| US-6180612-B1 | TREATING CANCER BY ADMINISTERING A COMPOSITION COMPRISING A PHOSPHORYLATED AMINOGLYCOSIDE | THE UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2001-01-30 | — | — | US | disclosed |
| US-6180107-B1 | STIMULATING ANGIOGENESIS OR WOUND HEALING THROUGH VASCULAR REPAIR, NEOVASCULARIZATION, OR BOTH, BY ADMINISTERING PHARMACEUTICALLY EFFECTIVE AMOUNT OF MAMMALIAN VASCULAR ENDOTHELIAL GROWTH FACTOR II FACTOR | MERCK & CO., INC. | 2001-01-30 | — | — | US | disclosed |
| EP-1066401-A2 | ANTHRAX LETHAL FACTOR IS A MAPK KINASE PROTEASE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services (US) | 2001-01-10 | — | — | EP | disclosed |
| US-6171846-B1 | CULTURING CELLS WHICH ARE BLOCKED IN THE SYNTHESIS OF VIRGINIMYCINS; MUTATING GENES IN TARGET MICROORGANISM AND RECOVERING CELLS WITH MUTATED TARGET GENES | AVENTIS PHARMA S.A. (FR) | 2001-01-09 | — | — | US | disclosed |
| EP-1061948-A1 | SUSTAINED-RELEASE PREPARATION OF PHYSIOLOGICALLY ACTIVE POLYPEPTIDE AND PRODUCTION THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2000-12-27 | — | — | EP | disclosed |
| EP-1060747-A2 | Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase | New York Blood Center, Inc. (US) | 2000-12-20 | — | — | EP | disclosed |
| EP-1060377-A2 | REAGENTS AND METHODS FOR PROTEIN MICROSEQUENCING | Biotraces Inc. (US) | 2000-12-20 | — | — | EP | disclosed |
| WO-2000075169-A1 | NOVEL FABH ENZYME, COMPOSITIONS CAPABLE OF BINDING TO SAID ENZYME AND METHODS OF USE THEREOF | SMITHKLINE BEECHAM CORPORATION (US) | 2000-12-14 | — | — | WO | disclosed |
| CN-1276729-A | Heparin Binding Growth Factor (HBGF) polypeptides | CHILDRENS HOSP RES FOUNDATION (US) | 2000-12-13 | — | — | CN | disclosed |
| WO-2000073325-A1 | METHODS FOR CARBON-CENTERED RADICAL MEDIATED HEAVY HYDROGEN LABELING OF COMPOUNDS | ANDERSON VERNON E (US) | 2000-12-07 | — | — | WO | disclosed |
| WO-2000071755-A2 | METHOD FOR SEQUENCY AND CHARACTERIZING POLYMERIC BIOMOLECULES USING APTAMERS AND A METHOD FOR PRODUCING APTAMERS | PRAELUX INCORPORATED (US) | 2000-11-30 | — | — | WO | disclosed |
| CN-1058715-C | Thiophene compounds, process for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 2000-11-22 | — | — | CN | disclosed |
| US-6147190-A | PROTEIN ASSOCIATED WITH ACTIVATING CELL PROPAGATION; FOR THE TREATMENT OF A NERVOUS SYSTEM DISORDERS; FOR DIAGNOSIS AND TREATMENT OF TUMORS; ANTITUMOR AGENTS | CAMBRIDGE NEUROSCIENCE, INC. (US) | 2000-11-14 | — | — | US | disclosed |
| US-6140073-A | USEFUL IN THE PROMOTION OF TISSUE REPAIR | MERCK & CO., INC. (US) | 2000-10-31 | — | — | US | disclosed |
| WO-2000062804-A2 | IDENTIFICATION OF SORTASE GENE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-10-26 | — | — | WO | disclosed |
| WO-2000063368-A1 | RECOMBINANT PROTEIN UK114 AND ITS USE IN THERAPY AND DIAGNOSTICS | ZETESIS S.P.A. (IT) | 2000-10-26 | — | — | WO | disclosed |
| WO-2000063693-A1 | IMPROVED METHOD OF IDENTIFYING AND LOCATING IMMUNOBIOLOGICALLY-ACTIVE LINEAR PEPTIDES | KOKOLUS WILLIAM J (US) | 2000-10-26 | — | — | WO | disclosed |
| US-6132775-A | TREATING GRAM-NEGATIVE BACTERIAL INFECTIONS IN MAMMALS BY ADMINISTERING PURIFIED, ISOLATED POLYPEPTIDE HAVING BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN ACTIVITY | NEW YORK UNIVERSITY (US) | 2000-10-17 | — | — | US | disclosed |
| WO-2000059528-A1 | DESLEUCYL GLYCOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING SAME | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2000-10-12 | — | — | WO | disclosed |
| WO-2000009757-A9 | OPTICALLY CHARACTERIZING POLYMERS | US GENOMICS INC (US) | 2000-10-12 | — | — | WO | disclosed |
| EP-1042511-A1 | PREPARATION OF BODY FLUID SAMPLE FOR RNA ANALYSIS | Hämäläinen, Mauri (FI) | 2000-10-11 | — | — | EP | disclosed |
| EP-1040189-A1 | POLYPEPTIDES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 2000-10-04 | — | — | EP | disclosed |
| EP-1041083-A1 | Modified timp | ORIENTAL YEAST CO., LTD. (JP) | 2000-10-04 | — | — | EP | disclosed |
| WO-2000055187-A1 | THERAPEUTIC AND DIAGNOSTIC APPLICATIONS OF P400: A NEWLY DISCOVERED BETA-AMYLOID BINDING PROTEIN PRESENT IN HUMAN BIOLOGICAL FLUIDS | PROTEOTECH, INC. (US) | 2000-09-21 | — | — | WO | disclosed |
| US-6120769-A | DETECTING SENSITIVITY TO CAT PROTEIN ALLERGENS | IMMULOGIC PHARMACEUTICAL CORPORATION (US) | 2000-09-19 | — | — | US | disclosed |
| US-6121014-A | DETERMINING AMINO ACID SEQUENCE ENCODED BY DESIRED GENE, REVERSE TRANSLATING INTO MAIZE-OPTIMIZED NUCLEIC ACID CODING SEQUENCE BY DETERMINING APPROPRIATE CODONS USING CALCULATED CODON USAGE PROFILE, AND SYNTHESIZING CODING SEQUENCE | NOVARTIS FINANCE CORPORATION (US) | 2000-09-19 | — | — | US | disclosed |
| EP-1034186-A2 | SYNTHETIC PEPTIDES CONTAINING CITRULLINE RECOGNIZED BY RHEUMATOID ARTHRITIS SERA AS TOOLS FOR DIAGNOSIS AND TREATMENT | INNOGENETICS N.V. (BE) | 2000-09-13 | — | — | EP | disclosed |
| US-6117650-A | TESTING SAMPLE FOR DEFECTS HEART MUSCLE ACTIVITY; COAT WELL WITH NUTRIENTS, PLATE MUSCLE CELLS, CULTURE CELLS, INSERT TEST SAMPLE INTO CULTURE, CULTURE CELLS, MONITOR ADJUSTMENT IN CELL SIZE AND RELEASE OF ATRIAL NATRIURETIC PROTEIN | GENENTECH, INC. (US) | 2000-09-12 | — | — | US | disclosed |
| WO-2000049871-A1 | AN ANTI-ANGIOGENIC KRINGLE PROTEIN AND ITS MUTANTS | HENRY FORD HEALTH SYSTEM (US) | 2000-08-31 | — | — | WO | disclosed |
| US-6107476-A | NUCLEOTIDE SEQUENCE OF TRANSFORMING GROWTH FACTOR-LIKE PROTEIN; ANTICANCER AGENTS AGAINST ANDROGEN-INDEPENDENT CANCER; GENE THERAPY | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2000-08-22 | — | — | US | disclosed |
| EP-1027455-A2 | METHODS AND COMPOSITIONS FOR TARGETING DNA METABOLIC PROCESSES USING AMINOGLYCOSIDE DERIVATIVES | THE UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2000-08-16 | — | — | EP | disclosed |
| US-6103880-A | HARP family growth factors | VALBIOFRANCE (FR) | 2000-08-15 | — | — | US | disclosed |
| US-6103882-A | PRODUCING A PEPTIDE LIGAND, AMIDE OR SALT BY SUBJECTING FUSION PROTEIN OR PEPTIDE TO CLEAVAGE OF THE PEPTIDE BOND ON THE AMINO TERMINAL SIDE OF A CYSTEINE IN THE HETEROLOGOUS PEPTIDE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2000-08-15 | — | — | US | disclosed |
| US-6103511-A | FUNGAL PROTEIN FOR THE DEGRADATION OF HEMICELLULOSE | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2000-08-15 | — | — | US | disclosed |
| WO-2000046242-A2 | 19 KILODALTON PROTEIN OF $i(HELICOBACTER PYLORI) | AMERICAN CYANAMID COMPANY (US) | 2000-08-10 | — | — | WO | disclosed |
| US-6096512-A | ALTERING THE GLYCOSYLATION OF A PROTEIN PRODUCED BY A EUKARYOTIC CELL BY TRANSFECTING CELL WITH VECTOR INCLUDING CDNA WHICH CODES FOR ENZYME AND EXPRESSING ENZYME | PHARMACIA & UPJOHN COMPANY (US) | 2000-08-01 | — | — | US | disclosed |
| US-6093568-A | DNA CONSTRUCT OF A DNA SEQUENCE ENCODING A COCONUT PLANT 1-ACYLGLYCEROL-3-PHOSPHATE ACYLTRANSFERASE PEPTIDE JOINED TO A SECOND DNA SEQUENCE HETEROLOGOUS TO FIRST; STUDY OF PLANT FATTY ACID SYNTHESIS SYSTEMS; DEVELOPMENT OF OIL SOURCES | CALGENE, INC. (US) | 2000-07-25 | — | — | US | disclosed |
| US-6090912-A | MULTIPLICITY OF SEPARATE SOLID SUPPORTS WITH SURFACE HAVING SUCEPTIBLE LINKER TO SINGLE SPECIES OF TEST COMPOUND AND WITH INTERIOR HAVING ATTACHED NON-CLEAVABLE CODING MOLECULE; FOR SCREENING LIGANDS OR ACCEPTORS | SELECTIDE CORPORATION (US) | 2000-07-18 | — | — | US | disclosed |
| WO-2000012994-A9 | APPARATUS FOR RAPID PROTEIN AND POLYPEPTIDE SEQUENCE ANALYSIS | GENENTECH INC (US) | 2000-07-13 | — | — | WO | disclosed |
| US-6087335-A | ADMINISTERING A POLYPEPTIDE ISOLATED FROM CORIOLUS VERSICOLOR AS AN ANTITUMOR AGENT | YANG MABLE M P (HK) | 2000-07-11 | — | — | US | disclosed |
| WO-2000014243-A9 | PHENOLIC ACID ESTERASES, CODING SEQUENCES AND METHODS | UNIV GEORGIA RES FOUND (US) | 2000-06-22 | — | — | WO | disclosed |
| EP-1009802-A2 | METHODS AND PRODUCTS FOR ANALYZING POLYMERS | Chan, Eugene Y. (US) | 2000-06-21 | — | — | EP | disclosed |
| US-6077699-A | PURIFIED NUCLEOTIDE SEQUENCE OF ORF1 GENE OF STREPTOMYCES PRISTINAESPIRALIS OR ITS COMPLEMENT; FOR RECOMBINANT PRODUCTION OF KNOWN AND NOVEL ANTIBIOTICS | AVENTIS PHARMA S.A. (FR) | 2000-06-20 | — | — | US | disclosed |
| EP-0677057-B1 | BIOPOLYMER SYNTHESIS UTILIZING SURFACE ACTIVATED, ORGANIC POLYMERS | BECKMAN COULTER INC (US) | 2000-06-14 | — | — | EP | disclosed |
| EP-1007570-A1 | MONOSPECIFIC ANTIBODY REACTIVE WITH FIBRINOGEN AND FIBRINOPEPTIDE B | THE NEW YORK BLOOD CENTER (US) | 2000-06-14 | — | — | EP | disclosed |
| US-6075185-A | NUCLEIC ACID SEQUENCE CODING BACILLUS CRYSTAL PROTEIN TOXIN; PESTICIDES AGAINST BEETLE OR MOTH PESTS | NOVARTIS FINANCE CORPORATION (US) | 2000-06-13 | — | — | US | disclosed |
| CN-1053218-C | Fatty acyl-coa, fatty alcohol acyltransferases | CALGENE INC (US) | 2000-06-07 | — | — | CN | disclosed |
| WO-2000015774-A9 | USEFUL PROPERTIES OF A BEE VENOM PROTEIN AND GENE ENCODING SAME | PAN PACIFIC PHARMACEUTICALS IN (US) | 2000-06-02 | — | — | WO | disclosed |
| US-6068838-A | PURIFIED MULTIMERASE HAVING PROTEOLYTIC ACTIVITY, CONVERTS VON WILLEBRAND FACTOR HAVING A SINGLET STRUCTURE TO VON WILLEBRAND FACTOR HAVING SATELLITE STRUCTURE AND IS ACTIVE IN PRESENCE OF SERINE PROTEASE AND CALPIN PROTEASE INHIBITOR | BAXTER AKTIENGESELLSCHAFT (AT) | 2000-05-30 | — | — | US | disclosed |
| US-6070126-A | Immunobiologically-active linear peptides and method of identification | Kokolus, William J. (US) | 2000-05-30 | — | — | US | disclosed |
| EP-0529031-B1 | IMPROVED INHIBITORS OF THROMBIN | BIOGEN INC (US) | 2000-05-24 | — | — | EP | disclosed |
| US-6066470-A | Method for removing N-terminal methionine | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2000-05-23 | — | — | US | disclosed |
| EP-0721458-B1 | BIOPOLYMER SYNTHESIS UTILIZING SURFACE ACTIVATED, ORGANIC POLYMERS | BECKMAN COULTER INC (US) | 2000-05-17 | — | — | EP | disclosed |
| US-6063906-A | ANTIBODIES WHICH BIND TO AMINO ACID SEQUENCES OF HIGHLY CHARGED REGION OF THE E SUBUNIT; FOR SCREENING LIBRARIES FOR COMPOUNDS WHICH SUPPRESS ANTIBODY-ANTIGEN BINDING | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2000-05-16 | — | — | US | disclosed |
| WO-2000026233-A1 | SELECTIVE TOXICITY OF AMINO-TERMINAL MODIFIED RNASE A SUPERFAMILY POLYPEPTIDES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-05-11 | — | — | WO | disclosed |
| WO-2000026348-A2 | MAMMALIAN SUBTILISIN/KEXIN ISOZYME SKI-1: A PROPROTEIN CONVERTASE WITH A UNIQUE CLEAVAGE SPECIFICITY | INSTITUT DE RECHERCHES CLINIQUES DE MONTREAL (CA) | 2000-05-11 | — | — | WO | disclosed |
| WO-2000024887-A2 | METHOD FOR BIOTECHNOLOGICAL PRODUCTION OF LIGAND BINDING, ESPECIALLY EXTRACELLULAR, FRAGMENTS OF RECEPTOR SUBUNITS, ESPECIALLY NEURORECEPTORS AND HORMONE RECEPTORS | MAELICKE ALFRED (DE) | 2000-05-04 | — | — | WO | disclosed |
| US-6057423-A | Integrin alpha subunit | BRIGHAM & WOMEN'S HOSPITAL, INC. (US) | 2000-05-02 | — | — | US | disclosed |
| CN-1251611-A | USPA1 and USPA2 antigens of moraxelia catarrhalis | UNIV TEXAS (US) | 2000-04-26 | — | — | CN | disclosed |
| CN-1251609-A | Method and product for analyzing polymers | EUGENE Y CHAN (US) | 2000-04-26 | — | — | CN | disclosed |
| US-6054637-A | SECRETING PROTEIN INTO EXTRACELLULAR SPACE OF PLANT BY DELETING C-TERMINAL VACUOLAR TARGETING SEQUENCE FROM DNA SEQUENCE, SPLICING INTO PLANT EXPRESSION VECTOR, TRANSFORMING AND CULTURING PLANT | NOVARTIS FINANCE CORPORATION (US) | 2000-04-25 | — | — | US | disclosed |
| US-6051760-A | NUCLEIC ACID WHICH ENCODES A CRYIB PROTEIN USING CODONS MOST PREFERED IN MAIZE; FOR HIGH LEVEL EXPRESSION IN TRANSGENIC PLANTS | NOVARTIS FINANCE CORPORATION (US) | 2000-04-18 | — | — | US | disclosed |
| US-6048962-A | MAMMALIAN PROTEIN ALLERGEN; FOR THE DIAGNOSIS AND TREATMENT OF MAMMALIAN ALLERGIC RESPONSE | IMMULOGIC PHARMACEUTICAL CORPORATION (US) | 2000-04-11 | — | — | US | disclosed |
| WO-2000000614-A9 | NOVEL ANTIGENS OF $i(HELICOBACTER PYLORI) | AMERICAN CYANAMID CO (US) | 2000-03-30 | — | — | WO | disclosed |
| WO-2000015655-A1 | PROCESS FOR PRODUCING PEPTIDES FROM BIOLOGICAL FLUIDS AND PEPTIDES OBTAINABLE BY SAID PROCESS | NIZO FOOD RESEARCH (NL) | 2000-03-23 | — | — | WO | disclosed |
| WO-2000015774-A1 | USEFUL PROPERTIES OF A BEE VENOM PROTEIN AND GENE ENCODING SAME | PAN PACIFIC PHARMACEUTICALS, INC. (US) | 2000-03-23 | — | — | WO | disclosed |
| EP-0986398-A1 | METHOD FOR THE PRODUCTION OF VACCINES AGAINST CELL SURFACE PROTEINS | UNIVERSITY OF VIRGINIA PATENTS FOUNDATION (US) | 2000-03-22 | — | — | EP | disclosed |
| CN-1248264-A | Specific pancreatic lipase inhibitors and uses thereof | LAPHAL LABORATOIRE DE PHARMACO (FR) | 2000-03-22 | — | — | CN | disclosed |
| WO-2000014237-A2 | 17 kDa FOAM PROTEIN | VAAG PIA (DK) | 2000-03-16 | — | — | WO | disclosed |
| WO-2000014243-A1 | PHENOLIC ACID ESTERASES, CODING SEQUENCES AND METHODS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2000-03-16 | — | — | WO | disclosed |
| EP-0609450-B1 | METHOD FOR HIGH-SENSITIVITY DETECTION OF AMINO ACID DERIVATIVE | SEIKO INSTR INC (JP) | 2000-03-15 | — | — | EP | disclosed |
| EP-0476983-B1 | Vascular endothelial cell growth factor II | MERCK & CO INC (US) | 2000-03-15 | — | — | EP | disclosed |
| US-6037135-A | PREPARING AN IMMUNOGENIC PEPTIDE COMPRISING A HUMAN LEUKOCYTE ANTIGEN; DETECTING LEUKOCYTE EPITOPE IN AMINO ACID SEQUENCE, PREPARING ONE OR MORE PEPTIDE FRAGMENTS OF THE ANTIGEN, TESTING COMPLEXES FOR CYTOTOXIC RESPONSE | EPIMMUNE INC. (US) | 2000-03-14 | — | — | US | disclosed |
| WO-2000012994-A1 | APPARATUS FOR RAPID PROTEIN AND POLYPEPTIDE SEQUENCE ANALYSIS | GENENTECH, INC. (US) | 2000-03-09 | — | — | WO | disclosed |
| WO-2000012506-A2 | COLLECTIONS OF COMPOUNDS | SPIROGEN LIMITED (GB) | 2000-03-09 | — | — | WO | disclosed |
| US-6031087-A | NUCLEOTIDE SEQUENCES OR COMPLEMENTARY SEQUENCES OF A TYPE II SERINE PROTEASE INHIBITOR PRECURSOR FROM A PLANT; FOR PATHOGEN RESISTANT TRANSGENIC PLANTS | THE UNIVERSITY OF MELBOURNE (AU) | 2000-02-29 | — | — | US | disclosed |
| WO-2000009757-A1 | OPTICALLY CHARACTERIZING POLYMERS | U.S. GENOMICS, INC. (US) | 2000-02-24 | — | — | WO | disclosed |
| US-6028247-A | RECOMBINANT DNA FROM SAFFLOWER OR BRASSICA; FOR MODIFICATION OF FATTY ACID COMPOSITION IN PLANTS | MONSANTO COMPANY | 2000-02-22 | — | — | US | disclosed |
| US-6025162-A | NUCLEIC ACID ENCODING AN AMINO ACID SEQUENCE OF PROTEIN; FOR DIAGNOSIS AND TREATMENT OF ALLERGIES | IMMULOGIC PHARMACEUTICAL CORPORATION (US) | 2000-02-15 | — | — | US | disclosed |
| EP-0632815-B1 | SEQUENTIAL DEGRADATION OF PROTEINS AND PEPTIDES FROM THE N-TERMINUS | HOPE CITY (US) | 2000-02-09 | — | — | EP | disclosed |
| EP-0975742-A1 | AMINOPEPTIDASE DERIVED FROM BACILLUS LICHENIFORMIS AND PROCESS FOR PREPARATION OF NATURAL TYPE PROTEINS | LG CHEMICAL LTD. (KR) | 2000-02-02 | — | — | EP | disclosed |
| US-6019972-A | Peptides of human T cell reactive feline protein (TRFP) | IMMULOGIC PHARMACEUTICAL CORPORATION (US) | 2000-02-01 | — | — | US | disclosed |
| US-6020181-A | Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase | NEW YORK BLOOD, INC. (US) | 2000-02-01 | — | — | US | disclosed |
| US-6018104-A | A DNA MOLECULE CONTAINING A PROMOTER ISOLATED UPSTREAM OF THE CODING REGION OF A PLANT TRYPTOPHAN SYNTHASE GENE; WHERE THE PROMOTER DIRECTS PITH PREFERRED EXPRESSION; INSECTICIDE | NOVARTIS FINANCE CORPORATION (US) | 2000-01-25 | — | — | US | disclosed |
| US-6015695-A | ISOLATED IMMUNOGLOBULIN OF TWO HEAVY POLYPEPTIDE CHAINS SUFFICIENT FOR THE FORMATION OF ONE OR MORE ANTIGEN BINDING SITES | VRIJE UNIVERSITEIT BRUSSEL (BE) | 2000-01-18 | — | — | US | disclosed |
| US-6015685-A | PURIFIED GLYCOSYLATED, PARTIALLY GLYCOSYLATED OR UNGLYCOSYLATED POLYPEPTIDES; FOR GENETICALLY ENGINEERED PRODUCTION OF FIBRINOGEN SPLITTING ENZYME FOUND IN PIT VIPER VENOM; THROMBOLYTIC AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 2000-01-18 | — | — | US | disclosed |
| WO-2000000614-A2 | NOVEL ANTIGENS OF $i(HELICOBACTER PYLORI) | AMERICAN CYANAMID COMPANY (US) | 2000-01-06 | — | — | WO | disclosed |
| US-6008016-A | A NUCLEIC ACID FROM CHORISTONEURA ENCODING A PROTEIN; FOR DECREASING FREEZING POINTS; FROZEN FOOD STORAGE; CRYOPRESERVATION OF THERAPEUTIC DRUGS, BLOOD AND ORGANS FOR TRANSPLANTS | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1999-12-28 | — | — | US | disclosed |
| WO-1999066043-A1 | RECOMBINANT PRODUCTION OF TOXOPLASMA SAG1 ANTIGEN | SMITHKLINE BEECHAM BIOLOGICALS S.A. (BE) | 1999-12-23 | — | — | WO | disclosed |
| WO-1999066321-A2 | PATTERN RECOGNITION PROTEINS WITH LECTIN HOMOLOGY FROM SEVERAL ANIMAL SPECIES AND METHOD TO USE THEM FOR MEASURE OR MODULATE INNATE RESISTANCE AGAINST BACTERIA AND OTHER PATHOGENIC AGENTS | UNIVERSITY OF GUELPH (CA) | 1999-12-23 | — | — | WO | disclosed |
| EP-0964869-A1 | METHODS AND COMPOSITIONS FOR GENERATING ANGIOSTATIN | NORTHWESTERN UNIVERSITY (US) | 1999-12-22 | — | — | EP | disclosed |
| EP-0964693-A1 | NOVEL BACTERIOCINS, TRANSPORT AND VECTOR SYSTEM AND METHOD OF USE THEREOF | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 1999-12-22 | — | — | EP | disclosed |
| EP-0804735-A4 | N-TERMINAL PROTEIN SEQUENCING REAGENTS AND METHODS WHICH FORM AMINO ACID DERIVATIVES | HOPE CITY (US) | 1999-12-22 | — | — | EP | disclosed |
| EP-0965595-A1 | Protein complex | Applied Research Systems ARS Holding N.V. (AN) | 1999-12-22 | — | — | EP | disclosed |
| US-6005079-A | USED FOR DIAGNOSIS OR THERAPEUTICAL PURPOSES INCLUDING PROTECTION AGAINST PATHOLOGICAL AGENTS OR REGULATION OF THE EXPRESSION OR ACTIVITY OF PROTEINS | VRIJE UNIVERSITEIT BRUSSELS (BE) | 1999-12-21 | — | — | US | disclosed |
| US-6001649-A | MAMMALIAN PROTEIN THAT HAS CHEMOTACTIC ACTIVITY; FOR EXPRESSION IN EUCARYOTIC CELLS AND TREATMENT OF INFECTIOUS DISEASES; ANTICARCINOGENIC AGENTS | SOCIETE ANONYME: ELF SANOFI (FR) | 1999-12-14 | — | — | US | disclosed |
| WO-1999049292-A9 | REAGENTS AND METHODS FOR PROTEIN MICROSEQUENCING | BIOTRACES INC (US) | 1999-12-09 | — | — | WO | disclosed |
| US-5998190-A | CULTURE PRODUCT | NOVO NORDISK A/S (DK) | 1999-12-07 | — | — | US | disclosed |
| US-5998213-A | C-TERMINAL DEGRADATION OF PROLINE-TERMINATED PEPTIDE BY REACTION WITH DIPHENYL PHOSPHOROISOTHIOCYANATIDATE AND A N-HETEROCYCLE, PROTONATION, CLEAVAGE WITH WATER TO PROVIDE SHORTENED PEPTIDE AND THIOHYDANTOIN PROLINE | CITY OF HOPE (US) | 1999-12-07 | — | — | US | disclosed |
| EP-0959682-A1 | THERAPEUTIC AND DIAGNOSTIC APPLICATIONS OF LAMININ AND LAMININ-DERIVED PROTEIN FRAGMENTS | University of Washington (US) | 1999-12-01 | — | — | EP | disclosed |
| US-5994300-A | POLYPEPTIDE | MERCK & CO., INC. (US) | 1999-11-30 | — | — | US | disclosed |
| US-5993865-A | A FOAMING BEVERAGE, SUCH AS BEER, A METHOD FOR PRODUCING A FOAMING BEVERAGE AND A USE OF A FOAM FORMING ADDITIVE. | CARLSBERG A/S (DK) | 1999-11-30 | — | — | US | disclosed |
| EP-0956354-A1 | RECOMBINANT N-PROTEINASE, AND THE PRODUCTION, METHODS AND USES THEREOF | Prockop, Darwin J. (US) | 1999-11-17 | — | — | EP | disclosed |
| US-5986136-A | Photolabeling reagent | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1999-11-16 | — | — | US | disclosed |
| WO-1999057287-A2 | BETA-GLUCOSIDASE CODING SEQUENCES AND PROTEIN FROM ORPINOMYCES PC-2 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1999-11-11 | — | — | WO | disclosed |
| EP-0955542-A1 | METHOD FOR SEPARATING PTH AMINO ACIDS | Amersham Pharmacia Biotech K.K. (JP) | 1999-11-10 | — | — | EP | disclosed |
| US-5980897-A | Biologically active bactericidal/permeability-increasing protein fragments | NEW YORK UNIVERSITY (US) | 1999-11-09 | — | — | US | disclosed |
| US-5981701-A | PROTEIN THAT IS CAPABLE OF SUPPRESSING CYTOTOXIC EFFECTS ON CELLS | YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED (IL) | 1999-11-09 | — | — | US | disclosed |
| EP-0768821-A4 | pp60PIK : A DOWNSTREAM ELEMENT IN INSULIN SIGNALING | JOSLIN DIABETES CENTER INC (US) | 1999-10-27 | — | — | EP | disclosed |
| CN-1233289-A | TNF-beta-like proteins, related nucleic acid molecules, pharmaceutical compositions and methods for treating prostate cancer | ORTHO MCNEIL PHARM INC (US) | 1999-10-27 | — | — | CN | disclosed |
| EP-0950105-A1 | TNF-BETA-LIKE PROTEIN FOR TREATING PROSTATE CANCER, AND RELATED NUCLEIC ACID MOLECULES, PHARMACEUTICAL COMPOSITIONS AND METHODS | Ortho-McNeil Pharmaceutical, Inc. (US) | 1999-10-20 | — | — | EP | disclosed |
| US-5968791-A | MODIFYING FATTY ACYL COMPOSITION OF TRIGLYCERIDES BY GROWING PLANT TO SEED; PLANT HAS DNA FOR EXPRESSION OF FOREIGN ENZYME WHICH INSERTS CARBON CHAIN OF LENGTH C8 TO C14 OR C20 OR GREATER FATTY ACYL-COENZYME A SUBSTRATE INTO SN2 POSTION | CALGENE, INC. (US) | 1999-10-19 | — | — | US | disclosed |
| EP-0949271-A1 | NOVEL DNA, NOVEL PROTEIN, AND NOVEL ANTIBODY | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1999-10-13 | — | — | EP | disclosed |
| EP-0949270-A1 | Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment | INNOGENETICS N.V. (BE) | 1999-10-13 | — | — | EP | disclosed |
| EP-0948631-A1 | OVER-EXPRESSION OF PROTEINS | MEDICAL RESEARCH COUNCIL (GB) | 1999-10-13 | — | — | EP | disclosed |
| EP-0948625-A2 | USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS) | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1999-10-13 | — | — | EP | disclosed |
| WO-1999050439-A2 | ANTHRAX LETHAL FACTOR IS A MAPK KINASE PROTEASE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-10-07 | — | — | WO | disclosed |
| WO-1999049292-A2 | REAGENTS AND METHODS FOR PROTEIN MICROSEQUENCING | BIOTRACES, INC. (US) | 1999-09-30 | — | — | WO | disclosed |
| WO-1999048519-A1 | SUSTAINED-RELEASE PREPARATION OF PHYSIOLOGICALLY ACTIVE POLYPEPTIDE AND PRODUCTION THEREOF | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-09-30 | — | — | WO | disclosed |
| EP-0606225-B1 | SEQUENCING OF PROTEIN IMMOBILIZED ON POLYTETRAFLUOROETHYLENE SUPPORT | HOPE CITY (US) | 1999-09-29 | — | — | EP | disclosed |
| EP-0474645-B1 | PROTEIN COMPLEX | APPLIED RESEARCH SYSTEMS (AN) | 1999-09-29 | — | — | EP | disclosed |
| WO-1999047070-A1 | IMPROVED IMPLANTABLE BIOMATERIALS, COMPOSITIONS AND METHODS FOR THEIR PREPARATION AND USES THEREOF | WAKE FOREST UNIVERSITY (US) | 1999-09-23 | — | — | WO | disclosed |
| EP-0939808-A1 | SPRUCE BUDWORM ANTIFREEZE PROTEINS, GENES AND METHODS OF USING SAME | Queen's University at Kingston (CA) | 1999-09-08 | — | — | EP | disclosed |
| US-5948408-A | DNA encoding bactericidal/permeability-increasing proteins | NEW YORK UNIVERSITY (US) | 1999-09-07 | — | — | US | disclosed |
| EP-0517779-B1 | NUCLEIC ACID ENCODING TRANSFORMING GROWTH FACTOR-BETA-1-BINDING PROTEIN | LUDWIG INST CANCER RES (US) | 1999-09-01 | — | — | EP | disclosed |
| US-5942662-A | AN INDUCIBLE PLANT GENE EXPRESSION CASSETTE INCLUDING AN INDUCIBLE PROMOTER LINKED TO A TARGET GENE CONFERRING THE RESISTANCE, INDUCERS BEING A 1,2,3-BENZOTHIAZOLE, AN ISONICOTINIC OR A SALICYLIC ACID | NOVARTIS FINANCE CORPORATION (US) | 1999-08-24 | — | — | US | disclosed |
| US-5932698-A | Recombinant gene coding for a protein having endochitinase activity | RUSTICA PROGRAIN GENETIQUE (FR) | 1999-08-03 | — | — | US | disclosed |
| EP-0931153-A1 | FUNGAL LICHENASE AND CODING SEQUENCES | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1999-07-28 | — | — | EP | disclosed |
| WO-1999036572-A1 | PREPARATION OF BODY FLUID SAMPLE FOR RNA ANALYSIS | HAEMAELAEINEN MAURI (FI) | 1999-07-22 | — | — | WO | disclosed |
| EP-0928328-A1 | METHODS FOR CULTURING CELLS | Academisch Ziekenhuis Leiden (NL) | 1999-07-14 | — | — | EP | disclosed |
| US-5922322-A | CLEAVES AT THE GAMMA GLYCINE404-ALANINE405 PEPTIDE BOND; APPLY TO MEDICAL EQUIPMENT TO INHIBIT THROMBUS FORMATION; ADMINISTERING TO TREAT RESTENOSIS POST-SURGERY, TO INHIBIT VASCULAR REOCCLUSION | NEW YORK BLOOD CENTER, INC. (US) | 1999-07-13 | — | — | US | disclosed |
| US-5922608-A | Macromolecule sequencing packet and method of use | BECKMAN INSTRUMENTS, INC. (US) | 1999-07-13 | — | — | US | disclosed |
| WO-1999033976-A1 | POLYPEPTIDE, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-07-08 | — | — | WO | disclosed |
| US-5919709-A | CONTROL PEPTIDES DESIGNED FOR USE IN MONITORING THE PROPER OPERATION OF AMINO ACID SEQUENCERS; OBTAIN DATA FOR AMINO ACIDS WITHIN 15 SEQENCER CYCLES AND TO PROVIDE CLEAVAGE SITES FOR 4 DIFFERENT AMINO ACID CLEAVAGE REACTIONS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-07-06 | — | — | US | disclosed |
| EP-0506477-B1 | Vascular endothelial cell growth factor C subunit | MERCK & CO INC (US) | 1999-06-23 | — | — | EP | disclosed |
| US-5914315-A | ISOLATED AMINO ACID SEQUENCES ENCODING A KUNITZ-TYPE INHIBITOR; ANTICOAGULANTS FOR TREATING DEEP VEIN THROMBOSIS | ZYMOGENETICS, INC. (US) | 1999-06-22 | — | — | US | disclosed |
| US-5914261-A | NUCLEIC ACID WHICH CODES FOR EXTRACELLULAR SIGNAL REGULATED KINASE 1; FOR SCREENING DRUGS FOR ALZHEIMER'S DISEASE AND OTHER NERVOUS SYSTEM DISORDERS; ANTIDIABETIC AGENTS | REGENERON PHARMACEUTICALS, INC. (US) | 1999-06-22 | — | — | US | disclosed |
| US-5911997-A | POLYPEPTIDES WITH AMINO ACID SEQUENCES WITH DISULFIDE BONDS | CONNETICS CORPORATION (US) | 1999-06-15 | — | — | US | disclosed |
| WO-1999028876-A2 | HYDROPHOBICALLY-MODIFIED PROTEIN COMPOSITIONS AND METHODS | BIOGEN, INC. (US) | 1999-06-10 | — | — | WO | disclosed |
| WO-1999028344-A2 | SYNTHETIC PEPTIDES CONTAINING CITRULLINE RECOGNIZED BY RHEUMATOID ARTHRITIS SERA AS TOOLS FOR DIAGNOSIS AND TREATMENT | INNOGENETICS N.V. (BE) | 1999-06-10 | — | — | WO | disclosed |
| US-5910570-A | AMINO ACID SEQUENCE OF ACCEPTOR PEPTIDE FOR ENZYME; FOR CONTROLLED GLYCOSYLATION OF PROTEINS | PHARMACIA & UPJOHN COMPANY (US) | 1999-06-08 | — | — | US | disclosed |
| US-5910630-A | ELUCIDATION OF THE FACTORS CRITICAL TO THE NATURAL PRODUCTION OF TRIGLYCERIDES IN PLANTS, ESPECIALLY NUCLEIC ACID SEQUENCES OF GENES ENCODING PROTEINS USEFUL FOR GENETIC ENGINEERING | MONSANTO COMPANY | 1999-06-08 | — | — | US | disclosed |
| US-5905032-A | ELECTROOXIDATION OF PENDANT (R) GROUPS OF AMINO ACIDS IN PROTEIN BY APPLYING VOLTAGE ACROSS ELECTROCHEMICAL CELL CONTAINING SOLUTION OR DISPERSION OF PROTEIN, RECOVERING REACTION PRODUCT | COVENTRY UNIVERSITY (GB) | 1999-05-18 | — | — | US | disclosed |
| WO-1999023246-A1 | METHODS AND COMPOSITIONS FOR TARGETING DNA METABOLIC PROCESSES USING AMINOGLYCOSIDE DERIVATIVES | THE UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 1999-05-14 | — | — | WO | disclosed |
| EP-0596524-B1 | Hepatocyte growth factor HGF converting protease and gene encoding said protease | MITSUBISHI CHEM CORP (JP) | 1999-04-21 | — | — | EP | disclosed |
| EP-0907724-A2 | VON WILLEBRAND FACTOR MULTIMERASE | IMMUNO Aktiengesellschaft (AT) | 1999-04-14 | — | — | EP | disclosed |
| EP-0854716-A4 | ANDROGENIC DIRECTED COMPOSITIONS | BIOPHYSICA FOUNDATION (US) | 1999-04-07 | — | — | EP | disclosed |
| US-5891434-A | POLYPEPTIDE | CENTOCOR, INC. (US) | 1999-04-06 | — | — | US | disclosed |
| US-5891695-A | Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use | RHONE-POULENC RORER S.A. (FR) | 1999-04-06 | — | — | US | disclosed |
| EP-0905143-A2 | Complex of human growth hormone and zinc and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-03-31 | — | — | EP | disclosed |
| US-5889147-A | OLIGOPEPTIDE, POLYPEPTIDE FROM VENOM OF A CONE SNAIL | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 1999-03-30 | — | — | US | disclosed |
| EP-0705279-A4 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORP (US) | 1999-03-24 | — | — | EP | disclosed |
| EP-0549752-B1 | PROTEIN SEQUENCING | BECKMAN COULTER INC (US) | 1999-03-17 | — | — | EP | disclosed |
| EP-0549752-B1 | PROTEIN SEQUENCING | BECKMAN COULTER INC (US) | 1999-03-17 | — | — | EP | disclosed |
| EP-0703783-A4 | HLA-A2.1 BINDING PEPTIDES AND THEIR USES | CYTEL CORP (US) | 1999-03-10 | — | — | EP | disclosed |
| US-5880328-A | ANTI-PATHOGENIC SEQUENCES DERIVED FROM NOVEL CDNAS CODING FOR PR PROTEINS WHICH CAN BE GENETICALLY ENGINEERED AND TRANSFORMED INTO PLANTS TO CONFER ENHANCED RESISTANCE TO DISEASE | NOVARTIS FINANCE CORPORATION (US) | 1999-03-09 | — | — | US | disclosed |
| US-5880258-A | HIGHER ANTI-THROMBIN ACTIVITY BY SULFATING THE HYDROXYL GROUP OF TYROSINE RESIDUES; MUTANT AMINO ACID SEQUENCE ALLOWS MORE EFFICIENT ENZYME SULFATION | JAPAN ENERGY CORPORATION (JP) | 1999-03-09 | — | — | US | disclosed |
| EP-0510693-B1 | Expression of human serum albumin in pichia pastoris | RES CORP TECHNOLOGIES INC (US) | 1999-03-03 | — | — | EP | disclosed |
| EP-0831871-A4 | RELAXIN-LIKE FACTOR AND METHODS AND USES THEREOF | CONNECTIVE THERAPEUTICS INC (US) | 1999-03-03 | — | — | EP | disclosed |
| US-5876973-A | IMMUNIZING MAMMAL WITH POLYPEPTIDE, PURIFYING ANTIBODY FROM TISSUE OR HYBRIDOMA; FOR DIAGNOSIS OF NERVOUS SYSTEM DISORDERS; ANTIPROLIFERATIVE/ANTITUMOR/ANTICARCINOGENIC AGENTS ESPECIALLY FOR SCHWANN CELLS | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1999-03-02 | — | — | US | disclosed |
| US-5876947-A | HYBRIDOMA CELL LINE WHICH PRODUCES MONOCLONAL ANTIBODY USED IN ACCURATE DIAGNOSIS OF THROMBOSIS AND ATHLEROSCLEROSIS | THE NEW YORK BLOOD CENTER, INC. (US) | 1999-03-02 | — | — | US | disclosed |
| US-5874247-A | POLYPEPTIDES WITH AMINO ACID SEQUENCES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-02-23 | — | — | US | disclosed |
| US-5874541-A | Immunoglobulins devoid of light chains | VRIJE UNIVERSITEIT (BE) | 1999-02-23 | — | — | US | disclosed |
| US-5872006-A | Family of MAP2 protein kinases | REGENERON PHARMACEUTICALS, INC. (US) | 1999-02-16 | — | — | US | disclosed |
| US-5872217-A | MONOCLONAL ANTIBODIES BINDING ON A EPITOPE WITH NUCLEOTIDE SEQUENCES | THE JOHNS HOPKINS UNIVERSITY (US) | 1999-02-16 | — | — | US | disclosed |
| WO-1999005176-A1 | MONOSPECIFIC ANTIBODY REACTIVE WITH FIBRINOGEN AND FIBRINOPEPTIDE B | THE NEW YORK BLOOD CENTER, INC. (US) | 1999-02-04 | — | — | WO | disclosed |
| EP-0894138-A1 | RECOMBINANT PROCESS FOR THE PRODUCTION IN PSEUDOMONAS PUTIDA OF THE CYTOCHROME C 551? OF PSEUDOMONAS AERUGINOSA | MINISTERO DELL' UNIVERSITA' E DELLA RICERCA SCIENTIFICA E TECNOLOGICA (IT) | 1999-02-03 | — | — | EP | disclosed |
| US-5866357-A | PROTEASE OBTAINED FROM BACILLUS LICHENIFORMIS, HAS A MASS OF ABOUT 23,600, IS INHIBITED BY DIISOPROPYL FLUOROPHOSPHATE BUT NOT BY PHENYLMETHANE SULFONYLFLUORIDE, AND HAS A PH OF MAXIMAL ACTIVITY BETWEEN 6.5 AND 10.0. | NOVO NORDISK A/S (DK) | 1999-02-02 | — | — | US | disclosed |
| EP-0473080-B1 | Chondromodulin-I protein | MITSUBISHI CHEM CORP (JP) | 1999-01-27 | — | — | EP | disclosed |
| EP-0778777-A4 | A METHOD OF SEQUENCING PROTEINS BY EPITOPE ORDERING AND PROTEIN RESTRICTION MAPPING | UNIV PENNSYLVANIA (US) | 1999-01-27 | — | — | EP | disclosed |
| US-5863573-A | ADDING PROTEOLYTIC ENZYME TO MILK FOR PARTIAL HYDROLYSIS OF MILK WHEY PROTEIN BUT NOT ABLE TO CLOT THE WHEY PROTEIN, SIMULTANEOUSLY ADDING STARTER CULTURE TO MILK, ADDING MILK CLOTTING ENZYME TO CLOT THE MILK FORMING CURD THEN CHEESE | NOVO NORDISK A/S (DK) | 1999-01-26 | — | — | US | disclosed |
| US-5864011-A | A POLYPEPTIDE CROSS-REACTIVE WITH THE HPR GENE PRODUCT EXPRESSED BY NEOPLASTIC CELLS BUT NOT WITH HAPTOGLOBIN 1 OR 2; DIAGNOSIS MARKER FOR BREAST AND OTHER CANCERS; IMMUNOSTIMULANTS | THE JOHNS HOPKINS UNIVERSITY (US) | 1999-01-26 | — | — | US | disclosed |
| US-5861125-A | Protein or peptide sequencing method and apparatus | CITY OF HOPE (US) | 1999-01-19 | — | — | US | disclosed |
| US-5859336-A | DNA SEQUENCES ENCODING INSECTICIDAL PROTEINS, AND EXPRESSION OF THESE SEQUENCES IN PLANTS. | NOVARTIS CORPORATION | 1999-01-12 | — | — | US | disclosed |
| US-5859333-A | INCORPORATING INTO GENOME OF PLANT A DONOR GENE ENCODING A STARCH PRIMER FOR ALTERED ABILITY TO SYNTHESIZE STARCH | ZENECA LIMITED (GB) | 1999-01-12 | — | — | US | disclosed |
| US-5859344-A | DNA CONSTRUCTS WHICH ARE TRANSFORMED INTO PLANTS ENCODES A GALACTOSIDASE/GALACTANASE ENZYME TO MODIFY CELL WALL METABOLISM AND FRUIT RIPENING | ZENECA LIMITED (GB) | 1999-01-12 | — | — | US | disclosed |
| US-5859340-A | CULTURING PLANT CELL OR CALLUSES CONTAINING, IN A CONTAXT CAPABLE OF PERMITTING ITS EXPRESSION, AN ISOLATED, PURIFIED GENE THAT COMPRISES A POLYNUCLEOTIDE CODING A POLYPEPTIDE HAVING ENDOCHITINASE ACTIVITY | SANOFI (FR) | 1999-01-12 | — | — | US | disclosed |
| EP-0421935-B1 | Insect neuropeptides | NOVARTIS AG (CH) | 1999-01-07 | — | — | EP | disclosed |
| US-5856154-A | DNA SEQUENCES | NOVARTIS FINANCE CORPORATION (US) | 1999-01-05 | — | — | US | disclosed |
| US-5856114-A | A MEANS TO EVALUATE POTENTIAL RISK OF HEMORRHAGE DURING THROMBOLYTIC THERAPY. | THE UNIVERSITY OF VERMONT (US) | 1999-01-05 | — | — | US | disclosed |
| EP-0526883-B1 | Chondromodulin-II protein | MITSUBISHI CHEM CORP (JP) | 1998-12-30 | — | — | EP | disclosed |
| EP-0703785-A4 | METHODS FOR TREATING MUSCLE DISEASES AND DISORDERS | CAMBRIDGE NEUROSCIENCE RES (US) | 1998-12-30 | — | — | EP | disclosed |
| EP-0887646-A1 | A method for de novo peptide sequence determination | Oxford GlycoSciences (UK) Limited (GB) | 1998-12-30 | — | — | EP | disclosed |
| US-5854050-A | Enzyme with protease activity | NOVO NORDISK A/S (DK) | 1998-12-29 | — | — | US | disclosed |
| US-5853668-A | Apparatus allowing sequential chemical reactions | LUDWIG INSTITUTE FOR CANCER RESEARCH (CH) | 1998-12-29 | — | — | US | disclosed |
| US-5854220-A | Glial mitogenic factors, their preparation and use | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1998-12-29 | — | — | US | disclosed |
| EP-0368823-B2 | Biologically active lipoprotein and its use | PHARMACIA & UPJOHN AB (SE) | 1998-12-23 | — | — | EP | disclosed |
| EP-0885970-A1 | METHOD FOR ASSAYING AMMONIA AND COMPOSITION THEREFOR | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1998-12-23 | — | — | EP | disclosed |
| US-5851766-A | Process for isolating chemically regulatable DNA sequences | NOVARTIS FINANCE CORPORATION (US) | 1998-12-22 | — | — | US | disclosed |
| EP-0884324-A2 | Method for generating an anilinothiozolinone by treatment of a phenylthiocarbamyl amino acid with a Lewis acid in protein sequencing | Beckman Coulter, Inc. (US) | 1998-12-16 | — | — | EP | disclosed |
| US-5847258-A | DNA encoding β-1,3-glucanases | NOVARTIS FINANCE CORPORATION (US) | 1998-12-08 | — | — | US | disclosed |
| US-5846841-A | Motif Libraries | SELECTIDE CORPORATION (US) | 1998-12-08 | — | — | US | disclosed |
| US-5843673-A | Method of screening for endometriosis | CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 1998-12-01 | — | — | US | disclosed |
| WO-1998052601-A1 | CLEAVAGE OF FIBRIN(OGEN) AND CROSS-LINKED FIBRIN BY FIBRINOLYTIC MATRIX METALLOPROTEINASES | THE NEW YORK BLOOD CENTER, INC. (US) | 1998-11-26 | — | — | WO | disclosed |
| WO-1998053323-A2 | A METHOD FOR DE NOVO PEPTIDE SEQUENCE DETERMINATION | OXFORD GLYCOSCIENCES (UK) LTD. (GB) | 1998-11-26 | — | — | WO | disclosed |
| US-5840526-A | TWO HEAVY POLYPEPTIDE CHAINS WITH VARIABLE AND CONSTANT REGIONS INCLUDING COMPLETE ANTIGEN BINDING SITES; CONSTANT REGION LACKS CH1 DOMAIN; INCREASED EASE OF PREPARATION BY GENETIC ENGINEERING; MEDICAL DIAGNOSIS | VRIJE UNIVERSITEIT BRUSSEL (BE) | 1998-11-24 | — | — | US | disclosed |
| US-5840314-A | Production of streptococcal M protein | THE ROCKEFELLER UNIVERSITY (US) | 1998-11-24 | — | — | US | disclosed |
| US-5840313-A | ANTIGENIC PEPTIDES INDUCE ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY AGAINST HIV | SYNTELLO VACCINE DEVELOPMENT KB (SE) | 1998-11-24 | — | — | US | disclosed |
| US-5840485-A | SYNTHETIC TEST COMPOUNDS ATTACHED TO SEPARATE PHASE SYNTHESIS SUPPORTS THAT ALSO CONTAIN CODING MOLECULES THAT ENCODE THE STRUCTURE OF THE SYNTHETIC TEST COMPOUND | SELECTIDE CORPORATION (US) | 1998-11-24 | — | — | US | disclosed |
| EP-0842269-A4 | MOCARHAGIN, A COBRA VENOM PROTEASE, AND THERAPEUTIC USES THEREOF | BERNDT MICHAEL C (AU) | 1998-11-11 | — | — | EP | disclosed |
| US-5834310-A | ISOLATED OR PURIFIED GENE SEQUENCE ENCODING ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERSE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1998-11-10 | — | — | US | disclosed |
| US-5834307-A | RECOMBINANT POLYNUCLEOTIDE WHICH CODES FOR A POLYPEPTIDE FROM A CYTOMEGALOVIRUS GLYCOPROTEIN; FOR VACCINES, DIAGNOSIS | CHIRON CORPORATION (US) | 1998-11-10 | — | — | US | disclosed |
| US-5834318-A | Screening of combinatorial peptide libraries for selection of peptide ligand useful in affinity purification of target proteins | BAYER CORPORATION (US) | 1998-11-10 | — | — | US | disclosed |
| US-5830995-A | DIAGNOSIS OF COLON CANCER | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-11-03 | — | — | US | disclosed |
| US-5827683-A | Nucleic acids encoding BSSL variants | ASTRA AKTIEBOLAG (SE) | 1998-10-27 | — | — | US | disclosed |
| US-5827672-A | Human monocyte elastase inhibitor antibodies | CENTER FOR BLOOD RESEARCH, INC. (US) | 1998-10-27 | — | — | US | disclosed |
| WO-1998028333-A9 | USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS) | — | 1998-10-22 | — | — | WO | disclosed |
| US-5824648-A | EXTRACTION OF POLYSACCHARIDE PEPTIDE WITH BOILING WATER TO FORM POWDER, CENTRIFUGING, FILTRATION AND PURIFICATION WITH AMINO ACID SEQUENCE | YANG MABLE M P (HK) | 1998-10-20 | — | — | US | disclosed |
| US-5824858-A | Plant lysophosphatidic acid acyltransferases | CALGENE, INC. (US) | 1998-10-20 | — | — | US | disclosed |
| US-5821336-A | POLYPEPTIDE HAVING SPECIFIED AMINO ACID SEQUENCE OR FRAGMENT THEREOF | NOVARTIS COPORATION (US) | 1998-10-13 | — | — | US | disclosed |
| US-5821224-A | PURIFIED BETA-DEFENSIN WITH CONSENSUS SEQUENCE HAVING NET POSITIVE CHARGE THAT LACKS THREE CONSECUTIVE BASIC AMINO ACIDS AT THE CARBOXYL TERMINUS; POLYCLONAL AND MONOCLONAL ANTIBODIES AND DRUGS | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-10-13 | — | — | US | disclosed |
| US-5820857-A | DNA FRAGMENT WHICH CARRIES THE GENE ENCODING THE ENZYME | SANOFI (FR) | 1998-10-13 | — | — | US | disclosed |
| EP-0868195-A2 | CONTROL OF PROTEIN SYNTHESIS, AND SCREENING METHOD FOR AGENTS | MEDICAL RESEARCH COUNCIL (GB) | 1998-10-07 | — | — | EP | disclosed |
| CN-1040126-C | Preparation method of protein | HOFFMANN LA ROCHE (CH) | 1998-10-07 | — | — | CN | disclosed |
| US-5807748-A | N-terminal protein sequencing reagents and methods which form amino acid detectable by a variety of techniques | CITY OF HOPE (US) | 1998-09-15 | — | — | US | disclosed |
| EP-0537270-B1 | DETECTION OF ANALYTES USING FLUORESCENT ENERGY TRANSFER | UNIV CALIFORNIA (US) | 1998-09-09 | — | — | EP | disclosed |
| US-5804693-A | TRANSGENIC PLANT, PLANT CELL OR PLANT TISSUE COMPRISING AN ENCODED ENZYME CAPABLE METABOLIZING SALICYLIC ACID | NOVARTIS FINANCE CORPORATION (US) | 1998-09-08 | — | — | US | disclosed |
| US-5804423-A | TRANSFORMING MICROORGANISM WITH VECTOR CONTAINING GENE SEQUENCE ENCODING PROTEIN OR FRAGMENT HAVING GLUCONATE:NADP-5-OXIDOREDUCTASE ACTIVITY, CULTURING IN MEDIUM CONTAINING GLUCONATE, RECOVERING 5-KETOGLUCONATE | FORSCHUNGSZENTRUM JULICH GMBH (DE) | 1998-09-08 | — | — | US | disclosed |
| WO-1998038290-A1 | AMINOPEPTIDASE DERIVED FROM BACILLUS LICHENIFORMIS AND PROCESS FOR PREPARATION OF NATURAL TYPE PROTEINS | LG CHEMICAL LTD. (KR) | 1998-09-03 | — | — | WO | disclosed |
| EP-0398753-B1 | Metalloproteinase inhibitor | AMGEN INC (US) | 1998-09-02 | — | — | EP | disclosed |
| US-5801012-A | CONTACTING PLASMINOGEN OF PLASMIN WITH A PLASMINOGEN ACTIVATOR AND A SULFHYDRYL DONOR | NORTHWESTERN UNIVERSITY (US) | 1998-09-01 | — | — | US | disclosed |
| US-5800988-A | CDNA LIBRARIES WITH NUCLEOTIDE SEQUENCES CODED FOR IMMUNOGLOBULINS WITH POLYPEPTIDE CHAINS | VRIJE UNIVERSITEIT BRUSSEL (BE) | 1998-09-01 | — | — | US | disclosed |
| WO-1998036771-A1 | METHOD FOR THE PRODUCTION OF VACCINES AGAINST CELL SURFACE PROTEINS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 1998-08-27 | — | — | WO | disclosed |
| CN-1191571-A | Method for modifying toxic and/or odorous compounds | GIST BROCADES BV (NL) | 1998-08-26 | — | — | CN | disclosed |
| EP-0859000-A1 | Isoxazole amide and crotonamid derivatives and drug and diagnostic uses thereof | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-08-19 | — | — | EP | disclosed |
| WO-1998035012-A2 | METHODS AND PRODUCTS FOR ANALYZING POLYMERS | CHAN EUGENE Y (US) | 1998-08-13 | — | — | WO | disclosed |
| US-5792849-A | POLYPEPTIDES USEFUL FOR THE STIMULATION OF GLIAL CELL (PARTICULARLY, SCHWANN CELL) MITOGENESIS AND TREATING GLIAL CELL TUMORS | LUDWIG INSTITUTE FOR CANCER RESEARCH AND CAMBRIDGE NEUROSCIENCE (US) | 1998-08-11 | — | — | US | disclosed |
| US-5789214-A | TRANSPORTATION OF PLANT TISSUES, NUCLEIC ACID PROMOTER FRAGMENTS, CODES AND EXPOSING TISSUES | NOVARTIS FINANCE CORPORATION (US) | 1998-08-04 | — | — | US | disclosed |
| EP-0697112-A4 | C-TERMINAL SEQUENCING OF PEPTIDES WHICH MAY INCLUDE PROLINE | HOPE CITY (US) | 1998-07-29 | — | — | EP | disclosed |
| EP-0854882-A1 | AN ACCEPTOR POLYPEPTIDE FOR AN N-ACETYLGALACTOSAMINYLTRANSFERASE | PHARMACIA & UPJOHN COMPANY (US) | 1998-07-29 | — | — | EP | disclosed |
| EP-0854716-A1 | ANDROGENIC DIRECTED COMPOSITIONS | BIOPHYSICA FOUNDATION (US) | 1998-07-29 | — | — | EP | disclosed |
| US-5785973-A | Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines | PRAXIS BIOLOGICS, INC. (US) | 1998-07-28 | — | — | US | disclosed |
| WO-1998031793-A2 | IMMUNOMODULATING PROPERTIES, AMINO ACID AND NUCLEOTIDE SEQUENCE OF COLOSTRUM DERIVED GROWTH FACTOR | THE ROWETT RESEARCH INSTITUTE (GB) | 1998-07-23 | — | — | WO | disclosed |
| WO-1998031705-A1 | BROMO-TRYPTOPHAN CONOPEPTIDES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 1998-07-23 | — | — | WO | disclosed |
| US-5783384-A | Selection of binding-molecules | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1998-07-21 | — | — | US | disclosed |
| CN-1187491-A | Recombinant coccidiosis vaccines | HOFFMANN LA ROCHE (CH) | 1998-07-15 | — | — | CN | disclosed |
| CN-1187368-A | Recombinant coccidiosis vaccines | HOFFMANN LA ROCHE (CH) | 1998-07-15 | — | — | CN | disclosed |
| US-5780597-A | Monoclonal antibodies to cytotoxic lymphocyte maturation factor | HOFFMANN-LA ROCHE INC. (US) | 1998-07-14 | — | — | US | disclosed |
| CN-1186695-A | Recombinant coccidiosis vaccines | HOFFMANN LA ROCHE (CH) | 1998-07-08 | — | — | CN | disclosed |
| US-5776751-A | MICROTUBULE ASSOCIATED PROTEIN 2 FROM CLONING, A POLYPEPTIDE | REGENERON PHARMACEUTICALS, INC. (US) | 1998-07-07 | — | — | US | disclosed |
| US-5777200-A | Chemically regulatable and anti-pathogenic DNA sequences and uses thereof | NOVARTIS FINANCE CORPORATION (US) | 1998-07-07 | — | — | US | disclosed |
| WO-1998028333-A2 | USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS) | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1998-07-02 | — | — | WO | disclosed |
| US-5773699-A | VARYING CONTENT OF CERTAIN OLIGOSACCHARIDES IN PLANTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-06-30 | — | — | US | disclosed |
| WO-1998026747-A2 | SUPERANTIGEN BASED METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASES | TERMAN DAVID S (US) | 1998-06-25 | — | — | WO | disclosed |
| EP-0361284-B1 | T cell growth factor | LUDWIG INST CANCER RES (US) | 1998-06-17 | — | — | EP | disclosed |
| US-5767235-A | SULFATED TYOSINE | NIPPON MINING COMPANY LIMITED (JP) | 1998-06-16 | — | — | US | disclosed |
| US-5767369-A | PLANT RESISTANCE | NOVARTIS FINANCE CORPORATION (US) | 1998-06-16 | — | — | US | disclosed |
| EP-0846950-A2 | Peptides useful as internal standards for microsequencing and method for their use | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1998-06-10 | — | — | EP | disclosed |
| US-5763739-A | GENETIC ENGINEERING | ASTRA AKTIEBOLAG (SE) | 1998-06-09 | — | — | US | disclosed |
| EP-0537981-B1 | Cleavage method for acyl thiohydantoins and use of the method in C-terminal peptide sequencing | PERKIN ELMER CORP (US) | 1998-06-03 | — | — | EP | disclosed |
| US-5759808-A | NUCLEOTIDE SEQUENCE CODING OF IMMUNOGLOBULINS AND POLYPEPTIDES | VRIJE UNIVERSITEIT BRUSSEL (BE) | 1998-06-02 | — | — | US | disclosed |
| US-5759791-A | KITS FOR DIAGNOSIS OF BREAST CANCER USING ANTIBODIES | THE JOHNS HOPKINS UNIVERSITY (US) | 1998-06-02 | — | — | US | disclosed |
| US-5756667-A | Method for preparation of amino acid thiohydantoins | GARVAN INSTITUTE OF MEDICAL RESEARCH (AU) | 1998-05-26 | — | — | US | disclosed |
| EP-0842269-A1 | MOCARHAGIN, A COBRA VENOM PROTEASE, AND THERAPEUTIC USES THEREOF | Berndt, Michael, C. (AU) | 1998-05-20 | — | — | EP | disclosed |
| EP-0651883-B1 | PEPTIDES USEFUL AS INTERNAL STANDARDS FOR MICROSEQUENCING AND METHODS FOR THEIR USE | US HEALTH (US) | 1998-05-13 | — | — | EP | disclosed |
| US-5750654-A | Leukaemia inhibitory factor | AMRAD CORPORATION LIMITED (AU) | 1998-05-12 | — | — | US | disclosed |
| US-5750377-A | SYNERGISTIC WITH INTERLEUKINS | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1998-05-12 | — | — | US | disclosed |
| US-5747329-A | Glutamylcysteine synthetase light subunit | CORNELL RESEARCH FOUNDATION, INC. (US) | 1998-05-05 | — | — | US | disclosed |
| CN-1180358-A | Bridged indoles as matrix metalloprotease inhibitors | SYNTEX INC (US) | 1998-04-29 | — | — | CN | disclosed |
| US-5744328-A | GENETIC ENGINEERING | MONSANTO COMPANY (US) | 1998-04-28 | — | — | US | disclosed |
| CN-1179780-A | Peptides with Growth Promoting Properties | AMERICAN CYANAMID CO (US) | 1998-04-22 | — | — | CN | disclosed |
| WO-1998015179-A1 | THERAPEUTIC AND DIAGNOSTIC APPLICATIONS OF LAMININ AND LAMININ-DERIVED PROTEIN FRAGMENTS | UNIVERSITY OF WASHINGTON (US) | 1998-04-16 | — | — | WO | disclosed |
| WO-1998015574-A1 | METHODS AND COMPOSITIONS FOR GENERATING ANGIOSTATIN | NORTHWESTERN UNIVERSITY (US) | 1998-04-16 | — | — | WO | disclosed |
| CN-1178798-A | Method for removing N-terminal methionine | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1998-04-15 | — | — | CN | disclosed |
| WO-1998014595-A1 | FUNGAL LICHENASE AND CODING SEQUENCES | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC. (US) | 1998-04-09 | — | — | WO | disclosed |
| EP-0834556-A1 | Methods for culturing cells | Academisch Ziekenhuis Leiden (NL) | 1998-04-08 | — | — | EP | disclosed |
| WO-1998013475-A1 | METHODS FOR CULTURING CELLS | ACADEMISCH ZIEKENHUIS LEIDEN (NL) | 1998-04-02 | — | — | WO | disclosed |
| EP-0639584-B1 | Preparation and screening of highly diverse peptide libraries for binding activity | INTERPHARM LAB LTD (IL) | 1998-04-01 | — | — | EP | disclosed |
| EP-0831871-A1 | RELAXIN-LIKE FACTOR AND METHODS AND USES THEREOF | CONNECTIVE THERAPEUTICS, INC. (US) | 1998-04-01 | — | — | EP | disclosed |
| EP-0663443-B1 | Dextranase enzyme, method for its production and DNA encoding the enzyme | CIGB (CU) | 1998-04-01 | — | — | EP | disclosed |
| WO-1998011224-A1 | TNF-BETA-LIKE PROTEIN FOR TREATING PROSTATE CANCER, AND RELATED NUCLEIC ACID MOLECULES, PHARMACEUTICAL COMPOSITIONS AND METHODS | ORTHO-MCNEIL PHARMACEUTICAL,INC (US) | 1998-03-19 | — | — | WO | disclosed |
| EP-0779985-B1 | ACETIC ANHYDRIDE ACTIVATION FOR C-TERMINAL PROTEIN SEQUENCING | PERKIN ELMER CORP (US) | 1998-03-18 | — | — | EP | disclosed |
| US-5728549-A | GENE EXPRESSION VECTORS WITH CONTROLLING SEQUENCES OF DNA | NOVARTIS CORPORATION (US) | 1998-03-17 | — | — | US | disclosed |
| US-5728674-A | POLYPEPTIDES AS ANTICOAGULANTS | ZYMOGENETICS, INC. (US) | 1998-03-17 | — | — | US | disclosed |
| WO-1998009639-A1 | NOVEL BACTERIOCINS, TRANSPORT AND VECTOR SYSTEM AND METHOD OF USE THEREOF | GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 1998-03-12 | — | — | WO | disclosed |
| US-5726152-A | Vascular endothelial cell growth factor II | MERCK & CO., INC. (US) | 1998-03-10 | — | — | US | disclosed |
| US-5726035-A | Recombinant production of mammalian calcium channel gamma subunits | SIBIA NEUROSCIENCES, INC. (US) | 1998-03-10 | — | — | US | disclosed |
| EP-0433827-B1 | Cytotoxic lymphocyte maturation factor | HOFFMANN LA ROCHE (CH) | 1998-03-04 | — | — | EP | disclosed |
| US-5723747-A | Wax esters in transformed plants | CALGENE, INC. (US) | 1998-03-03 | — | — | US | disclosed |
| US-5723301-A | BINDING ENZYMES OF GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE TO POLYGLUTAMINE | DUKE UNIVERSITY (US) | 1998-03-03 | — | — | US | disclosed |
| US-5723585-A | Method of purifying cardiac hypertrophy factor | GENENTECH, INC. (US) | 1998-03-03 | — | — | US | disclosed |
| EP-0563222-B1 | BIOLOGICALLY ACTIVE BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN FRAGMENTS | UNIV NEW YORK (US) | 1998-02-25 | — | — | EP | disclosed |
| US-5716930-A | POLYPEPTIDE FROM GENETICALLY ENGINEERED CELLS | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1998-02-10 | — | — | US | disclosed |
| US-5717075-A | FORMED BY REACTING MEMBRANE THAT HAS BOUND CARBOXYLIC ACID GROUPS WITH 2-ETHYL-5'-PHENYLISOXAZOLIUM SULFONATE | THE PERKIN-ELMER CORPORATION (US) | 1998-02-10 | — | — | US | disclosed |
| EP-0460072-B1 | HUMAN ELASTASE INHIBITOR | BLOOD RES CENTER (US) | 1998-02-04 | — | — | EP | disclosed |
| US-5714588-A | COATING SOLID SUPPORT; WOUND HEALING AGENTS | ADVANCED TISSUE SCIENCES (US) | 1998-02-03 | — | — | US | disclosed |
| US-5714465-A | Method of inhibiting tumor cell dissemination with a metalloproteinase inhibitor | AMGEN INC. (US) | 1998-02-03 | — | — | US | disclosed |
| WO-1998003537-A2 | HIRUSTASIN AND A HIRUSTASIN/KALLIKREIN COMPLEX IN CRYSTALLINE FORM | NOVARTIS AG (CH) | 1998-01-29 | — | — | WO | disclosed |
| WO-1998002559-A1 | OVER-EXPRESSION OF PROTEINS | MEDICAL RESEARCH COUNCIL (GB) | 1998-01-22 | — | — | WO | disclosed |
| US-5707828-A | EXPRESSION CASSETTES FOR ALBUMIN IN GENES | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1998-01-13 | — | — | US | disclosed |
| WO-1998000555-A1 | RECOMBINANT N-PROTEINASE, AND THE PRODUCTION, METHODS AND USES THEREOF | PROCKOP DARWIN J (US) | 1998-01-08 | — | — | WO | disclosed |
| EP-0815222-A1 | SPERM FACTOR | MEDICAL RESEARCH COUNCIL (GB) | 1998-01-07 | — | — | EP | disclosed |
| EP-0639607-B1 | Method and apparatus for degradation and sequencing of polymers which sequentially eliminate terminal residues | PERSEPTIVE BIOSYSTEMS INC (US) | 1998-01-07 | — | — | EP | disclosed |
| EP-0689550-A4 | NOVEL ANTIMICROBIAL PEPTIDES FROM BOVINE NEUTROPHILS | UNIV CALIFORNIA (US) | 1998-01-07 | — | — | EP | disclosed |
| US-5702920-A | POLYPEPTIDES | NOVARTIS CORPORATION (US) | 1997-12-30 | — | — | US | disclosed |
| US-5700678-A | Protein disulfide-isomerase and production thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-12-23 | — | — | US | disclosed |
| WO-1997046674-A1 | SPRUCE BUDWORM ANTIFREEZE PROTEINS, GENES AND METHODS OF USING SAME | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1997-12-11 | — | — | WO | disclosed |
| US-5695953-A | GENETIC ENGINEERING; CULTURING TRANSFORMANT HOST CELL | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1997-12-09 | — | — | US | disclosed |
| US-5691311-A | Methods for coating invasive devices with inhibitors of thrombin | BIOGEN, INC. (US) | 1997-11-25 | — | — | US | disclosed |
| US-5689044-A | GENETIC ENGINEERING | NOVARTIS CORPORATION (US) | 1997-11-18 | — | — | US | disclosed |
| WO-1997041206-A2 | VON WILLEBRAND FACTOR MULTIMERASE | IMMUNO AKTIENGESELLSCHAFT (AT) | 1997-11-06 | — | — | WO | disclosed |
| EP-0804735-A1 | N-TERMINAL PROTEIN SEQUENCING REAGENTS AND METHODS WHICH FORM AMINO ACID DERIVATIVES | CITY OF HOPE (US) | 1997-11-05 | — | — | EP | disclosed |
| EP-0804564-A1 | NEURAL AXON OUTGROWTH MODULATORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-11-05 | — | — | EP | disclosed |
| US-5681751-A | IMMOBILIZED IN A POROUS MATRIX; ELECTROPHORESIS | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1997-10-28 | — | — | US | disclosed |
| US-5681934-A | GENETIC ENGINEERING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1997-10-28 | — | — | US | disclosed |
| EP-0693122-A4 | GLUTAMYLCYSTEINE SYNTHETASE LIGHT SUBUNIT | CORNELL RES FOUNDATION INC (US) | 1997-10-22 | — | — | EP | disclosed |
| US-5679545-A | THERAPY FOR HEART FAILURE, ARRHYTHMIC, INOTROPIC AND NEUROLOGICAL DISORDERS | GENENTECH, INC. (US) | 1997-10-21 | — | — | US | disclosed |
| US-5679881-A | FREE FROM INTACT PLANT CELLS; CAPABLE OF CATALYZING PRODUCTION OF VERY LONG CHAIN FATTY ACIDS | CALGENE, INC. (US) | 1997-10-21 | — | — | US | disclosed |
| EP-0540064-B1 | Apoaequorin peptides, recombinant DNA vectors capable of expressing the same and microorganisms containing said vectors | UNIV GEORGIA RES FOUND (US) | 1997-10-15 | — | — | EP | disclosed |
| US-5677164-A | PROTEIN | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-10-14 | — | — | US | disclosed |
| EP-0673440-A4 | MAMMALIAN MUSCLE NAD:ARGININE ADP-RIBOSYLTRANSFERASE. | US HEALTH (US) | 1997-10-01 | — | — | EP | disclosed |
| WO-1997035011-A1 | RECOMBINANT PROCESS FOR THE PRODUCTION IN PSEUDOMONAS PUTIDA OF THE CYTOCHROME C551 OF PSEUDOMONAS AERUGINOSA | MINISTERO DELL'UNIVERSITA' E DELLA RICERCA SCIENT IFICA E TECNOLOGICA (IT) | 1997-09-25 | — | — | WO | disclosed |
| EP-0677058-A4 | SUPPORT AND METHOD FOR IMMOBILIZING POLYPEPTIDES. | APPLIED BIOSYSTEMS (US) | 1997-09-24 | — | — | EP | disclosed |
| US-5668001-A | DRUG FOR INHIBITION OF CHOLESTEROL SYNTHESIS | MCW RESEARCH FOUNDATION, INC. (US) | 1997-09-16 | — | — | US | disclosed |
| US-5665874-A | Cancer related antigen | JOHN HOPKINS UNIVERSITY (US) | 1997-09-09 | — | — | US | disclosed |
| EP-0453055-B1 | Antigenic proteins and vaccines containing them for prevention of coccidiosis | DIMMINACO AG SA LTD (CH) | 1997-09-03 | — | — | EP | disclosed |
| US-5663299-A | Human monocyte elastase inhibitor | CENTER FOR BLOOD RESEARCH, INC. (US) | 1997-09-02 | — | — | US | disclosed |
| US-5661015-A | DNA SEQUENCES CODING FOR EIMERIA SURFACE ANTIGENS | HOFFMANN-LA ROCHE INC. (US) | 1997-08-26 | — | — | US | disclosed |
| EP-0790255-A2 | Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto | F. HOFFMANN-LA ROCHE AG (CH) | 1997-08-20 | — | — | EP | disclosed |
| EP-0790309-A1 | Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto | F. HOFFMANN-LA ROCHE AG (CH) | 1997-08-20 | — | — | EP | disclosed |
| EP-0790308-A1 | Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto | F. HOFFMANN-LA ROCHE AG (CH) | 1997-08-20 | — | — | EP | disclosed |
| US-5659018-A | ANTIINFLAMMATORY AGENTS | GENETICS INSTITUTE, INC. (US) | 1997-08-19 | — | — | US | disclosed |
| US-5656651-A | DETECTING TUMOR CELLS | BIOPHYSICA INC. (US) | 1997-08-12 | — | — | US | disclosed |
| EP-0787190-A2 | HEPATITIS E VIRUS ANTIGENS AND USES THEREFOR | GENELABS TECHNOLOGIES, INC. (US) | 1997-08-06 | — | — | EP | disclosed |
| US-5654414-A | GENETIC ENGINEERING | NOVARTIS FINANCE CORPORATION (US) | 1997-08-05 | — | — | US | disclosed |
| US-5654167-A | Antimicrobial proteins, compositions containing same and uses thereof | CORNELL RESEARCH FOUNDATION, INC. (US) | 1997-08-05 | — | — | US | disclosed |
| US-5652123-A | INHIBITS PRODUCTION OF INTERLEUKIN-1BETA BY LIPOPOLYSACCHARIDE-STIMULATED PERIPHERAL BLOOD MONOCYTES | Sanofi, Elf (FR) | 1997-07-29 | — | — | US | disclosed |
| US-5650492-A | P-40 homodimer of interleukin-12 | HOFFMANN-LA ROCHE INC. (US) | 1997-07-22 | — | — | US | disclosed |
| US-5650505-A | Chemically regulatable and anti-pathogenic DNA sequences and uses thereof | NOVARTIS CORPORATION (US) | 1997-07-22 | — | — | US | disclosed |
| US-5650293-A | PROTEIN THAT MEDIATES INSULIN REGULATION OF 3'-PHOSPHATIDYL INOSITOL KINASE WITH NUCLEIC ACID SEQUENCES | JOSLIN DIABETES CENTER, INC. (US) | 1997-07-22 | — | — | US | disclosed |
| US-5648210-A | HYBRIDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-07-15 | — | — | US | disclosed |
| US-5644026-A | ANTITUMOR AGENT POLYPEPTIDES | LA JOLLA CANCER RESEARCH FOUNDATION (US) | 1997-07-01 | — | — | US | disclosed |
| WO-1997022360-A2 | CONTROL OF PROTEIN SYNTHESIS, AND SCREENING METHOD FOR AGENTS | MEDICAL RESEARCH COUNCIL (GB) | 1997-06-26 | — | — | WO | disclosed |
| EP-0779985-A1 | ACETIC ANHYDRIDE ACTIVATION FOR C-TERMINAL PROTEIN SEQUENCING | THE PERKIN-ELMER CORPORATION (US) | 1997-06-25 | — | — | EP | disclosed |
| US-5641743-A | ADMINISTERING TO PROMOTE ANGIOGENESIS IN MAMMALS | AMERICAN CYANAMID COMPANY (US) | 1997-06-24 | — | — | US | disclosed |
| US-5641874-A | DNA encoding bactericidal/permeability increasing proteins | NEW YORK UNIVERSITY (US) | 1997-06-24 | — | — | US | disclosed |
| EP-0778777-A1 | A METHOD OF SEQUENCING PROTEINS BY EPITOPE ORDERING AND PROTEIN RESTRICTION MAPPING | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1997-06-18 | — | — | EP | disclosed |
| EP-0674712-A4 | A PROTEINASE INHIBITOR, PRECURSOR THEREOF AND GENETIC SEQUENCES ENCODING SAME. | UNIV MELBOURNE (AU) | 1997-06-18 | — | — | EP | disclosed |
| US-5637491-A | GENETIC ENGINEERING; CULTURE PRODUCT OF PENICILLIUM | CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA (CU) | 1997-06-10 | — | — | US | disclosed |
| CN-1150390-A | Glial mitogenic factors, their preparation and use | LUDWIG INST CANCER RES (US) | 1997-05-21 | — | — | CN | disclosed |
| US-5631131-A | cDNA probes and antibodies for human methenyltetrahydrofolate synthetase | UNIVERSITE DE MONTREAL (CA) | 1997-05-20 | — | — | US | disclosed |
| WO-1997016699-A1 | PIEZOELECTRIC FORCE SENSING APPARATUS AND METHODS FOR BIOPOLYMER SEQUENCING | TRUSTEES OF BOSTON UNIVERSITY (US) | 1997-05-09 | — | — | WO | disclosed |
| EP-0771146-A1 | FIBRIN(OGEN) DEGRADATION AND CLOT LYSIS BY FIBRINOLYTIC MATRIX METALLOPROTEINASE | THE NEW YORK BLOOD CENTER, INC. (US) | 1997-05-07 | — | — | EP | disclosed |
| EP-0458918-B1 | METHOD FOR OBTAINING A RECOMBINANT PROTEIN AND ITS UTILIZATION IN THE ASSAY FOR THE AFRICAN SWINE PEST VIRUS (ASPV) | UNIV OVIEDO (ES) | 1997-05-07 | — | — | EP | disclosed |
| EP-0728188-B1 | BEVERAGE AND A METHOD OF PREPARING IT | CARLSBERG AS (DK) | 1997-05-07 | — | — | EP | disclosed |
| US-5627073-A | Hybridomas producing antibodies to cardiac hypertrophy factor | GENENTECH, INC. | 1997-05-06 | — | — | US | disclosed |
| US-5625136-A | NUCLEOTIDE SEQUENCE, CHIMERIC GENE, TRANSFORMED PLANT, TRANSGENIC SEED | CIBA-GEIGY CORPORATION (US) | 1997-04-29 | — | — | US | disclosed |
| US-5624659-A | Method of treating brain tumors expressing tenascin | DUKE UNIVERSITY (US) | 1997-04-29 | — | — | US | disclosed |
| US-5624806-A | DNA CODES AND ANTAGONIST, ANTAGONISM | GENENTECH, INC. (US) | 1997-04-29 | — | — | US | disclosed |
| EP-0768869-A1 | FACTOR TO GROW TISSUE EX VIVO | ADVANCED TISSUE SCIENCES (US) | 1997-04-23 | — | — | EP | disclosed |
| EP-0768821-A1 | pp60PIK : A DOWNSTREAM ELEMENT IN INSULIN SIGNALING | THE JOSLIN DIABETES CENTER, INC. (US) | 1997-04-23 | — | — | EP | disclosed |
| EP-0474313-B1 | Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations | CIGB (CU) | 1997-04-23 | — | — | EP | disclosed |
| US-5623067-A | Seed-specific promoter region | PLANT GENETIC SYSTEMS, N.V. (BE) | 1997-04-22 | — | — | US | disclosed |
| WO-1997013783-A1 | AN ACCEPTOR POLYPEPTIDE FOR AN N-ACETYLGALACTOSAMINYLTRANSFERASE | PHARMACIA & UPJOHN COMPANY (US) | 1997-04-17 | — | — | WO | disclosed |
| EP-0454782-B1 | CANCER RELATED HAPTOGLOBIN (HPR) | UNIV JOHNS HOPKINS (US) | 1997-04-16 | — | — | EP | disclosed |
| US-5621081-A | POLYPEPTIDE; TREATMENT OF NERVOUS SYSTEM DISORDERS | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1997-04-15 | — | — | US | disclosed |
| US-5618715-A | PURE NUCLEOTIDE SEQUENCE ENCODING ONCOSTATIN M | ONCOGEN LIMITED PARTNERSHIP (US) | 1997-04-08 | — | — | US | disclosed |
| US-5614395-A | SCREENING FOR AGROCHEMICALS HAVING THE ABILITY TO INDUCE SYSTEMIC ACQUIRED RESISTANCE IN PLANTS | CIBA-GEIGY CORPORATION (US) | 1997-03-25 | — | — | US | disclosed |
| EP-0762885-A1 | GLIAL MITOGENIC FACTORS, THEIR PREPARATION AND USE | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1997-03-19 | — | — | EP | disclosed |
| EP-0763598-A1 | Method of preparing a fusion protein | KAJI, Akira (JP) | 1997-03-19 | — | — | EP | disclosed |
| EP-0653940-A4 | GLIAL MITOGENIC FACTORS, THEIR PREPARATION AND USE. | LUDWIG INST CANCER RES (US) | 1997-02-26 | — | — | EP | disclosed |
| US-5605839-A | Methods and apparatus for use in sequential chemical reactions | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1997-02-25 | — | — | US | disclosed |
| US-5606032-A | EXTRACTION OF VERTEBRATE BRAIN MATERIAL TO OBTAIN PROTEIN; CHROMATOGRAPHIC PURIFICATION | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1997-02-25 | — | — | US | disclosed |
| EP-0758393-A1 | MAC-1 I-DOMAIN PROTEIN USEFUL IN BLOCKING ADHESION AND MIGRATION OF NEUTROPHILS | PHARMACIA & UPJOHN COMPANY (US) | 1997-02-19 | — | — | EP | disclosed |
| WO-1997005244-A1 | MOCARHAGIN, A COBRA VENOM PROTEASE, AND THERAPEUTIC USES THEREOF | BERNDT MICHAEL C (AU) | 1997-02-13 | — | — | WO | disclosed |
| US-5602096-A | CONTACTING CELL WITH GLIAL GROWTH FACTOR | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1997-02-11 | — | — | US | disclosed |
| US-5602207-A | A POLYVINYLIDENE FLUORIDE MEMBRANE HAVING SURFACE-ATTACHED ENOL ESTER GROUPS AND SURFACE ATTACHED SULFONATE GROUPS | THE PERKIN-ELMER CORPORATION (US) | 1997-02-11 | — | — | US | disclosed |
| CN-1141920-A | Thiophene compounds, process for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1997-02-05 | — | — | CN | disclosed |
| US-5599690-A | USING HIGH CONCENTRATION OF LEUCINE AND, OR METHIONINE IN CULTURE | AMGEN INC. (US) | 1997-02-04 | — | — | US | disclosed |
| US-5599788-A | WOUND HEALING AGENTS; DERMAL FIBROPLAST ADHESION PROMOTER | ADVANCED TISSUE SCIENCES (US) | 1997-02-04 | — | — | US | disclosed |
| EP-0755446-A1 | CARDIOTROPHIN AND USES THEREFOR | GENENTECH, INC. (US) | 1997-01-29 | — | — | EP | disclosed |
| US-5597708-A | GENETIC ENGINEERING; DNA SEQUENCES ENCODING PLASMODIUM PROTEIN | BURROUGHS WELLCOME COMPANY (US) | 1997-01-28 | — | — | US | disclosed |
| EP-0754232-A1 | PLANT LYSOPHOSPHATIDIC ACID ACYLTRANSFERASES | CALGENE, INC. (US) | 1997-01-22 | — | — | EP | disclosed |
| CN-1141061-A | Thrombopoietin | GENENTECH INC (US) | 1997-01-22 | — | — | CN | disclosed |
| US-5595904-A | Family of map2 protein kinases | BOARD OF REGENTS, UNIV. OF TEXAS (US) | 1997-01-21 | — | — | US | disclosed |
| EP-0753013-A1 | NEUROTROPHIN-6: A NEW MEMBER OF THE NEUROTROPHIN FAMILY | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. (DE) | 1997-01-15 | — | — | EP | disclosed |
| US-5594120-A | Integrin alpha subunit | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 1997-01-14 | — | — | US | disclosed |
| EP-0580672-B1 | SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN | HALE GEOFFREY (GB) | 1997-01-08 | — | — | EP | disclosed |
| CN-1139955-A | Human kunitz-type protease inhibitors | ZYMOGENETICS INC (US) | 1997-01-08 | — | — | CN | disclosed |
| US-5591619-A | GENETIC ENGINEERING | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1997-01-07 | — | — | US | disclosed |
| WO-1997000071-A1 | ANDROGENIC DIRECTED COMPOSITIONS | BIOPHYSICA FOUNDATION (US) | 1997-01-03 | — | — | WO | disclosed |
| WO-1997000081-A1 | A METHOD FOR INHIBITING BACTEREMIA AND BACTERIAL DISSEMINATION | GOYERT SANNA M (US) | 1997-01-03 | — | — | WO | disclosed |
| US-5589397-A | SIMULTANEOUSLY SEQUENCING INTERNAL STANDARD COMPRISING PEPTIDE CONSISTING OF UNNATURAL AMINO ACID RESIDUES AND UNKNOWN PEPTIDE IN SEQUENCER TO PRODUCE CHROMATOGRAM, COMPARING RETENTION TIMES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-12-31 | — | — | US | disclosed |
| US-5587302-A | ISOLATED POLYNUCLEOTIDES ENCODES POLYPEPTIDE INTERLEUKINS | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1996-12-24 | — | — | US | disclosed |
| WO-1996040890-A1 | NON-NATURALLY OCCURRING TARGETED LIPOLYTIC COMPOUNDS: SYNTHESIS, DEMONSTRATION OF POTENCY, AND PRACTICAL AND THERAPEUTIC APPLICATIONS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN CITY OF NEW YORK (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996040186-A1 | RELAXIN-LIKE FACTOR AND METHODS AND USES THEREOF | CONNECTIVE THERAPEUTICS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| US-5583211-A | FORMING NUCLEOPHILES ON POLYPROPYLENE SUPPORT SELECTED FROM GROUPS CONSISTING OF-NH2,-SH, AND -OH; REACTING BIOMONOMERS | BECKMAN INSTRUMENTS, INC. (US) | 1996-12-10 | — | — | US | disclosed |
| CN-1137291-A | Beverage and method of preparing it | CARLSBERG AS (DK) | 1996-12-04 | — | — | CN | disclosed |
| US-5580740-A | ENZYME IMMUNOASSAY | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1996-12-03 | — | — | US | disclosed |
| WO-1996036227-A1 | FIBRIN(OGEN) DEGRADATION AND CLOT LYSIS BY FIBRINOLYTIC MATRIX METALLOPROTEINASE | THE NEW YORK BLOOD CENTER, INC. (US) | 1996-11-21 | — | — | WO | disclosed |
| EP-0517931-B1 | Physiologically active peptides, use thereof and a method of producing said peptides | AKIRA KAJI (JP) | 1996-11-20 | — | — | EP | disclosed |
| US-5576292-A | Biologically active bactericidal/permeability-increasing protein fragments | NEW YORK UNIVERSITY (US) | 1996-11-19 | — | — | US | disclosed |
| EP-0742438-A2 | Screening of combinatorial peptide libraries for selection of peptide ligand useful in affinity purification of target proteins | Bayer Corporation (US) | 1996-11-13 | — | — | EP | disclosed |
| US-5571893-A | Cardiac hypertrophy factor | GENENTECH, INC. (US) | 1996-11-05 | — | — | US | disclosed |
| US-5571675-A | HYBRIDIZING SELECTED NUCLEIC ACID TO SAMPLE NUCLEIC ACID, DETERMINE PRESENCE BY HYBRID MOLECULE | GENENTECH, INC. (US) | 1996-11-05 | — | — | US | disclosed |
| EP-0389585-B1 | DERIVATIZED GLASS SUPPORTS FOR PEPTIDE AND PROTEIN SEQUENCING | BECKMAN INSTRUMENTS INC (US) | 1996-10-30 | — | — | EP | disclosed |
| US-5565171-A | CONTINUOUS CAPILLARY INCLUDING REACTION END AND IDENTIFICATION END, FLUID FLOW CONTROL MEANS, SUPPLY PORTION, SAMPLE HOLDER, IDENTIFICATION MEANS FOR IDENTIFYING REACTION PRODUCT | GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 1996-10-15 | — | — | US | disclosed |
| US-5565331-A | GENETIC ENGINEERING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-10-15 | — | — | US | disclosed |
| EP-0618296-B1 | Method for cloning restriction modification systems | NEW ENGLAND BIOLABS INC (US) | 1996-10-09 | — | — | EP | disclosed |
| US-5563058-A | PURIFIED PLANT PROTEIN CAPABLE OF CATALYZING PRODUCTION OF 1,2-DIACYLGLYCEROL-3-PHOSPHATE FROM 1-ACYLGLYCEROL-3-PHOSPHATE SUBSTRATE AND MEDIUM CHAIN ACYL-COENZYME A | CALGENE, INC. (US) | 1996-10-08 | — | — | US | disclosed |
| EP-0635024-A4 | METHOD FOR PREPARATION OF AMINO ACID THIOHYDANTOINS. | GARVAN INST MED RES (AU) | 1996-10-02 | — | — | EP | disclosed |
| EP-0319353-B1 | A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants | PLANT GENETIC SYSTEMS NV (BE) | 1996-10-02 | — | — | EP | disclosed |
| EP-0733064-A1 | NUCLEIC ACIDS ENCODING A HOUSE DUST MITE ALLERGEN, $i(DER P) III, AND USES THEREFOR | IMMULOGIC PHARMACEUTICAL CORPORATION (US) | 1996-09-25 | — | — | EP | disclosed |
| EP-0733117-A1 | CHEMICALLY REGULATABLE AND ANTI-PATHOGENIC DNA SEQUENCES AND USES THEREOF | CIBA-GEIGY AG (CH) | 1996-09-25 | — | — | EP | disclosed |
| EP-0731840-A1 | NUCLEIC ACID SEQUENCES ENCODING A PLANT CYTOPLASMIC PROTEIN INVOLVED IN FATTY ACYL-COA METABOLISM | CALGENE, INC. (US) | 1996-09-18 | — | — | EP | disclosed |
| EP-0531537-B1 | HIRUDIN ANALOGUE OR SALT THEREOF, PRODUCTION THEREOF, AND ANTICOAGULANT CONTAINING THE SAME AS ACTIVE INGREDIENT | JAPAN ENERGY CORP (JP) | 1996-09-11 | — | — | EP | disclosed |
| US-5554501-A | GENETIC ANALYSIS OF PATIENT SAMPLES | BECKMAN INSTRUMENTS, INC. (US) | 1996-09-10 | — | — | US | disclosed |
| EP-0251244-B1 | Polypeptide and production thereof | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1996-09-04 | — | — | EP | disclosed |
| US-5552299-A | ANTICOAGULANT | BIOGAL GYOGYSZERGYAR RT. (HU) | 1996-09-03 | — | — | US | disclosed |
| EP-0728188-A1 | BEVERAGE AND A METHOD OF PREPARING IT | CARLSBERG AS (DK) | 1996-08-28 | — | — | EP | disclosed |
| WO-1996025495-A1 | SPERM FACTOR | MEDICAL RESEARCH COUNCIL (GB) | 1996-08-22 | — | — | WO | disclosed |
| EP-0726953-A1 | HUMAN KUNITZ-TYPE PROTEASE INHIBITORS | ZymoGenetics, Inc. (US) | 1996-08-21 | — | — | EP | disclosed |
| EP-0632815-A4 | SEQUENTIAL DEGRADATION OF PROTEINS AND PEPTIDES FROM THE N-TERMINUS. | HOPE CITY (US) | 1996-08-21 | — | — | EP | disclosed |
| EP-0395375-B1 | Novel DNA sequences which encode ancrod-like polypeptides and compositions comprising the expression products thereof | KNOLL AG (DE) | 1996-08-21 | — | — | EP | disclosed |
| US-5547834-A | MODIFIED ENDOPROTEOLYTIC CLEAVAGE SITES | CHIRON CORPORATION (US) | 1996-08-20 | — | — | US | disclosed |
| WO-1994026298-A9 | METHODS FOR TREATING MUSCLE DISEASES AND DISORDERS | — | 1996-08-15 | — | — | WO | disclosed |
| EP-0193515-B1 | Method for obtaining biologically active bovine and porcine growth hormone and composition comprising biologically active porcine growth hormone | MONSANTO CO (US) | 1996-08-14 | — | — | EP | disclosed |
| EP-0464105-B1 | MELANIN-CONCENTRATING HORMONES AND DNA FOR EXPRESSING THE SAME | SALK INST FOR BIOLOGICAL STUDI (US) | 1996-08-14 | — | — | EP | disclosed |
| EP-0726318-A1 | An acceptor polypeptide for an N-acetylgalactosaminyltransferase | THE UPJOHN COMPANY (US) | 1996-08-14 | — | — | EP | disclosed |
| CN-1129014-A | Wax esters in transformed plants | CALGENE INC (US) | 1996-08-14 | — | — | CN | disclosed |
| EP-0724640-A1 | MODIFIED FRUIT CONTAINING GALACTANASE TRANSGENE | ZENECA LIMITED (GB) | 1996-08-07 | — | — | EP | disclosed |
| US-5541098-A | Urate oxidase activity protein, recombinant gene coding therefor, expression vector, micro-organisms and transformed cells | SANOFI (FR) | 1996-07-30 | — | — | US | disclosed |
| US-5541114-A | BLOTTING PEPTIDE SAMPLE FROM ELECTROPHORESIS GEL ONTO POROUS POLYTETRAFLUOROETHYLENE SUPPORT, PLACING IN SEQUENCER | CITY OF HOPE (US) | 1996-07-30 | — | — | US | disclosed |
| EP-0723019-A1 | A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants | PLANT GENETIC SYSTEMS N.V. (BE) | 1996-07-24 | — | — | EP | disclosed |
| EP-0537270-A4 | DETECTION OF ANALYTES USING FLUORESCENT ENERGY TRANSFER | UNIV CALIFORNIA (US) | 1996-07-24 | — | — | EP | disclosed |
| US-5538896-A | GAS CHROMATOGRAPHY | SEIKO INSTRUMENTS INC. (JP) | 1996-07-23 | — | — | US | disclosed |
| EP-0721458-A1 | BIOPOLYMER SYNTHESIS UTILIZING SURFACE ACTIVATED, ORGANIC POLYMERS | BECKMAN INSTRUMENTS, INC. (US) | 1996-07-17 | — | — | EP | disclosed |
| CN-1127013-A | An enzyme with protease activity | NOVO NORDISK AS (DK) | 1996-07-17 | — | — | CN | disclosed |
| EP-0656069-A4 | INHIBITORS OF CELL PROLIFERATION, THEIR PREPARATION AND USE. | CAMBRIDGE NEUROSCIENCE INC (US) | 1996-07-10 | — | — | EP | disclosed |
| US-5534440-A | ISOTHIOCYANATE, IONIZABLE GROUP | BIOMEDICAL RESEARCH CENTRE LIMITED (CA) | 1996-07-09 | — | — | US | disclosed |
| US-5534615-A | TREATMENT OF HEART FAILURE AND NEUROLOGICAL DISORDERS | GENENTECH, INC. (US) | 1996-07-09 | — | — | US | disclosed |
| EP-0453054-B1 | Antigenic proteins and vaccines containing them for prevention of coccidiosis | SOLVAY (BE) | 1996-07-03 | — | — | EP | disclosed |
| US-5532343-A | ISOLATION AND PURIFICATION OF GLIOMA GROWTH FACTOR FOR CELLS | MERCK & CO., INC. (US) | 1996-07-02 | — | — | US | disclosed |
| US-5532351-A | Nucleic acid sequences encoding OMGP | ARCH DEVELOPMENT CORPORATION (US) | 1996-07-02 | — | — | US | disclosed |
| US-5530095-A | SKIN DISORDERS, ANTITUMOR AGENTS | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1996-06-25 | — | — | US | disclosed |
| US-5530109-A | FOR STIMULATING GLIAL CELL MITOGENESIS | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1996-06-25 | — | — | US | disclosed |
| EP-0524173-B1 | SOLUBILIZATION AND PURIFICATION OF THE GASTRIN RELEASING PEPTIDE RECEPTOR | BERLEX LAB (US) | 1996-06-19 | — | — | EP | disclosed |
| US-5527675-A | Method for degradation and sequencing of polymers which sequentially eliminate terminal residues | MILLIPORE CORPORATION (US) | 1996-06-18 | — | — | US | disclosed |
| US-5523237-A | MAKING A PLASTEIN MATERIAL BY REVERSING THE NORMAL HYDROLYTIC ACTIVITY OF A SERINE PROTEASE | NOVO NORDISK A/S (DK) | 1996-06-04 | — | — | US | disclosed |
| EP-0711351-A1 | WAX ESTERS IN TRANSFORMED PLANTS | CALGENE, INC. (US) | 1996-05-15 | — | — | EP | disclosed |
| US-5516698-A | BIOCHEMICAL IMMOBILIZATION; ELECTROPHORETIC REMOVAL OF BY-PRODUCT | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1996-05-14 | — | — | US | disclosed |
| US-5514409-A | ANTICOAGULANT PEPTIDES | BIOGEN, INC. (US) | 1996-05-07 | — | — | US | disclosed |
| WO-1996012807-A2 | HEPATITIS E VIRUS ANTIGENS AND USES THEREFOR | GENELABS TECHNOLOGIES, INC. (US) | 1996-05-02 | — | — | WO | disclosed |
| US-5512482-A | CATALYZE PRODUCTION OF FREE FATTY ACIDS FROM ACYL-CARRIER PROTEINS DURING BIOSYNTHESIS OF LIPIDS IN PLANT CELLS | CALGENE, INC. (US) | 1996-04-30 | — | — | US | disclosed |
| EP-0707641-A1 | AN ENZYME WITH PROTEASE ACTIVITY | NOVO NORDISK A/S (DK) | 1996-04-24 | — | — | EP | disclosed |
| EP-0489070-B1 | NOVEL INHIBITORS OF THROMBIN | BIOGEN INC (US) | 1996-04-24 | — | — | EP | disclosed |
| US-5510255-A | POLYPEPTIDE | MONSANTO COMPANY | 1996-04-23 | — | — | US | disclosed |
| WO-1996010418-A1 | HUMAN MONOCYTE ELASTASE INHIBITOR | CENTER FOR BLOOD RESEARCH, INC. (US) | 1996-04-11 | — | — | WO | disclosed |
| EP-0705279-A1 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORPORATION (US) | 1996-04-10 | — | — | EP | disclosed |
| EP-0703785-A1 | METHODS FOR TREATING MUSCLE DISEASES AND DISORDERS | CAMBRIDGE NEUROSCIENCE (US) | 1996-04-03 | — | — | EP | disclosed |
| EP-0703783-A1 | HLA-A2.1 BINDING PEPTIDES AND THEIR USES | CYTEL CORPORATION (US) | 1996-04-03 | — | — | EP | disclosed |
| WO-1996007916-A1 | ACETIC ANHYDRIDE ACTIVATION FOR C-TERMINAL PROTEIN SEQUENCING | THE PERKIN-ELMER CORPORATION (US) | 1996-03-14 | — | — | WO | disclosed |
| EP-0272489-B1 | Antimicrobial proteins, compositions containing same and uses thereof | CORNELL RES FOUNDATION INC (US) | 1996-03-13 | — | — | EP | disclosed |
| EP-0618295-B1 | Method for cloning the DdeI restriction modification system | NEW ENGLAND BIOLABS INC (US) | 1996-03-06 | — | — | EP | disclosed |
| WO-1996005847-A1 | A METHOD OF SEQUENCING PROTEINS BY EPITOPE ORDERING AND PROTEIN RESTRICTION MAPPING | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1996-02-29 | — | — | WO | disclosed |
| EP-0698035-A1 | ELECTROSYNTHETIC METHOD OF MODIFYING BIOMOLECULES IN PARTICULAR ENZYMES | COVENTRY UNIVERSITY (GB) | 1996-02-28 | — | — | EP | disclosed |
| EP-0698103-A1 | CLONED DNA ENCODING A UDP-GALNAc:POLYPEPTIDE,N-ACETYLGALACTOS AMINYLTRANSFERASE | PHARMACIA & UPJOHN COMPANY (US) | 1996-02-28 | — | — | EP | disclosed |
| US-5494999-A | FOR ASSAYING, PURIFYING OR INDUCING CDW52 ANTIBODY | HALE GEOFFREY (GB) | 1996-02-27 | — | — | US | disclosed |
| US-5494895-A | POLYPEPTIDE | MERCK & CO., INC. (US) | 1996-02-27 | — | — | US | disclosed |
| EP-0697112-A1 | C-TERMINAL SEQUENCING OF PEPTIDES WHICH MAY INCLUDE PROLINE | CITY OF HOPE (US) | 1996-02-21 | — | — | EP | disclosed |
| EP-0419099-B1 | Proteins having anticoagulant properties | MERCK & CO INC (US) | 1996-02-07 | — | — | EP | disclosed |
| US-5489676-A | ISOLATED NUCLEIC ACID ENCODING MAMMALIAN POLYPEPTIDE | NEW YORK UNIVERSITY | 1996-02-06 | — | — | US | disclosed |
| US-5489670-A | LAXATIVES; CONTROL INTESTINAL FLUID ABSORPTION | G. D. SEARLE & CO. (US) | 1996-02-06 | — | — | US | disclosed |
| EP-0278355-B1 | Novel expression system | CIBA GEIGY AG (CH) | 1996-01-31 | — | — | EP | disclosed |
| EP-0693938-A1 | PEPTIDES FOR USE IN VACCINATION AND INDUCTION OF NEUTRALIZING ANTIBODIES AGAINST HUMAN IMMUNODEFICIENCY VIRUS | SYNTELLO VACCINE DEVELOPMENT AB (SE) | 1996-01-31 | — | — | EP | disclosed |
| US-5487991-A | POLYPEPTIDES AND DNA SEQUENCES FOR PLANTS AND PROTEINS | PLANT GENETIC SYSTEMS N.V. (BE) | 1996-01-30 | — | — | US | disclosed |
| WO-1996002003-A1 | N-TERMINAL PROTEIN SEQUENCING REAGENTS AND METHODS WHICH FORM AMINO ACID DERIVATIVES | CITY OF HOPE (US) | 1996-01-25 | — | — | WO | disclosed |
| EP-0693122-A1 | GLUTAMYLCYSTEINE SYNTHETASE LIGHT SUBUNIT | CORNELL RESEARCH FOUNDATION, INC. (US) | 1996-01-24 | — | — | EP | disclosed |
| WO-1996001102-A1 | FACTOR TO GROW TISSUE EX VIVO | ADVANCED TISSUE SCIENCES (US) | 1996-01-18 | — | — | WO | disclosed |
| US-5484711-A | DNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VI | BIOGEN, INC. (US) | 1996-01-16 | — | — | US | disclosed |
| US-5484885-A | FOR TREATING WOUNDS, DISEASED TISSUE AND INFECTIONS | EMORY UNIVERSITY (US) | 1996-01-16 | — | — | US | disclosed |
| EP-0689550-A1 | NOVEL ANTIMICROBIAL PEPTIDES FROM BOVINE NEUTROPHILS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-01-03 | — | — | EP | disclosed |
| US-5480800-A | STRAIN CARRYING PLASMID PERMITTING PRODUCTION OF RECOMBINANT ENZYME THAT FRAGMENTS N-ACETYLHEPAROSAN, STRAIN OBTAINED BY TRANSFORMING STRAIN RRI OF ESCHERICHIA COLI/K12/ OR EQUIVALENT STRAIN WITH VECTOR CARRYING THE DNA FRAGMENT; PLASMID P868,26 | SANOFI (FR) | 1996-01-02 | — | — | US | disclosed |
| EP-0573482-B1 | COMPOUNDS AND METHODS FOR SEQUENCING AMINO ACIDS | B R CENTRE LIMITED (CA) | 1995-12-27 | — | — | EP | disclosed |
| WO-1995034201-A1 | pp60PIK: A DOWNSTREAM ELEMENT IN INSULIN SIGNALING | JOSLIN DIABETES CENTER, INC. (US) | 1995-12-21 | — | — | WO | disclosed |
| EP-0687296-A1 | VARIANTS OF BILE SALT-STIMULATED LIPASE, DNA MOLECULES ENCODING THEM, AND TRANSGENIC NON-HUMAN MAMMALS | Astra Aktiebolag (SE) | 1995-12-20 | — | — | EP | disclosed |
| EP-0399816-B1 | Purification and characterization of a glioma-derived growth factor | MERCK & CO INC (US) | 1995-12-20 | — | — | EP | disclosed |
| EP-0527149-B1 | METHODS AND APPARATUS ALLOWING SEQUENTIAL CHEMICAL REACTIONS | LUDWIG INST CANCER RES (CH) | 1995-12-20 | — | — | EP | disclosed |
| EP-0412050-B1 | Novel cytokines | CIBA GEIGY AG (CH) | 1995-12-20 | — | — | EP | disclosed |
| US-5477001-A | Recombinant DNA coding for a novel protein having β-1,3-glucanase activity, bacteria containing this DNA, transformed plant cells and plants | ELF SANOFI (FR) | 1995-12-19 | — | — | US | disclosed |
| EP-0686695-A1 | Rat protein kinare C and production thereof | Takeda Chemical Industries, Ltd. (JP) | 1995-12-13 | — | — | EP | disclosed |
| EP-0402068-B1 | Polypeptides and polypeptide analogues with inhibitory activity against human elastase | ZENECA LTD (GB) | 1995-12-13 | — | — | EP | disclosed |
| US-5475099-A | Nucleic acid sequence encoding Ricinus or Brassica beta-ketoacyl-ACP synthase factor A or B protein | CALGENE INC. (US) | 1995-12-12 | — | — | US | disclosed |
| WO-1995032724-A1 | GLIAL MITOGENIC FACTORS, THEIR PREPARATION AND USE | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1995-12-07 | — | — | WO | disclosed |
| WO-1995033055-A2 | WAX ESTERS IN TRANSFORMED PLANTS | CALGENE INC. (US) | 1995-12-07 | — | — | WO | disclosed |
| US-5470735-A | Insecticidal plectoxins from Plectreurys tristis | SANDOZ LTD. (CH) | 1995-11-28 | — | — | US | disclosed |
| EP-0683228-A2 | Novel expression system | CIBA-GEIGY AG (CH) | 1995-11-22 | — | — | EP | disclosed |
| US-5468843-A | Acetic anhydride activation for C-terminal protein sequencing | PERKIN-ELMER (US) | 1995-11-21 | — | — | US | disclosed |
| EP-0400920-B1 | Solid phase multiple peptide synthesis | APPLIED IMMUNESCIENCES (US) | 1995-11-15 | — | — | EP | disclosed |
| US-5466593-A | DNA fragments and gene expression | MITSUBISHI KASEI CORPORATION (JP) | 1995-11-14 | — | — | US | disclosed |
| US-5466671-A | Apidaecin-type peptide antibiotics with improved activities and/or different antibacterial spectrum | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1995-11-14 | — | — | US | disclosed |
| WO-1995029695-A1 | EPITAXIN, A CELL MOTILITY FACTOR | LA JOLLA CANCER RESEARCH FOUNDATION (US) | 1995-11-09 | — | — | WO | disclosed |
| US-5464822-A | Enzyme inhibitors for human leukocyte elastase for plasmid expression | ZENECA LIMITED (GB) | 1995-11-07 | — | — | US | disclosed |
| WO-1995029243-A1 | MAC-1 I-DOMAIN PROTEIN USEFUL IN BLOCKING ADHESION AND MIGRATION OF NEUTROPHILS | PHARMACIA & UPJOHN COMPANY (US) | 1995-11-02 | — | — | WO | disclosed |
| WO-1995029237-A1 | CARDIOTROPHIN AND USES THEREFOR | GENENTECH, INC. (US) | 1995-11-02 | — | — | WO | disclosed |
| US-5461029-A | Method of treating herpes viral infections using HBNF and MK proteins | AMERICAN CYANAMID COMPANY (US) | 1995-10-24 | — | — | US | disclosed |
| WO-1995027791-A1 | PLANT LYSOPHOSPHATIDIC ACID ACYLTRANSFERASES | CALGENE INC. (US) | 1995-10-19 | — | — | WO | disclosed |
| EP-0677058-A1 | SUPPORT AND METHOD FOR IMMOBILIZING POLYPEPTIDES | THE PERKIN-ELMER CORPORATION (US) | 1995-10-18 | — | — | EP | disclosed |
| EP-0677057-A1 | BIOPOLYMER SYNTHESIS UTILIZING SURFACE ACTIVATED, ORGANIC POLYMERS | BECKMAN INSTRUMENTS, INC. (US) | 1995-10-18 | — | — | EP | disclosed |
| US-5459235-A | Beta defensin | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-10-17 | — | — | US | disclosed |
| US-5458874-A | Wound healing | EMORY UNIVERSITY (US) | 1995-10-17 | — | — | US | disclosed |
| EP-0518995-B1 | A PROCESS FOR PRODUCING CHEESE | NOVO NORDISK AS (DK) | 1995-10-11 | — | — | EP | disclosed |
| WO-1995026363-A1 | NEUROTROPHIN-6: A NEW MEMBER OF THE NEUROTROPHIN FAMILY | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1995-10-05 | — | — | WO | disclosed |
| EP-0674712-A1 | A PROTEINASE INHIBITOR, PRECURSOR THEREOF AND GENETIC SEQUENCES ENCODING SAME | THE UNIVERSITY OF MELBOURNE (AU) | 1995-10-04 | — | — | EP | disclosed |
| US-5455227-A | Fatty acid bound to polypeptide | KABIGEN AB (SE) | 1995-10-03 | — | — | US | disclosed |
| US-5455338-A | Anticoagulants; protease inhibitors; thrombosis; surgery | ZYMOGENETICS, INC. (US) | 1995-10-03 | — | — | US | disclosed |
| EP-0673440-A1 | MAMMALIAN MUSCLE NAD:ARGININE ADP-RIBOSYLTRANSFERASE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-09-27 | — | — | EP | disclosed |
| US-5453354-A | Macromolecule protein complex of apolipoprotein and immunoglobulin | Akerlof, Eva (SE) | 1995-09-26 | — | — | US | disclosed |
| US-5451399-A | Antiinflammatory | BRIGHAM AND WOMEN'S HOSPITAL (US) | 1995-09-19 | — | — | US | disclosed |
| US-5451506-A | DETECTING ONCOSTATIN M RECEPTOR EXPRESSION ON CELLS IN A SAMPLE | ONCOGEN LIMITED PARTNERSHIP (US) | 1995-09-19 | — | — | US | disclosed |
| US-5449766-A | DNA encoding NEI and NGE peptides | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1995-09-12 | — | — | US | disclosed |
| WO-1995023513-A1 | APIDAECIN-TYPE PEPTIDE ANTIBIOTICS WITH IMPROVED ACTIVITIES AND/OR DIFFERENT ANTIBACTERIAL SPECTRUM | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1995-09-08 | — | — | WO | disclosed |
| US-5447862-A | Pectin lyase genes of aspergillus niger | CIBA-GEIGY CORPORATION (US) | 1995-09-05 | — | — | US | disclosed |
| EP-0518999-B1 | PROTEIN HYDROLYSATES | NOVO NORDISK AS (DK) | 1995-08-30 | — | — | EP | disclosed |
| EP-0668911-A1 | SYNTHESIS AND PURIFICATION OF TRUNCATED AND MUTEIN FORMS OF HUMAN CILIARY NEURONOTROPHIC FACTOR | FIDIA S.p.A. (IT) | 1995-08-30 | — | — | EP | disclosed |
| US-5446138-A | Obtaining plants resistant to phytopathogens | ELF SANOFI (FR) | 1995-08-29 | — | — | US | disclosed |
| US-5446131-A | Polypeptides or cylic polypeptide; therapeutic and prophylactic; inhibit thrombin-induced platelet aggregation | BIOGEN, INC. (US) | 1995-08-29 | — | — | US | disclosed |
| US-5445947-A | Jojoba wax biosynthesis gene | CALGENE INC. (US) | 1995-08-29 | — | — | US | disclosed |
| WO-1995022610-A1 | NOVEL INTEGRIN ALPHA SUBUNIT | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 1995-08-24 | — | — | WO | disclosed |
| US-5444157-A | Stimulates growth of chondrocytes and/or inhibits growth of tumors | MITSUBISHI KASEI CORPORATION (JP) | 1995-08-22 | — | — | US | disclosed |
| US-5443825-A | A polypeptide sequence as anticarcinogenic agent, suppressors; cytolysis | AMRAD CORPORATION LIMITED (AU) | 1995-08-22 | — | — | US | disclosed |
| WO-1995022060-A1 | C-TERMINAL SEQUENCING OF PEPTIDES WHICH MAY INCLUDE PROLINE | CITY OF HOPE (US) | 1995-08-17 | — | — | WO | disclosed |
| US-5439797-A | Detection of analytes using fluorescent energy transfer | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-08-08 | — | — | US | disclosed |
| WO-1995019443-A2 | CHEMICALLY REGULATABLE AND ANTI-PATHOGENIC DNA SEQUENCES AND USES THEREOF | CIBA-GEIGY AG (CH) | 1995-07-20 | — | — | WO | disclosed |
| EP-0663443-A1 | Dextranase enzyme, method for its production and DNA encoding the enzyme | CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA (CU) | 1995-07-19 | — | — | EP | disclosed |
| US-5433940-A | Synthetic molecules mimic action of hirudin by binding to both the low affinity anion-binding exosite and the catalytic site of thrombin | BIOGEN, INC. (US) | 1995-07-18 | — | — | US | disclosed |
| US-5432093-A | Sequential degradation of proteins and peptides from the N-terminus | CITY OF HOPE (US) | 1995-07-11 | — | — | US | disclosed |
| US-5427954-A | Detection of aggrecan by-products | SHRINER'S HOSPITALS FOR CRIPPLED CHILDREN (US) | 1995-06-27 | — | — | US | disclosed |
| US-5427925-A | Recombniant method for making leukemia inhibitor factor | AMRAD CORPORATION LIMITED (AU) | 1995-06-27 | — | — | US | disclosed |
| US-5428012-A | Oncostatin M and novel compositions having anti-neoplastic activity | ONCOGEN LIMITED PARTNERSHIP (US) | 1995-06-27 | — | — | US | disclosed |
| EP-0658208-A1 | NOVEL PLANTS AND PROCESSES FOR OBTAINING THEM | ZENECA LIMITED (GB) | 1995-06-21 | — | — | EP | disclosed |
| EP-0330396-B1 | DNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VI | BIOGEN INC (US) | 1995-06-21 | — | — | EP | disclosed |
| US-5425936-A | Useful for therapeutic, prophylactic and diagnostic purposes | BIOGEN, INC. (US) | 1995-06-20 | — | — | US | disclosed |
| WO-1995015976-A1 | NUCLEIC ACIDS ENCODING A HOUSE DUST MITE ALLERGEN, DER P III, AND USES THEREFOR | IMMULOGIC PHARMACEUTICAL CORPORATION (US) | 1995-06-15 | — | — | WO | disclosed |
| EP-0656788-A1 | HLA BINDING PEPTIDES AND THEIR USES | CYTEL CORPORATION (US) | 1995-06-14 | — | — | EP | disclosed |
| EP-0656946-A1 | IMMUNOGLOBULINS DEVOID OF LIGHT CHAINS | VRIJE UNIVERSITEIT BRUSSEL (BE) | 1995-06-14 | — | — | EP | disclosed |
| WO-1995015387-A2 | NUCLEIC ACID SEQUENCES ENCODING A PLANT CYTOPLASMIC PROTEIN INVOLVED IN FATTY ACYL-COA METABOLISM | CALGENE, INC. (US) | 1995-06-08 | — | — | WO | disclosed |
| EP-0656069-A1 | INHIBITORS OF CELL PROLIFERATION, THEIR PREPARATION AND USE | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1995-06-07 | — | — | EP | disclosed |
| US-5422249-A | Polypeptides | CIBA-GEIGY CORPORATION (US) | 1995-06-06 | — | — | US | disclosed |
| EP-0375724-B1 | BIOLOGICALLY ACTIVE BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN FRAGMENTS | UNIV NEW YORK (US) | 1995-05-31 | — | — | EP | disclosed |
| EP-0653940-A1 | GLIAL MITOGENIC FACTORS, THEIR PREPARATION AND USE | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1995-05-24 | — | — | EP | disclosed |
| US-5417970-A | Purity | SANOFI (FR) | 1995-05-23 | — | — | US | disclosed |
| US-5418147-A | Genetic engineering | HOFFMANN-LA ROCHE INC. (US) | 1995-05-23 | — | — | US | disclosed |
| WO-1995013367-A1 | NEURAL AXON OUTGROWTH MODULATORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-05-18 | — | — | WO | disclosed |
| WO-1995013359-A1 | BEVERAGE AND A METHOD OF PREPARING IT | CARLSBERG A/S (DK) | 1995-05-18 | — | — | WO | disclosed |
| US-5415841-A | Continuous biochemical reactor for analysis of sub-picomole quantities of complex organic molecules | GOVERNERS OF THE UNIVERSITY OF ALBERTA (CA) | 1995-05-16 | — | — | US | disclosed |
| WO-1995012674-A1 | HUMAN KUNITZ-TYPE PROTEASE INHIBITORS | ZYMOGENETICS, INC. (US) | 1995-05-11 | — | — | WO | disclosed |
| EP-0652230-A1 | Biologically active bactericidal/permeability-increasing protein fragments | NEW YORK UNIVERSITY (US) | 1995-05-10 | — | — | EP | disclosed |
| EP-0651809-A1 | A FAMILY OF MAP2 PROTEIN KINASES | REGENERON PHARMACEUTICALS, INC. (US) | 1995-05-10 | — | — | EP | disclosed |
| EP-0651883-A1 | PEPTIDES USEFUL AS INTERNAL STANDARDS FOR MICROSEQUENCING AND METHODS FOR THEIR USE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-05-10 | — | — | EP | disclosed |
| US-5413907-A | Isolation of DNA codes for ryanodine receivers for diagnosis | THE UNIVERSITY OF TORONTO INNOVATIONS FOUNDATION (CA) | 1995-05-09 | — | — | US | disclosed |
| WO-1995011912-A2 | BIOPOLYMER SYNTHESIS UTILIZING SURFACE ACTIVATED, ORGANIC POLYMERS | BECKMAN INSTRUMENTS, INC. (US) | 1995-05-04 | — | — | WO | disclosed |
| US-5411882-A | Cytokine which mediates inflammation | CIBA-GEIGY CORPORATION (US) | 1995-05-02 | — | — | US | disclosed |
| US-5411879-A | From jojoba embryo protein, reduction of acyl groups bound to Coenzyme A | CALGENE INC. (US) | 1995-05-02 | — | — | US | disclosed |
| WO-1995010622-A1 | MODIFIED FRUIT CONTAINING GALACTANASE TRANSGENE | ZENECA LIMITED (GB) | 1995-04-20 | — | — | WO | disclosed |
| EP-0648838-A1 | Tissue inhibitor of metalloproteinase type three (TIMP-3) | AMGEN INC. (US) | 1995-04-19 | — | — | EP | disclosed |
| US-5407822-A | Artificial promoter for the expression of proteins in yeast | SANOFI (FR) | 1995-04-18 | — | — | US | disclosed |
| US-5407915-A | Enzyme inhibitors | BAYER AKTIENGESELLSCHAFT (DE) | 1995-04-18 | — | — | US | disclosed |
| WO-1995009918-A1 | TISSUE INHIBITOR METALLOPROTEINASE TYPE THREE (TIMP-3) | AMGEN INC. (US) | 1995-04-13 | — | — | WO | disclosed |
| EP-0647276-A1 | PROTEIN PREPARATIONS | NOVO NORDISK A/S (DK) | 1995-04-12 | — | — | EP | disclosed |
| WO-1995009176-A1 | BIOPOLYMER SYNTHESIS UTILIZING SURFACE ACTIVATED, ORGANIC POLYMERS | BECKMAN INSTRUMENTS, INC. (US) | 1995-04-06 | — | — | WO | disclosed |
| US-5403918-A | Plant extract | CALGENE, INC. (US) | 1995-04-04 | — | — | US | disclosed |
| EP-0344808-B1 | Recombinant coccidiosis vaccines | HOFFMANN LA ROCHE (CH) | 1995-03-29 | — | — | EP | disclosed |
| EP-0645399-A2 | Ribosome inactivating proteins (RIB), their method of production and medical preparation containing RIP | LOMAPHARM Rudolf Lohmann GmbH KG Pharmazeutische Fabrik (DE) | 1995-03-29 | — | — | EP | disclosed |
| US-5399317-A | Reaction cell for protein sequencer and the like | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1995-03-21 | — | — | US | disclosed |
| US-5399489-A | Production of proteins in procaryotes | MONSANTO COMPANY (US) | 1995-03-21 | — | — | US | disclosed |
| EP-0640134-A1 | PROTEIN L AND PROCESS FOR ITS PREPARATION BY RECOMBINANT DNA TECHNOLOGY | Microbiological Research Authority (GB) | 1995-03-01 | — | — | EP | disclosed |
| EP-0640689-A2 | p40 Homodimer of interleukin-12 | F. HOFFMANN-LA ROCHE AG (CH) | 1995-03-01 | — | — | EP | disclosed |
| US-5393739-A | Use of bone morphogenetic protein in synergistic combination with TGF-β for bone repair | CELTRIX PHARMACEUTICALS, INC. (US) | 1995-02-28 | — | — | US | disclosed |
| EP-0639584-A1 | Preparation and screening of highly diverse peptide libraries for binding activity | INTERPHARM LABORATORIES LTD. (IL) | 1995-02-22 | — | — | EP | disclosed |
| EP-0639607-A2 | Method and apparatus for degradation and sequencing of polymers which sequentially eliminate terminal residues | PERSEPTIVE BIOSYSTEMS, INC. (US) | 1995-02-22 | — | — | EP | disclosed |
| CN-1098742-A | Aminopeptidase and this enzyme and its proteic preparation method | LUCKY LTD (KR) | 1995-02-15 | — | — | CN | disclosed |
| US-5389516-A | Efficiency of colon chemotherapy | UNIVERSITE DE MONTREAL (CA) | 1995-02-14 | — | — | US | disclosed |
| US-5387746-A | Hyaline membrane disease for infants | SCIOS NOVA INC. (US) | 1995-02-07 | — | — | US | disclosed |
| WO-1995003065-A1 | SCORPION PEPTIDE WITH IMMUNOSUPPRESSANT ACTIVITY | MERCK & CO., INC. (US) | 1995-02-02 | — | — | WO | disclosed |
| US-5386025-A | Sequence of nucleotides that encodes the gamma-subunit of a rabbit skeletal muscle calcium channel | THE SALK INSTITUTE BIOTECHNOLOGY/INDUSTRIAL ASSOCIATES (US) | 1995-01-31 | — | — | US | disclosed |
| WO-1995002455-A1 | REACTION CELL FOR PROTEIN SEQUENCER AND THE LIKE | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1995-01-26 | — | — | WO | disclosed |
| EP-0635024-A1 | METHOD FOR PREPARATION OF AMINO ACID THIOHYDANTOINS | GARVAN INSTITUTE OF MEDICAL RESEARCH (AU) | 1995-01-25 | — | — | EP | disclosed |
| WO-1995002044-A1 | AN ENZYME WITH PROTEASE ACTIVITY | NOVO NORDISK A/S (DK) | 1995-01-19 | — | — | WO | disclosed |
| WO-1995001991-A1 | ALLATOSTATINS AND THEIR USE | THE MINISTER OF AGRICULTURE, FISHERIES AND FOOD IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) | 1995-01-19 | — | — | WO | disclosed |
| US-5382518-A | Proteins | SANOFI (FR) | 1995-01-17 | — | — | US | disclosed |
| EP-0632815-A1 | SEQUENTIAL DEGRADATION OF PROTEINS AND PEPTIDES FROM THE N-TERMINUS | CITY OF HOPE (US) | 1995-01-11 | — | — | EP | disclosed |
| EP-0632829-A1 | THROMBIN RECEPTOR ANTAGONISTS | BIOGEN, INC. (US) | 1995-01-11 | — | — | EP | disclosed |
| EP-0247906-B1 | DNA coding for anti-tumour polypeptides, the polypeptides and anti-tumour agents comprising said polypeptides | MIZUNO DEN ICHI (JP) | 1994-12-28 | — | — | EP | disclosed |
| WO-1994029441-A1 | PROTEIN WHICH CATALYSES PEPTIDE REFOLDING AND USES THEREOF | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 1994-12-22 | — | — | WO | disclosed |
| EP-0494193-B1 | DIAGNOSIS FOR MALIGNANT HYPERTHERMIA | UNIV TORONTO (CA) | 1994-12-21 | — | — | EP | disclosed |
| WO-1994028028-A1 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORPORATION (US) | 1994-12-08 | — | — | WO | disclosed |
| EP-0627486-A1 | New extracellular superoxide dismutase, a process for preparing the same and compositions containing the same | N.V. INNOGENETICS S.A. (BE) | 1994-12-07 | — | — | EP | disclosed |
| US-5370991-A | Forms complex with elastase and inhibits elastinolytic activity of elastase | THE CENTER FOR BLOOD RESEARCH, INC. (US) | 1994-12-06 | — | — | US | disclosed |
| US-5370996-A | Nucleic acid sequence codes a jojoba embroyo long chain fatty acyl-CoA reductase which is active in formation of fatty alcohol from fatty acyl substrate | CALGENE, INC. (US) | 1994-12-06 | — | — | US | disclosed |
| JP-H06331620-A | METHOD FOR ANALYSIS OF PHENYLTHIOHYDANTOIN DERIVATIVE OF AMINO ACID | WAKO PURE CHEM IND LTD | 1994-12-02 | — | — | JP | disclosed |
| EP-0606225-A4 | SEQUENCING OF PROTEIN IMMOBILIZED OF POLYTETRAFLUOROETHYLENE SUPPORTS. | HOPE CITY (US) | 1994-11-30 | — | — | EP | disclosed |
| EP-0308378-B1 | Tumor necrosis factor (TNF)inhibitory protein and its purification | YEDA RES & DEV (IL) | 1994-11-30 | — | — | EP | disclosed |
| WO-1994026298-A1 | METHODS FOR TREATING MUSCLE DISEASES AND DISORDERS | CAMBRIDGE NEUROSCIENCE (US) | 1994-11-24 | — | — | WO | disclosed |
| WO-1994026906-A2 | CLONED DNA ENCODING A UDP-GALNAc:POLYPEPTIDE,N-ACETYLGALACTOS AMINYLTRANSFERASE | THE UPJOHN COMPANY (US) | 1994-11-24 | — | — | WO | disclosed |
| WO-1994026770-A1 | ELECTROSYNTHETIC METHOD OF MODIFYING BIOMOLECULES IN PARTICULAR ENZYMES | COVENTRY UNIVERSITY (GB) | 1994-11-24 | — | — | WO | disclosed |
| EP-0623676-A1 | Metalloproteinase inhibitor | AMGEN INC. (US) | 1994-11-09 | — | — | EP | disclosed |
| EP-0623141-A1 | SELECTION OF BINDING-MOLECULES | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1994-11-09 | — | — | EP | disclosed |
| EP-0248678-B1 | Method for cloning restriction modification system | NEW ENGLAND BIOLABS INC (US) | 1994-11-02 | — | — | EP | disclosed |
| WO-1994024276-A1 | GLUTAMYLCYSTEINE SYNTHETASE LIGHT SUBUNIT | CORNELL RESEARCH FOUNDATION, INC. (US) | 1994-10-27 | — | — | WO | disclosed |
| WO-1994023746-A1 | PEPTIDES FOR USE IN VACCINATION AND INDUCTION OF NEUTRALIZING ANTIBODIES AGAINST HUMAN IMMUNODEFICIENCY VIRUS | SYNTELLO VACCINE DEVELOPMENT AB (SE) | 1994-10-27 | — | — | WO | disclosed |
| EP-0618976-A1 | SYNTHETIC DNA SEQUENCE HAVING ENHANCED INSECTICIDAL ACTIVITY IN MAIZE | Novartis AG (CH) | 1994-10-12 | — | — | EP | disclosed |
| US-5354680-A | Isolated DNA for genetic engineering cloning | NEW ENGLAND BIOLABS, INC. (US) | 1994-10-11 | — | — | US | disclosed |
| EP-0256676-B1 | A continuous flow reactor for peptide sequenators | BECKMAN RES INST CITY HOPE (US) | 1994-10-05 | — | — | EP | disclosed |
| EP-0618295-A1 | Method for cloning the DdeI restriction modification system | NEW ENGLAND BIOLABS, INC. (US) | 1994-10-05 | — | — | EP | disclosed |
| EP-0618296-A1 | Method for cloning restriction modification systems | NEW ENGLAND BIOLABS, INC. (US) | 1994-10-05 | — | — | EP | disclosed |
| WO-1994021293-A1 | METHOD OF TREATMENT OF TUMORS WITH AN ANTIBODY BINDING TO TENASCIN | DUKE UNIVERSITY (US) | 1994-09-29 | — | — | WO | disclosed |
| WO-1994021672-A1 | NOVEL ANTIMICROBIAL PEPTIDES FROM BOVINE NEUTROPHILS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-09-29 | — | — | WO | disclosed |
| US-5350842-A | Diagnosis and prevention of syphilis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1994-09-27 | — | — | US | disclosed |
| US-5350687-A | Antibodies which bind to novel lymphokine related peptides | CIBA-GEIGY CORPORATION (US) | 1994-09-27 | — | — | US | disclosed |
| WO-1994020610-A1 | VARIANTS OF BILE SALT-STIMULATED LIPASE, DNA MOLECULES ENCODING THEM, AND TRANSGENIC NON-HUMAN MAMMALS | ASTRA AKTIEBOLAG (SE) | 1994-09-15 | — | — | WO | disclosed |
| WO-1994020127-A1 | HLA-A2.1 BINDING PEPTIDES AND THEIR USES | CYTEL CORPORATION (US) | 1994-09-15 | — | — | WO | disclosed |
| US-5344771-A | Fatty acid synthesis | CALGENE, INC. (US) | 1994-09-06 | — | — | US | disclosed |
| EP-0529048-A4 | SEED PLANT FATTY ACYL REDUCTASE PROTEINS AND GENES | CALGENE INC (US) | 1994-08-17 | — | — | EP | disclosed |
| US-5338724-A | Purified human polymorphonuclear leukocyte polypeptide; bactericide, fungicide | CORNELL RESEARCH FOUNDATION, INC. (US) | 1994-08-16 | — | — | US | disclosed |
| US-5338840-A | DNA encoding glioma-derived growth factor having vascular endothelial cell growth promoting activity | MERCK & CO., INC. (US) | 1994-08-16 | — | — | US | disclosed |
| EP-0609580-A1 | Recombinant CMV neutralising proteins | CHIRON CORPORATION (US) | 1994-08-10 | — | — | EP | disclosed |
| EP-0609450-A1 | METHOD FOR HIGH-SENSITIVITY DETECTION OF AMINO ACID DERIVATIVE | SEIKO INSTRUMENTS INC. (JP) | 1994-08-10 | — | — | EP | disclosed |
| EP-0399001-B1 | T-CELL EPITOPE AS CARRIERS MOLECULE FOR CONJUGATE VACCINES | PRAXIS BIOLOG INC (US) | 1994-07-27 | — | — | EP | disclosed |
| US-5332669-A | Polypeptide growth factor isolated from prostate gland of rats | THE JEWISH HOSPITAL OF ST. LOUIS (US) | 1994-07-26 | — | — | US | disclosed |
| WO-1994015948-A1 | SUPPORT AND METHOD FOR IMMOBILIZING POLYPEPTIDES | APPLIED BIOSYSTEMS, INC. (US) | 1994-07-21 | — | — | WO | disclosed |
| EP-0606225-A1 | SEQUENCING OF PROTEIN IMMOBILIZED OF POLYTETRAFLUOROETHYLENE SUPPORTS | CITY OF HOPE (US) | 1994-07-20 | — | — | EP | disclosed |
| EP-0378641-B1 | NOVEL ANTIMICROBIAL PEPTIDE, COMPOSITIONS CONTAINING SAME AND USES THEREOF | INCYTE PHARMA INC (US) | 1994-07-20 | — | — | EP | disclosed |
| US-5328997-A | Genetic engineering, inhibitors of coagulation Factor Xa | MERCK & CO., INC. (US) | 1994-07-12 | — | — | US | disclosed |
| US-5328898-A | Thrombolysis, coagulants, localization of blood clots | DUKE UNIVERSITY (US) | 1994-07-12 | — | — | US | disclosed |
| EP-0604458-A1 | NUCLEOTIDE SEQUENCES OF GALACTINOL SYNTHASE FROM ZUCCHINI AND SOYBEAN | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-07-06 | — | — | EP | disclosed |
| US-5324651-A | Useful as reagent for studying cellular signal transduction mechanism | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-06-28 | — | — | US | disclosed |
| WO-1994013810-A1 | A PROTEINASE INHIBITOR, PRECURSOR THEREOF AND GENETIC SEQUENCES ENCODING SAME | THE UNIVERSITY OF MELBOURNE (AU) | 1994-06-23 | — | — | WO | disclosed |
| US-5320957-A | Introducing modification gene into host cell, expresing gene while protecting host cell DNA from degradation, introding restriction gene into host cell | NEW ENGLAND BIOLABS, INC. (US) | 1994-06-14 | — | — | US | disclosed |
| WO-1994012538-A1 | SEQUENTIAL DEGRADATION OF PROTEINS AND PEPTIDES FROM THE N-TERMINUS | CITY OF HOPE (US) | 1994-06-09 | — | — | WO | disclosed |
| WO-1994012668-A1 | MAMMALIAN MUSCLE NAD:ARGININE ADP-RIBOSYLTRANSFERASE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-06-09 | — | — | WO | disclosed |
| EP-0563222-A4 | BIOLOGICALLY ACTIVE BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN FRAGMENTS | UNIV NEW YORK (US) | 1994-06-08 | — | — | EP | disclosed |
| US-5316954-A | Methods and apparatus for processing liquids | HEWLETT-PACKARD COMPANY (US) | 1994-05-31 | — | — | US | disclosed |
| US-5316919-A | Genetic engineering; vasodialtors, hypotensive and bronchodilator agents | AKIRA KAJI | 1994-05-31 | — | — | US | disclosed |
| EP-0596524-A2 | Hepatocyte growth factor HGF converting protease and gene encoding said protease | Mitsubishi Chemical Corporation (JP) | 1994-05-11 | — | — | EP | disclosed |
| WO-1994003205-A9 | HLA BINDING PEPTIDES AND THEIR USES | — | 1994-05-11 | — | — | WO | disclosed |
| US-5304464-A | Protein complex enhancing sperm motility | Akerlof, Eva (SE) | 1994-04-19 | — | — | US | disclosed |
| US-5298489-A | Containing specific amino acid sequences | BIOGEN, INC. (US) | 1994-03-29 | — | — | US | disclosed |
| EP-0263072-B1 | Novel lymphokine related peptides | CIBA GEIGY AG (CH) | 1994-03-23 | — | — | EP | disclosed |
| EP-0285448-B1 | Leukaemia inhibitory factor | AMRAD CORP LTD (AU) | 1994-03-16 | — | — | EP | disclosed |
| WO-1994004678-A1 | IMMUNOGLOBULINS DEVOID OF LIGHT CHAINS | CASTERMAN CECILE (BE) | 1994-03-03 | — | — | WO | disclosed |
| WO-1994004693-A2 | NOVEL PLANTS AND PROCESSES FOR OBTAINING THEM | ZENECA LIMITED (GB) | 1994-03-03 | — | — | WO | disclosed |
| EP-0584421-A1 | Immunoglobulins devoid of light chains | Casterman, Cécile (BE) | 1994-03-02 | — | — | EP | disclosed |
| EP-0527149-A4 | — | — | 1994-02-23 | — | — | EP | disclosed |
| WO-1994003644-A1 | INHIBITORS OF CELL PROLIFERATION, THEIR PREPARATION AND USE | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1994-02-17 | — | — | WO | disclosed |
| WO-1994003205-A1 | HLA BINDING PEPTIDES AND THEIR USES | CYTEL CORPORATION (US) | 1994-02-17 | — | — | WO | disclosed |
| WO-1994003605-A2 | COMPOSITIONS AND METHODS FOR DETECTING HUMAN HERPESVIRUS 6 STRAIN Z29 | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-02-17 | — | — | WO | disclosed |
| CN-1082112-A | The derivative of steatogenesis supressor, Its Preparation Method And Use | SANKYO CO (JP) | 1994-02-16 | — | — | CN | disclosed |
| US-5286789-A | Clear polystyrene functionalized with linking groups | APPLIED IMMUNE SCIENCES, INC. (US) | 1994-02-15 | — | — | US | disclosed |
| US-5286484-A | Bactericides | CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA (CU) | 1994-02-15 | — | — | US | disclosed |
| WO-1994002856-A1 | PEPTIDES USEFUL AS INTERNAL STANDARDS FOR MICROSEQUENCING AND METHODS FOR THEIR USE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-02-03 | — | — | WO | disclosed |
| WO-1994002855-A1 | SEQUENCING OF PROTEIN IMMOBILIZED OF POLYTETRAFLUOROETHYLENE SUPPORTS | CITY OF HOPE (US) | 1994-02-03 | — | — | WO | disclosed |
| WO-1994002844-A1 | THIOBENZOYLATION METHOD OF PEPTIDE SEQUENCING WITH GAS CHROMATOGRAPHY AND MASS SPECTROMETRIC DETECTION | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1994-02-03 | — | — | WO | disclosed |
| EP-0580672-A1 | SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN. | HALE GEOFFREY (GB) | 1994-02-02 | — | — | EP | disclosed |
| CN-1080959-A | The recombinant stimulating factor of neuroreceptor | AMGEN INC (US) | 1994-01-19 | — | — | CN | disclosed |
| EP-0359714-B1 | Diuretic factor | SANDOZ AG (CH) | 1994-01-12 | — | — | EP | disclosed |
| US-5278285-A | Enzyme inhibitor | BAYER AKTIENGESELLSCHAFT (DE) | 1994-01-11 | — | — | US | disclosed |
| WO-1994000140-A1 | GLIAL MITOGENIC FACTORS, THEIR PREPARATION AND USE | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1994-01-06 | — | — | WO | disclosed |
| EP-0576609-A1 | RECEPTORS FOR BOMBESIN-LIKE PEPTIDES | BERLEX LABORATORIES, INC. (US) | 1994-01-05 | — | — | EP | disclosed |
| EP-0576792-A2 | Plasmids and process for producing recombinant desulphatohirudin HV-1 peptide | BIOGAL GYOGYSZERGYAR RT. (HU) | 1994-01-05 | — | — | EP | disclosed |
| EP-0573482-A1 | COMPOUNDS AND METHODS FOR SEQUENCING AMINO ACIDS. | B R CENTRE LIMITED (CA) | 1993-12-15 | — | — | EP | disclosed |
| US-5270213-A | Protein sequencing | PORTON INSTRUMENTS, INC. (US) | 1993-12-14 | — | — | US | disclosed |
| US-5270213-A | Protein sequencing | PORTON INSTRUMENTS, INC. (US) | 1993-12-14 | — | — | US | disclosed |
| US-5270449-A | Methods for the isolation of heparin-binding brain mitogens | AMERICAN CYANAMID COMPANY (US) | 1993-12-14 | — | — | US | disclosed |
| US-5270303-A | Chondromodulin-II protein | MITSUBISHI KASEI CORPORATION (JP) | 1993-12-14 | — | — | US | disclosed |
| EP-0572603-A1 | FATTY ACYL-CoA: FATTY ALCOHOL O-ACYLTRANSFERASES | CALGENE, INC. (US) | 1993-12-08 | — | — | EP | disclosed |
| EP-0569703-A2 | Method of treating and preventing viral infections using HBNF and MK protein | AMERICAN CYANAMID COMPANY (US) | 1993-11-18 | — | — | EP | disclosed |
| CN-1078492-A | Aliphatic alcohol: Fatty Alcohol(C12-C14 and C12-C18) O-acyltransferase | CALGENE INC (US) | 1993-11-17 | — | — | CN | disclosed |
| WO-1993022429-A1 | NOVEL COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF HUMAN OSTEOARTHRITIS | SHRINERS HOSPITALS FOR CRIPPLED CHILDREN (US) | 1993-11-11 | — | — | WO | disclosed |
| WO-1993022438-A1 | PROTEIN L AND PROCESS FOR ITS PREPARATION BY RECOMBINANT DNA TECHNOLOGY | MICROBIOLOGICAL RESEARCH AUTHORITY (GB) | 1993-11-11 | — | — | WO | disclosed |
| WO-1993021217-A1 | INVERTEBRATE PEPTIDES | MALLINCKRODT VETERINARY, INC. (US) | 1993-10-28 | — | — | WO | disclosed |
| EP-0566630-A1 | PROCESS FOR THE SYNTHESIS AND PURIFICATION OF HUMAN CILIARY NEURONOTROPHIC FACTOR (CNTF) FROM ESCHERICHIA COLI | FIDIA S.p.A. (IT) | 1993-10-27 | — | — | EP | disclosed |
| EP-0566410-A2 | Derivatives of adipogenesis inhibitory factor, their preparation and their use | SANKYO COMPANY LIMITED (JP) | 1993-10-20 | — | — | EP | disclosed |
| US-5254476-A | Attaching coupling reagent to end groups; then degradation; determination of dna sequences | MILLIPORE CORPORATION (US) | 1993-10-19 | — | — | US | disclosed |
| EP-0563091-A1 | VACCINES BASED ON HEPATITIS B SURFACE ANTIGEN | SMITHKLINE BEECHAM BIOLOGICALS s.a. (BE) | 1993-10-06 | — | — | EP | disclosed |
| EP-0563222-A1 | BIOLOGICALLY ACTIVE BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN FRAGMENTS | NEW YORK UNIVERSITY (US) | 1993-10-06 | — | — | EP | disclosed |
| WO-1993019082-A1 | METHOD FOR PREPARATION OF AMINO ACID THIOHYDANTOINS | GARVAN INSTITUTE OF MEDICAL RESEARCH (AU) | 1993-09-30 | — | — | WO | disclosed |
| WO-1993019087-A1 | CHEMOTACTIC, ANTIBIOTIC AND LIPOPOLYSACCHARIDE-BINDING PEPTIDE FRAGMENTS OF CAP37 | EMORY UNIVERSITY SCHOOL OF MEDICINE (US) | 1993-09-30 | — | — | WO | disclosed |
| EP-0326075-B1 | HEPARIN-BINDING BRAIN MITOGENS | AMERICAN CYANAMID COMPANY (US) | 1993-09-22 | — | — | EP | disclosed |
| WO-1993018141-A1 | THROMBIN RECEPTOR ANTAGONISTS | BIOGEN, INC. (US) | 1993-09-16 | — | — | WO | disclosed |
| EP-0187519-B1 | RECOMBINANT DNA VECTORS CAPABLE OF EXPRESSING APOAEQUORIN, APOAEQUORIN PEPTIDES AND THEIR PRODUCTION, AND MICROORGANISMS INCLUDING SAID VECTORS | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1993-09-01 | — | — | EP | disclosed |
| US-5240913-A | Polypeptide anticoagulants | BIOGEN, INC. (US) | 1993-08-31 | — | — | US | disclosed |
| US-5241048-A | Organic syntheses employing supercritical carbon dioxide as a reaction solvent | PROTEIN TECHNOLOGIES, INC. (US) | 1993-08-31 | — | — | US | disclosed |
| US-5240859-A | Coupling terminal amino acid with thioisocyanate, cleaving and identification; spectometrometric analysis | B.R. CENTRE LIMITED (CA) | 1993-08-31 | — | — | US | disclosed |
| EP-0651809-A4 | A FAMILY OF MAP2 PROTEIN KINASES. | REGENERON PHARMA (US) | 1993-08-25 | — | — | EP | disclosed |
| EP-0295966-B1 | DETERMINATION OF PEPTIDE SEQUENCES | APPLIED BIOSYSTEMS, INC. (US) | 1993-08-25 | — | — | EP | disclosed |
| EP-0556395-A1 | NOVEL CYTOKINE | SANKYO COMPANY LIMITED (JP) | 1993-08-25 | — | — | EP | disclosed |
| US-5239058-A | Selectively inhibit coagulation factor Xa | MERCK & CO., INC. (US) | 1993-08-24 | — | — | US | disclosed |
| EP-0556160-A2 | Insecticidal toxins from plectreurys tristis | SANDOZ AG (CH) | 1993-08-18 | — | — | EP | disclosed |
| WO-1993015195-A1 | GRANULINS FROM LEUKOCYTES | SOLOMON SAMUEL (CA) | 1993-08-05 | — | — | WO | disclosed |
| EP-0513334-A4 | USE OF A BONE MORPHOGENETIC PROTEIN IN SYNERGISTIC COMBINATION WITH TGF--G(B) FOR BONE REPAIR | — | 1993-08-04 | — | — | EP | disclosed |
| EP-0293793-B1 | POLYPEPTIDE AND PRODUCTION THEREOF | Takeda Chemical Industries, Ltd. (JP) | 1993-07-28 | — | — | EP | disclosed |
| US-5231010-A | Deletion of proline or addition of alanine-glutamine to arginine transforming S. cerevisiae vector | BAYER AKTIENGESELLSCHAFT (DE) | 1993-07-27 | — | — | US | disclosed |
| WO-1993014108-A1 | SELECTION OF BINDING-MOLECULES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1993-07-22 | — | — | WO | disclosed |
| EP-0549752-A1 | PROTEIN SEQUENCING | BECKMAN INSTRUMENTS, INC. (US) | 1993-07-07 | — | — | EP | disclosed |
| EP-0549752-A1 | PROTEIN SEQUENCING | BECKMAN INSTRUMENTS, INC. (US) | 1993-07-07 | — | — | EP | disclosed |
| US-5225354-A | Binding glycosylated lysine in albumin to monoclonal antibodies | MOLECULAR DIAGNOSTICS, INC. (US) | 1993-07-06 | — | — | US | disclosed |
| US-5223481-A | Facilitating respiration in mammals; administering directly to trachea or bronchii; fatty acid esterified | KABIGEN AB (SE) | 1993-06-29 | — | — | US | disclosed |
| US-5219748-A | Studying cellular signal transduction mechanism, diagnostic and inspection agent for disease | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-06-15 | — | — | US | disclosed |
| EP-0495096-A4 | PLANT FATTY ACID SYNTHASES | — | 1993-06-09 | — | — | EP | disclosed |
| EP-0239600-B1 | APPARATUS FOR, AND METHODS OF, OPERATING UPON A FLUID | MEHL, Ehrenfried, L. (DE) | 1993-06-02 | — | — | EP | disclosed |
| WO-1993010241-A1 | FATTY ACYL-CoA: FATTY ALCOHOL O-ACYLTRANSFERASES | CALGENE, INC. (US) | 1993-05-27 | — | — | WO | disclosed |
| WO-1993010233-A1 | SYNTHESIS AND PURIFICATION OF TRUNCATED AND MUTEIN FORMS OF HUMAN CILIARY NEURONOTROPHIC FACTOR | FIDIA S.P.A. (IT) | 1993-05-27 | — | — | WO | disclosed |
| US-5210027-A | DNA encoding novel antimicrobial polypeptide and methods for obtaining such polypeptide | INCYTE PHARMACEUTICALS, INC. (US) | 1993-05-11 | — | — | US | disclosed |
| EP-0540064-A1 | Apoaequorin peptides, recombinant DNA vectors capable of expressing the same and microorganisms containing said vectors | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1993-05-05 | — | — | EP | disclosed |
| EP-0515569-A4 | CALCIUM CHANNEL COMPOSITIONS AND METHODS | — | 1993-05-05 | — | — | EP | disclosed |
| EP-0353361-B1 | A METHOD FOR DETECTING AMINO ACID DERIVATIVES | SEIKO INSTRUMENTS INC. (JP) | 1993-04-28 | — | — | EP | disclosed |
| EP-0537981-A2 | Cleavage method for acyl thiohydantoins and use of the method in C-terminal peptide sequencing | THE PERKIN-ELMER CORPORATION (US) | 1993-04-21 | — | — | EP | disclosed |
| EP-0537270-A1 | DETECTION OF ANALYTES USING FLUORESCENT ENERGY TRANSFER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1993-04-21 | — | — | EP | disclosed |
| WO-1993007271-A1 | OSTEOCLAST COLONY STIMULATING FACTOR (O-CSF) | WASHINGTON RESEARCH FOUNDATION (US) | 1993-04-15 | — | — | WO | disclosed |
| WO-1993007278-A1 | SYNTHETIC DNA SEQUENCE HAVING ENHANCED INSECTICIDAL ACTIVITY IN MAIZE | CIBA-GEIGY AG (CH) | 1993-04-15 | — | — | WO | disclosed |
| US-5202113-A | Used in mouthwashes, dentifrices, diagnosis of oral diseases | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-04-13 | — | — | US | disclosed |
| EP-0535337-A2 | Cell growth inhibiting activities of heparin binding neurite-outgrowth promoting factor | AMERICAN CYANAMID COMPANY (US) | 1993-04-07 | — | — | EP | disclosed |
| EP-0535039-A1 | NOVEL BACTERIOCIN FROM A STRAIN OF LACTOCOCCUS LACTIS SUBSP. CREMORIS | NORWEGIAN DAIRIES ASSOCIATION (NO) | 1993-04-07 | — | — | EP | disclosed |
| EP-0466854-A4 | T CELL GROWTH FACTOR | — | 1993-03-31 | — | — | EP | disclosed |
| EP-0517779-A4 | SUBSTANTIALLY PURE TRANSFORMING GROWTH FACTOR--G(B)1-BINDING PROTEIN AND NUCLEOTIDE SEQUENCES EXPRESSING THE BINDING PROTEIN | — | 1993-03-31 | — | — | EP | disclosed |
| US-5198541-A | Culturing host cells and separation of the protein | NEW YORK UNIVERSITY (US) | 1993-03-30 | — | — | US | disclosed |
| US-5196404-A | Hirudin mimic, polypeptide, hirulog; bivalirudin FDA Orange book listed patent | BIOGEN, INC. (US) | 1993-03-23 | — | — | US | disclosed |
| US-5196403-A | Polypeptide inhibitors | BIOGEN, INC. (US) | 1993-03-23 | — | — | US | disclosed |
| EP-0531537-A1 | HIRUDIN ANALOGUE OR SALT THEREOF, PRODUCTION THEREOF, AND ANTICOAGULANT CONTAINING THE SAME AS ACTIVE INGREDIENT | JAPAN ENERGY CORPORATION (JP) | 1993-03-17 | — | — | EP | disclosed |
| EP-0504257-A4 | (ALA IL-8) 77 AS A LEUKOCYTE ADHESION INHIBITOR | — | 1993-03-03 | — | — | EP | disclosed |
| EP-0529048-A1 | SEED PLANT FATTY ACYL REDUCTASE PROTEINS AND GENES | CALGENE, INC. (US) | 1993-03-03 | — | — | EP | disclosed |
| EP-0529031-A1 | IMPROVED INHIBITORS OF THROMBIN | BIOGEN, INC. (US) | 1993-03-03 | — | — | EP | disclosed |
| EP-0527789-A1 | HIV ENVELOPE POLYPEPTIDES | GENENTECH, INC. (US) | 1993-02-24 | — | — | EP | disclosed |
| EP-0527149-A1 | METHODS AND APPARATUS ALLOWING SEQUENTIAL CHEMICAL REACTIONS. | LUDWIG INST CANCER RES (CH) | 1993-02-17 | — | — | EP | disclosed |
| US-5187080-A | For inducing immune response in chickens | SOLVAY & CIE S.A. (BE) | 1993-02-16 | — | — | US | disclosed |
| US-5187077-A | Recombinant DNA comprising nucleotide sequence which codes for leukemia inhibiting factor polypeptide | AMRAD CORPORATION LIMITED (AU) | 1993-02-16 | — | — | US | disclosed |
| EP-0526883-A2 | Chondromodulin-II protein | Mitsubishi Chemical Corporation (JP) | 1993-02-10 | — | — | EP | disclosed |
| US-5185266-A | Cleaving an alkylated thiohydantoin adduct from a peptide under anhydrous, acidic conditions and analyzing the side chain of the amino acid | APPLIED BIOSYSTEMS, INC. (US) | 1993-02-09 | — | — | US | disclosed |
| WO-1993002196-A1 | NUCLEOTIDE SEQUENCES OF GALACTINOL SYNTHASE FROM ZUCCHINI AND SOYBEAN | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-02-04 | — | — | WO | disclosed |
| EP-0524173-A1 | SOLUBILIZATION AND PURIFICATION OF THE GASTRIN RELEASING PEPTIDE RECEPTOR. | BERLEX LAB (US) | 1993-01-27 | — | — | EP | disclosed |
| US-5182260-A | DNA SEQUENCES ENCODING SNAKE VENOM INHIBITORS OF PLATELET ACTIVATION PROCESSES FOR PRODUCING THOSE INHIBITORS AND COMPOSITIONS USING THEM | BIOGEN, INC. (US) | 1993-01-26 | — | — | US | disclosed |
| EP-0359739-B1 | TRANFORMING GROWTH FACTOR-BETA | TECHNE CORPORATION (US) | 1993-01-20 | — | — | EP | disclosed |
| WO-1993000355-A1 | PROTEIN SEQUENCING | PORTON INSTRUMENTS, INC. (US) | 1993-01-07 | — | — | WO | disclosed |
| WO-1993000355-A1 | PROTEIN SEQUENCING | PORTON INSTRUMENTS, INC. (US) | 1993-01-07 | — | — | WO | disclosed |
| US-5177197-A | Isolated nucleotide sequence expressing human transforming growth factor-β1-binding protein | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1993-01-05 | — | — | US | disclosed |
| EP-0518999-A1 | PROTEIN HYDROLYSATES. | NOVO NORDISK AS (DK) | 1992-12-23 | — | — | EP | disclosed |
| EP-0518995-A1 | A PROCESS FOR PRODUCING CHEESE. | NOVO NORDISK AS (DK) | 1992-12-23 | — | — | EP | disclosed |
| EP-0519728-A2 | Anti-TCF-II monoclonal antibodies and method for the measurement of TCF-II by applying the antibodies | SNOW BRAND MILK PRODUCTS CO., LTD. (JP) | 1992-12-23 | — | — | EP | disclosed |
| US-5173422-A | Diabetes diagnosis | MILES INC. (US) | 1992-12-22 | — | — | US | disclosed |
| EP-0518295-A2 | Allyl side chain protection in peptide synthesis | MILLIPORE CORPORATION (US) | 1992-12-16 | — | — | EP | disclosed |
| EP-0517779-A1 | SUBSTANTIALLY PURE TRANSFORMING GROWTH FACTOR-$g(b)1-BINDING PROTEIN AND NUCLEOTIDE SEQUENCES EXPRESSING THE BINDING PROTEIN | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1992-12-16 | — | — | EP | disclosed |
| EP-0517931-A1 | Physiologically active peptides, use thereof and a method of producing said peptides | KAJI, Akira (JP) | 1992-12-16 | — | — | EP | disclosed |
| US-5171842-A | Heparin-binding brain mitogens | AMERICAN CYANAMID COMPANY (US) | 1992-12-15 | — | — | US | disclosed |
| WO-1992021767-A1 | ME20: MONOCLONAL ANTIBODIES AND ANTIGEN FOR HUMAN MELANOMA | BRISTOL-MYERS SQUIBB COMPANY (US) | 1992-12-10 | — | — | WO | disclosed |
| US-5169835-A | Administering purified glycoproteins to stimulate growth and proliferation of blood cells | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1992-12-08 | — | — | US | disclosed |
| EP-0515569-A1 | CALCIUM CHANNEL COMPOSITIONS AND METHODS | SIBIA NEUROSCIENCES, INC. (US) | 1992-12-02 | — | — | EP | disclosed |
| US-5166316-A | Polypeptides for genetic engineering | AKIRA KAJI (JP) | 1992-11-24 | — | — | US | disclosed |
| EP-0513334-A1 | USE OF A BONE MORPHOGENETIC PROTEIN IN SYNERGISTIC COMBINATION WITH TGF-$g(b) FOR BONE REPAIR | CELTRIX PHARMACEUTICALS, INC. (US) | 1992-11-19 | — | — | EP | disclosed |
| US-5164482-A | RECOMBINANT APROTININ VARIANTS GENETICALLY ENGINEERED PROCESS FOR THE MICROBIAL PREPARATION OF HOMOGENEOUSLY PROCESSED APROTININ VARIANTS AND THE THERAPEUTIC USE THEREOF | BAYER AKTIENGESELLSCHAFT (DE) | 1992-11-17 | — | — | US | disclosed |
| US-5162227-A | Dna sequences; single or double stranded | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1992-11-10 | — | — | US | disclosed |
| EP-0454765-A4 | PREGNANCY SPECIFIC PROTEINS APPLICATIONS | — | 1992-11-04 | — | — | EP | disclosed |
| WO-1992018530-A1 | SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN | HALE GEOFFREY (GB) | 1992-10-29 | — | — | WO | disclosed |
| EP-0510693-A2 | Expression of human serum albumin in pichia pastoris | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1992-10-28 | — | — | EP | disclosed |
| CN-1018793-B | HOMOLOGUES OF APROTININ PRODUCED FROM RECOMBINANT HOST, PROCESS, EXPRESSION VECTOR AND RECOMBINANT HOST THEREFOR AND PHARMACEUTICAL USE THEREOF | BAYER AG (DE) | 1992-10-28 | — | — | CN | disclosed |
| US-5157112-A | Supports interleukin-2 and interleukin-4 independent growth of helper T cells | LUDWIG INSTITUTE FOR CANCER RESEARCH (CH) | 1992-10-20 | — | — | US | disclosed |
| US-5156809-A | APPARATUS FOR THE STEPWISE PERFORMANCE OF CHEMICAL REACTIONS | HEWLETT PACKARD COMPANY (US) | 1992-10-20 | — | — | US | disclosed |
| WO-1992016623-A2 | RECEPTORS FOR BOMBESIN-LIKE PEPTIDES | BERLEX LABORATORIES, INC. (US) | 1992-10-01 | — | — | WO | disclosed |
| EP-0506477-A1 | Vascular endothelial cell growth factor C subunit | MERCK & CO. INC. (US) | 1992-09-30 | — | — | EP | disclosed |
| EP-0504257-A1 | [Ala IL-8] 77 AS A LEUKOCYTE ADHESION INHIBITOR | BRIGHAM AND WOMEN'S HOSPITAL (US) | 1992-09-23 | — | — | EP | disclosed |
| US-5149528-A | Inhibits protein synthesis | ZYMOGENETICS, INC. (US) | 1992-09-22 | — | — | US | disclosed |
| EP-0257421-B1 | ANTIBODIES FOR USE IN DETERMINING HUMAN GLYCOALBUMIN | MILES INC. (US) | 1992-09-16 | — | — | EP | disclosed |
| CN-1064312-A | FATTY ACYL REDUCTASES | CALGENE INC (US) | 1992-09-09 | — | — | CN | disclosed |
| WO-1992014702-A1 | COMPOUNDS AND METHODS FOR SEQUENCING AMINO ACIDS | B.R. CENTRE LIMITED (CA) | 1992-09-03 | — | — | WO | disclosed |
| WO-1992014816-A1 | SEED PLANT FATTY ACYL REDUCTASE PROTEINS AND GENES | CALGENE, INC. (US) | 1992-09-03 | — | — | WO | disclosed |
| EP-0296781-B1 | QUANTITATION OF CHROMATOGRAPHIC INFORMATION | APPLIED BIOSYSTEMS, INC. (US) | 1992-09-02 | — | — | EP | disclosed |
| EP-0500785-A1 | A HUMAN T CELL REACTIVE FELINE PROTEIN (TRFP) ISOLATED FROM HOUSE DUST AND USES THEREFOR | IMMULOGIC PHARMACEUTICAL CORPORATION (US) | 1992-09-02 | — | — | EP | disclosed |
| US-5143851-A | METHOD FOR SEPARATING DIPHENYLUREA (DPU) AND PHENYLTHIOHYDANTOIN-TRYPTOPHAN (PTH-TRP) ALLOWING UNAMBIGUOUS IDENTIFICATION OF TRP IN AUTOMATIC SEQUENCE ANALYSIS | AMERICAN CYANAMID COMPANY (US) | 1992-09-01 | — | — | US | disclosed |
| WO-1992013952-A1 | IMPROVED INHIBITORS OF THROMBIN | BIOGEN, INC. (US) | 1992-08-20 | — | — | WO | disclosed |
| WO-1992013964-A1 | PROTEIN PREPARATIONS | NOVO NORDISK A/S (DK) | 1992-08-20 | — | — | WO | disclosed |
| EP-0254249-B1 | PREPARATION OF BINDING FACTOR RELATED POLYPEPTIDES | CIBA-GEIGY AG (CH) | 1992-08-19 | — | — | EP | disclosed |
| EP-0497866-A1 | GASTRIN RELEASING PEPTIDE RECEPTOR | BERLEX LABORATORIES, INC. (US) | 1992-08-12 | — | — | EP | disclosed |
| EP-0225633-B1 | PRODUCTION OF THROMBIN INHIBITORS | CIBA-GEIGY AG (CH) | 1992-08-12 | — | — | EP | disclosed |
| EP-0464105-A4 | MELANIN-CONCENTRATING HORMONES AND METHODS OF TREATMENT USING SAME | — | 1992-08-12 | — | — | EP | disclosed |
| US-5137695-A | Polypeptides | CITY OF HOPE (US) | 1992-08-11 | — | — | US | disclosed |
| US-5137765-A | Derivatized glass supports for peptide and protein sequencing | PORTON INSTRUMENTS, INC. (US) | 1992-08-11 | — | — | US | disclosed |
| US-5137823-A | METHOD FOR PRODUCING THE BAMHI RESTRICTION ENDONUCLEASE AND METHYLASE | NEW ENGLAND BIOLABS, INC. (US) | 1992-08-11 | — | — | US | disclosed |
| WO-1992013072-A2 | PROCESS FOR THE SYNTHESIS AND PURIFICATION OF HUMAN CILIARY NEURONOTROPHIC FACTOR (CNTF) FROM ESCHERICHIA COLI | FIDIA S.P.A. (IT) | 1992-08-06 | — | — | WO | disclosed |
| EP-0396555-B1 | PURIFICATION OF MONOMERIC INTERFERON | INTERFERON SCIENCES, INC. (US) | 1992-07-29 | — | — | EP | disclosed |
| EP-0495096-A1 | PLANT FATTY ACID SYNTHASES | CALGENE, INC. (US) | 1992-07-22 | — | — | EP | disclosed |
| US-5132401-A | MB-35 a peptide enhancing the production of growth hormone and prolactin from the anterior pituitary | GEORGE WASHINGTON UNIVERSITY, OFFICE OF SPONSORED RESEARCH (US) | 1992-07-21 | — | — | US | disclosed |
| EP-0494193-A1 | DIAGNOSIS FOR MALIGNANT HYPERTHERMIA. | UNIV TORONTO (CA) | 1992-07-15 | — | — | EP | disclosed |
| WO-1992011291-A1 | VACCINES BASED ON HEPATITIS B SURFACE ANTIGEN | SMITHKLINE BEECHAM BIOLOGICALS (S.A.) (BE) | 1992-07-09 | — | — | WO | disclosed |
| WO-1992011363-A1 | RECOMBINANT MOLECULES USEFUL FOR PRODUCING INSECTICIDAL MICROBES | CIBA-GEIGY AG (CH) | 1992-07-09 | — | — | WO | disclosed |
| EP-0480024-A4 | PLANT THIOESTERASES | — | 1992-07-08 | — | — | EP | disclosed |
| US-5126257-A | Extract from human polymorphonuclear leukocytes | CORNELL RESEARCH FOUNDATION (US) | 1992-06-30 | — | — | US | disclosed |
| EP-0458903-A4 | SOLUBLE ANALOGS OF THROMBOMODULIN | — | 1992-06-17 | — | — | EP | disclosed |
| WO-1992009694-A2 | CLONING OF UDP-N-ACETYLGLUCOSAMINE:α-3-D-MANNOSIDE β-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE I | HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) | 1992-06-11 | — | — | WO | disclosed |
| WO-1992009697-A1 | USE OF A BONE MORPHOGENETIC PROTEIN IN SYNERGISTIC COMBINATION WITH TGF-β FOR BONE REPAIR | CELTRIX LABORATORIES, INC. (US) | 1992-06-11 | — | — | WO | disclosed |
| WO-1992009621-A1 | BIOLOGICALLY ACTIVE BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN FRAGMENTS | NEW YORK UNIVERSITY (US) | 1992-06-11 | — | — | WO | disclosed |
| EP-0116784-B1 | ATRIAL NATRIURETIC FACTOR | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1992-06-10 | — | — | EP | disclosed |
| EP-0489070-A1 | NOVEL INHIBITORS OF THROMBIN. | BIOGEN INC (US) | 1992-06-10 | — | — | EP | disclosed |
| US-5120535-A | Synergistic mixture with interferons | ONCOGEN (US) | 1992-06-09 | — | — | US | disclosed |
| WO-1992007875-A1 | CYTOLYTIC FACTOR ASSOCIATED WITH EFFECTOR CELL PLASMA MEMBRANES | HISERODT JOHN C (US) | 1992-05-14 | — | — | WO | disclosed |
| EP-0484452-A1 | FIBULIN | LA JOLLA CANCER RESEARCH FOUNDATION (US) | 1992-05-13 | — | — | EP | disclosed |
| US-5112955-A | Incubation plasminogen activator inhibitor with vitronectin in the presence of arginine and a carrier protein albumin or globulin | MONSANTO COMPANY (US) | 1992-05-12 | — | — | US | disclosed |
| US-5112749-A | Recombinant DNA sequences for attenuated bacterium, Salmonella or Shigella and epitopes | PRAXIS BIOLOGICS, INC. (US) | 1992-05-12 | — | — | US | disclosed |
| EP-0480024-A1 | PLANT THIOESTERASES | CALGENE, INC. (US) | 1992-04-15 | — | — | EP | disclosed |
| EP-0436537-A4 | RECOMBINANT CMV NEUTRALIZING PROTEINS | — | 1992-04-08 | — | — | EP | disclosed |
| EP-0477739-A2 | Glycosyl-Phosphatidylinositol-Specific Phospholipase D | F. HOFFMANN-LA ROCHE AG (CH) | 1992-04-01 | — | — | EP | disclosed |
| EP-0476983-A1 | Vascular endothelial cell growth factor II | MERCK & CO. INC. (US) | 1992-03-25 | — | — | EP | disclosed |
| EP-0474645-A1 | PROTEIN COMPLEX | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 1992-03-18 | — | — | EP | disclosed |
| EP-0474979-A1 | Heparin binding neurotrophic factor gene sequence | AMERICAN CYANAMID COMPANY (US) | 1992-03-18 | — | — | EP | disclosed |
| EP-0231537-B1 | ANTIGENIC PROTEINS AND VACCINES CONTAINING THEM FOR PREVENTION OF COCCIDIOSIS | SOLVAY (BE) | 1992-03-11 | — | — | EP | disclosed |
| EP-0426778-A4 | APPARATUS AND METHOD FOR THE SEQUENTIAL PERFORMANCE OF CHEMICAL PROCESSES | — | 1992-03-11 | — | — | EP | disclosed |
| EP-0474313-A2 | Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations | CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA (CU) | 1992-03-11 | — | — | EP | disclosed |
| WO-1992003564-A1 | PLANT FATTY ACID SYNTHASES | CALGENE, INC. (US) | 1992-03-05 | — | — | WO | disclosed |
| EP-0473080-A2 | Chondromodulin-I protein | Mitsubishi Chemical Corporation (JP) | 1992-03-04 | — | — | EP | disclosed |
| EP-0202894-B1 | A METHOD FOR DETECTING AMINO ACID DERIVATIVES | SEIKO INSTRUMENTS INC. (JP) | 1992-02-19 | — | — | EP | disclosed |
| CN-1058782-A | Last hide collagen (Epithclins): the new growth regulator matter that is rich in halfcystine | BRISTOL MYERS SQUIBB CO (US) | 1992-02-19 | — | — | CN | disclosed |
| EP-0460072-A4 | HUMAN ELASTASE INHIBITOR | — | 1992-02-12 | — | — | EP | disclosed |
| US-5087569-A | Antimicrobial proteins, compositions containing same and uses thereof | CORNELL RESEARCH FOUNDATION, INC. AND THE ROCKEFELLER UNIVERSITY (US) | 1992-02-11 | — | — | US | disclosed |
| EP-0364481-A4 | GROWTH FACTORS | — | 1992-01-22 | — | — | EP | disclosed |
| EP-0466854-A1 | T CELL GROWTH FACTOR | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1992-01-22 | — | — | EP | disclosed |
| EP-0465691-A1 | Apparatus for processing liquids | Hewlett-Packard GmbH (DE) | 1992-01-15 | — | — | EP | disclosed |
| US-5081028-A | Gene expession; antiallergens | CIBA-GEIGY CORPORATION (US) | 1992-01-14 | — | — | US | disclosed |
| US-5081021-A | DNA encoding HTNF variants exhibiting enhanced activity | MIZUNO DEN ICHI (JP) | 1992-01-14 | — | — | US | disclosed |
| WO-1992000526-A1 | PEPTIDE SEQUENCING METHOD AND REAGENTS THEREFOR | GARIEPY KATHLEEN COX (US) | 1992-01-09 | — | — | WO | disclosed |
| WO-1992000388-A1 | DETECTION OF ANALYTES USING FLUORESCENT ENERGY TRANSFER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1992-01-09 | — | — | WO | disclosed |
| EP-0408634-A4 | ORGANIC SYNTHESIS EMPLOYING SUPERCRITICAL CARBON DIOXIDE AS A REACTION SOLVENT | — | 1992-01-08 | — | — | EP | disclosed |
| EP-0464105-A1 | MELANIN-CONCENTRATING HORMONES AND METHODS OF TREATMENT USING SAME. | SALK INST FOR BIOLOGICAL STUDI (US) | 1992-01-08 | — | — | EP | disclosed |
| WO-1991019802-A1 | NOVEL BACTERIOCIN FROM A STRAIN OF LACTOCOCCUS LACTIS SUBSP. CREMORIS | NORWEGIAN DAIRIES ASSOCIATION (NO) | 1991-12-26 | — | — | WO | disclosed |
| EP-0462065-A2 | New signal sequences | CIBA-GEIGY AG (CH) | 1991-12-18 | — | — | EP | disclosed |
| US-5073626-A | Anhydrourokinase or urokinase mutated at position 356 from ser to gly | MONSANTO COMPANY (US) | 1991-12-17 | — | — | US | disclosed |
| WO-1991019008-A1 | A FAMILY OF MAP2 PROTEIN KINASES | REGENERON PHARMACEUTICALS, INC. (US) | 1991-12-12 | — | — | WO | disclosed |
| EP-0460072-A1 | HUMAN ELASTASE INHIBITOR | CENTER FOR BLOOD RESEARCH, INC. (US) | 1991-12-11 | — | — | EP | disclosed |
| EP-0375724-A4 | BIOLOGICALLY ACTIVE BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN FRAGMENTS | — | 1991-12-11 | — | — | EP | disclosed |
| US-5071909-A | IMMOBILIZATION OF PROTEINS AND PEPTIDES ON INSOLUBLE SUPPORTS | MILLIPORE CORPORATION (US) | 1991-12-10 | — | — | US | disclosed |
| EP-0458903-A1 | SOLUBLE ANALOGS OF THROMBOMODULIN | CODON (US) | 1991-12-04 | — | — | EP | disclosed |
| EP-0458918-A1 | METHOD FOR OBTAINING A RECOMBINANT PROTEIN AND ITS UTILIZATION IN THE ASSAY FOR THE AFRICAN SWINE PEST VIRUS (ASPV) | UNIVERSIDAD DE OVIEDO (ES) | 1991-12-04 | — | — | EP | disclosed |
| WO-1991017185-A1 | PLAQUE-INHIBITING PROTEIN FROM BACTEROIDES LOESCHEI AND METHODS FOR USING THE SAME | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, UNITED STATES DEPARTMENT OF COMMERCE (US) | 1991-11-14 | — | — | WO | disclosed |
| WO-1991017182-A1 | HUMAN AND RAT THYMOPOIETIN | ORTHO PHARMACEUTICAL CORPORATION (US) | 1991-11-14 | — | — | WO | disclosed |
| EP-0455722-A1 | PROCESSES FOR PRODUCING POLYPEPTIDE INHIBITORS OF PLATELET ACTIVATION AND METHODS, COMBINATIONS AND COMPOSITIONS USING THEM | BIOGEN, INC. (US) | 1991-11-13 | — | — | EP | disclosed |
| EP-0152468-B1 | PRODUCTION OF STREPTOCOCAL M PROTEIN IMMUNOGENS AND MOLECULAR PROBES | THE ROCKEFELLER UNIVERSITY (US) | 1991-11-13 | — | — | EP | disclosed |
| US-5064941-A | Collagen extracted from collagen-containing tissue | BOSTON BIOMEDICAL RESEARCH INSTITUTE (US) | 1991-11-12 | — | — | US | disclosed |
| EP-0454765-A1 | PREGNANCY SPECIFIC PROTEINS APPLICATIONS | Oklahoma Medical Research Foundation (US) | 1991-11-06 | — | — | EP | disclosed |
| EP-0454782-A1 | CANCER RELATED HAPTOGLOBIN (HPR). | UNIV JOHNS HOPKINS (US) | 1991-11-06 | — | — | EP | disclosed |
| WO-1991016421-A1 | PLANT THIOESTERASES | CALGENE, INC. (US) | 1991-10-31 | — | — | WO | disclosed |
| US-5061635-A | PROTEIN OR PEPTIDE SEQUENCING METHOD | CITY OF HOPE (US) | 1991-10-29 | — | — | US | disclosed |
| EP-0453055-A2 | Antigenic proteins and vaccines containing them for prevention of coccidiosis | SOLVAY (Société Anonyme) (BE) | 1991-10-23 | — | — | EP | disclosed |
| EP-0453054-A2 | Antigenic proteins and vaccines containing them for prevention of coccidiosis | SOLVAY (Société Anonyme) (BE) | 1991-10-23 | — | — | EP | disclosed |
| WO-1991015512-A2 | HIV ENVELOPE POLYPEPTIDES | GENENTECH, INC. (US) | 1991-10-17 | — | — | WO | disclosed |
| WO-1991015758-A1 | METHODS AND APPARATUS ALLOWING SEQUENTIAL CHEMICAL REACTIONS | LUDWIG INSTITUTE FOR CANCER RESEARCH (CH) | 1991-10-17 | — | — | WO | disclosed |
| EP-0162032-B1 | NOVEL ATRIAL PEPTIDE | WASHINGTON UNIVERSITY (US) | 1991-10-16 | — | — | EP | disclosed |
| US-5057495-A | Hypotensive agents, diuretics | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1991-10-15 | — | — | US | disclosed |
| EP-0447746-A1 | A method for separating Diphenylurea(DPU) and phenylthiohydantoin-tryptophan (PTH-TRP) allowing unambiguous indentification of TRP in automatic sequence analysis | AMERICAN CYANAMID COMPANY (US) | 1991-09-25 | — | — | EP | disclosed |
| US-5051369-A | Formation of fluorescein or rhodamine derivatives of amino compounds to form phenylthiocarbamyl aminoacids and detection by fluorescence | SEIKO INSTRUMENTS INC. (JP) | 1991-09-24 | — | — | US | disclosed |
| WO-1991013553-A1 | A PROCESS FOR PRODUCING CHEESE | NOVO NORDISK A/S (DK) | 1991-09-19 | — | — | WO | disclosed |
| WO-1991013962-A1 | DETERGENT COMPOSITIONS | NOVO NORDISK A/S (DK) | 1991-09-19 | — | — | WO | disclosed |
| WO-1991013554-A1 | PROTEIN HYDROLYSATES | NOVO NORDISK A/S (DK) | 1991-09-19 | — | — | WO | disclosed |
| US-5049655-A | Cyclic polypeptides | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1991-09-17 | — | — | US | disclosed |
| EP-0389585-A4 | DERIVATIZED GLASS SUPPORTS FOR PEPTIDE AND PROTEIN SEQUENCING | — | 1991-09-11 | — | — | EP | disclosed |
| WO-1991013152-A1 | SUBSTANTIALLY PURE TRANSFORMING GROWTH FACTOR-β1-BINDING PROTEIN AND NUCLEOTIDE SEQUENCES EXPRESSING THE BINDING PROTEIN | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1991-09-05 | — | — | WO | disclosed |
| WO-1991013077-A1 | CALCIUM CHANNEL COMPOSITIONS AND METHODS | THE SALK INSTITUTE BIOTECHNOLOGY/INDUSTRIAL ASSOCIATES, INC. (US) | 1991-09-05 | — | — | WO | disclosed |
| US-5037806-A | Enhancing lactation of cow with bovine growth hormone containing valine at 126 position | MONSANTO COMPANY (US) | 1991-08-06 | — | — | US | disclosed |
| US-5037959-A | Purified glycoprotein isolated from Solanaceae | LUBRIZOL GENETICS, INC. (US) | 1991-08-06 | — | — | US | disclosed |
| WO-1991010738-A1 | T CELL GROWTH FACTOR | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-07-25 | — | — | WO | disclosed |
| EP-0436537-A1 | RECOMBINANT CMV NEUTRALIZING PROTEINS | CHIRON CORPORATION (US) | 1991-07-17 | — | — | EP | disclosed |
| US-5032574-A | Bactericide, fungicide | INVITRON CORPORATION (US) | 1991-07-16 | — | — | US | disclosed |
| EP-0154454-B1 | CLONING OF DNA FOR PROTOZOAL ANTIGENS | THE WELLCOME FOUNDATION LIMITED (GB) | 1991-07-03 | — | — | EP | disclosed |
| EP-0168342-B1 | PROCESS FOR THE PREPARATION OF THROMBIN INHIBITORS | CIBA-GEIGY AG (CH) | 1991-07-03 | — | — | EP | disclosed |
| US-5028694-A | Inducing An Immune Response In Poultry | SOLVAY & CIE, S.A. (BE) | 1991-07-02 | — | — | US | disclosed |
| EP-0433827-A2 | Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto | F. HOFFMANN-LA ROCHE AG (CH) | 1991-06-26 | — | — | EP | disclosed |
| WO-1991008231-A1 | [Ala IL-8]77 AS A LEUKOCYTE ADHESION INHIBITOR | BRIGHAM AND WOMEN'S HOSPITAL (US) | 1991-06-13 | — | — | WO | disclosed |
| US-5019348-A | Automated chemical conversion unit in a peptide/protein sequenator | BECKMAN INSTRUMENTS, INC. (US) | 1991-05-28 | — | — | US | disclosed |
| WO-1991006571-A1 | A HUMAN T CELL REACTIVE FELINE PROTEIN (TRFP) ISOLATED FROM HOUSE DUST AND USES THEREFOR | IMMULOGIC PHARMACEUTICAL CORPORATION (US) | 1991-05-16 | — | — | WO | disclosed |
| WO-1991006646-A1 | SOLUBILIZATION AND PURIFICATION OF THE GASTRIN RELEASING PEPTIDE RECEPTOR | TRITON BIOSCIENCES, INC. (US) | 1991-05-16 | — | — | WO | disclosed |
| WO-1991006647-A1 | GASTRIN RELEASING PEPTIDE RECEPTOR | TRITON BIOSCIENCES, INC. (US) | 1991-05-16 | — | — | WO | disclosed |
| EP-0426778-A1 | APPARATUS AND METHOD FOR THE SEQUENTIAL PERFORMANCE OF CHEMICAL PROCESSES | CITY OF HOPE (US) | 1991-05-15 | — | — | EP | disclosed |
| US-5015730-A | Viricides or antitumor agents | HOFFMANN-LA ROCHE INC. (US) | 1991-05-14 | — | — | US | disclosed |
| US-5013720-A | Isolated lung specific hydrophobic surfactant-associated protein with multiple valine residues; combined with phospholipids maintains normal lung surface tension | ABBOTT LABORATORIES | 1991-05-07 | — | — | US | disclosed |
| EP-0279882-B1 | APPARATUS FOR THE STEPWISE PERFORMANCE OF CHEMICAL REACTIONS | Hewlett-Packard GmbH (DE) | 1991-05-02 | — | — | EP | disclosed |
| US-5011861-A | Containing functional groups capable of bonding peptides and proteins | MILLIPORE CORPORATION (US) | 1991-04-30 | — | — | US | disclosed |
| EP-0414828-A4 | PROCESS FOR THE PREPARATION OF UROKINASE DERIVATIVES | — | 1991-04-17 | — | — | EP | disclosed |
| US-5008372-A | Reacting with anhydrous trifluoroacetic acid | CORNELL RESEARCH FOUNDATION, INC. (US) | 1991-04-16 | — | — | US | disclosed |
| EP-0421919-A2 | Polygalacturonase encoding fungal expression system | CIBA-GEIGY AG (CH) | 1991-04-10 | — | — | EP | disclosed |
| EP-0421935-A2 | Insect neuropeptides | SANDOZ LTD. (CH) | 1991-04-10 | — | — | EP | disclosed |
| WO-1991004328-A1 | DIAGNOSIS FOR MALIGNANT HYPERTHERMIA | THE UNIVERSITY OF TORONTO INNOVATIONS FOUNDATION (CA) | 1991-04-04 | — | — | WO | disclosed |
| EP-0419099-A1 | Proteins having anticoagulant properties | MERCK & CO. INC. (US) | 1991-03-27 | — | — | EP | disclosed |
| US-5001224-A | Organic syntheses employing supercritical carbon dioxide as a reaction solvent | PROTEIN TECHNOLOGIES, INC. (US) | 1991-03-19 | — | — | US | disclosed |
| WO-1991002755-A1 | FIBULIN | LA JOLLA CANCER RESEARCH FOUNDATION (US) | 1991-03-07 | — | — | WO | disclosed |
| WO-1991002750-A1 | NOVEL INHIBITORS OF THROMBIN | BIOGEN, INC. (US) | 1991-03-07 | — | — | WO | disclosed |
| EP-0414828-A1 | PROCESS FOR THE PREPARATION OF UROKINASE DERIVATIVES | ABBOTT LABORATORIES (US) | 1991-03-06 | — | — | EP | disclosed |
| US-4992383-A | Method for protein and peptide sequencing using derivatized glass supports | PORTON INSTRUMENTS, INC. (US) | 1991-02-12 | — | — | US | disclosed |
| EP-0412050-A1 | Novel cytokines | CIBA-GEIGY AG (CH) | 1991-02-06 | — | — | EP | disclosed |
| EP-0410323-A2 | Immobilization of proteins and peptides on insoluble supports | PERSEPTIVE BIOSYSTEMS, INC. (US) | 1991-01-30 | — | — | EP | disclosed |
| WO-1991000907-A1 | MONOCYTE CHEMOTACTIC PROTEINS AND RELATED PEPTIDES | EMORY UNIVERSITY (US) | 1991-01-24 | — | — | WO | disclosed |
| EP-0408634-A1 | ORGANIC SYNTHESIS EMPLOYING SUPERCRITICAL CARBON DIOXIDE AS A REACTION SOLVENT | PROTEIN TECHNOLOGIES, INC. (US) | 1991-01-23 | — | — | EP | disclosed |
| US-4985541-A | PROTEIN SYSTHESIS INHIBITORS | ZYMOGENETICS, INC. (US) | 1991-01-15 | — | — | US | disclosed |
| US-4983721-A | Solvents for collagen | BOSTON BIOMEDICAL RESEARCH INSTITUTE (US) | 1991-01-08 | — | — | US | disclosed |
| US-4981956-A | LACTATION | MONSANTO COMPANY (US) | 1991-01-01 | — | — | US | disclosed |
| EP-0396555-A4 | PURIFICATION OF MONOMERIC INTERFERON | — | 1990-12-27 | — | — | EP | disclosed |
| EP-0402068-A1 | Polypeptides and polypeptide analogues with inhibitory activity against human elastase | ZENECA LIMITED (GB) | 1990-12-12 | — | — | EP | disclosed |
| EP-0378641-A4 | NOVEL ANTIMICROBIAL PEPTIDE, COMPOSITIONS CONTAINING SAME AND USES THEREOF | — | 1990-12-12 | — | — | EP | disclosed |
| EP-0400920-A1 | Solid phase multiple peptide synthesis | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1990-12-05 | — | — | EP | disclosed |
| WO-1990014363-A1 | METALLOPROTEINASE INHIBITOR | AMGEN INC. (US) | 1990-11-29 | — | — | WO | disclosed |
| WO-1990014098-A1 | BACTERICIDAL AND/OR BACTERIOSTATIC PEPTIDE ISOLATED FROM COLEOPTERAN INSECTS | PLANT GENETIC SYSTEMS N.V. (BE) | 1990-11-29 | — | — | WO | disclosed |
| EP-0399816-A1 | Purification and characterization of a glioma-derived growth factor | MERCK & CO. INC. (US) | 1990-11-28 | — | — | EP | disclosed |
| US-4973578-A | THYROTROPIN INHIBITION | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 1990-11-27 | — | — | US | disclosed |
| EP-0398753-A2 | Metalloproteinase inhibitor | AMGEN INC. (US) | 1990-11-22 | — | — | EP | disclosed |
| EP-0396555-A1 | PURIFICATION OF MONOMERIC INTERFERON. | INTERFERON SCIENCES INC (US) | 1990-11-14 | — | — | EP | disclosed |
| EP-0383833-A4 | VACCINES FOR MALARIA | — | 1990-11-07 | — | — | EP | disclosed |
| EP-0395375-A1 | Novel DNA sequences which encode ancrod-like polypeptides and compositions comprising the expression products thereof | KNOLL AG (DE) | 1990-10-31 | — | — | EP | disclosed |
| WO-1990012032-A1 | PROTEIN COMPLEX | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 1990-10-18 | — | — | WO | disclosed |
| EP-0392225-A2 | Disease-resistant transgenic plants | CIBA-GEIGY AG (CH) | 1990-10-17 | — | — | EP | disclosed |
| US-4963488-A | GENETIC ENGINEERING; INDUSTRIAL PREPARATION OF PROTEIN IN LARGE AMOUNTS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1990-10-16 | — | — | US | disclosed |
| EP-0391214-A1 | Bifunctional protein designated IDF 45 | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1990-10-10 | — | — | EP | disclosed |
| WO-1990011295-A1 | MELANIN-CONCENTRATING HORMONES AND METHODS OF TREATMENT USING SAME | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1990-10-04 | — | — | WO | disclosed |
| EP-0389585-A1 | DERIVATIZED GLASS SUPPORTS FOR PEPTIDE AND PROTEIN SEQUENCING. | PORTON INSTR INC (US) | 1990-10-03 | — | — | EP | disclosed |
| WO-1990010081-A1 | SOLUBLE ANALOGS OF THROMBOMODULIN | CODON (US) | 1990-09-07 | — | — | WO | disclosed |
| WO-1990009737-A1 | HUMAN ELASTASE INHIBITOR | THE CENTER FOR BLOOD RESEARCH (US) | 1990-09-07 | — | — | WO | disclosed |
| EP-0383833-A1 | VACCINES FOR MALARIA | AMERICAN CYANAMID COMPANY (US) | 1990-08-29 | — | — | EP | disclosed |
| WO-1990009595-A1 | APPARATUS AND METHOD FOR THE SEQUENTIAL PERFORMANCE OF CHEMICAL PROCESSES | CITY OF HOPE (US) | 1990-08-23 | — | — | WO | disclosed |
| EP-0382531-A1 | Eimeria membrane associated protein immunogens | MERCK & CO. INC. (US) | 1990-08-16 | — | — | EP | disclosed |
| WO-1990008772-A1 | PROCESSES FOR PRODUCING POLYPEPTIDE INHIBITORS OF PLATELET ACTIVATION AND METHODS, COMBINATIONS AND COMPOSITIONS USING THEM | BIOGEN, INC. (US) | 1990-08-09 | — | — | WO | disclosed |
| WO-1990008324-A1 | CANCER RELATED HAPTOGLOBIN (HPR) | THE JOHNS HOPKINS UNIVERSITY (US) | 1990-07-26 | — | — | WO | disclosed |
| WO-1990007937-A1 | PREGNANCY SPECIFIC PROTEINS APPLICATIONS | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1990-07-26 | — | — | WO | disclosed |
| EP-0378641-A1 | NOVEL ANTIMICROBIAL PEPTIDE, COMPOSITIONS CONTAINING SAME AND USES THEREOF. | INVITRON CORP (US) | 1990-07-25 | — | — | EP | disclosed |
| US-4943562-A | ANTICOAGULANTS, TREATMENT AND PREVENTION | INSTITUT DES VAISSEAUX ET DU SANG (FR) | 1990-07-24 | — | — | US | disclosed |
| EP-0375724-A1 | BIOLOGICALLY ACTIVE BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN FRAGMENTS. | UNIV NEW YORK (US) | 1990-07-04 | — | — | EP | disclosed |
| EP-0374940-A2 | Polypeptides isolated from the venom of the spider hololena curta | MERRELL DOW PHARMACEUTICALS INC. (US) | 1990-06-27 | — | — | EP | disclosed |
| US-4931548-A | Heterodimer form of transforming growth factor-beta | TECHNE CORPORATION (US) | 1990-06-05 | — | — | US | disclosed |
| EP-0368823-A2 | Biologically active lipoprotein and its use | Kabi Pharmacia AB (SE) | 1990-05-16 | — | — | EP | disclosed |
| EP-0364481-A1 | GROWTH FACTORS | MONASH UNIVERSITY (AU) | 1990-04-25 | — | — | EP | disclosed |
| WO-1990004026-A1 | NEW PLASMID CONSTRUCTIONS FOR HIGH LEVEL PRODUCTION OF EUKARYOTIC PROTEINS | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, UNITED STATES DEPARTMENT OF COMMERCE (US) | 1990-04-19 | — | — | WO | disclosed |
| WO-1990004024-A1 | PROCESS FOR THE PREPARATION OF UROKINASE DERIVATIVES | ABBOTT LABORATORIES (US) | 1990-04-19 | — | — | WO | disclosed |
| WO-1990004183-A1 | METHOD FOR PREPARATION OF THIOHYDANTOINS AND FOR PROTEIN SEQUENCE ANALYSIS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1990-04-19 | — | — | WO | disclosed |
| EP-0363898-A2 | Process for the preparation of urokinase derivatives | ABBOTT LABORATORIES (US) | 1990-04-18 | — | — | EP | disclosed |
| EP-0362298-A1 | NOVEL POLYPEPTIDE HAVING GAMMA-INTERFERON ACTIVITY | NEW YORK UNIVERSITY (US) | 1990-04-11 | — | — | EP | disclosed |
| EP-0359739-A4 | TRANFORMING GROWTH FACTOR-BETA. | TECHNE INC (US) | 1990-04-10 | — | — | EP | disclosed |
| EP-0361284-A2 | T cell growth factor | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1990-04-04 | — | — | EP | disclosed |
| EP-0359739-A1 | TRANFORMING GROWTH FACTOR-BETA. | TECHNE INC (US) | 1990-03-28 | — | — | EP | disclosed |
| WO-1990002557-A1 | VACCINES AND DIAGNOSTIC ASSAYS FOR HAEMOPHILUS INFLUENZAE | PRAXIS BIOLOGICS, INC. (US) | 1990-03-22 | — | — | WO | disclosed |
| EP-0359714-A2 | Diuretic factor | SANDOZ AG (CH) | 1990-03-21 | — | — | EP | disclosed |
| EP-0356007-A2 | Antigenic determinants | MEDICAL RESEARCH COUNCIL (GB) | 1990-02-28 | — | — | EP | disclosed |
| WO-1990001702-A1 | DERIVATIZED GLASS SUPPORTS FOR PEPTIDE AND PROTEIN SEQUENCING | PORTON INSTRUMENTS, INC. (US) | 1990-02-22 | — | — | WO | disclosed |
| EP-0353361-A1 | A method for detecting amino acid derivatives | SEIKO INSTRUMENTS INC. (JP) | 1990-02-07 | — | — | EP | disclosed |
| EP-0353460-A2 | Membranes for solid phase protein sequencing | MILLIPORE CORPORATION (US) | 1990-02-07 | — | — | EP | disclosed |
| EP-0362298-A4 | NOVEL POLYPEPTIDE HAVING GAMMA-INTERFERON ACTIVITY. | UNIV NEW YORK (US) | 1990-01-26 | — | — | EP | disclosed |
| CN-1038837-A | RECOMBINANT COCCIDIOSIS VACCINES | HOFFMANN LA ROCHE (CH) | 1990-01-17 | — | — | CN | disclosed |
| US-4892826-A | Process for the preparation of urokinase derivatives | ABBOTT LABORATORIES (US) | 1990-01-09 | — | — | US | disclosed |
| EP-0347262-A1 | Cloning and expression of human tissue factor | MOUNT SINAI SCHOOL OF MEDICINE OF THE CITY UNIVERSITY OF NEW YORK (US) | 1989-12-20 | — | — | EP | disclosed |
| EP-0344808-A1 | Recombinant coccidiosis vaccines | F. HOFFMANN-LA ROCHE AG (CH) | 1989-12-06 | — | — | EP | disclosed |
| EP-0273916-A4 | PULMONARY HYDROPHOBIC SURFACTANT-ASSOCIATED PROTEIN OF 6,000 DALTONS MOLECULAR WEIGHT AND MULTIMERS THEREOF. | CHILDRENS HOSP MEDICAL CENTER (US) | 1989-11-30 | — | — | EP | disclosed |
| WO-1989011291-A1 | NOVEL ANTIMICROBIAL PEPTIDE, COMPOSITIONS CONTAINING SAME AND USES THEREOF | INVITRON CORPORATION (US) | 1989-11-30 | — | — | WO | disclosed |
| EP-0341734-A2 | Proteins having anti-tumor activity | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1989-11-15 | — | — | EP | disclosed |
| EP-0290516-A4 | PULMONARY HYDROPHOBIC SURFACTANT-ASSOCIATED PROTEINS. | WHITSETT JEFFREY A (US) | 1989-11-14 | — | — | EP | disclosed |
| EP-0340170-A2 | Process for the production of polypeptides | CIBA-GEIGY AG (CH) | 1989-11-02 | — | — | EP | disclosed |
| EP-0335949-A1 | PAIRED HELICAL FILAMENT CORE AND ANTIBODY THERETO USEFUL IN DIAGNOSING ALZHEIMER'S DISEASE | MEDICAL RESEARCH COUNCIL (GB) | 1989-10-11 | — | — | EP | disclosed |
| WO-1989008659-A1 | ORGANIC SYNTHESIS EMPLOYING SUPERCRITICAL CARBON DIOXIDE AS A REACTION SOLVENT | PROTEIN TECHNOLOGIES, INC. (US) | 1989-09-21 | — | — | WO | disclosed |
| WO-1989008663-A1 | SYNTHETIC PEPTIDES DERIVED FROM THE ALPHA-SUBUNIT OF HUMAN GLYCOPROTEIN HORMONES | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 1989-09-21 | — | — | WO | disclosed |
| US-4868286-A | CARDIOVASCULAR DISORDRES | YALE UNIVERSITY (US) | 1989-09-19 | — | — | US | disclosed |
| EP-0332104-A2 | Chemically regulatable DNA sequences and genes and uses thereof | CIBA-GEIGY AG (CH) | 1989-09-13 | — | — | EP | disclosed |
| US-4865994-A | REACTING 2-ANILINO-S-THIAZOLINONE MODIFIED AMINO ACID WITH AMINO COMPOUND LABELED WITH RADIOACTIVE ISOTOPE | SEIKO INSTRUMENTS & ELECTRONICS LTD. (JP) | 1989-09-12 | — | — | US | disclosed |
| EP-0330725-A1 | Preparation and expression of DNA sequences coding for proteins having the biological properties of cystatin C | Grünenthal GmbH (DE) | 1989-09-06 | — | — | EP | disclosed |
| EP-0330396-A2 | DNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VI | BIOGEN, INC. (US) | 1989-08-30 | — | — | EP | disclosed |
| US-4861868-A | Production of proteins in procaryotes | MONSANTO COMPANY (US) | 1989-08-29 | — | — | US | disclosed |
| WO-1989007143-A1 | RECOMBINANT CMV NEUTRALIZING PROTEINS | CHIRON CORPORATION (US) | 1989-08-10 | — | — | WO | disclosed |
| WO-1989006974-A2 | T-CELL EPITOPE AS CARRIERS MOLECULE FOR CONJUGATE VACCINES | PRAXIS BIOLOGICS, INC. (US) | 1989-08-10 | — | — | WO | disclosed |
| EP-0326075-A2 | Heparin-binding brain mitogens | AMERICAN CYANAMID COMPANY (US) | 1989-08-02 | — | — | EP | disclosed |
| US-4852017-A | Determination of peptide sequences | APPLIED BIOSYSTEMS, INC. (US) | 1989-07-25 | — | — | US | disclosed |
| EP-0321526-A1 | CLONING AND EXPRESSION OF HUMAN TISSUE FACTOR | MOUNT SINAI SCHOOL OF MEDICINE OF THE CITY UNIVERSITY OF NEW YORK (US) | 1989-06-28 | — | — | EP | disclosed |
| US-4843011-A | Monoclonal antibodies for binding HTLV-III proteins, and cell lines for their production | AKZO N.V. (NL) | 1989-06-27 | — | — | US | disclosed |
| US-4839231-A | CONTAINING AT LEAST A MONOMOLECULAR LAYER OF A VINYLPYRIDINE POLYMER | PLANT GENETIC SYSTEMS N.V. (BE) | 1989-06-13 | — | — | US | disclosed |
| EP-0319353-A1 | A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants | PLANT GENETIC SYSTEMS N.V. (BE) | 1989-06-07 | — | — | EP | disclosed |
| US-4837726-A | Quantitation of chromatographic information | APPLIED BIOSYSTEMS, INC. (US) | 1989-06-06 | — | — | US | disclosed |
| WO-1989003887-A1 | A PROCESS FOR THE PRODUCTION OF BIOLOGICALLY ACTIVE PEPTIDE VIA THE EXPRESSION OF MODIFIED STORAGE SEED PROTEIN GENES IN TRANSGENIC PLANTS | PLANT GENETIC SYSTEMS N.V. (BE) | 1989-05-05 | — | — | WO | disclosed |
| WO-1989003993-A1 | PAIRED HELICAL FILAMENT CORE AND ANTIBODY THERETO USEFUL IN DIAGNOSING ALZHEIMER'S DISEASE | MEDICAL RESEARCH COUNCIL (GB) | 1989-05-05 | — | — | WO | disclosed |
| WO-1989003225-A1 | PURIFICATION OF MONOMERIC INTERFERON | INTERFERON SCIENCES, INC. (US) | 1989-04-20 | — | — | WO | disclosed |
| WO-1989002924-A1 | VACCINES FOR MALARIA | PRAXIS BIOLOGICS, INC. (US) | 1989-04-06 | — | — | WO | disclosed |
| US-4818763-A | Biologically active substance with hormonal properties, production process thereof and utilization of histones for medical purposes | Rusch, Volker (DE) | 1989-04-04 | — | — | US | disclosed |
| EP-0309120-A2 | Atrial hypotensive peptide | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1989-03-29 | — | — | EP | disclosed |
| US-4816441-A | ANTICARCINOGENIC AGENTS, VIRICIDES | NOVO INDUSTRI A/S (DK) | 1989-03-28 | — | — | US | disclosed |
| EP-0308378-A2 | Tumor necrosis factor (TNF)inhibitory protein and its purification | YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED (IL) | 1989-03-22 | — | — | EP | disclosed |
| EP-0307513-A2 | Pulmonary hydrophobic surfactant-associated proteins | ABBOTT LABORATORIES (US) | 1989-03-22 | — | — | EP | disclosed |
| WO-1989001486-A1 | BIOLOGICALLY ACTIVE BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN FRAGMENTS | NEW YORK UNIVERSITY (US) | 1989-02-23 | — | — | WO | disclosed |
| EP-0300459-A2 | Human pancreatic secretory trypsin inhibitor | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 1989-01-25 | — | — | EP | disclosed |
| EP-0299741-A2 | Protein or peptide sequencing method and apparatus | CITY OF HOPE (US) | 1989-01-18 | — | — | EP | disclosed |
| WO-1989000167-A1 | PROTEINS AND PROTEIN COMPOSITIONS AND THEIR USE | KABIGEN AB (SE) | 1989-01-12 | — | — | WO | disclosed |
| WO-1988010269-A1 | GROWTH FACTORS | MONASH UNIVERSITY (AU) | 1988-12-29 | — | — | WO | disclosed |
| EP-0296781-A2 | Quantitation of chromatographic information | APPLIED BIOSYSTEMS, INC. (US) | 1988-12-28 | — | — | EP | disclosed |
| EP-0297068-A2 | Mammal intestine hormone precursor | KabiGen AB (SE) | 1988-12-28 | — | — | EP | disclosed |
| EP-0295966-A2 | Determination of peptide sequences | APPLIED BIOSYSTEMS, INC. (US) | 1988-12-21 | — | — | EP | disclosed |
| WO-1988009817-A1 | CLONING AND EXPRESSION OF HUMAN TISSUE FACTOR | MOUNT SINAI SCHOOL OF MEDICINE OF THE CITY UNIVERS (US) | 1988-12-15 | — | — | WO | disclosed |
| EP-0293793-A2 | Polypeptide and production thereof | Takeda Chemical Industries, Ltd. (JP) | 1988-12-07 | — | — | EP | disclosed |
| EP-0290948-A2 | Oncostatin M and novel compositions having anti-neoplastic activity | ONCOGEN (US) | 1988-11-17 | — | — | EP | disclosed |
| EP-0290516-A1 | PULMONARY HYDROPHOBIC SURFACTANT-ASSOCIATED PROTEINS | WHITSETT, Jeffrey A. (US) | 1988-11-17 | — | — | EP | disclosed |
| US-4784948-A | Production of streptococcal m protein immunogens and molecular probes | THE ROCKEFELLER UNIVERSITY (US) | 1988-11-15 | — | — | US | disclosed |
| US-4783524-A | Growth factors | MONSANTO COMPANY (US) | 1988-11-08 | — | — | US | disclosed |
| EP-0286441-A2 | Novel cytotoxic protein | ZYMOGENETICS, INC. (US) | 1988-10-12 | — | — | EP | disclosed |
| WO-1988007548-A1 | LEUKAEMIA-INHIBITORY FACTOR | AMRAD CORPORATION LIMITED (AU) | 1988-10-06 | — | — | WO | disclosed |
| EP-0285448-A2 | Leukaemia inhibitory factor | AMRAD CORPORATION LIMITED (AU) | 1988-10-05 | — | — | EP | disclosed |
| US-4774058-A | Apparatus for, and methods of, operating upon a fluid | MEHL EHRENFRIED L (DE) | 1988-09-27 | — | — | US | disclosed |
| US-4772557-A | DNA clone of human skin fibroblast collagenase enzyme | WASHINGTON UNIVERSITY (US) | 1988-09-20 | — | — | US | disclosed |
| EP-0279882-A1 | Apparatus for the stepwise performance of chemical reactions | Hewlett-Packard GmbH (DE) | 1988-08-31 | — | — | EP | disclosed |
| US-4765903-A | FAST-MOVING ALPHA-2 OBTAINED USING IMMUNOASSAY AND REVERSE PHASE CHROMATOGRAPHY, CATION EXCHANGING AND GEL FILTRATION | INTERFERON SCIENCES, INC. (US) | 1988-08-23 | — | — | US | disclosed |
| EP-0278355-A2 | Novel expression system | CIBA-GEIGY AG (CH) | 1988-08-17 | — | — | EP | disclosed |
| WO-1988005788-A1 | TRANFORMING GROWTH FACTOR-BETA | TECHNE CORPORATION (US) | 1988-08-11 | — | — | WO | disclosed |
| WO-1988005787-A1 | TRANSFORMING GROWTH FACTOR-BETA | TECHNE CORPORATION (US) | 1988-08-11 | — | — | WO | disclosed |
| WO-1988004937-A1 | NOVEL POLYPEPTIDE HAVING GAMMA-INTERFERON ACTIVITY | NEW YORK UNIVERSITY (US) | 1988-07-14 | — | — | WO | disclosed |
| EP-0273916-A1 | PULMONARY HYDROPHOBIC SURFACTANT-ASSOCIATED PROTEIN OF 6,000 DALTONS MOLECULAR WEIGHT AND MULTIMERS THEREOF | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1988-07-13 | — | — | EP | disclosed |
| EP-0272489-A2 | Antimicrobial proteins, compositions containing same and uses thereof | CORNELL RESEARCH FOUNDATION, INC. (US) | 1988-06-29 | — | — | EP | disclosed |
| WO-1988004324-A1 | PULMONARY HYDROPHOBIC SURFACTANT-ASSOCIATED PROTEINS | ABBOTT LABORATORIES (US) | 1988-06-16 | — | — | WO | disclosed |
| US-4745101-A | ANTICARIES AGENTS | TEIKOKU HORMONE MFG. CO., LTD. (JP) | 1988-05-17 | — | — | US | disclosed |
| WO-1988003170-A1 | PULMONARY HYDROPHOBIC SURFACTANT-ASSOCIATED PROTEINS | WHITSETT JEFFREY A (US) | 1988-05-05 | — | — | WO | disclosed |
| EP-0143789-B1 | AN IMPROVED APPARATUS FOR SEQUENCING PEPTIDES AND PROTEINS | BECKMAN INSTRUMENTS, INC. (US) | 1988-04-20 | — | — | EP | disclosed |
| EP-0263072-A2 | Novel lymphokine related peptides | CIBA-GEIGY AG (CH) | 1988-04-06 | — | — | EP | disclosed |
| EP-0257421-A2 | Antibodies for use in determining human glycoalbumin | MILES INC. (US) | 1988-03-02 | — | — | EP | disclosed |
| EP-0256676-A2 | A continuous flow reactor for peptide sequenators | Beckman Research Institute of the City of Hope (US) | 1988-02-24 | — | — | EP | disclosed |
| EP-0254249-A1 | Preparation of binding factor related polypeptides | CIBA-GEIGY AG (CH) | 1988-01-27 | — | — | EP | disclosed |
| EP-0253582-A1 | Modified tissue plasminogenen activator | NOVO NORDISK A/S (DK) | 1988-01-20 | — | — | EP | disclosed |
| EP-0251244-A2 | Polypeptide and production thereof | Takeda Chemical Industries, Ltd. (JP) | 1988-01-07 | — | — | EP | disclosed |
| US-4716148-A | POLYPEPTIDE HORMONE FROM MAMMALIAN THYMUS | HOFFMAN-LA ROCHE INC. (US) | 1987-12-29 | — | — | US | disclosed |
| EP-0248678-A2 | Method for cloning restriction modification system | NEW ENGLAND BIOLABS, INC. (US) | 1987-12-09 | — | — | EP | disclosed |
| EP-0247906-A2 | DNA coding for anti-tumour polypeptides, the polypeptides and anti-tumour agents comprising said polypeptides | Mizuno, Den'Ichi (JP) | 1987-12-02 | — | — | EP | disclosed |
| WO-1987006943-A1 | PULMONARY HYDROPHOBIC SURFACTANT-ASSOCIATED PROTEIN OF 6,000 DALTONS MOLECULAR WEIGHT AND MULTIMERS THEREOF | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1987-11-19 | — | — | WO | disclosed |
| EP-0244055-A2 | Method of sequencing peptides | BIO-AFFINITY SYSTEMS, INC. (US) | 1987-11-04 | — | — | EP | disclosed |
| US-4704256-A | AMINO ACID SEQUENCE IN PROTEINS AND PEPTIDES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1987-11-03 | — | — | US | disclosed |
| EP-0241136-A2 | Human class 1 heparin-binding growth factor | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1987-10-14 | — | — | EP | disclosed |
| EP-0239622-A1 | METHOD AND APPARATUS FOR SEQUENCING SMALL SAMPLES OF PEPTIDES AND PROTEINS | BECKMAN INSTRUMENTS, INC. (US) | 1987-10-07 | — | — | EP | disclosed |
| EP-0239600-A1 | APPARATUS FOR, AND METHODS OF, OPERATING UPON A FLUID. | MEHL EHRENFRIED L | 1987-10-07 | — | — | EP | disclosed |
| US-4695562-A | IMMUNOLOGY | UNIV. OF TENNESSEE RESEARCH CORP. (US) | 1987-09-22 | — | — | US | disclosed |
| EP-0231537-A2 | Antigenic proteins and vaccines containing them for prevention of coccidiosis | SOLVAY (BE) | 1987-08-12 | — | — | EP | disclosed |
| EP-0225633-A2 | Production of thrombin inhibitors | CIBA-GEIGY AG (CH) | 1987-06-16 | — | — | EP | disclosed |
| US-4670539-A | CANCER DIAGNOSIS ANF THERAPY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS (US) | 1987-06-02 | — | — | US | disclosed |
| EP-0223579-A2 | Peptides and compositions | NOVO NORDISK A/S (DK) | 1987-05-27 | — | — | EP | disclosed |
| US-4665037-A | Method of sequencing peptides | ANALYTICHEM INTERNATIONAL, INC. (US) | 1987-05-12 | — | — | US | disclosed |
| US-4663437-A | Atrial natriuretic peptide | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1987-05-05 | — | — | US | disclosed |
| US-4659694-A | POLYPEPTIDE HORMONE FOR PREVENTION OF INFECTIONS | HOFFMANN-LA ROCHE INC. (US) | 1987-04-21 | — | — | US | disclosed |
| WO-1987002139-A1 | METHOD AND APPARATUS FOR SEQUENCING SMALL SAMPLES OF PEPTIDES AND PROTEINS | BECKMAN INSTRUMENTS, INC. (US) | 1987-04-09 | — | — | WO | disclosed |
| WO-1987001956-A1 | APPARATUS FOR, AND METHODS OF, OPERATING UPON A FLUID | MEHL EHRENFRIED L | 1987-04-09 | — | — | WO | disclosed |
| EP-0216742-A2 | Growth factors | Monsanto Company (US) | 1987-04-01 | — | — | EP | disclosed |
| EP-0152468-A4 | PRODUCTION OF STREPTOCOCAL M PROTEIN IMMUNOGENS AND MOLECULAR PROBES. | UNIV ROCKEFELLER (US) | 1987-03-12 | — | — | EP | disclosed |
| EP-0208706-A1 | DNA SEQUENCE USEFUL FOR THE PRODUCTION AND SECRETION FROM YEAST OF PEPTIDES AND PROTEINS | ALLELIX INC. (CA) | 1987-01-21 | — | — | EP | disclosed |
| US-4632780-A | GYLCOPROTEIN ISOLATED FROM HUMAN PITUITARY GLANDS | INSTITUT DE RECHERCHES CLINIQUES DE MONTREAL (CA) | 1986-12-30 | — | — | US | disclosed |
| EP-0203359-A2 | Novel peptide having dentinal fluid transport stimulating activity | TEIKOKU HORMONE MFG. CO., LTD. (JP) | 1986-12-03 | — | — | EP | disclosed |
| EP-0202894-A2 | A method for detecting amino acid derivatives | SEIKO INSTRUMENTS INC. (JP) | 1986-11-26 | — | — | EP | disclosed |
| US-4624944-A | GONADAL PEPTIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1986-11-25 | — | — | US | disclosed |
| US-4610847-A | Conversion flask for sequential performance apparatus | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1986-09-09 | — | — | US | disclosed |
| US-4607023-A | DIURETICS, POLYPEPTIDES | L'INSTITUT DE RECHERCHES CLINIQUES DE MONTREAL (CA) | 1986-08-19 | — | — | US | disclosed |
| US-4605615-A | CULTURING STREPTOMYCES | TOYO JOZO KABUSHIKI KAISHA (JP) | 1986-08-12 | — | — | US | disclosed |
| US-4603114-A | Method for the sequential performance of chemical processes | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1986-07-29 | — | — | US | disclosed |
| EP-0187519-A2 | Recombinant DNA vectors capable of expressing apoaequorin, apoaequorin peptides and their production, and microorganisms including said vectors | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1986-07-16 | — | — | EP | disclosed |
| WO-1986003777-A1 | DNA SEQUENCE USEFUL FOR THE PRODUCTION AND SECRETION FROM YEAST OF PEPTIDES AND PROTEINS | ALLELIX, INC. (CA) | 1986-07-03 | — | — | WO | disclosed |
| US-4597412-A | Valve for sequential chemical operations | STARK ANTON W | 1986-07-01 | — | — | US | disclosed |
| US-4597967-A | STREPTOCOCCUS, IMMUNOLOGY | THE UNIVERSITY OF TENNESSEE RESEARCH CORP. (US) | 1986-07-01 | — | — | US | disclosed |
| EP-0168342-A1 | Process for the preparation of thrombin inhibitors | CIBA-GEIGY AG (CH) | 1986-01-15 | — | — | EP | disclosed |
| US-4560676-A | N.sup.α -desacetylthymosinα1 and process | THE ROCKEFELLER UNIVERSITY (US) | 1985-12-24 | — | — | US | disclosed |
| EP-0162032-A2 | Novel atrial peptide | WASHINGTON UNIVERSITY (US) | 1985-11-21 | — | — | EP | disclosed |
| EP-0155319-A1 | MONOCLONAL ANTI-INTERLEUKIN-2 ANTIBODY USEFUL FOR IMMUNOPURIFICATION FOR INTERLEUKIN-2 | The Trustees of Dartmouth College (US) | 1985-09-25 | — | — | EP | disclosed |
| EP-0154454-A1 | Cloning of DNA for protozoal antigens | THE WELLCOME FOUNDATION LIMITED (GB) | 1985-09-11 | — | — | EP | disclosed |
| EP-0152468-A1 | PRODUCTION OF STREPTOCOCAL M PROTEIN IMMUNOGENS AND MOLECULAR PROBES. | UNIV ROCKEFELLER (US) | 1985-08-28 | — | — | EP | disclosed |
| EP-0148311-A1 | A novel physiologically active polypeptide | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1985-07-17 | — | — | EP | disclosed |
| EP-0143789-A1 | AN IMPROVED APPARATUS FOR SEQUENCING PEPTIDES AND PROTEINS. | BECKMAN INSTRUMENTS INC (US) | 1985-06-12 | — | — | EP | disclosed |
| US-4521334-A | Synthetic polypeptide fragments | THE UNIVERSITY OF TENNESSE RESEARCH CORPORATION (US) | 1985-06-04 | — | — | US | disclosed |
| EP-0140731-A2 | Natriuretic factors | INSTITUT DE RECHERCHES CLINIQUES DE MONTREAL (CA) | 1985-05-08 | — | — | EP | disclosed |
| US-4508712-A | NATRIURETIC, DIURETIC, VASODILATION | WASHINGTON UNIVERSITY (US) | 1985-04-02 | — | — | US | disclosed |
| WO-1985001298-A1 | MONOCLONAL ANTI-INTERLEUKIN-2 ANTIBODY USEFUL FOR IMMUNOPURIFICATION FOR INTERLEUKIN-2 | TRUSTEES OF DARTMOUTH COLLEGE (US) | 1985-03-28 | — | — | WO | disclosed |
| US-4503035-A | HUMAN LEUKOCYTE INTERFERON | HOFFMANN-LA ROCHE INC. (US) | 1985-03-05 | — | — | US | disclosed |
| WO-1985000832-A1 | PRODUCTION OF STREPTOCOCAL M PROTEIN IMMUNOGENS AND MOLECULAR PROBES | THE ROCKEFELLER UNIVERSITY (US) | 1985-02-28 | — | — | WO | disclosed |
| EP-0116784-A2 | Atrial natriuretic factor | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1984-08-29 | — | — | EP | disclosed |
| WO-1984002776-A1 | AN IMPROVED APPARATUS FOR SEQUENCING PEPTIDES AND PROTEINS | BECKMAN INSTRUMENTS INC (US) | 1984-07-19 | — | — | WO | disclosed |
| US-4423037-A | Inhibitors of peptide hormone action | THE GENERAL HOSPITAL CORPORATION (US) | 1983-12-27 | — | — | US | disclosed |
| US-4355023-A | ISOLATING ANTI-LIGHT AND/OR -HEAVY VARIABLE CHAIN OF RABBIT IMMUNOGLOBIN G ANTIBODY; JOINING; IMMUNOLOGY | THE MASSACHUSETTS GENERAL HOSPITAL (US) | 1982-10-19 | — | — | US | disclosed |
| US-4293455-A | N.sup.α -Desacetylthymosinα1 and process | ROCKEFELLER UNIVERSITY (US) | 1981-10-06 | — | — | US | disclosed |
| JP-S56125669-A | ANALYTICAL METHOD FOR PEPTIDE MIXTURE USING FD MASS SPECTROMETER | UNIV OSAKA | 1981-10-02 | — | — | JP | disclosed |
| US-4289690-A | HIGH PERFORMANCE LIQUID CHROMATOGRAPHY TO PURIFY INTERFERON | HOFFMANN-LA ROCHE INC. (US) | 1981-09-15 | — | — | US | disclosed |
| US-4289689-A | AFFINITY CHROMATOGRAPHY AND HIGH PRESSURE LIQUID CHROMATOGRAPHY | HOFFMANN-LA ROCHE INC. (US) | 1981-09-15 | — | — | US | disclosed |
| US-4252769-A | Apparatus for the performance of chemical processes | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1981-02-24 | — | — | US | disclosed |
| JP-S5536740-A | FLUORESCENT ESTIMATION OF PHENYLTHIOHYDANTOIC AMINO ACID | YUKI GOSEI YAKUHIN KOGYO KK | 1980-03-14 | — | — | JP | disclosed |
| US-4155714-A | Process and apparatus for conversion of atz to pth amino acid derivatives of proteins | HEWLETT-PACKARD COMPANY, 3000 HANOVER ST., PALO ALTO, CA A CORP. OF CA | 1979-05-22 | — | — | US | disclosed |
| US-4153416-A | Process and apparatus for pulse labelling protein material in the Edman degradation process | HEWLETT-PACKARD COMPANY, 3000 HANOVER ST., PALO ALTO, CA A CORP. OF CA | 1979-05-08 | — | — | US | disclosed |
| US-4088751-A | SHAVING CREAM, SHAMPOO, LOTION, 2-THIO-4-OXYPYRIMIDINE OR THIOHYDANTOIN AND HYDROGEN PEROXIDE, EXOTHERMIC REDOX REACTION | COLGATE-PALMOLIVE COMPANY (US) | 1978-05-09 | — | — | US | disclosed |
| US-3959307-A | Method to determine automatically the sequence of amino acids | WITTMANN BRIGITTE | 1976-05-25 | — | — | US | disclosed |
| US-3959307-A | Method to determine automatically the sequence of amino acids | WITTMANN BRIGITTE | 1976-05-25 | — | — | US | disclosed |